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Preface
The Health Systems in Transition (HiT) profiles are country-based reports that provide a detailed description of a health system and of reform and policy initiatives in progress or under development in a specific 
country. Each profile is produced by country experts in collaboration with the 
Observatory’s staff. In order to facilitate comparisons between countries, the 
profiles are based on a template, which is revised periodically. The template 
provides detailed guidelines and specific questions, definitions and examples 
needed to compile a profile.
HiT profiles seek to provide relevant information to support policy-makers 
and analysts in the development of health systems in Europe. They are building 
blocks that can be used:
• to learn in detail about different approaches to the organization, financing 
and delivery of health services and the role of the main actors in health 
systems;
• to describe the institutional framework, the process, content and 
implementation of health care reform programmes;
• to highlight challenges and areas that require more in-depth analysis;
• to provide a tool for the dissemination of information on health systems 
and the exchange of experiences of reform strategies between policy-
makers and analysts in different countries; and
• to assist other researchers in more in-depth comparative health 
policy analysis.
Compiling the profiles poses a number of methodological problems. In many 
countries, there is relatively little information available on the health system and 
the impact of reforms. Due to the lack of a uniform data source, quantitative 
data on health services are based on a number of different sources, including 
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the European Health for All database, national statistical offices, Eurostat, the 
Organisation for Economic Co-operation and Development (OECD) Health 
Data, the International Monetary Fund (IMF), the World Bank and any other 
relevant sources considered useful by the authors. Data collection methods and 
definitions sometimes vary, but typically are consistent within each separate 
series.
A standardized profile has certain disadvantages because the financing and 
delivery of health care differs across countries. However, it also offers advantages, 
because it raises similar issues and questions. The HiT profiles can be used to 
inform policy-makers about experiences in other countries that may be relevant 
to their own national situation. They can also be used to inform comparative 
analysis of health systems. This series is an ongoing initiative and material is 
updated at regular intervals. Comments and suggestions for the further 
development and improvement of the HiT series are most welcome and can be 
sent to info@obs.euro.who.int.
HiT profiles and HiT summaries are available on the Observatory’s web site 
at www.healthobservatory.eu.
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Abbreviation English term Dutch term French term
A&E Accident and emergency – –
ABVV-FGTB General Labour Federation 
of Belgium
Algemeen Belgisch Vakverbond Fédération Générale du Travail 
de Belgique 
Achil Ambulatory Care Health 
Information Lab 
– –
ACLVB-CGSLB General Confederation of 
Liberal Trade Unions of Belgium
Algemene Centrale der Liberale 
Vakbonden van België
Centrale Générale des 
Syndicats Libéraux de Belgique
ACV-CSC Confederation of Christian 
Trade Unions
Algemeen Christelijk 
Vakverbond
Confédération des syndicats 
chrétiens de Belgique
ADL Activities of daily living – –
AED Automated external 
defibrillators 
– –
AHRQ Agency for Health Care 
Research and Quality
– –
AIDS Acquired immunodeficiency 
syndrome
– –
AMI Acute myocardial infarction – –
AP-DRG All patients diagnosis-related 
groups
– –
APR-DRG All Patients Refined 
diagnosis-related groups
– –
ATC Anatomical Therapeutic 
Chemical classification
– –
AWIPH Walloon Agency for People 
with Disabilities
– Agence Wallonne pour 
l’Intégration des Personnes 
Handicapées
BCGH-CBPH Belgian Centre for 
Pharmacovigilance
Belgisch Centrum voor 
Geneesmiddelenbewaking
Centre Belge de 
Pharmacovigilance 
BESADL Belgian Evaluation Scale for 
Activities of Daily Living
– –
BIVV-IBSR Belgian Institute for 
Traffic Safety
Belgisch Instituut voor de 
Verkeersveiligheid
Institut Belge de la Sécurité 
Routière
BMI Body mass index – –
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Abbreviation English term Dutch term French term
BOT Dutch-speaking Coordination 
Centres for Home Care and 
Services (Brussels)
Brussels Thuis Overleg –
BS-MB Belgian Official Journal Belgisch Staatsblad Moniteur Belge
CBFA Banking, Finance and Insurance 
Commission 
Commissie voor het Bank-, 
Financie- en Assurantiewezen
Commission bancaire, 
financière et des assurances
CBO Dutch Institute for Health Care 
Improvement
Centraal Begeleidingsorgaan 
voor Intercollegiale Toetsing
–
CBSS-KSZ-
BCSS
Crossroads Bank of Social 
Security
Kruispuntbank van de Sociale 
Zekerheid
Banque Carrefour de la Sécurité 
Sociale
CE European Conformity – –
CEBAM Belgian Centre for Evidence-
based Medicine 
Belgisch Centrum voor 
Evidence-Based Medicine
Centre belge pour l’Evidence-
Based Medicine
CIS Commonwealth of Independent 
States
Gemenebest van Onafhankelijke 
Staten
Communauté des États 
Indépendants
CITES Convention on International 
Trade in Endangered Species of 
Wild Fauna and Flora
– –
CLB Centre for student counselling Centra voor 
Leerlingenbegeleiding
–
CLPS Local Centres for Health 
Promotion (French community)
– Centres Locaux de Promotion 
de la Santé
CMPH Committee for Medicinal 
Products for Human Use
– –
COCOF French Community 
Commission 
– Commission communautaire 
française 
CPP-CBPL-
CPVP 
Commission for the Protection 
of Privacy 
Commissie voor de 
bescherming van de 
persoonlijke levenssfeer
Commission de la protection de 
la vie privée
CRP-CTG-CRM Commission for the 
Reimbursement of 
Pharmaceuticals
Commissie Tegemoetkoming 
Geneesmiddelen
Commission de 
Remboursement des 
Médicaments
CSSD Coordination Centres for Home 
Care and Services (Walloon 
region)
– Centres de Coordination de 
Soins et Services à Domicile
CT Computer (axial) tomography – –
CVA Cerebrovascular accident – –
DALE Disability-adjusted life 
expectancy
– –
DDD Defined daily dose – –
DGEC-SECM Department for Medical 
Evaluation and Inspection
Dienst voor Geneeskundige 
Evaluatie en Controle
Service d’évaluation et de 
contrôle médicaux
DMFT Decayed, missing or filled teeth – –
DPB German Agency for People with 
Disabilities
– –
DRG Diagnosis-related group – –
ECJ Court of Justice of the 
European Communities
– –
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Abbreviation English term Dutch term French term
EEA European Economic Area – –
EHIC European Health Insurance 
Card
– –
EMEA European Medicines Agency – –
ESW Extracorporeal shock wave – –
EU European Union – –
EU15 EU Member States before 
May 2004
– –
EU27 EU Member States including 
those acceding in May 2004 
and January 2007
– –
FAMHP-FAGG-
AFMPS 
Federal Agency for Medicines 
and Health Products
Federaal Agentschap voor 
Geneesmiddelen en 
Gezondheidsproducten
Agence fédérale des 
Médicaments et des Produits 
de Santé
FARES Tuberculosis register for the 
French and German 
communities 
– Registre de la Tubercolose pour 
la communauté française et la 
communauté germanophone
FPS-FOD-SPF Federal Public Service Federale Overheidsdienst Service Public Fédérale
FTE Full-time equivalent – –
GATS General Agreement on Trade 
in Services
– –
GDP Gross domestic product – –
GGC-COCOM Joint Community Commission Gemeenschappelijke 
Gemeenschapscommissie
Commission communautaire 
commune
GMD-DMG Global Medical File Globaal Medisch Dossier Dossier Médical Global
GP General practitioner – –
HALE Health-adjusted life expectancy – –
HBD-AZV-SHA Hospital Billing Data Anonieme ziekenhuis verblijven Séjours hospitaliers 
anonymisés
HIS Health Interview Survey – –
HIV Human immunodeficiency virus – –
HPV Human papilloma virus – –
HTA Health technology assessment – –
IADL Instrumental Activities of 
Daily Living
– –
IMA-AIM Common Sickness 
Funds Agency
Intermutualistisch Agentschap Agence Intermutualiste
INN International Nonproprietary 
Name
– –
IPH-WIV-ISP Scientific Institute of 
Public Health
Wetenschappelijk Instituut 
Volksgezondheid
Institut Scientifique de Santé 
Publique
IQED-IKED-
IPQED
Initiative for Quality Promotion 
and Epidemiology in Diabetes 
Care
Initiatief voor 
Kwaliteitsbevordering en 
Epidemiologie bij Diabetes
Initiative pour la Promotion de 
la Qualité et Epidémiologie du 
Diabète sucré
ISHC-GDT-
SISD
Integrated Services for 
Home Care
Geïntegreerde Diensten voor 
Thuisverzorging
Services Intégrés de Soins 
à Domicile
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Abbreviation English term Dutch term French term
IWSM Walloon Institute for 
Mental Health 
– Institut Wallon de Santé 
Mentale
K&G Child and Family Kind & Gezin –
KCE Belgian Health Care 
Knowledge Centre
Federaal Kenniscentrum voor 
de Gezondheidszorg
Centre fédéral d’expertise 
des soins de santé
KUL Catholic University (Leuven) Katholieke Universiteit Leuven –
LOGO Local Health Network Locaal Gezondheidsoverleg –
LOK-GLEM Local Quality Evaluation Group Lokale Kwaliteitsgroep Groupe Locaux d’Evaluation 
Médicale
LoS Length of stay – –
LUSS French federation of patients 
associations
– Ligue des Usagers des Services 
de Santé
MAB-MAF-
MAF
Maximum billing Maximumfactuur Maximum à Facturer
MCD-MKG-
RCM
Minimal Clinical Data Minimale Klinische Gegevens Résumé Clinique Minimum
MHD-MZG-
RHM 
Minimum Hospital Data Minimale Ziekenhuisgegevens Résumé Hospitalier Minimal
MIP Medical Intervention Plan – –
MND-MVG-
RIM
Minimal Nursing Data Minimale Verpleegkundige 
Gegevens
Résumé Infirmier Minimum
MPD-MPG-
RPM
Minimal Psychiatric Data Minimale Psychiatrische 
Gegevens
Résumé Psychiatrique 
Minimum
MRI Magnetic resonance imaging – –
MRPA Homes for the elderly Woonzorgcentra (previously 
called Rusthuis)
Maison de repos pour 
personnes âgées 
MRSA Methicillin-resistant 
Staphylococcus aureus
– –
MUG-SMUR Mobile Urgency Group Mobiele urgentiegroep Service mobile d’urgence
NACM-LCM-
ANMC
National Alliance of Christian 
Mutualities
Landsbond der Christelijke 
Mutualiteiten
Alliance nationale des 
mutualités chrétiennes
NATO North Atlantic Treaty 
Organization
– –
NICE National Institute for Health 
and Clinical Excellence 
– –
NIHDI-RIZIV-
INAMI
National Institute for Health 
and Disability Insurance
Rijksinstituut voor Ziekte- en 
Invaliditeitsverzekering
Institut National d’Assurance 
Maladie-Invalidité
NISSE-RSVZ-
INASTI 
National Institute for the Social 
Security of the Self-employed
Rijksinstituut voor de Sociale 
Verzekeringen der 
Zelfstandigen
Institut national d’assurances 
sociales pour travailleurs 
indépendants
NHS National Health Service – –
NSIH National Surveillance of 
Infections in Hospitals
– –
NSSO-RSZ-
ONSS
National Social Security Office Rijksdienst voor Sociale 
Zekerheid
Office National de Sécurité 
Sociale
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NSSOLPA-
RSZPPO-
ONSSAPL
National Social Security Office 
for the Local and Provincial 
Administrations 
Rijksdienst voor sociale 
zekerheid van de provinciale en 
plaatselijke overheidsdiensten
Office national de sécurité 
sociale des administrations 
provinciales et locales
NUFPM-LOZ-
MLOZ
National Union of the Free and 
Professional Mutualities
Landsbond van de 
onafhankelijke ziekenfondsen
Union nationale des mutualités 
libres
NULM-LLM-
UNML
National Union of Liberal 
Mutualities 
Landsbond van de liberale 
mutualiteiten
Union Nationale des Mutualités 
Libres
NUNM-LNM-
UNMN
National Union of Neutral 
Mutualities
Landsbond van de neutrale 
ziekenfondsen
Union nationale des mutualités 
neutres
NUSM-NVSM-
UNMS
National Union of Socialist 
Mutualities
Nationaal verbond van 
Socialistische Mutualiteiten
Union Nationale des Mutualités 
Socialistes
OCMW-CPAS Public municipal welfare centre Openbare Centra voor 
Maatschappelijk Welzijn
Centres Publics d’Action 
Sociale
OECD-OESO-
OCDE
Organisation for Economic 
Co-operation and Development
Organisatie voor Economische 
Samenwerking en Ontwikkeling
Organisation de Coopération 
et de Développement 
Economiques
ONE Birth and Childhood 
Organization Office
– Office de la Naissance et 
de l’Enfance
Orthopride Orthopaedic Prosthesis 
Identification Data 
– –
OSSO-DOSZ-
OSSOM
Overseas Social Security Office Dienst voor de Overzeese 
Sociale Zekerheid
Office de Sécurité Sociale 
d’Outre-Mer
PAAZ Psychiatric departments in 
acute hospitals
Psychiatrische Afdeling 
Algemeen Ziekenhuis
–
PAB Personal Assistance Budget Persoonlijke-assistentiebudget Budget d’assistance personnel
PET Positron emission tomography – –
PHARE Agency for People with 
Disabilities (for the 
French-speakers of the 
Brussels-Capital region)
– Personne Handicapée 
Autonomie Retrouvée
PIT Paramedical Intervention Team – –
PPP Purchasing power parity Koopkrachtpariteit Parité de pouvoir d’achat
PSIP Psychosocial Intervention Plan – –
PTCA Percutaneous transluminal 
coronary angioplasty
– –
QERMID Quality Electronic Registration 
of Medical Implants and 
Devices 
– –
RVT-MRS Nursing home Rust-en verzorgingstehuis Maison de repos et de soins
SAFE Shared Arthritis File for 
Electronic use
– –
SBU Swedish Council on Technology 
Assessment in Health Care 
– –
SCPS Community Services for Health 
Promotion (French community)
– Services Communautaires de 
Promotion de la Santé
SCSS&H Sectoral Committee of the 
Social Security and Health
– –
SEL Cooperation Initiatives in 
front-line health care (Flanders)
Samenwerkingsinitiatieven 
eerstelijnsgezondheidszorg
–
Health systems in transition  Belgiumxviii
Abbreviation English term Dutch term French term
SHA System of Health Accounts – –
SIT-HISC Cooperation Initiatives in 
Home Care (Flanders)
Samenwerkingsinitiatieven 
inzake thuisverzorging
–
STD Sexually transmitted disease – –
Sumehr Summarized Electronic 
Health Record
– –
UCL Catholic University 
(Louvain-La-Neuve)
– Université catholique de 
Louvain-La-Neuve
ULB Free University of Brussels – Université libre de Bruxelles
VAPH Flemish Agency for People 
with Disabilities
Vlaams Agentschap voor 
Personen met een Handicap
–
VGC Flemish Community 
Commission 
Vlaamse 
Gemeenschapscommissie
–
VHI Voluntary health insurance – –
VIGeZ Flemish Institute of Health 
Promotion and Sickness 
Prevention
Vlaams Instituut voor 
Gezondheidspromotie en 
Ziektepreventie
–
VINCA Pilot project to provide nurses 
with administrative support 
across mobile computing
– –
VIPA Flemish Infrastructure Fund 
for Personal Affairs
Vlaams Infrastructuurfonds 
voor Persoonsgebonden 
Aangelegenheden
–
VPP Flemish Federation of Patients 
Associations
Vlaams Patiëntenplatform –
VRGT Flemish Association for 
Respiratory Care and 
Tuberculosis
Vlaamse Vereniging voor 
Respiratoire Gezondheidzorg 
en Tuberculosebestrijding
–
VVGG Flemish Association for 
Mental Health 
Vlaamse Vereniging voor 
Geestelijke Gezondheid
–
WHO World Health Organization – –
WTO World Trade Organization – –
ZOAST Organized Cross-border Areas 
for Access to Care 
– Zones organisées d’accès aux 
soins transfrontaliers 
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English term Dutch term French term
Care pathways Zorgtraject Trajet de soins
Committee for Medical Supply 
Planning
Belgische Planningscommissie 
Medisch Aanbod
–
Community care centres Dagverzorgingscentra Centre d’accueil de jour
Day-care centres Centra voor dagverzorging–Centres 
de soins de jours) 
Centres de soins de jours
Flemish Care Insurance Scheme Vlaams Zorgverzekering –
FPS Health, Food Chain Safety and 
Environment
FOD Volksgezondheid, Veiligheid van 
de Voedselketen en Leefmilieu
SPF Santé Publique, Sécurité de la 
Chaîne alimentaire et Environement
FPS Social Security FOD Sociale Zekerheid SPF Sécurité Sociale
Medical houses Wijkgezondheidscentra Maison médicale
Networks of palliative care Samenwerkingsverbanden in 
palliatieve zorg
Associations en matière de soins 
palliatifs
Permanent Sample Permanente steekproef Echantillon Permanent
Short-stay centres Centrum voor kortverblijf Centre de court séjour
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Abstract
The Health Systems in Transition (HiT) profiles are country-based reports that provide a detailed description of a health system and of policy initiatives in progress or under development. HiTs examine different 
approaches to the organization, financing and delivery of health services 
and the role of the main actors in health systems; describe the institutional 
framework, process, content and implementation of health and health care 
policies; and highlight challenges and areas that require more in-depth analysis.
The Belgian population continues to enjoy good health and long life 
expectancy. This is partly due to good access to health services of high quality. 
Financing is based mostly on proportional social security contributions and 
progressive direct taxation. The compulsory health insurance is combined with 
a mostly private system of health care delivery, based on independent medical 
practice, free choice of physician and predominantly fee-for-service payment.
This Belgian HiT profile (2010) presents the evolution of the health system 
since 2007, including detailed information on new policies. While no drastic 
reforms were undertaken during this period, policy-makers have pursued the 
goals of improving access to good quality of care while making the system 
sustainable. Reforms to increase the accessibility of the health system include 
measures to reduce the out-of-pocket payments of more vulnerable populations 
(low-income families and individuals as well as the chronically ill). Quality 
of care related reforms have included incentives to better integrate different 
levels of care and the establishment of information systems, among others. 
Additionally, several measures on pharmaceutical products have aimed to 
reduce costs for both the National Institute for Health and Disability Insurance 
(NIHDI) and patients, while maintaining the quality of care.
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Executive summary
Belgium is a federal state with a parliamentary democracy. There are three 
levels of government – the federal government, the federated entities (three 
regions and three communities) and the local governments (provinces and 
municipalities). 
Health policy is both a responsibility of the federal authorities and federated 
entities (regions and communities). The federal authorities are responsible for the 
regulation and financing of the compulsory health insurance; the determination 
of accreditation criteria (i.e. minimum standards for the running of hospital 
services); the financing of hospital budgets and heavy medical care units; 
legislation covering different professional qualifications; and the registration 
of pharmaceuticals and their price control. Federated entities are responsible 
for health promotion and prevention; maternity and child health care and social 
services; different aspects of community care; coordination and collaboration 
in primary health care and palliative care; the implementation of accreditation 
standards and the determination of additional accreditation criteria; and the 
financing of hospital investment. To facilitate cooperation between the federal 
authorities and the federated entities, interministerial conferences are regularly 
organized.
The Belgian population reached 10.7 million in 2008. In 2007, life expectancy 
at birth was 82.6 years for females and 77.1 years for males. Almost the whole 
population (> 99%) is covered for a very broad benefits package. Since January 
2008, there is no longer any difference between health insurance coverage in 
the general scheme and the scheme for the self-employed, as the latter now 
includes the coverage of minor risks.
The organization of health services is characterized by the principles of 
therapeutic freedom for physicians, freedom of choice for patients, and 
remuneration based on fee-for-service payments.
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The compulsory health insurance is managed by the National Institute for 
Health and Disability Insurance (NIHDI-RIZIV-INAMI), which allocates a 
prospective budget to the sickness funds to finance the health care costs of 
their members. All individuals entitled to health insurance must join or register 
with a sickness fund: either one of the six national associations of sickness 
funds, including the Health Insurance Fund of the Belgian railway company, 
or a regional service of the public Auxiliary Fund for Sickness and Disability 
Insurance. Private profit-making health insurance companies account for only a 
small part of the non-compulsory health insurance market. In the past, sickness 
funds received the budget they needed to reimburse their members but since 
1995, they have been held financially accountable for a proportion (25%) of any 
discrepancy between their actual spending and their budget, for which 30% is 
determined according to a normative risk-adjusted allocation.
Decision-making in the Belgian health system mainly relies on negotiations 
between several stakeholders. General policy matters concerning health 
insurance and its budget are decided by representatives of the government and 
the sickness funds but also by representatives of employers, salaried employees 
and self-employed workers. The health insurance system is also regulated by 
national conventions and agreements between representatives of health care 
providers and sickness funds (e.g. fees determination).
The Belgian health system is based on the principle of social insurance 
characterized by horizontal solidarity (between healthy and sick people) and 
vertical solidarity (based to a large extent on the labour incomes) and without 
risk selection. Financing is based mostly on proportional social security 
contributions related to taxable income and, to a lesser extent, on progressive 
direct taxation, and a growing area of alternative financing related to the 
consumption of goods and services (mainly value added tax).
The budget for public health expenditure is fixed by a legal real growth norm 
(4.5% since 2004). In 2007, Belgian total health expenditure was 10.2% of gross 
domestic product (GDP). Health expenditure expressed in US$ PPP (purchasing 
power parity) per capita was 3595 in 2007, which was the sixth highest health 
expenditure per capita among the EU27 countries.
Patients in Belgium participate in health care financing through official 
co-payments and diverse supplements. The main payment mechanism is 
the fee-for-service payment. There are two systems of payments: (1) a direct 
payment (mainly for ambulatory care), where the patient pays for the full cost 
of the service and then obtains a reimbursement from the sickness fund for 
part of the expense; and (2) a third-party payer system (mainly for ambulatory 
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drugs and hospitals), where the sickness fund pays the provider directly and 
the patient is only responsible for paying any co-payments, supplements or 
non-reimbursed services. However, the third-party payer system can be applied 
under specific conditions for ambulatory care to ameliorate the financial access 
for vulnerable population groups.
The reimbursement of services depends on the type of service provided, the 
income and social status of the patient (preferential reimbursement or not), as 
well as the accumulated amount of co-payments already paid for that year. For 
more vulnerable population groups, several measures were taken to ensure their 
access to high-quality care (OMNIO, maximum billing (MAB) system, etc.)
A significant proportion of health care providers are paid on a fee-for-service 
basis. For salaried employees in the health sector, salaries and career evolution 
are negotiated through a series of collective agreements. The number of health 
care professionals has been quite stable since 2000. Planning for physicians, 
dentists and other health care personnel is undertaken by the Committee 
for Medical Supply Planning. This committee is responsible for formulating 
proposals for the federal Minister of Public Health on the annual number of 
candidates per community that are eligible to be granted the professional title 
of physician, dentist or physiotherapist, after obtaining the relevant diploma. 
Based on the committee’s work, a proposal was made to establish a quota 
mechanism. The quota mechanism is applied immediately after the completion 
of basic training, at the moment of application for recognition as a dentist or 
physiotherapist, and at the time of application for specialization for a physician 
(general practitioner (GP) or specialist). In order to achieve the quotas, the 
communities, which are responsible for education policy, were requested to 
take measures to limit the number of students. Some measures to increase the 
attractiveness of the GP and nursing professions, to make health care providers 
more accountable, to strengthen primary care and to promote the integration of 
health services and multidisciplinarity have also been undertaken.
In Belgium, hospitals can be classified into two categories: general and 
psychiatric. In 2008, there were 207 hospitals, of which 139 were general and 68 
psychiatric. The general hospital sector consists of acute (112), specialized (19) 
and geriatric hospitals (8). The basic feature of Belgian hospital financing is 
its dual remuneration structure according to the type of services provided: 
accommodation costs, nursing activities in the nursing units, operating room, and 
sterilization are financed via a fixed prospective budget system; while medical 
services, polyclinics and medico-technical services (laboratories, medical 
imaging and technical procedures) and paramedical activities (physiotherapy) 
are mainly paid via a fee-for-service system to the service provider.
Health systems in transition  Belgiumxxx
As an alternative to hospitalization, intermediary structures and services have 
been developed. These alternatives include day hospitalizations and long-term 
care centres. For specific groups, such as the elderly and persons suffering 
from mental illnesses, a wide range of community services are available as an 
alternative to residential long-term care.
Pharmaceuticals are exclusively distributed through community and 
hospital pharmacies. Only physicians and (to the extent that their profession 
requires) dentists and midwives can prescribe pharmaceuticals. About 2500 
pharmaceutical products are on a positive list and therefore are partly or fully 
reimbursable. The percentage of the cost that is reimbursable varies, depending 
on the therapeutic importance of the pharmaceutical. To reduce expenditure 
on pharmaceuticals several measures have been undertaken. These include a 
further reduction in prices for products within the reference price system and 
establishment of prescription quotas for low-cost drugs, among others.
Overall, the health system was recently assessed as having good accessibility and 
an appropriate level of safety. However, further improvements in effectiveness 
of preventive care, appropriateness of care, efficiency and sustainability could 
further enhance the performance of the overall system.
Recent reforms to the health system essentially aim to provide a high quality of 
care to the whole population and, at the same time, protect the sustainability of 
the system. The reforms that will be carried out in the coming years will likely 
continue to promote the objectives of accessibility, quality and sustainability. 
Further changes will also aim at simplifying the system in order to make it 
more homogeneous.
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1.1 Geography and sociodemography
Belgium is situated in the west of Europe and shares borders with the Netherlands, Luxembourg, Germany and France (see Fig. 1.1 for map). Belgium has one of the highest population densities in Europe. 
Its 10 666 866 inhabitants (in 2008) live in a total land area of 30 528 km2 
(349 people per km2). Brussels is the capital and the largest city with around 
1 million inhabitants. Brussels is also the capital of Europe and the site of 
the headquarters of the European Commission, the Council of Ministers and 
the European Parliament. Other major international organizations, such as 
the North Atlantic Treaty Organization (NATO), are also located in Brussels 
(Statistics Belgium 2009; Belgium Federal Portal 2009).
The geography of Belgium falls into three major areas: lower Belgium (up 
to 100 m above sea level), central Belgium (between 100 and 200 m above sea 
level) and upper Belgium (from 200 to over 500 m above sea level). Belgium 
has a coastline of 65 km and is crossed by the Lys, Meuse and Schelde rivers 
(Belgium Federal Portal 2009). The Belgian climate is temperate and is 
characterized by relatively cool and wet summers and mild and rainy winters 
(IRM 2009).
Belgium has three official languages: Dutch, French and German. Dutch is 
spoken by around 59% of the population, French by around 40% and German 
by less than 1% (Belgium Federal Portal 2005). The country is divided into 
Dutch-speaking Flanders in the north and French-speaking Wallonia in the 
south. Brussels is bilingual, but its dominant language is French. German is 
spoken in nine communities close to Germany. About 9.1% of the population 
are foreigners mostly from Italy (1.6%), France (1.2%), the Netherlands (1.2%), 
Morocco (0.7%), Spain (0.4%), Turkey (0.4%) and Germany (0.4%) (Statistics 
Belgium 2009). The majority of the population is classified as Roman Catholic, 
although most of them are not practising on a regular basis. 
1 This chapter was written by Sophie Gerkens and Maria Isabel Farfan.
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According to the Federal Planning Bureau, international immigration has 
been particularly important since 2004. In addition to the usual immigration 
from the former EU15, there was a surge of immigrants from the new Member 
States. Conversely, the number of immigrants from non-European countries, 
especially Turks and Moroccans, is stagnating and even declining slightly.
Individuals aged 65 years and older made up 17.1% of the population in 
2008 compared to 14.3% in 1980. The fertility rate has increased very slightly 
from 1.7 children per woman between 15 and 49 years old in 1980 to 1.8 in 
2007. In recent years, the birth rate has also increased slightly to 11.7 per 
1000 population in 2007 after declining continuously up till 2002. The death 
rate declined slightly from 11.5 per 1000 population in 1980 to 9.5 per 1000 
population in 2008 (see Table 1.1).
Table 1.1
Population and demographic indicators, 1980–2008 (selected years)
 1980 1990 2000 2005 2006 2007 2008
Total population  
(thousands; 1 January)
9 855 9 948 10 239 10 446 10 511 10 585 10 667
Population, female  
(% of total)
51.1 51.1 51.1 51.1 51.1 51.0 51.0
Population ages 0–14 years 
(% of total)
20.3 18.1 17.6 17.2 17.1 17.0 16.9
Population ages 65 and above  
(% of total)
14.3 14.8 16.8 17.2 17.2 17.1 17.1
Population ages 80 and above  
(% of total)
2.6 3.5 3.5 4.3 4.4 4.6 4.7
Population growth  
(average annual growth rate)
+0.1 +0.2 +0.2 +0.5 +0.6 +0.7 +0.8
Population density  
(people per sq km)
323 326 335 342 344 347 349
Fertility rate  
(births per woman 15–49)
1.7 1.6 1.7 1.8 1.8 1.8 –
Live birth rate  
(crude, per 1 000 people)
12.6 12.4 11.2 11.3 11.5 11.4 11.7
Death rate  
(crude, per 1 000 people)
11.5 10.5 10.2 9.9 9.7 9.5 9.5
Age dependency ratio  
(0–14 and 65+ / 15–64 years)
52.4 49.4 52.5 52.3 52.3 52.3 –
% of urban population 95 97 97 97 – – –
Population aged 25–64 having completed at least 
upper secondary education (%)
– – 58.5 66.1 66.9 68.0 69.6
Sources: Eurostat 2009; OECD 2009a; WHO Regional Office for Europe 2008a (August).
The further increase in life expectancy and the expected substantially 
positive immigration balance should lead to a rise in the Belgian population of 
24% between 2000 and 2060 (see Table 1.2). This increase will be especially 
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important in the region of Brussels-Capital (+38%; +29% in the Walloon region 
and +18% in the Flemish region). Moreover, the ageing of the population will 
be amplified in the future. The population over 65 will increase from 16.8% 
of the population in 2000 to 26.3% in 2060 (+48%). Very old people (80+) will 
represent 10% of the population, compared to 3.5% in 2000. Therefore, the 
ageing intensity ratio, measuring the proportion of “very old people” (80+) in 
the group of old people (65+), will increase to 39.5% in 2060.
Table 1.2
Population projections, 2000–2060
2000 2010 2020 2030 2040 2050 2060
Total population (in thousands, situation  
in January)
10 239 10 807 11 538 11 982 12 227 12 439 12 663
Brussels-Capital (% of total) 9.4 9.9 10.4 10.5 10.3 10.4 10.5
Wallonia (% of total) 32.6 32.4 32.5 32.9 33.4 33.8 34.2
Flanders (% of total) 58.0 57.7 57.1 56.6 56.3 55.9 55.4
Balance of external migration 13 732 55 991 39 119 17 407 19 473 26 176 28 707
Life expectancy at birth, females 81.42 83.86 85.51 87.03 88.43 89.73 90.94
Life expectancy at birth, males 75.08 77.87 79.61 81.17 82.63 83.99 85.27
Population 65 and over (% of total) 16.8 17.2 19.2 22.7 25.0 25.7 26.3
Population 80 and over (% of total) 3.5 4.9 5.5 6.5 8.5 10.1 10.4
Ageing intensity ratio (80+/65+) 20.8 28.6 28.7 28.5 33.9 39.2 39.5
Age dependency ratio  
(0–14 and 65+ / 15–64 years)
52.4 51.7 57.3 64.4 69.0 71.0 72.5
Fertility rate (births per woman 15–49) 1.66 1.84 1.78 1.76 1.75 1.76 1.77
Source: Federal Planning Bureau 2008.
1.2 Economic context
Living standards are considered high in Belgium; Belgium ranks 17th in 
the 2009 United Nations Human development report (United Nations 2009). 
The adjusted purchasing power parity (PPP) gross domestic product (GDP) 
per capita amounts to €28 600 in 2008, which is above the EU15 and EU27 
averages of €27 800 and €25 100 respectively (Eurostat 2009). 
Belgium has a mixed economy based on services, international trade 
and manufacturing. In 2009, the service sector accounted for 77.6% of GDP, 
whereas the manufacturing sector and agriculture represented 21.8% and 
0.6%, respectively (Eurostat 2009). Together with 11 other Member States 
of the European Union (EU), Belgium began circulating euro currency in 
January 2002. 
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Fig. 1.1
Map of Belgium 
Source: CIA 2006.
The Belgian economy depends heavily on the export of a large volume of 
manufactured goods and is therefore very dependent on the state of the world 
market and the European market in particular. In 2008, exports and imports 
of goods and services accounted for 85.8% and 84.9% of GDP respectively. 
Between 1985 and 2007, Belgium ran a current account surplus. In 2007 this 
surplus totalled 2.2% of GDP. However, in 2008 the current account ran a deficit 
of -2.65% (National Bank of Belgium 2009). The global economic slowdown, 
higher prices of imported commodities as well as the declining market shares 
of Belgian exports could partly explain this deficit. However, for 2009 a surplus 
of 0.5% is expected for the current account (National Bank of Belgium 2010a).
Between 1995 and 2008, Belgium had an average real economic annual 
growth of 2.2%. Nevertheless, in 2008, the slowdown in activity meant that 
GDP growth dropped to 0.8% and in 2009, first estimates show a GDP decrease 
of -3.0% with respect to the previous year (see Table 1.3) (National Bank of 
Belgium 2010b). Over the same period (1995–2008), prices increased modestly 
with an average inflation rate of 2.3%. The annual average inflation rate surged 
to 4.5% in 2008 and was estimated at -0.1% in 2009 (Eurostat 2009; National 
Bank of Belgium 2009; National Bank of Belgium 2010b). 
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Table 1.3
Macroeconomic indicators, 2009
GDP (current prices, in million €) 337 758
GDP, PPP (current prices, in million €) 295 584
GDP per capita, PPP, (current prices, in €) 28 600 1
Real GDP growth (annual % change 2) -3.0
Public debt (% of GDP) 97.8
Value added in agriculture (% of GDP) 0.6
Value added in industry (% of GDP) 21.8
Value added in services (% of GDP) 77.6
Labour force (total) 5 071
Employment rate (% population of working age) 61.5
Unemployment (% of labour force) 7.9
Exchange rate (US$/euro) 1.4
Gini coefficient 3 28 1
At-risk-of-poverty rate 4 15 1
Sources: National Bank of Belgium 2009; Eurostat 2009; OECD 2009a; Statistics Belgium 2009. 
Notes:  
1 Latest available data 2008. 
2 Data adjusted for seasonal and calendar effects and calculated in terms of chained 2007 prices. 
3 Gini coefficient (data for 2008): “Measure of (income) inequality or concentration derived from the Lorenz curve, which plots 
cumulative shares of the population, from the poorest upwards, against the cumulative share of incomes that they receive. The Gini 
coefficient is defined as the area between the Lorenz curve and the 45°-line, taken as a ratio of the whole triangle. An increase in the 
Gini coefficient represents an increase in inequality.”  
4 “The at-risk-of-poverty rate is measured as the share of persons with an equivalized disposable income below the at-risk-of-poverty 
threshold. The threshold is set at 60% of the national median equivalized disposable income” (Eurostat 2009).
In 2008, the employment rate in Belgium was 62.4%, which is below the 
EU27 average of 65.9%. In comparison to other Member States in the EU27, 
Belgium ranked 20th (see Fig. 1.2). This low employment rate can be partially 
attributed to the slow economic growth, but mostly to the specific characteristics 
of the Belgian job market (Corens 2007). 
Employment rates in 2009 are particularly low for older workers (at 34.9% of 
the population aged 55–64), younger workers (at 25.2% of the population aged 
15–24) and ethnic minorities (at 38.6% for those of non-EU nationality). By 
contrast, employment rates are near international averages for those of prime 
working age (25–54 years) (see Fig. 1.3) (Eurostat 2009). The low employment 
rate in Belgium implies that there is a high level of an unused potential labour 
force. Higher employment would contribute to economic growth by helping to 
alleviate strains on public finances and to sustain the social security system 
faced with an ageing population. 
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Fig. 1.2
Employment rate in the EU27, 2008
Source: Eurostat 2010.
Fig. 1.3
Employment rate by age category, 2009
Source: National Bank of Belgium 2010c.
0 10 20 30 40 50 60 70 80
Malta
Hungary
Italy
Romania
Poland
Greece
Slovakia
Belgium
Luxembourg
Bulgaria
Spain
Lithuania
France
EU27
Czech Republic
EU15
Ireland
Portugal
Slovenia
Latvia
Estonia
Germany
Cyprus
Finland
United Kingdom
Austria
Sweden
The Netherlands
Denmark 78.1
77.2
74.3
72.1
71.5
71.1
70.9
70.7
69.8
68.6
68.6
68.2
67.6
67.3
66.6
65.9
64.9
64.3
64.3
64.0
63.4
62.4
62.3
61.9
59.2
59.0
58.7
56.7
55.3
Age category
0
10
20
30
40
50
60
70
80
90
EU15
Belgium
55–6425–5415–24
38.5
25.2
78.6 79.8
47.9
34.9
Health systems in transition  Belgium 7
Although it decreased from 1993 to 2007, the consolidated gross public debt 
to GDP ratio has remained high (84.2% in 2007) and increased to 89.8% in 2008 
(National Bank of Belgium 2009; Eurostat 2009). In 2009, the debt to GDP 
ratio was 97.8%. This can be attributed to both a decrease in the nominal GDP 
and a generalized deficit among most public administrations (National Bank 
of Belgium 2010b). Since 2000, the government has succeeded in balancing its 
budget but further debt reduction is necessary to respect stability programmes 
and the Maastricht Treaty, which call for gross public debt to be reduced to less 
than 60% of GDP to prepare for the future costs of the ageing population. The 
resulting decrease in interest payments should create financial possibilities to 
pay for expenses related to ageing, such as pensions and health care.
1.3 Political context
Belgium is a federal parliamentary democracy under a constitutional monarch. 
The King is the head of the state, but in practice the executive power is exercised 
by the government. Federal legislation is approved by a bicameral parliament 
consisting of a Chamber of Representatives (150 members) and a Senate 
(71 members). Elections are held every four years and voting is compulsory for 
all citizens 18 and over (Belgium Federal Portal 2009).
At the federated level, Belgium is divided into three regions (based on 
territory) and three communities (based on language and culture) (see Fig. 1.4 
and Fig. 1.5). The devolved structure of regions and communities has developed 
as a result of several revisions to Belgium’s Constitution since it was originally 
drafted in 1831. Important constitutional reforms were carried out in 1970, 
1980, 1988 and 1993. The three regions are the Flemish region, the Walloon 
region and the region of Brussels-Capital (Belgium Federal Portal 2009). The 
three communities are the Flemish community, the French community and 
the German community. The French community exercises its competence 
throughout the Walloon region (except for the German-speaking area) and the 
Brussels-Capital region. The German community covers the German-speaking 
part of Belgium. The Flemish community is responsible for the citizens living 
within the Flemish and Brussels-Capital regions. Both French- and Dutch-
speaking citizens live in the region of Brussels-Capital. To enable each of the 
two communities (French and Flemish communities) to conduct community-
specific policies in Brussels-Capital, three special institutions were created: 
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the French Community Commission (COCOF), the Flemish Community 
Commission (VGC) and the Joint Community Commission (GGC-COCOM) 
(Belgium Federal Portal 2009).
Repartition of competences between these three levels of power (federal, 
federated and local authorities) is discussed in Section 2.4 Decentralization 
and centralization.
Fig. 1.4
Belgian regions
Source: Belgium Federal Portal 2005.
Fig. 1.5
Belgian communities 
Source: Belgium Federal Portal 2005.
Each region and community has a legislative body (the parliament) and an 
executive body (the government). In Flanders, however, institutions merged in 
1980 so that a single government and a single parliament are responsible for 
both the community and the region (Belgium Federal Portal 2009).
The region of Brussels-CapitalThe Walloon regionThe Flemish region
The German communityThe French communityThe Flemish community
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Regional elections are held every five years. At the local level, there are 
ten provinces (Antwerp, Flemish Brabant, Walloon Brabant, West Flanders, 
East Flanders, Hainaut, Liège, Limburg, Luxembourg and Namur) and 589 
municipalities, elected every six years (Belgium Federal Portal 2009).
Belgium is characterized by a proportional system of elections where 
political parties present lists of candidates. According to results of the election, 
parties have to agree on a coalition government.
The three main trade union organizations present in Belgium are the 
Confederation of Christian Trade Unions (ACV-CSC), the General Labour 
Federation of Belgium (ABVV-FGTB) and the General Confederation of 
Liberal Trade Unions of Belgium (ACLVB-CGSLB). These organizations 
defend the interests of workers and their actions range from the expression of 
workers’ conflicts in enterprises to participation in the management of large 
organizations, such as the National Social Security Office (NSSO-RSZ-ONSS), 
to pressure on political decisions, both at the federal level and at the level of 
federated authorities (regions and communities) (Arcq and Blaise 1999). 
At the international level, Belgium is member of the EU, the Council of 
Europe, the World Trade Organization (WTO), the United Nations, NATO, 
the World Health Organization (WHO) and the Organisation for Economic 
Co-operation and Development (OECD), and has signed up to major 
international treaties, such as the General Agreement on Trade in Services 
(GATS), the Convention on the Rights of the Child, the European Human 
Rights Convention and the International Bill of Human Rights (WTO 2009; 
United Nations 1989; Europa 2009; Council of Europe 2009). 
1.4 Health status
In Belgium, life expectancy at birth is 82.6 years for females and 77.1 years 
for males (2007) (see Table 1.4). Since 1980, life expectancy has increased 
on average by three months per year. Belgian life expectancy is in line with 
EU27 averages of 82.2 years for females and 76.1 years for males. Regional 
differences in life expectancy exist in Belgium. For example, life expectancy 
at birth for males was lower in the Walloon region, and especially in Hainaut 
with a difference of three years compared to the Belgian life expectancy in 2006 
(see Section 7.2 Equity).
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Since its World Health Report 2000, WHO has been encouraging its Member 
States to collect data on disability-adjusted life expectancy (DALE) in order to 
compare the extent to which societies are not only lengthening people’s lives, 
but also improving the quality of their lives by assessing the number of years 
that people live without disabling conditions (WHO 2000). In 2002 (latest year 
available), DALE at birth was 73.3 years for females and 68.9 years for males 
(see Table 1.5).
Infant mortality, which represents the ratio of the number of child deaths 
under one year of age per 1000 live births, has declined between 1980 and 2007 
from 12.1 to 4. This declining trend is noted throughout the whole of the EU27. 
The EU27 average in 2006 was 4.7 (Eurostat 2009).
Table 1.4
Mortality and health indicators, 1980–2007 (selected years)
1980 1990 2000 2005 2007
Life expectancy at birth, total a 73.3 76.1 77.8 79.1 79.9
Life expectancy at birth, males a 69.9 72.7 75.0 76.2 77.1
Life expectancy at birth, females a 76.7 79.5 81.4 81.9 82.6
Total mortality rate, adult, male b 
(deaths per 100 000, standardized rates)
1 291.1 1 055.0 925.5 d 823.7 e –
Total mortality rate, adult, male (1–64 years) b 
(deaths per 100 000, standardized rates)
462.5 345.2 303.94 d 267.9 e –
Total mortality rate, adult, female  
(deaths per 100 000, standardized rates) b
772.13 602.14 539.2 d 500.2 e –
Total mortality rate, adult, female (1–64 years) 
(deaths per 100 000, standardized rates) b
230.4 178.87 154.3 d 141.2 e –
Mortality rate, infant (0–1 years) a 
(deaths per 1 000 live births)
12.1 8.0 4.8 3.7 4.0
Mortality rate, infant (1–4 years) b, c 
(deaths per 1 000 live births)
– – 1.05 d 0.8 e – 
Sources: a OECD 2009a; b WHO Regional Office for Europe 2010 (March); c FPS Economy 2009. 
Notes: Mortality rate, infant (1–4 years) – own calculation. d 1999; e 2004.
Table 1.5
DALE and HALE, 2000–2002
2000 2001 2002
DALE, females 71.6 71.8 73.3
DALE, males 67.5 67.7 68.9
DALE, total 69.6 69.7 71.1
HALE, females 71.6 71.8 73.3
HALE, males 67.5 67.7 68.9
HALE, total 69.6 69.7 71.1
Source: WHO Regional Office for Europe 2008a (August).
Note: HALE: Health-adjusted life expectancy.
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No national data on the causes of death after 2004 are currently available, but 
such data will soon be available again. The main causes of death in Belgium in 
2004 were cardiovascular disorders, neoplasms and disorders of the respiratory 
system. The primary causes of death vary according to the different age groups 
(see Table 1.6). At a younger age (with females up to age 24 and males up to 
age 44), non-natural causes, together with cancer, are the main causes. After 
this age, cancer and cardiovascular disorders become the principal causes of 
death. In the older age groups, cardiovascular diseases are the most prevalent 
causes of death (Eurostat 2009; OECD 2009a). More recent indicators for the 
Flemish region can be found from the Flemish Agency for Care and Health 
(2010).
Table 1.6
Main causes of death, 1980–2004 (deaths per 100 000, standardized rates,  
selected years) 
1980 1990 1995 1999 2004
Infectious and parasitic diseases 7.19 7.59 9.48 10.69 16.32
Tuberculosis 2.08 0.82 0.86 0.78 0.44
HIV/AIDS – 0.81 2.17 0.52 0.59
Circulatory diseases 414.16 284.76 258.87 232.66 207.62
Malignant neoplasms 232.50 215.24 213.37 193.39 173.87
Trachea/bronchus/lung cancers 116.46 109.04 106.19 87.88 76.43
Mental and behavioural disorders 16.66 4.29 13.25 21.08 18.29
Suicide 21.59 17.53 19.68 16.80 17.46
Diseases of the respiratory system 65.50 63.48 67.59 72.25 65.02
Digestive diseases 37.92 30.00 31.42 29.87 28.85
Transport accidents 25.40 17.84 15.62 14.78 11.07
Sources: OECD 2009a; Eurostat 2009.
The last complete results of the Health Interview Survey (HIS) were 
published in 2006, and were related to the situation in 2004 (Bayingana et al. 
2006). Additional surveys were organized in 1997 (Demarest et al. 1998), 2001 
(Gisle et al. 2002) and 2008. Complete results of the 2008 survey are expected 
at the end of 2010. Methods used for each survey can be found on the web site 
of the Scientific Institute of Public Health (IPH 2010a).
In 2008, 23% of the population regarded their health as “not satisfactory”. 
This percentage increases to 48% in those aged 75 years and older. People with 
low levels of education are relatively more dissatisfied with their health. The 
results on subjective health status for the four surveys (1997, 2001, 2004 and 
2008) are very similar, showing that this indicator is very stable in Belgium. 
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In 2008, more than one quarter (27.6%) of the population reported having 
at least one long-term illness, disorder or disabling condition (see Table 1.7). 
Although the population between 1997 and 2004 grew older, no important 
increases in the prevalence of chronic diseases were reported. However, from 
2004 to 2008 there was an observed increase in the prevalence of chronic 
diseases. This increase can be attributed in part to a higher prevalence of some 
diseases, such as hypertension, diabetes, cancer and osteoporosis (Van der 
Heyden et al. 2001).
On the topic of mental health, the results of the health survey indicate that 
for the population aged 15 years and older, one out of four (26%) has to contend 
with psychological distress, a little more than half of these individuals (14.2% 
of the total) could have quite a serious mental disorder, 9.5% have depressive 
feelings, 8% have somatic complaints, 6% have anxiety disorder and 21.3% have 
sleeping problems. Furthermore, 11.7% of the population have thought about 
suicide and 4.9% have tried to commit suicide (IPH 2010a). New results from 
the 2008 survey show a slight deterioration of mental health among individuals 
aged 15 years and older when compared to the 2004 survey results. 
Table 1.7
Indicators on long-term illness, drug consumption and mental health 1997–2008 
(selected years)
1997 2001 2004 2008
Having a long-term illness (% of population) 24.6 25.3 23.8 27.6
Having an officially recognized disability (% of population) 7.6 9.3 6.4 –
Use of medicines in the past two weeks (% of population) 60.1 62.0 59.3 –
Mean GHQ-12 score of psychological distress 1.6 1.3 1.3 1.4
Psychological distress (GHQ score 2+) (% of the population) 31.1 24.8 24.5 26.0
Probable mental disorder (GHQ score 4+) (% of the population) 17.2 13.2 12.7 14.2
Lifetime suicidal ideation (% of population) – – 12.2 11.7
Lifetime suicide attempt(s) (% of the population) – – 3.7 4.9
Prevalence of depressive disorder (% of the population) – 8.6 8.0 9.5
Reported depression in the last 12 months (% of the population) 6.5 6.3 5.9 6.1
Source: IPH 2010a.
Note: GHQ: General Health Questionnaire.
Since the 1980s, the number of daily smokers has decreased substantially 
from 40.5% in 1980 to 20.0% in 2008. Daily smokers smoke an average of 
17 cigarettes per day. The percentage of heavy smokers (> 20 cigarettes per day) 
is 10%. The age when people start to smoke regularly is 17 years, but 10% of 
the current smokers started smoking at the early age of 14. Additionally, 6% of 
the population are occasional smokers (CRIOC 2009).
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In 2004, 26% of the population aged 15–24 smoked, which is an improvement 
in comparison to 31% in 2001. The reduction in tobacco use could be attributed 
to the adoption of non-smoking campaigns and tax increases on tobacco 
products (Demotte 2004). However, 34% of current smokers are moderately 
dependent to very dependent on tobacco, while 68% have already tried in vain 
to give up smoking. 
Nevertheless, smoking-related mortality has decreased (from 321.2 per 
100 000 inhabitants in 1980 to 248.5 in 1995) (see Table 1.8). Both alcohol 
consumption and alcohol-related mortality have been decreasing since the 
1980s.
In 2004, the average body mass index (BMI) of Belgians aged 18 years and 
older was 25.1. Moreover, 44.1% of the adult population has a BMI above 25, 
with 31.4% classified as overweight (BMI between 25 and 30) and 12.7% as 
obese (BMI above 30).
Table 1.8
Factors affecting health status, 1980–2004 (selected years)
1980 1985 1990 1995 2000 2004
Daily smokers  
(% of population, 15+)
40.5 38.4 32.0 28.5 31.0 20.0
Selected smoking-related causes of death  
(deaths per 100 000, standardized rates)
321.2 297.4 248.4 248.5 – –
Alcohol consumption  
(litres per capita, 15+)
14.0 12.9 12.1 11.1 10.3 10.7 c
Selected alcohol-related causes of death  
(deaths per 100 000, standardized rates)
135.8 108.1 101.5 76.3 – –
Overweight population  
(% of total population 25 <BMI <30kg/m²)
– – – 30.5 a 32.4 b 31.4
Obese population (% of total population BMI >30kg/m²) – – – 10.8 a 12.1 b 12.7
Sources: OECD 2009a; WHO Regional Office for Europe 2009 (August); IPH 2010a. 
Notes: a 1997; b 2001; c 2003.
Between 1980 and 2005, neonatal mortality decreased from 7.5 to 2.3 deaths 
per 1000 live births and postneonatal mortality decreased from 4.5 to 1.4 deaths 
per 1000 live births (2004 rate) (see Table 1.9). Although maternal mortality 
shows an overall decrease from 20.4 to 7.0 deaths per 100 000 live births from 
1970 to 2006, an increase has been observed since its lowest level of 2.5 deaths 
per 100 000 live births recorded in 2004. 
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Table 1.9
Maternal and child health indicators, 1980–2006 (selected years)
 1980 1990 2000 2004 2005 2006
Termination of pregnancy rates (abortion/1 000 live births) a – 134.4 b 119.8 138.6 141.5 145.5
Neonatal mortality (deaths/1 000 live births) 7.5 4.2 2.9 2.2 2.3 –
Postneonatal mortality(deaths/1 000 live births) 4.5 3.6 – 1.4 – –
Maternal mortality (death/100 000 live births) 5.6 3.4  8.1 2.5 7.7 7.0
Sources: OECD 2009a; a WHO Regional Office for Europe 2010 (March). 
Note: b 1989.
Since 3 April 1990, the voluntary termination of pregnancy is allowed on 
condition that the procedure is carried out before the end of the twelfth week 
of gestation and that the woman is considered to be in distress. After this date, 
termination of pregnancy is allowed if the mother’s health is in danger or if 
the child to be born suffers from an incurable disease (Code Penal 1990-04-
03/30, Art. 2, 002). Termination of pregnancy rates increased from 2001 to 
2004, but have been stable (with only a slight increase) between 2004 and 2006.
Since the 1980s, the dental health status of Belgian children and adolescents 
has improved significantly. In 2001, the number of decayed, missing or filled 
teeth (DMFT) was 0.92 among 12-year-olds in comparison with 3.1 in 1985 
(see Table 1.10). Epidemiological study data show that Belgian schoolchildren 
are among those in European countries with moderate to low caries prevalence. 
However, attention should be paid to socioeconomically underprivileged 
children whose dental health status is significantly worse than that of privileged 
ones (Van Nieuwenhuysen and Carvalho 2000). More information on social 
inequalities in health is discussed in Section 7.2 Equity.
Table 1.10
Decayed, missing or filled teeth at age 12, 1985–2001 (in the Flemish region,  
selected years)
1985 1990 1998 2001
DMFT 3.1 2.7 1.6 0.92 a
Sources: WHO Regional Office for Europe 2009 (August). a Source for the year 2001: De Vos and Vanobbergen 2006.
2
.
 O
rg
a
nizatio
n
al stru
ctu
re
2. Organizational structure 1
2.1 Overview of the health system 
The Belgian health system is based on the principle of social insurance characterized by solidarity between the rich and poor, healthy and sick people and with no selection of risk. The organization of health 
services allows for therapeutic freedom for physicians, freedom of choice for 
patients and remuneration based on fee-for-service payments. Almost the whole 
population (> 99%) is covered for a very broad benefits package. The services 
that are covered by compulsory health insurance are described in the nationally 
established fee schedule (more than 8000 services). Services not included in 
the fee schedule are not reimbursable. Financing is based on progressive direct 
taxation, proportional social security contributions related to income and 
alternative financing related to the consumption of goods and services (value 
added tax). Approximately 20% of the total health care expenditures are paid 
by the patients through official co-payments, supplements and non-reimbursed 
medical acts, drugs and devices. Co-payments are the same for everyone except 
for people with preferential reimbursement status. 
Decision-making in the Belgian health system relies on negotiations between 
several stakeholders. General policy matters concerning health insurance and 
the public health budget are decided by representatives of the government and 
the sickness funds, but also by representatives of employers, salaried employees 
and self-employed workers. An important part of the health system is also 
regulated by national conventions and agreements between representatives of 
health care providers and sickness funds.
In Belgium, responsibilities for health policy are shared between the federal 
level and the federated entities (regions and communities). The federal level is 
responsible for the regulation and financing of compulsory health insurance; 
the determination of accreditation criteria (that is, minimum standards for 
the running of hospital services); the financing of hospital budgets and heavy 
1 This chapter was written by Sophie Gerkens, Maria Isabel Farfan and Stefaan Van de Sande.
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medical equipment (e.g. CT and MRI scanners); legislation covering different 
professional qualifications; and the registration of pharmaceuticals and their 
price control. At the level of federated entities (regions and communities), 
governments are responsible for health promotion and prevention; maternity and 
child health services; different aspects of elderly care, home care, coordination 
and collaboration in primary health care and palliative care; the implementation 
of accreditation standards and the determination of additional accreditation 
criteria; and the financing of hospital investment. To facilitate cooperation 
between the federal level and governments of regions and communities, 
interministerial conferences are regularly organized.
Compulsory health insurance is organized through six private, non-profit-
making national associations of sickness funds and one public national 
association sickness fund. The major responsibilities of the sickness funds are to 
reimburse health service benefits and to represent their members in the National 
Institute for Health and Disability Insurance (NIHDI-RIZIV-INAMI). Since 
1995, Belgian sickness funds have been made more financially accountable 
for the expenditure of their insured members. Private profit-making health 
insurance companies account for only a small part of the non-compulsory 
health insurance market.
Health care is provided by public health services, independent ambulatory 
care professionals, independent pharmacists, hospitals and specific facilities 
for the elderly. Hospital care is provided by either private non-profit-making or 
public hospitals. Most medical specialists work independently in hospitals or in 
private practices on an ambulatory basis. General practitioners (GPs) provide 
ambulatory or primary care. Dentists and pharmacists also generally work 
independently. 
Several measures have been undertaken to increase the accountability of 
health care providers. Some of the new objectives of policy-makers include the 
integration of care and multidisciplinary cooperation; patients’ pathways, care 
programmes and networks have been created.
Fig. 2.1 shows the overview of the health system in Belgium.
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Fig. 2.1
Overview chart of the health system 
Source: Adapted from Corens 2007.
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2.2 Historical background 
Table 2.1 provides an overview of the major health care reforms and policy 
measures from the introduction of the compulsory health insurance system in 
1944 to 2006. Further developments and reforms are described in Chapter 6.
Table 2.1
Major health care reforms and policy measures, 1944–2006
Year of approbation Reform Description
1944 Social security legislation Introduction of compulsory social security for 
salaried workers.
1963 Health Insurance Act Completion of the compulsory social health insurance 
system combined with a private system of medical care 
based on independent medical practice, free choice of 
physician and hospital, and reimbursed fee-for-service 
payment.
1963 Hospital Act Provision of free hospital care for all insured citizens, 
improvement of the quality of hospital care via the use of 
norms and accreditation, insuring financial viability of public 
and private hospitals via a per diem financing system and 
the introduction of planning in the hospital sector.
1967 Practice of Medicine (and Other 
Health Care Professions) Act 
Regulation of medical and paramedical professions.
1980 State reform Devolution of responsibility for preventive health care, 
health promotion, implementation of hospital accreditation, 
and planning, and coordination of home care from the 
national (federal) level to the level of federated entities 
(see Section 2.4 Decentralization and centralization).
1982–1986 Hospital reform Introduction of moratorium on the increase of hospital 
beds, creation of specialized geriatric services in hospitals, 
planned conversion of acute and chronic hospital beds into 
geriatric beds and beds in homes for the elderly and nursing 
homes, introduction of minimum capacity, imposition of 
bed-day quotas.
1986 Hospital financing reform Towards the better allocation of resources between hospitals 
by putting less emphasis on historical costs and more on 
activities, functions and performance.
1989 Financing reform Reform of funding for clinical laboratory tests and medical 
imaging.
1990 Psychiatric care reform Provision of the most appropriate treatment of psychiatric 
patients.
1990 Sickness Funds Act Confirmation of the role of sickness funds as administrators 
of the compulsory health insurance system and 
implementation of increased control on sickness funds.
1993 Health Insurance Reform Act Reform of the NIHDI management structure, introduction of 
a stricter budgetary procedure and expenditure control, and 
measures to reinforce the financial responsibility of the care 
providers.
1993 State reform Devolution of some responsibilities on person-related 
matters from the French community to the French 
Community Commission (COCOF) and the Walloon region. 
Person-related matters include policy on curative and 
preventive care as well as family support services (youth 
protection, social and family support, etc.).
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Year of approbation Reform Description
1994 Reform of sickness funds Increased accountability of sickness funds for 
health expenditure.
1997 Planning for medical supply Determining the number of physicians authorized to practise 
medicine in 2004 and projecting numbers for future years.
1997 Elderly care The federal and federated authorities (regions and 
communities) signed a protocol agreement in order to 
pursue a coherent policy on health care for the elderly. In this 
protocol, they agreed on how health insurance could be used 
by the regions and communities. Two other protocols were 
signed in 2003 and 2005.
1998 Annual right Placing all health insurance beneficiaries under either the 
general scheme or the self-employed scheme, and ensuring 
stability of the health insurance status and entitlements.
1999 Global Medical File Introduction of a Global Medical File (GMD) to strengthen 
the role of primary care.
2001–2002 Pharmaceutical policy reform Introduction of reference pricing for generics, reform of the 
reimbursement procedure, introduction of new rules for the 
removal of products from reimbursement status.
2002 Maximum billing Introduction of a maximum annual ceiling for cost-sharing 
according to social status and the family’s net income.
2002 Euthanasia Legalizing euthanasia. 
2002 Palliative care Law on the definition of palliative care as a right 
for everybody.
2002 Hospital financing reform Introduction of hospital budgets based on the case mix of 
the hospital (“justified activity”), surgical day hospitalization 
included in the hospital budget, introduction of a specific 
budget for university hospitals and monthly payment for 
hospital budgets.
2002 Regulation of patients’ rights Strengthens the legal status of the patient in the 
health system.
2002 Reference amounts in hospitals Introduction of reference amounts for standard surgical 
procedures.
2003 Belgian Health Care Knowledge 
Centre
Foundation of the Belgian Health Care Knowledge Centre 
to support health care policy with objective research.
2003 Reform of the Office for Medical 
Evaluation and Control
Making health care providers individually accountable.
2005 Pharmaceutical policy reform Introduction of a number of reforms to control public 
spending on pharmaceuticals, e.g. introduction of a tender 
process for certain pharmaceuticals and stricter control 
over prescription of pharmaceuticals.
2006 Lump sum financing for hospital 
pharmaceuticals
Introduction of a prospective financing system for 
hospitalized patients.
2006 Federal Pharmaceuticals and 
Health Products Agency
Foundation of the Federal Pharmaceuticals and Health 
Products Agency to ensure the quality, safety and 
effectiveness of pharmaceuticals for humans and animals.
2006 GP Impulse fund I Special fund to support doctors to start up a practice in 
a region with a shortage of GPs.
2.2.1 Health insurance and sickness funds
The origins of the health insurance system can be traced to the late 19th century, 
when workers created mutual benefit societies to protect affiliated members 
against the risk of disease, unemployment and incapacity for work. Small-scale 
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voluntary “mutualities” or sickness funds were organized according to 
employment type without state subsidies. These associations were then made 
official by the state in 1851 and in 1894, more legislation was passed to serve 
as the sickness funds’ legal foundation for about a century. At the beginning 
of the 20th century, the sickness funds were then grouped into national 
associations according to their political or ideological background as follows: 
the National Alliance of Christian Mutualities (1906); the National Union of 
Neutral Mutualities (1908); the National Union of Socialist Mutualities (1913); 
the National Union of Liberal Mutualities (1914); and the Union of the Free 
and Professional Mutualities (1920) (Engels 1970; NIHDI 2007a). The legal 
framework for sickness funds of 1894 was replaced by the 1990 Sickness Funds 
Act, which stipulates the tasks of the sickness funds within and outside the 
compulsory health insurance system, the basic rules for their functioning as 
well as their supervision. This Act was introduced because of political demand 
for stronger democratization of management and more financial transparency.
The principal characteristics of the Belgian health system result from 
decisions made after the Second World War to create a compulsory health 
insurance system based on independent medical practice, free choice of 
health care provider by the patient, fee-for-service payment of providers 
and reimbursement. During the Second World War, important steps were 
taken towards a compulsory social insurance system. On 7 August 1943, 
representatives of employers and trade unions signed a draft Agreement on 
Social Solidarity which laid the foundations for the Social Security Act of 
28 December 1944 that established a social security system compulsory for 
all salaried workers. This law created the NSSO-RSZ-ONSS to collect the 
contributions for all social security sectors, and the National Fund for Sickness 
and Disability to manage health insurance in particular.
One of the main turning points in the history of the Belgian health system 
was the Health Insurance Act of 9 August 1963. This law extended coverage 
under compulsory health insurance within a private system of medical care 
based on the principles of independent medical practice, free choice of physician 
and hospital for the patient, and fee-for-service payment. This law introduced 
the following developments: the so-called “nomenclature”, which lists the 
reimbursed medical services and gives them a relative value; the current NIHDI 
replacing the National Fund for Sickness and Disability; the definition of a new 
category of beneficiaries – including widows, orphans, pensioners and disabled 
people – having a preferential reimbursement rate for health care costs; and 
the current system of conventions and agreements between representatives of 
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sickness funds and of health care providers. Further details about elements 
introduced by this law and the reaction of physicians can be found in the 
Belgium HiT 2007 (Corens 2007).
The Belgian health insurance system has gradually evolved towards universal 
coverage. In 1964, the self-employed were obliged to insure themselves against 
major risks2 in medical care. Health insurance coverage was extended to public 
sector workers for both major and minor risks3 in 1965; to those physically 
incapable of working in 1967; to the mentally ill in 1968; and to everyone 
not yet protected in 1969. From 1998, all beneficiaries of compulsory health 
insurance were covered either under the general scheme (for minor and major 
risks) or the scheme for self-employed workers (for major risks) and since 2008, 
all beneficiaries are covered for both minor and major risks.
In the 1980s, 1990s and 2000s, many reforms attempted to control the supply 
of health care and to increase the financial responsibility of the main actors 
in the system. In 1991, a fixed budget for each subsector of health care was 
introduced into the health insurance system. If the budget limits were surpassed, 
correction mechanisms would be activated. This cost-controlling reform 
represented a fundamental change in government policy towards health care 
from the previous demand-led funding strategy. A more extensive reform of the 
budgetary procedures was introduced in 1993, when the system of compulsory 
health insurance was thoroughly reformed. In 1995, a real growth norm of 
health expenditures fixed at 1.5% per year was introduced. This norm was then 
raised to 2.5% in the period from 2000 to 2003 and to 4.5% since 2004. In 1995, 
sickness funds were also made partially financially accountable for their health 
care expenditures. Additional reforms undertaken to increase the accountability 
of the main actors of the system are described in Section 2.6.3 Mechanisms to 
ensure the quality of care, and in Chapter 6.
2.2.2 Health care facilities
Hospitals had opened in Belgium as early as the 12th century in the case of 
Saint Jan’s Hospital in Bruges and Elisabeth’s Hospital in Antwerp, but until 
1963 hospital legislation had been limited. In 1963, the government decided to 
regulate the hospital system via specific legislation rather than include hospitals 
in the Health Insurance Act. The 1963 Hospital Act had four objectives: to 
provide open-access hospital care for all citizens; to improve the quality of 
2 Major risks include hospital care, delivery of babies, major surgery, dialysis functional rehabilitation care, 
implantable medical devices and specialist care, among others. 
3 Minor risks include physicians’ visits, dental care, minor surgery, home care and pharmaceuticals for outpatient 
care, among others.
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hospital care via the use of norms and accreditation criteria; to ensure the 
financial viability of public and private hospitals via a per diem financing 
system; and to introduce planning in the hospital sector. It should be noted that 
this hospital act did not determine the financing of medical, medico-technical 
and paramedical services (chargeable to the compulsory health insurance 
system). Physicians are paid for their medical services separately from the 
hospital and then they cede part of their fees to help finance the operating 
costs of medical activities in the hospital. The physicians’ contribution to 
the operating cost would depend on the general agreement between hospital 
management and hospitals’ physicians (see also Section 3.6.2 Paying health 
care professionals) (Van de Sande et al., 2010).
In 1973, a system of mandatory hospital planning was introduced to remedy 
the estimated surplus of hospital beds and to reorient hospital provision towards 
areas which were underserved. It was necessary for hospitals or a particular 
hospital service to follow the hospital planning framework in order to obtain 
accreditation.
In 1982, a moratorium on the number of general hospital beds was introduced 
such that the number of beds on 1 July 1982 cannot be exceeded. The National 
Council for Hospital Supplies was also established to give advice to the federal 
government in the field of planning, accreditation and financing of hospitals. 
Also in the 1980s, the government introduced a policy of concentration 
whereby every hospital had to maintain a minimum of 150 beds spread across 
at least three departments, or else close or merge with another hospital. Specific 
financial incentives were created to promote hospital mergers. 
Hospital financing was also significantly reformed from the 1980s. 
Prospective financing in this sector was introduced in 1986. Prior to this, 
hospitals received a fixed per diem payment for each patient-day. As of 1982, 
a patient-day quota was imposed on hospitals based on number of beds and a 
normative rate of occupancy. Since 1991, different measures have also been 
put in place in order to better account for the activities of hospitals and to 
progressively reduce the historical component of the budget.
Moreover, incentives have been created to improve hospital efficiency. In 
1994, diagnosis-related groups (DRGs) were introduced into the hospital budget 
in order to reward or penalize financially those hospitals that make use of their 
beds in more or less efficient ways. Since 1995, the hospital budget has been 
based on patient characteristics, such as type of pathology, age (more or less 
than 75 years) and the nature of the stay. Hospital performance with regard 
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to length of stay is measured by the difference between the actual length of 
stay and the national average according to the three factors mentioned above. 
Hospitals with an average length of stay for all patients that is greater than that 
of the sample of all Belgian patients see their budget decrease in favour of those 
hospitals with a shorter length of stay. 
Since 2002, hospital budgets have been based on the case mix of the hospital 
(‘justified activity’); surgical day hospitalization is included in the hospital 
budget; a specific budget for university hospitals has been introduced; and the 
hospital budgets are paid each month (see Section 3.6 Payment mechanisms). 
In order to address significant differences in medical practice between 
hospitals, which can not be explained medically, a system of reference amounts 
for standard interventions was also introduced in 2002 (see Section 2.6.3 
Mechanisms to ensure the quality of care). Incentives were also created for 
hospitals within the hospital financing system to rationalize supply, to create 
complementarities between different hospital sites or to reduce their number of 
beds (see Section 2.6.3 Mechanisms to ensure the quality of care).
Reforms on the financing of pharmaceuticals in hospitals were also 
undertaken. In 1997, the first step was taken towards the prospective financing 
of pharmaceuticals in hospitals through the introduction of a fixed sum for the 
prophylactic use of antibiotics for surgical interventions. The fixed sum covers 
75% of the costs for antibiotics that are administered to hospitalized patients 
the day before, on the day of and the day after a surgical intervention. For the 
remaining 25%, the antibiotics remain reimbursed per product. Since July 2006, 
a system of lump sum payment per hospital stay applies for pharmaceutical 
products administered in acute hospitals (see also Section 5.6 Pharmaceutical 
care).
Furthermore, there has been a progressive shift in Belgium from general 
hospitals towards other structures. In 1982, the first nursing homes were created 
with the explicit intention to create an intermediary structure between a home 
for the elderly and a hospital. Financial incentives were also provided to convert 
acute and chronic hospital beds into geriatric beds and beds in homes for the 
elderly and nursing homes. These measures were not intended to have any 
impact on access to services for the elderly, as beds were not closed but only 
altered in status. An important reform was also carried out in the psychiatric 
sector in 1990, aimed at cutting back on psychiatric hospital beds; instead, 
new provisions aimed to stimulate the social integration of patients. The new 
initiatives arose as a reaction to the increasing tendency to offer chronic patients 
appropriate care outside of psychiatric hospital. Alternative facilities for 
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mental health care were created, such as psychiatric nursing homes, sheltered 
accommodation and home care. The reform also aimed to improve the quality 
of residential care by resisting large-scale operations and developing a better 
regional distribution in the supply of mental health care facilities. In addition, 
the focus shifted somewhat from prevention to treatment. Also, a policy reform 
of 1999 aimed to improve intensive and specialized care in psychiatric hospitals, 
set up cooperation between the intramural and extramural sectors, and further 
shifted hospital and elderly care beds to psychiatric nursing homes and places 
of sheltered accommodation (see also Chapter 5 for more reforms). 
More recently, incentives to promote the integration of care between 
organizations and multidisciplinary cooperation between health care providers 
have also been undertaken (see Section 2.6.3 Mechanisms to ensure the quality 
of care and Chapter 6.
2.3 Organization
Numerous public authorities are responsible for the funding of health care and 
the oversight of its organization. The division of responsibilities mirrors the 
fragmented structure of the Belgian state. Since the early 1980s, elements of 
responsibility for health care have been devolved to the communities. However, 
devolution is limited, especially for curative medicine, for which the federal 
authorities remain responsible.
Fig. 2.2 shows the organization of the health system at the federal level and 
the level of federated entities, with the most important departments, agencies 
and advisory bodies. Their roles are detailed in the next sections. Only the 
most important advisory bodies are mentioned here. In reality, there are about 
150 official commissions in the Belgian health care sector (Peers et al. 1999). 
2.3.1 Federal level
At the federal level, the parliament is the legislative body. The federal government 
and the Minister of Social Affairs and Public Health are the executive bodies. 
The federal authorities are described in the following subsections (see also 
Section 2.4 Decentralization and centralization).
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Fig. 2.2
Organization of the health system 
Note: (*) (**) (***)To allow the French and Flemish communities to pursue community policies in the bilingual territory of the 
Brussels-Capital Region, three institutions have been created: the VGC, the COCOF and the GGC-COCOM. (*)The VGC is under  
the Flemish community supervision and only plays an additional role (no transfer of competences). (**) The French community  
has transferred some person-related competences to the Walloon region and the COCOF. (***)The GGC-COCOM is responsible  
for matters relating to the two communities.
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The FPS Health, Food Chain Safety and Environment
The Federal Public Service (FPS) Health, Food Chain Safety and Environment 
is accountable to the Minister of Social Affairs and Public Health and consists 
of four departments: Health Care Facilities Organization; Primary Health 
Care and Crisis Management; Animal, Plant and Foodstuffs; and Environment 
(see Fig. 2.3). 
Fig. 2.3
Organization of the FPS Health, Food Chain Safety and Environment 
The Health Care Facilities Organization department is in charge of the 
organization, planning rules, recognition criteria, evaluation of the quality of 
medical and nursing practices in health care facilities, registration of data and 
financing of inpatient health care facilities, as well as the implementation of 
patients’ rights. This covers hospitals (acute, specialized, geriatric, psychiatric 
and university hospitals), homes for the elderly and nursing homes, psychiatric 
rest homes and sheltered accommodation, and cooperative ventures. 
Directorate-General
Health Care Facilities
Organization
Financing
Acute hospital policy, 
care for the elderly 
and the chronically ill
Mental health care 
Data registration
Legal management 
and patient rights
Directorate-General
Primary Health Care and 
Crisis Management
Health professionals
Legal management
Crisis management
Medical commissions 
and health inspection
International and 
strategic coordination
Saniport 
(airports and ports)
Directorate-General 
Animals, Plants and 
Foodstuff
Pesticides 
and fertilizers
Sanitary policy, 
animals and plants
Nutrition, food, 
feed and other 
consumer products
Animal welfare 
and CITES
Inspection of animal 
welfare, CITES and 
consumer products
Directorate-General 
Environment
Health systems in transition  Belgium 27
The responsibilities of the Primary Health Care and Crisis Management 
department include the recognition and planning of activities for health care 
professionals, and designing a policy for the prevention and monitoring of 
health crises, including crisis scenarios, emergency plans and organization of 
relief. In addition, this department is also responsible for the organization of 
emergency medical assistance. Other competences involve following up on 
the international health situation and the policy concerning infectious diseases. 
The Animal, Plant and Foodstuffs department is responsible for policies, 
notification, standardization and inspection in the domains of food, food chain 
safety, alcohol, tobacco, cosmetics and pesticides (FPS Health, Food Chain 
Safety and Environment 2009a).
The Environment department is responsible for matters concerning climate 
change, biodiversity and genetically modified organisms, marine environment, 
chemical substances, electromagnetic fields, products’ inspection and 
environmental rights.
The FPS Social Security
The FPS Social Security sits at the crossroads of all legislation that contributes to 
the social security of citizens. The FPS Social Security ensures that everybody 
appropriately enjoys social rights and aims to ensure the viability of a system of 
support and solidarity that is as efficient as it is fair. This FPS is also in charge 
of the recognition of benefits for disabled people (FPS Social Security 2009d).
The National Social Security Office (NSSO)
The NSSO is the central institution in the social security system for private 
sector employees and most civil servants. It is managed by a management 
committee composed of an equal number of representatives of the trade unions 
and the employers’ organizations, under the control of the Minister of Social 
Affairs and Public Health. For aspects relating to unemployment insurance, the 
Minister of Labour also controls the NSSO.
The NSSO collects both the employers’ and the employees’ social security 
contributions and redistributes the social security budget to the payment 
institution for each social security sector (i.e. the NIHDI for health insurance). 
The NSSO also collects and redistributes administrative data to the other social 
security institutions. 
Self-employed workers pay their own social insurance contributions to the 
social insurance fund to which they are affiliated, which in turn forwards the 
funds to the National Institute for the Social Security of the Self-employed 
(NISSE-RSVZ-INASTI). The National Social Security Office for the Local 
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and Provincial Administrations (NSSOLPA-RSZPPO-ONSSAPL) collects 
social security contributions for the civil servants of the local and provincial 
authorities. For other “small” schemes, there are also specific collection agencies, 
such as the Overseas Social Security Office (OSSO-DOSZ-OSSOM) for people 
working abroad and having paid a contribution (FPS Social Security 2006; 
NSSO-ONSS 2009).
The National Institute for Health and Disability Insurance (NIHDI)
The NIHDI is a public social security institution accountable to the Minister of 
Social Affairs and Public Health. This institute is responsible for the general 
organization and financial management of the compulsory health care and 
benefits insurance. Its most important tasks are: 
• to organize reimbursement of medical costs; 
• to ensure a replacement income in case of incapacity; 
• to elaborate legislation and regulation; 
•  to prepare the budget and to make sure that activities of health care 
providers and sickness funds are appropriately financed; 
• to monitor the evolution of health care spending; 
• to inform health care providers, sickness funds and the insured, and to 
ensure they apply the legislation and regulation correctly; and
• to organize the negotiations between the different actors involved in 
compulsory health insurance. 
The NIHDI is composed of five departments: the Health Care Department; 
the Department for Medical Evaluation and Inspection; the Benefits 
Department; the Department for Administrative Inspection; and the General 
Support Departments (see Fig. 2.4) (De Cock 2007; NIHDI 2009d).
The Health Care Department is charged with the administrative and financial 
management of compulsory health insurance. This department determines 
the reimbursement criteria, establishes and monitors the budget, informs the 
health care providers, promotes the quality of care for physicians and organizes 
negotiations between different actors involved in compulsory health insurance. 
This department is managed by the General Council and the Committee for 
Health Care Insurance. 
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Fig. 2.4
Organization of the NIHDI 
The Department for Medical Evaluation and Inspection informs the health 
care providers about the correct application of the health care and benefits 
insurance regulation, more specifically to prevent administrative errors. It 
evaluates the professional practice of a group of health care providers by 
examining the use of health care services. It verifies whether the services 
performed by the health care providers and the prescribing of medicines are 
correctly carried out and are in line with the rules of the health care and benefits 
insurance regulation. The inspection also encompasses the incapacity for work 
and the accumulation of incapacity for work benefits with the practice of a 
non-allowed activity.4
The Benefits Department is in charge of determining criteria and guidelines 
concerning benefits in case of incapacity for work, and in case of maternity, 
paternity or adoption leave.
4 Activities which may have an economic impact on society are not allowed for people with incapacity to work; 
however, it is possible (under certain conditions) for those with incapacity to work to undertake professional 
activity and earn an income for the work with prior authorization of the medical adviser of the sickness fund.
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The Department for Administrative Inspection is responsible for monitoring 
legal and other regulations of the sickness funds. This department is also in 
charge of sanctioning non-adherence to the rules.
The General Support Departments offer “strategic” support to the other 
departments of the NIHDI (human resources management, ICT support, etc.).
In the General Council, decision-making power is shared between the 
financial contributors to the system (government, employers, salaried 
employees and self-employed workers) and the sickness funds. Representatives 
of health care providers have an advisory role. The General Council decides 
on general policy matters concerning health insurance, approves the annual 
global budget target for health benefits on the basis of a proposal from the 
Committee for Health Care Insurance, establishes the budget of the health 
insurance, determines the distribution of the budget for the different health 
care sectors and monitors the financial balance of the health insurance. The 
government has a power of veto over decisions made in the General Council 
(De Cock 2007; NIHDI 2009d).
The Committee for Health Care Insurance reports to the General Council 
and is made up of an equal number of representatives of sickness funds and 
health care providers. Representatives from employer and employee (salaried 
and self-employed) organizations and representatives of the government 
have an advisory role. One of the tasks of the Committee for Health Care 
Insurance is drafting the annual global budget target for the General Council. 
This committee also decides on the transmission of proposals to modify the 
nomenclature of health benefits and approves agreements and conventions, 
subject to the decision of the General Council.
Moreover, the following structures play an important role in the Health Care 
Department: the Commission for Budgetary Control; the Scientific Council; 
and the College of Medical Officers. 
The Commission for Budgetary Control oversees funding and expenditures, 
alerts the General Council when budget limits are exceeded and proposes 
measures to respect the budgetary target. This Commission is composed of 
representatives of sickness funds and health care providers, representatives 
from employer and employee (salaried and self-employed) organizations and 
representatives of the government. The Scientific Council gives scientific 
advice and recommendations in relation to health care insurance and quality of 
care. The College of Medical Officers plays an important role in the regulation 
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of the rehabilitation sector. This College is also responsible for the management 
of the Special Solidarity Funds (see Section 3.4.3 Fixed payments to patients) 
(De Cock 2007; NIHDI 2009d).
There are various other committees within the Health Care Department, 
most notably the Committees on Conventions and Agreements, which negotiate 
fees between insurers and health care providers. One example is the National 
Committee of Representatives of Physicians and Sickness Funds. These 
committees are assisted by technical councils that are responsible for helping 
to define services that should be delivered (e.g. the Technical Pharmaceutical 
Council, the Technical Medical Council and the Technical Dental Council). 
There is also the National Council for Quality Promotion, composed of 
representatives of physicians, the universities, the scientific medical associations, 
the sickness funds and the Minister of Social Affairs and Public Health (see 
Section 2.6.2 Regulation of providers), and the Committee for the Evaluation 
of Medical Practices for Drugs which focus on prescribing quality.
Sickness funds
The NIHDI oversees the general organization of compulsory health insurance; 
however, the task of actually providing insurance falls to the sickness funds. 
Sickness funds receive their financial resources from the NIHDI. Sickness 
funds are private non-profit-making organizations with a public interest mission. 
They are active members of both the executive and the advisory committees 
of the NIHDI. They are also in charge of medical auditing: they verify that 
services have really been carried out and that the fees charged conform to 
regulations (see also Section 2.6.1 Regulation of third-party payers).
The Federal Agency for Medicines and Health Products 
The Federal Agency for Medicines and Health Products (FAMHP-FAGG-
AFMPS) ensures the quality, safety and effectiveness of pharmaceuticals for 
humans and animals. The main tasks of the agency are: 
• to control the risk to which patients are exposed during the development 
stage of a pharmaceutical;
• to evaluate applications to bring a new pharmaceutical on the market;
• to distribute licences for trading pharmaceuticals;
• to collect and evaluate all relevant information to trace, diminish and 
avoid possible side-effects for the user;
• to control the production, distribution and delivery of pharmaceuticals;
• to spread information on the best use of pharmaceuticals; and
• to supervise advertising on pharmaceuticals.
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The Supervising Authority for Sickness Funds and National Associations 
of Sickness Funds
General control over the sickness funds and the national associations of 
sickness funds is exercised by the Supervising Authority for Sickness Funds 
and National Associations of Sickness Funds. The Supervising Authority is a 
public agency under the supervision of the FPS Social Security, established in 
1990. The Supervising Authority oversees the services and activities established 
by the sickness funds and their associations, ensuring that they are in agreement 
with the Sickness Funds Act and that administrative, accounting and financial 
regulation is respected. Furthermore, the authority supervises the valid 
composition and functioning of the general assemblies and governing boards 
of the sickness funds and the national associations. The authority submits a 
report to the General Council of the NIHDI regarding their tasks as relevant 
to the regulations of the compulsory health insurance. A report is compiled 
annually concerning the activities and the financial situation of the sickness 
funds and their national associations (Supervising Authority for Sickness Funds 
and National Associations of Sickness Funds 2006). 
In 1993, the powers of the Supervising Authority were extended as a 
result of the financial responsibility of the sickness funds (see also Chapter 3 
Financing). The Supervising Authority was, among other things, charged with 
the evaluation of the management performance of the sickness funds.
The Federal Agency for Nuclear Control
The mission of the Federal Agency for Nuclear Control is to ensure that the 
population and the environment are effectively protected against the dangers 
of ionizing radiation. The Federal Agency is concerned with determining basic 
standards for radiation protection, the regulation of classified facilities, control 
of facilities, the transport and import of radioactive substances, radiological 
monitoring of the territory, the emergency plan, medical applications of ionizing 
radiation and natural radioactivity.
Consultative bodies
The Scientific Institute of Public Health (IPH-WIV-ISP) is a federal research 
institute in public health. It consists of four operational directions: communicable 
and infectious diseases; food, medicines and consumer safety; public health and 
surveillance; and expertise, service provision and customer relations. The main 
tasks of the IPH are health promotion and disease prevention by providing the 
federal and federated governments with knowledge based on scientific evidence. 
The main activities are the surveillance of communicable and noncommunicable 
diseases (e.g. AIDS, hepatitis, newly emerging and re-emerging infections); the 
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verification of federal product norms (e.g. food, pharmaceuticals and vaccines); 
risk assessment (e.g. chemical products, genetically modified organisms); 
management of biological resources (collections of strains of micro-organisms); 
gaining insight into the population’s health status and its determinants; and 
coordinating health information. 
The direction on public health and surveillance is involved in Health Services 
Research in different health care settings with a focus on primary care, diabetes 
care and care for specific conditions, such as mucoviscidosis or neuromuscular 
diseases. The direction works with hospitals and nursing homes in the domain 
of prevention of health care associated infections, antibiotic consumption and 
antibiotic-resistance. Infectious diseases in the general population are monitored 
through registers, sentinel laboratory surveillance systems and a network of 
reference laboratories. The direction is responsible for several health-related 
surveys in Belgium of which the HIS is the most important. In 1997, the first 
HIS, involving 10 000 respondents, was organized to evaluate the health status, 
lifestyle and use of health care services in Belgium (Van Oyen et al. 1997). The 
survey has been regularly repeated since then (in 2001, 2004 and 2008) (see 
also Section 2.5.2 Information systems). Inequality in health is a major theme 
in several research programmes of the direction. Finally, the direction provides 
to the different Belgian authorities a 24/7 duty call system for epidemiological 
support in case of a public health emergency. 
The National Council for Hospital Supplies is composed of stakeholders 
from the hospital sector. It plays an important role in the formation of Belgian 
health care policy by advising the Minister of Social Affairs and Public 
Health on issues related to hospital planning, accreditation and financing. The 
National Council for Hospital Supplies consists of two departments: planning 
and accreditation, and hospital financing. The main responsibilities of the 
planning and accreditation department are: setting up the planning criteria for 
different types of hospitals, hospital services and hospital groups; authorizing 
the installation of high-technology medical equipment and drawing up the 
appropriate standards; defining the rules and regulations for reducing a 
surplus of beds; drawing up the accreditation requirements for hospitals and 
hospital services; determining the rules for the general planning of hospitals; 
and organizing and implementing hospital services. The recommendations 
of the department for hospital financing are primarily related to the budget 
for financial resources, accounting matters and the financing of hospital 
construction and renovation.
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The multipartite consultation structure for hospital policy has existed 
since 1996; however, it was reformed in 2002 with clearly defined advising 
responsibilities. The goal of this consultative structure is to build bridges 
between the NIHDI (providing insurance for inpatient care) and the FPS Health, 
Food Chain Safety and Environment (responsible for the organization and 
quality regulation of inpatient care) to improve administration in the hospital 
sector. Within this structure, an equal number of hospital physicians, hospital 
administrators and sickness fund representatives consult with each other and 
give advice on matters which concern both the hospital budget and the fee-for-
service system for physicians (such as radiotherapy, MRI and positron emission 
tomography (PET)). They also have an important advisory role in the regulation 
of the system of reference amounts for standard interventions (see Chapter 6), 
the reimbursement of pharmaceuticals in hospitals, the financing of endoscopic 
and viscerosynthesis material, and the evaluation of the hospital admission 
policy.
The Belgian Health Care Knowledge Centre (KCE) was set up in 2002 to 
provide scientific support to health care decision-makers and became active 
in 2003. The KCE is scientifically and professionally independent but works 
together with all main stakeholders in the health care sector, universities, other 
scientific institutions and international organizations. The KCE is active in 
producing recommendations and carrying out research in the following areas: 
the analysis of clinical practice and the development of guidelines for Good 
Clinical Practice (Good Clinical Practice); the assessment of medical technology 
and medicine (health technology assessment (HTA)); and the study of health 
care organization and financing (Health Services Research, including research 
on equity and patient behaviour). The KCE is neither involved in the policy 
decisions themselves nor in their implementation. Its mission is more to suggest 
the most effective solutions and to work towards greater accessibility of high 
quality care, taking into account both growing need and budget limitations. 
The Superior Health Council is the link between government policy and 
the scientific community in the field of public health. The Council provides 
independent advice and recommendations to the Minister of Social Affairs 
and Public Health, on the Minister’s specific request for information or on 
its own initiative. The Superior Health Council is competent on all matters 
related to public health; in particular, it deals mostly with the following areas: 
mental health (e.g. behaviour, addiction, psychosocial factors in public health, 
training professionals and psychotherapy), physical and chemical environment 
(e.g. ionizing radiation, nonionizing radiation, noise pollution, chemicals, 
pollutants, biocides and pesticides), nutrition (e.g. healthy eating, additives, 
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safety, packaging, novel foods, contaminants and microbiology), and biological 
problems (e.g. infectious diseases, vaccines and hygiene issues). The council 
has 90 members and an indeterminate number of invited members. They are 
drawn mostly from university and governmental circles and appointed on the 
basis of their specialist knowledge.
The National Council of Nursing provides independent advice and 
recommendations to the Minister of Social Affairs and Public Health on 
all matters relating to the art of nursing and particularly on the practice of 
nursing and required qualifications. The National Council of Nursing may also 
give an opinion to the community authorities on any matter relating to the 
education and training of nurses. The Council is composed of representatives 
of nurses, physicians, the competent authorities in the field of education and 
representatives of the Minister.
2.3.2 Federated authorities
Flemish community
For the Flemish community, the Flemish Agency for Care and Health of the 
Flemish Ministry of Welfare, Public Health and Family is responsible for the 
development, implementation and evaluation of policies concerning regional 
health and care responsibilities. The agency is charged with the programming, 
accreditation and funding of facilities for elderly care, and general and mental 
health care in the area of public health and welfare. In the context of the 
implementation of the preventive health policies, the agency develops and 
implements projects and programmes; recognizes and subsidizes initiatives for 
the implementation of projects and programmes; and coordinates and monitors 
vaccination programmes and prophylaxis of infectious diseases. It conducts 
inspections, gives advice on environmental permits, and handles complaints 
and incidents in the field of public health. Additionally, the agency manages 
the Flemish Care Insurance Scheme (Vlaams Zorgverzekering).5 The objectives 
of the Flemish Agency for Care and Health are to promote healthy lifestyles; 
prevent diseases, including related risk factors and complications; optimize the 
performance of health and care facilities; adjust the supply of health and care 
facilities to meet the needs of the population; provide accessible and affordable 
care; and strengthen the active participation and correct treatment of users 
of care.
5 The Flemish Care Insurance Scheme is a compulsory insurance scheme for everybody who lives in Flanders and 
is older than 25 years (since October 2001). This insurance provides partial or full coverage for nonmedical care 
services from professional care providers or informal carers to those who need it. The Flemish Care Insurance 
pays an allowance to people who have a significantly decreased ability to take care of themselves and who 
need residential treatment, partial residential treatment or treatment at home (Vlaams Agentschap Zorg en 
Gezondheid 2010a). 
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Other agencies responsible for health and welfare in Flanders are: the Child 
and Family Agency (K&G); the Youth Welfare Agency; the Flemish Agency 
for People with Disabilities (VAPH); and the Welfare, Public Health and Family 
Inspectorate Agency. K&G is responsible for organizing preventive health care 
for children under 3 years of age and supporting parents and families in the 
care of young children. The Welfare, Public Health and Family Inspectorate 
Agency is responsible for inspecting all health and care services recognized by 
the Flemish government. To this end, it monitors compliance with regulations 
and ensures that government resources are spent legitimately and transparently.
French community
For the French community, public health policies are administered by the 
Directorate-General of Health within the Ministry of the French Community. 
The following agencies are also involved in public health policy in the French 
community: the Birth and Childhood Organization Office (ONE) and the 
Superior Council of Health Promotion. The Superior Council of Health 
Promotion provides advice to the government on health promotion and 
preventive health care. 
Since 1993, some responsibilities of the French community have been 
devolved to the Walloon region (see Section 2.4 Decentralization and 
centralization). For example, at the Ministry of the Walloon Region the 
Directorate-General of Social Action and Health is responsible for policies 
regarding hospitals, homes for the elderly and nursing homes.
The French community also transferred responsibility on the integration of 
people with disabilities to the Walloon region and to the COCOF for the French-
speaking population of the region of Brussels-Capital (see also Section 1.3 
Political context). The Walloon Agency for People with Disabilities (AWIPH) 
is responsible for carrying out the Walloon policy and the agency for French-
speaking people with disabilities (Personne Handicapée Autonomie Retrouvée, 
PHARE) is responsible for carrying out the policy of the COCOF. A Regional 
Health Observatory was also set up in the Walloon region to improve health in 
the region and to contribute to health information.
German-speaking community
For the German-speaking community, the Department of Cultural and Social 
Affairs of the Ministry of the German-speaking Community is responsible for 
matters related to public health and health promotion. The German Agency 
for People with Disabilities (DPB) is responsible for carrying out the German 
policy on the integration of people with disabilities.
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2.3.3 Intergovernmental level
Since the devolution of public health policy to the communities in 1980, 
so-called interministerial conferences have been regularly organized to 
facilitate cooperation between the federal government, the communities and 
the regions. The interministerial conferences are composed of the ministers 
responsible for health policy from the federal and federated governments. 
These conferences have no binding decision-making power, but they are the 
ideal forum for smooth and efficient consultation between the governments, 
with respect for the autonomy of each of them. Within the framework of the 
interministerial conferences for health policy, protocol agreements have been 
made concerning the most divergent problems in the field of public health. 
The most important protocols are related to long-term and elderly care, home 
care, mental health care, the organization of cancer screening (breast cancer 
and colorectal cancer), the harmonization of vaccination policy, the food plan, 
the organization of the health survey, the policy on drug abuse, the hepatitis B 
prevention policy and the control of the number of hospital beds.
2.3.4 Nongovernmental bodies
Belgian health care organization and policies are highly influenced by a number 
of nongovernmental stakeholders including the Order of Physicians, health 
professionals’ associations, hospital associations, pharmacists’ associations, 
the Order of Pharmacists, the pharmaceutical industry, trade unions, employer 
organizations and others. Patients’ associations are also beginning to have an 
impact on health policy (see Section 2.7 Patient empowerment). Not only do 
these stakeholders influence health care policy by traditional lobbying, they are 
also directly involved in the management of the system, mostly by membership 
on one or more of the executive councils or committees in the NIHDI, and are 
represented in different advisory bodies. Some of the larger or more influential 
of these stakeholders are described below.
Within the health insurance management bodies, health care providers are 
represented by different professional associations (physicians, dentists and 
physiotherapists). Their representation is determined on the basis of elections 
which are organized every four years. All health providers can take part in 
these elections irrespective of whether they are members of a professional 
organization or not. In 2006, the Committee for Health Care Insurance of the 
NIHDI decided to give public funding to some professional associations. 
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The Order of Physicians is an organization that self-regulates the Belgian 
medical profession. Every Belgian physician must be registered on the list of 
the council of the Order of Physicians in the province where he/she is active. 
The most important function of the provincial councils is to ensure observance 
of the rules of professional conduct for physicians and preservation of the 
reputation, standards of discretion, probity and dignity of the members of the 
Order. To this end, the councils are responsible for disciplining any misconduct 
committed by their registered members in, or in connection with, the practice 
of the profession, as well as serious misconduct committed outside the realm 
of professional activity, whenever such misconduct is liable to damage the 
reputation or dignity of the profession. 
The national council of the Order of Physicians is responsible for establishing 
the general principles and rules concerning the morality, honour, discretion, 
honesty, dignity and devotion indispensable to the practice of medicine. Together 
these principles and rules form the code of professional ethics. This code also 
stipulates rules concerning continuity of care, medical secrecy, handing over of 
medical data to colleagues and individual relations between physicians and their 
patients, colleagues, dentists, pharmacists and allied health professionals. The 
Order has its own disciplinary system that can impose various sanctions, such 
as warning, censure, reprimand and suspension of the right to practise medicine.
2.4 Decentralization and centralization 
The devolved structure of regions and communities has developed as a result 
of several revisions to Belgium’s Constitution since it was originally drafted 
in 1831. Important constitutional reforms were carried out in 1970, 1980, 1988 
and 1993. The process of devolution has resulted in a shift in responsibilities 
from the national level to the communities and the regions. The federal state is 
now responsible for foreign affairs, national defence, justice, fiscal policy, social 
security, and a share of public health and domestic affairs. The three regions 
are responsible for territorial matters, such as policy on the economy, energy, 
agriculture, environment, urban planning, subordinate authorities, employment, 
housing, public works and public transport (Belgium Federal Portal 2009). The 
three communities are responsible for so-called person-related matters, such 
as education, cultural affairs, language, and health and welfare, insofar as they 
are not part of the social security system. 
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Since the Institutional Reform Act of 1980, in which person-related 
matters were transferred to the communities, health care policy has been a 
responsibility of both the federal state and the communities. The Institutional 
Reform Act defines the person-related matters in the sphere of health care 
policy as intramural and extramural curative health care and policy regarding 
health education, health promotion and preventive health care. Concerning 
the competences for intramural and extramural health care, the law provides 
important exceptions, as a result of which the federal government has kept the 
most important powers.
In the field of health care, the federal authorities determine the general 
legislative framework for the health system by issuing laws and by drawing up 
the annual budget. They are responsible for the regulation of the compulsory 
health insurance; the determination of the overall budget for health care; the 
determination of norms and standards for granting accreditation to hospitals, 
nursing homes and heavy medical equipment units (which allow them to be 
reimbursed by the health insurance); the financing regulations concerning 
operating costs of hospitals and nursing homes; the planning and financing 
regulation of the health care infrastructure and of heavy medical equipment 
units; the granting of university hospital status; the legislation covering 
professional qualifications and remuneration; the control of health care 
technology; the regulation of pharmaceuticals and their price control; and the 
management of urgent medical assistance. In the field of preventive health care, 
the federal state also remains responsible for compulsory polio vaccinations and 
the protection of the population against ionizing radiation.
The most specific health competences of the communities lie in the domains 
of health promotion, health education and preventive health care. This includes 
mandatory notification of infectious diseases; outbreak investigation and control 
of infectious and non-infectious diseases; management of the free (childhood) 
vaccination programme; complaints and incident management in environmental 
public health; environmental licence procedures; different kinds of information 
and awareness campaigns; data collection, such as on mortality and natality; 
the organization of medical screening; and control activities, such as medical 
school surveillance, medical sports inspections and occupational health control. 
Most of the budget is nevertheless invested in inpatient and ambulatory 
care policy. The communities are responsible for: defining priorities related to 
investments in construction and heavy medical equipment; granting permission 
and subsidies for the establishment, conversion and equipping of services as 
well as for heavy medical equipment; the inspection and closure of medical 
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facilities (hospitals, homes for the elderly and nursing homes, mental health 
services) as well as their internal organization and reception, to the extent that 
this does not affect operating expenses. The communities are responsible for 
the determination and implementation of accreditation standards for homes 
for the elderly and mental health services, and for the implementation of the 
accreditation standards determined at the federal level for hospitals and nursing 
homes. For the latter (hospitals and nursing homes), the communities can set 
additional accreditation standards if they do not have any effect on the finances 
supported at the federal level. With regard to mental health services, the 
communities are also fully responsible for the funding of the centres for mental 
health care. Regarding outpatient care policy, the communities are responsible 
for coordinating and setting accreditation standards for home care services and 
for cooperation initiatives in primary health care and palliative care. 
It should be noted that the French community exercises its health competence 
partly throughout the French community (prevention, health promotion, 
collection of data in several areas) and throughout the Walloon region for the 
other matters (homes for the elderly, mental health, health infrastructures, front-
line health services and care) except for the German-speaking area.
The health care responsibilities of the provinces and municipalities 
are limited. Each of the ten provinces has a provincial health officer, who 
represents the federal Minister of Public Health in the field of public hygiene 
and whose responsibilities include taking necessary actions in cases of acute 
communicable diseases and the administration of the provincial medical 
commissions. These commissions have a general advisory function and they 
may take any measure necessary to deal with contagious diseases. Moreover, 
provincial medical commissions are responsible for: controlling the authenticity 
of the diplomas of physicians, pharmacists, dentists, physiotherapists, nurses 
and paramedics; supervising the practice of medicine, nursing and paramedics; 
and determining the need for organizing on-call duties for physicians during 
nights and weekends. Municipalities are responsible for organizing social 
support for low-income groups, the organization of emergency care and public 
hospitals.
As shown in Section 3.2 Sources of revenue and financial flows, expenditures 
of the federal, federated (communities and regions) and local authorities 
accounted in 2006 for 68%, 1.5% and 2% of total health expenditures 
respectively. 
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2.5 Health information management
2.5.1 HTA
A number of initiatives have been undertaken in the field of HTA to improve 
the scientific support of health care policy. 
In 1992, a Scientific Council was set up within the Health Care Department 
of the NIHDI. The Scientific Council has been required to research the scientific 
aspects of health insurance and to examine the quality of health care. It has two 
departments: the committee for the evaluation of medical practice concerning 
pharmaceuticals and the committee for recommendations concerning health 
care with respect to chronic and specific disorders.
In 2002, the KCE was established with HTA as one of its core activities. 
Its overall objective is to support health policy decisions which offer value for 
money and so contribute to an efficient allocation of scare health care resources. 
The specific methodological approach used by the KCE was inspired by the 
approach adopted by foreign centres of expertise, including the National 
Institute for Health and Clinical Excellence (NICE) in the United Kingdom 
and the Swedish Council on Technology Assessment in Health Care (SBU) in 
Sweden. 
The KCE works to ensure the quality and transparency of studies. It aims to 
achieve this by imposing the definition of a precise research questions, a rigid 
schedule and rigorous scientific procedures based on international standards 
and using external expert reviewers (so-called validators), while paying 
attention to potential conflicts of interest. When a report is rejected during the 
review process, it must be reworked. Each report is then submitted for approval 
to the board of directors, which is composed of representatives of the different 
health care stakeholders. Recommendations are made to health-policy makers 
at the end of each report. The KCE is involved in neither the policy decisions nor 
their implementation. The reports are published on the KCE web site,6 where 
they can be consulted and downloaded free of charge. Between 2004 and the 
beginning of 2010, 124 reports have been approved and published, including 
46 HTA reports. At the end of 2009, the KCE employed 42 full-time equivalent 
(FTE) workers, including 27 experts.
6 See: http://www.kce.fgov.be
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2.5.2 Information systems 
Data collection and dissemination 
In Belgium, a great deal of detailed data is collected on health and health 
care. However, significant challenges remain which make it difficult to report 
reliable data internationally, including a lack of reporting data in the correct 
manner, and the need to use international classifications and concepts in data 
collection. Furthermore, additional challenges remain, including: a lack of a 
unique patient identification between all available databases; a lack of data 
concerning voluntary health insurance (VHI); difficulties with diagnosis and 
treatment data as far as validity is concerned, in particular for co-morbidity 
and complications; a lack of data concerning extramural health care; only 
moderately useful data concerning psychiatry and very limited data concerning 
homes for the elderly and nursing homes; a lack of data concerning technology 
used in health care; and a lack of data concerning non-reimbursed payments 
(Van de Sande et al. 2006). 
In 2009, 131 databases containing different types of health-related 
information were found in Belgium. The actors involved in collecting these 
data, as well as obligations to provide information, vary from one database to 
another. An overview of the existing databases according to the main actors 
involved in collecting information is presented below.7 
FPS Health, Food Chain Safety and Environment 
The FPS Health, Food Chain Safety and Environment collects, reports and 
analyses data provided by hospitals. The most important data sets developed 
for hospital policy since the 1980s are: Minimal Clinical Data (MCD-MKG-
RCM), Minimal Nursing Data (MND-MVG-RIM), Minimal Psychiatric Data 
(MPD-MPG-RPM), Hospital Billing Data (HBD-SHA-AZV) and Mobile 
Urgency Group Data (MUG-SMUR). These data are mainly collected as tools 
for the measurement of hospital needs for public financing, and evaluation 
of the effectiveness and quality of hospital care (FPS Health, Food Chain 
Safety and Environment 2009c). Other objectives include the possibility of 
using the data for internal management and to determine population needs 
through epidemiological studies (Roger France and Mertens 2001). In 2007, 
an integrated system for data collection, the Minimum Hospital Data Set 
(MHD-MZG-RHM) was launched, covering the MCD, MND and MUG data 
(FPS Health, Food Chain Safety and Environment 2009c). It is mandatory for 
all hospitals to provide data for these data sets.
7 This list is not exhaustive. For a complete list of available databases see Vlayen et al. (2009).
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MCD registration for hospitalized patients was developed in the 1980s 
and recording this data for all patients became compulsory in 1990. The 
information in the MCD includes relevant clinical data (e.g. primary and 
secondary diagnosis) and demographic characteristics of patients. Records are 
pseudonymized, thus patients cannot be directly identified in the data set.8 The 
MCD are used to group hospitalized patients in DRGs. In 1995, All Patient 
DRGs (AP-DRGs) were chosen as the grouping method to establish hospital 
comparisons for financial purposes. In 2002, AP-DRGs were replaced by 
APR-DRGs (All Patient Refined DRGs, 3M HIS version 15.0) in order to pay 
more attention to the severity of illness (FPS Health, Food Chain Safety and 
Environment 2009c).
The MND registration includes information on a whole series of nursing 
activities, including the numbers of nurses per care unit, their qualifications and 
some diagnostic elements. The recording of MND has been mandatory since 
1988 and is mainly used for hospital financing and nurse staffing allocation. 
Since 2000, day hospitalizations as well as in-hospital stays of neonates who 
are not in the room of their mothers are recorded, in addition to conventional 
stays. In 2007, the original MND registration was replaced by a renewed data 
set based on the Nursing Intervention Classification (2nd edition) to take into 
account changes in nursing practice, the international development of nursing 
classification languages and changes in health care management. Nursing data 
and the MCD were integrated into one overall health care management system 
(Sermeus et al. 2005).
The MPD contains socioeconomic characteristics of the patient, diagnosis 
and pre-admission problems, treatment data, and diagnosis and residual 
problems at discharge. Psychiatric hospitals (and psychiatric departments of 
acute care hospitals), and psychiatric nursing homes and initiatives for sheltered 
living have recorded psychiatric data since 1996 and 1998 respectively. 
The HBD are based on the billing data for hospitalized patients sent by 
hospitals to the health insurance companies for NIHDI reimbursement. By 
linking the financial data with the clinical data it became possible to compare 
the cost per DRG between hospitals. These linked data were used to reform 
the financing of laboratories in hospitals, and pharmaceuticals for hospitalized 
patients (see Section 5.6 Pharmaceutical care and Chapter 6).
8 It should be noted that in very particular cases, even without the presence of direct identification information, 
the information in the MCD can be so unique that an analyst with sufficient background information could 
contextually identify the person involved (indirect identification).
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The MUG registration contains information on mobile emergency services. 
The MUG is a fast intervention vehicle with an emergency physician, who 
is specialized in the treatment of emergencies, but does not transport the 
patient (see Section 5.5 Emergency care). The aim is to monitor the activities 
of the MUG on a daily (real-time) basis (FPS Health, Food Chain Safety and 
Environment 2009c).
Scientific Institute of Public Health (IPH)
The overall responsibility for collecting and analysing databases for 
epidemiological surveillance lies with the IPH. The objectives of the IPH are 
to collect, analyse and report on the distribution and development of health 
and diseases, and their causes, in different population groups within Belgium 
(IPH 2010b).
Information on incidence of specific diseases is collected in collaboration 
with two surveillance networks. The first consists of a group of sentinel 
laboratories that carry out surveillance of infectious diseases. Participation of 
laboratories is voluntary and accounts for 58% of all laboratories in Belgium. 
The second network consists of a group of sentinel GPs and provides data on 
specific health problems on a weekly basis. Around 200 GPs are included, 
participation is voluntary and patients’ information is anonymized. Surveillance 
and monitoring of new cases of HIV infections and AIDS is carried out by the 
IPH. In accordance with the Ministry of Social Affairs, Public Health and the 
Environment guidelines, registration of seropositives diagnosis is carried out 
by AIDS reference laboratories. 
The National Surveillance of Health Care-Associated Infections and 
Antimicrobial Resistance in Belgian hospital (NSIH) aims to decrease hospital 
infection rates through surveillance, confidential feedback system and 
self-assessment. Participating hospitals are able to monitor local infection and 
antibiotic resistance rates. These results can be compared with those of other 
Belgian hospitals (Suetens et al. 2007). Data are available for several infections, 
such as nosocomial bloodstream infections, Clostridium difficile associated 
disease, and antibiotic resistance and use.
The IPH also coordinates the most important health survey in Belgium. The 
HIS includes a vast amount of information on different health outcomes for 
the general population, such as health status, lifestyle, use of health services 
and cancer screening. Four waves of the survey have been carried out in 1997, 
2001, 2004 and 2008. Complete results for 2008 survey are expected by the 
end of 2010. 
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Other initiatives on health monitoring and data collection include 
the Initiative for Quality Promotion and Epidemiology in Diabetes Care 
(IQED-IKED-IPQED). As required by the NIHDI, every centre for the 
treatment of diabetes reports to the IPH data on 10% of their patients who 
receive at least two daily injections of insulin. This initiative aims at improving 
the quality of treatment of diabetes in specialized centres. 
The National Institute for Health and Disability Insurance (NIHDI)
The NIHDI receives information either directly from sickness funds or through 
intermediate organizations on different health care expenses. Sickness funds 
provide official documents on health expenses (aggregated data, e.g. physician 
visits) and information that is used for administrative purposes (documents 
C and N). The Common Sickness Funds Agency (IMA-AIM) also provides 
information on hospitalizations (document H),9 use of pharmaceutical products 
in hospitals (document PH) as well as hospitalization fees not included in 
document H, such as lump sums for day hospitalizations (document FH). 
Provision of data is compulsory and was established in the Royal Decree of 
1996 (Prevoyance sociale: santé publique et environnement 1996). A large 
database containing longitudinal information on the use of health care services 
is also available at the NIHDI. The Permanent Sample (Echantillon Permanent 
– permanente steekproef ) contains information at the individual level for 
300 000 people (1 in 20 of the population). The database combines information 
on demographic and socioeconomic characteristics of patients, the use of 
pharmaceutical products (data comes from Pharmanet – see next section) and 
the use of other health services (e.g. physician visits). The database is managed 
by the IMA. Waves of the sample exist on an annual basis from 2002. In general, 
data from each wave is available on December of the following year.
Moreover, the NIHDI, in partnership with sickness funds and health care 
professionals, is in the process of establishing a non-profit-making organization 
eCare. The aim of this organization is to collect and analyse data on specific 
reimbursed treatments as well as to register the incidence and treatment of 
specific illnesses. The most recent initiatives within the eCare project include 
the Shared Arthritis File for Electronic Use (SAFE), Orthopaedic Prosthesis 
Identification Data (Orthopride), Quality Electronic Registration of Medical 
Implants and Devices (QERMID) and the Ambulatory Care Health Information 
Lab (Achil). 
9 With some exceptions such as lump sums for day hospitalizations which are included in the document FH.
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Pharmanet
In 1996, Pharmanet was created to inform physicians about their prescription 
behaviour and to allow them to compare their own prescription habits with 
those of their colleagues. With Pharmanet, data are collected per prescribing 
physician and per patient. The data registered relates to the supply of 
reimbursed pharmaceuticals (prescription drugs, magistral preparations and 
related products, sterile insulin syringes, medical foods, medical devices and 
lump sums which are reimbursable for patients with cystic fibrosis) that are 
delivered by public pharmacies. The collection of the data is carried out via 
pharmacies, the pharmacists’ fee-setting services and the sickness funds. The 
latter transfer the data to the NIHDI, which is assisted by the Committee for 
the Evaluation of Medical Practices for Drugs. One of this Committee’s tasks 
is to organize regularly – at least twice a year – consensus meetings that are 
meant to evaluate medical practice concerning pharmaceuticals in a certain 
sector and to formulate recommendations for all prescribing physicians. In 
addition, information campaigns based on Pharmanet data and intended for 
prescribing physicians are run on a regular basis (e.g. on the use of non-steroidal 
anti-inflammatory drugs) (NIHDI 2007a; NIHDI 2009f).
The Common Sickness Funds Agency (IMA-AIM)
In 2002, the sickness funds created a common health data centre, IMA-AIM, 
entrusted with the task of analysing health data gathered by the health insurance 
bodies within the framework of their public mission and drawing policy 
information from them. More specifically, IMA-AIM develops surveys and 
sample studies based on patient panels, analysing disease-related expenditure 
and consumption (IMA-AIM 2009). 
The Belgian Cancer Registry Foundation
Since June 2005, the Belgian Cancer Registry Foundation has been in charge 
of collecting, registering and analysing information on new cancer cases for 
Belgium (Belgian Cancer Registry 2008). It is mandatory for physicians as well 
as for laboratories to register data on new cancer diagnoses. 
Data collected by federated authorities 
Data are also available and collected by the regions and communities in 
relation to health promotion and health prevention (including immunization, 
cancer screening, schoolchildren’s health) and to services provided under 
responsibilities of regions or communities (including data about infectious 
diseases). Communities are also responsible for collecting natality and mortality 
data. 
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For instance, data on the health of children and pregnant women is collected 
by three institutions: the ONE, the K&G and the Dienst for Kind und Familie 
agency for the French, Flemish and German communities, respectively. The 
surveillance and monitoring of tuberculosis is divided between FARES 
(Registre de la Tubercolose) for the French and German communities 
and VRGT (Vlaamse Vereniging voor Respiratoire Gezondheidzorg en 
Tuberculosebestrijding) for the Flemish community. 
Legislation on freedom of information
The processing of personal data is regulated by the Act of 8 December 1992 
on the protection of privacy with regard to the processing of personal data, 
modified by the Act of 11 December 1998, and by the Act of 26 February 2003. 
General conditions for personal data processing are summarized in Fig. 2.5. 
Because data relating to health are sensitive, specific regulations have been 
defined. As a general rule, health data can only be processed after written 
consent of the person concerned. This requirement is however revoked if such 
an approach has been proved impossible or extremely difficult. The invoking 
of impossibility or disproportionate effort to inform the people involved must 
be justified to the Commission for the Protection of Privacy (CPP-CPVP-
CBPL), and more specifically to the Sectoral Committee of the Social Security 
and Health (SCSS&H) (CPP 2007). It is only after approval by the latter that 
processing is officially authorized, and these decisions are published online.10 
Before granting any authorization, the SCSS&H asks the Crossroads Bank 
to provide juridical and technical advice. This Sectoral Committee is also 
responsible for ensuring compliance with laws and standards on data protection 
(CPP 2009).
10 See: http://www.privacycommission.be/en/decisions/
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Fig. 2.5
General conditions for personal data processing 
Source: Van de Sande et al. 2010.
Personal health data can only be processed under specific conditions as 
outlined in Fig. 2.6. Moreover, additional safeguards must be met by the person 
responsible for the data processing. They must: 
• designate the people who have access to the data and accurately describe 
their functions in relation to data processing – this does not require the 
designation of people by name, but rather the establishment of access 
profiles (e.g. doctors and nurses of the hospital);
• include the basic legal or regulatory ground(s) permitting the person to 
process the data during information collection; 
• notify to the patient of the reasons for which these data are processed 
and must provide the profiles of persons having access to data during 
the written consent process;
• take technical and organizational measures to ensure data security and 
prevent unauthorized access or accidental destruction; and 
• take all reasonable steps to correct or delete inaccurate or incomplete data.
Except for:
• Historical purposes
• Statistical purposes
• Scientific purposes
For coded personal data:
• Full information to persons
• Right of opting out (implicit informed consent)
For non-coded personal data:
• Proof of informed consent 
  (explicit informed consent)
If informed consent is impossible or 
disproportionately arduous:
• Explicit ad hoc approval of the CPP
• Personal consent
• Personal contractual obligation
• Personal vital interest
• Legal obligation
• Weighted interest of data processor
All data processing must be:
• Relevant/pertinent
• Necessary (“no less”)
• Proportional (“no more”)
Secondary processing must be:
• Restricted to original purpose
• Limited in time
• Anonymization > independent foregoing
  encoding (TTP) > uncode data
• Equitable
• Transparent
• Ascertained data
• No decoding attempts
• Quality
• Legitimate
• Predefined
• Precise
ACCESS
to data
PROCESSING
of data
FINALITY
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The processing of personal health data should be made under the supervision 
and responsibility of a health care professional. Furthermore, personal data 
should not be kept in a form that identifies individuals longer than is necessary 
in relation to the objective pursued. Data should then be deleted or sufficiently 
aggregated to the level of anonymity, such that direct or indirect identification 
is made possible. Failing to do this can lead to a fine from €550 to €550 000 
(CPP 2007). Everyone has the right to refuse the processing of his personal 
data. However, the right of opposition is not allowed for the processing of data 
necessary to the conclusion or execution of a contract, or if the processing of a 
person’s data is an obligation imposed by the law. The data processed must be 
accurate and, if necessary, updated. 
The transfer of personal data is free between EU Member States. A person 
established in Belgium can freely send personal data to another EU country if 
the transfer is legal according to Belgian law. Outside the European Economic 
Area (EEA), personal data can only be transferred to countries guaranteeing 
protection of data corresponding to the level of protection provided in the EEA 
(CPP 2007).
Fig. 2.6 
Belgian Privacy Law conditions for processing personal health data
Processing forbidden unless:
• written informed consent
• labour law rights
• social security law rights
• public health care interest/population screening
• legally entitled public interest 
• personal vital interest
• crime prevention
• publicized by person involved
• personal defence in court
• personal health interest
• scientific interest
Data collection:
• direct data collection from persons involved unless impossible ➛ justification in declaration to the CPP
Special conditions for processing:
• “full information” to persons involved unless impossible or disproportionately arduous 
• right of opting out
• formal declaration at CPP and foregoing approval by CPP (SCSS&H)
• explicit and limited list of involved data analysers
• contractual confidentiality clauses
• ICT security plan
• medical supervisor required (unless otherwise agreed in written informed consent)
Source: Van de Sande et al. 2010.
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2.6 Regulation
Three political and administrative levels operate in the Belgian health system: 
the federal government, the federated governments and the local governments 
(provinces and municipalities). All levels play important roles, but the federal 
level is mainly responsible for social security, compulsory health insurance, 
pharmaceutical policy and hospital legislation. A typical characteristic of 
the Belgian health system is the participation of several stakeholders in the 
management of the system. Besides extensive regulation by the federal and 
federated governments, an important part of the health system is regulated by 
national collective agreements made between representatives of health care 
providers and sickness funds.
The basic right to health care has been set out in the Constitution. Article 
23(2) of the Belgian Constitution recognizes the right to social security, 
protection of health and medical assistance. This constitutional right has been 
further developed in several laws and decrees. 
2.6.1 Regulation of third-party payers 
Compulsory health insurance is solely administered by sickness funds, which 
are non-profit-making, non-commercial organizations. 
All individuals entitled to health insurance must join or register with 
a sickness fund. The choice is free, except for railway workers (1.1% of the 
insured in the general system in 2009), who are automatically covered by 
the health insurance fund of the Belgian railway company. Sickness funds 
are mainly organized according to religious or political affiliations into five 
national alliances: the National Alliance of Christian Mutualities (NACM), the 
National Union of Neutral Mutualities (NUNM), the National Union of Socialist 
Mutualities (NUSM), the National Union of Liberal Mutualities (NULM) and 
the National Union of the Free and Professional Mutualities (NUFPM). In 2009, 
the NACM and the NUSM together had the largest share of the general system, 
covering about 42.0% and 28.1% of the population, respectively. The Auxiliary 
Fund is an additional neutral public body intended for those patients who do not 
want to affiliate themselves with any of these groups. It accounts for not more 
than 0.7% of the insured (see Fig. 2.7) (NIHDI 2008c).
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Fig. 2.7
Distribution of members, 2009
Source: NIHDI 2009j.
By means of the Sickness Funds Act, sickness funds are entrusted with a 
central position in the compulsory health insurance system. They have to control 
health care expenditure and ensure it conforms with the legal regulations. Some 
services are only reimbursed if there has been a prior approval by the so-called 
advisory physicians of the sickness funds. These advisory physicians can 
question the prescription of expensive pharmaceuticals, the length of hospital 
stays and the ascription of patients to the various classes of the Katz-scale in 
long-term care financing (see Section 5.8 Long-term care for the elderly).
Sickness funds act collectively in their negotiations with health care 
providers. To evaluate and to avoid abuse of their members, they have medical 
examiners. Moreover, since 1995, Belgian sickness funds have been made 
more financially accountable for the expenditure of their insured members 
(see Section 3.3.3 Pooling of funds).
For their role in the compulsory health insurance system, as well as in the 
administration of the incapacity and disability insurance, sickness funds receive 
subsidies from the NIHDI to cover their administrative costs. This subsidy is 
based on the number and social characteristics of their members, with some 
corrections for efficiency in the management of the system.
1.1%  Public sickness fund (NMBS/SNCB)
0.7%  Auxilliary fund
18.4%  NUFPM
5.4%  NULM
28.1%  NUSM
4.3%  NUNM
42.0%  NACM
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The Sickness Funds Act also allows sickness funds to develop services and 
activities outside mandatory social security so long as they are related to the 
health and well-being of their members. In the field of VHI, they compete 
with commercial insurance companies. Unlike the latter, sickness funds are 
not allowed to operate risk selection.
Competition among sickness funds concentrates mainly on their service 
to members and the complementary activities and services they offer. Legally, 
sickness fund members have the opportunity to change their sickness fund each 
quarter if they have been enrolled for a period of at least one year. With only 
about 1% of all members switching each year, insurance mobility has been low 
(Schokkaert and Van De Voorde 2003).
2.6.2 Regulation of providers 
Providers fall into two groups: (1) health institutions such as hospitals, homes for 
the elderly and nursing homes, day centres, laboratories and outpatient clinics; 
and (2) health professionals, such as physicians, dentists, physiotherapists, 
pharmacists, nursing practitioners and nursing auxiliaries, midwives and 
paramedical practitioners, who are generally organized as self-employed 
professionals (except nurses and midwives). Both groups are discussed further 
in the following subsections.
Health institutions
The government plans global hospital capacity by requiring that hospitals obtain 
accreditation from the regional ministries of public health to operate a certain 
number of beds for each service category (e.g. acute care, surgery, maternity). 
Accreditation is granted only if a proposal for hospital opening, extension or 
alteration respects national planning. Planning usually takes the form of target 
figures (e.g. 2.9 beds per 1000 inhabitants for general inpatient services; 32 beds 
per 1000 births for maternity services). 
There is a variety of accreditation norms for hospitals. Organizational 
norms relate to staff requirements (e.g. qualification levels, ratio between 
qualified personnel and auxiliaries) and responsibilities (e.g. hygiene, ethical 
requirements); architectural criteria (e.g. the number, size, comfort and 
hygiene standard of hospital rooms); functional standards (e.g. convenience, 
accessibility); additional norms relating to minimum activity (e.g. they stipulate 
that hospitals should have no less than 150 beds; diagnosis/surgical units no 
fewer than 30 beds; intensive neonatal units no fewer than 15 beds), setting 
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minimum facility standards; and expected staff numbers. Accreditation criteria 
are developed at the federal level and are implemented and controlled at the 
community level. 
There are also specific accreditation norms for services involving heavy 
medical equipment (e.g. radiology with CT and MRI, radiotherapy, renal 
dialysis, nuclear medicine, non-urgent patient transport, centres for human 
heredity) and for certain hospital functions (e.g. hospital pharmacy, local 
neonatal care, perinatal care, palliative care, surgical day hospitalization, initial 
relief of emergency cases, specialized emergency care, intensive care, mobile 
urgency groups and psychiatric family nursing). Since 1999, the regulation and 
accreditation of medical hospital services and functions have also gradually 
been replaced by the accreditation of “care programmes” (see Section 2.6.3 
Mechanisms to ensure the quality of care). 
The communities are responsible for authorizing hospital building, while 
capital subsidies are shared by the communities and the federal government. 
Only the investments listed in the building programme can be paid for from the 
hospital budget provided by the federal government. The federal government 
managed to reach an agreement with the communities for a building programme 
just as the merging of hospitals threatened to greatly multiply the level of federal 
expenditure for hospital building. Hospitals were obliged to merge to work on 
a larger scale to improve their productivity.
Regulations of other health institutions, such as homes for the elderly and 
nursing homes, are described in Chapter 5.
Health professionals
The practice of most health care professionals is regulated by the Practice of 
Health Care Professions Act. This law regulates access to professions such 
as physicians, dentists, physiotherapists, pharmacists, nurses, midwives and 
practitioners of a paramedical profession (see also Section 4.2.2 Registration/
licensing and planning of health care personnel). 
In 1996, the federal government set up the Committee for Medical Supply 
Planning. The original remit of this Committee was to ascertain medical supply 
needs with regard to physicians and dentists, and to take account of the evolving 
needs of medical care, the quality of care provision, and the demographic and 
sociological development of the professions concerned. Later, the remit of this 
committee was extended to cover physiotherapists (1997), nurses, midwives 
and logopaedists (1999) as well (see also Section 4.2.2 Registration/licensing 
and planning of health care personnel).
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2.6.3 Mechanisms to ensure the quality of care
Health institutions
Hospital regulations
The Hospital Act contains several provisions promoting quality of care. 
Architectural, organizational and functional accreditation standards aim to 
guarantee a minimal level of quality for inpatient care. However, because of 
their static character, accreditation standards can guarantee quality only to a 
limited extent (Callens and Peers 2003).
Besides accreditation standards, the Hospital Act contains several 
requirements which can promote quality of care, such as those concerning the 
organization of medical and nursing activity, the description of the tasks of the 
medical manager, the obligation to maintain a medical file, the tasks of the 
Medical Council, the establishment of an ethical committee, a committee for 
hospital hygiene, a medical pharmaceutical committee, a committee for medical 
material, a committee for blood transfusions, as well as other specialized 
committees.
Since 1999, the medical manager of each hospital must compile a report 
concerning the internal evaluation of the quality of the medical activity. 
This report must be sent to the colleges of physicians, established at the FPS 
Public Health. The objective of these colleges is to promote quality of care by 
consensually developing indicators of quality and ways of evaluating good 
medical practice; recording and reporting activities; giving information to the 
multipartite consultation structure for hospital policy; and giving feedback 
to the hospitals and physicians concerned. These colleges of physicians were 
established in several fields: cardiac pathology, specialized emergency care, 
intensive care, renal dialysis, mother and neonate, radiology and nuclear 
medicine, radiotherapy, reproductive medicine and oncology. The appointment 
of the members of the colleges is generally based on the advice of the scientific 
associations of the respective disciplines.
Since 1999, the regulation and accreditation of medical hospital services 
and functions have also gradually been replaced by the accreditation of 
“care programmes”. A care programme is the collection of several hospital 
activities which are organized around certain pathologies or patient groups (e.g. 
paediatric patients). For each care programme, legal criteria are set related to 
the target group, nature and content of care, minimum activity level, necessary 
infrastructure, required medical and nonmedical staff and their required 
expertise, standards concerning quality and quality monitoring, economic 
Health systems in transition  Belgium 55
standards and geographical accessibility criteria. At present, there are care 
programmes for reproductive medicine, cardiac pathology, oncology, and 
geriatric and paediatric activities (see also Section 5.4 Secondary care). 
The quality requirements for nursing staff were also upgraded and the 
hospital nursing department was defined. To improve the functioning of nurses, 
a nursing record was designed and recommendations were formulated for an 
electronic record, which fits with the new registration of the nursing activity 
in hospitals. Furthermore, a new statute for midwives was established, as well 
as for nursing assistants in hospitals, in nursing and homes for the elderly and 
in home care. 
Furthermore, with regard to the organization of hospital hygiene, the 
integration of the hygienist physician and nurse team has been emphasized. 
Additional measures are in place to improve staff compliance and to generalize 
registration with an obligation to register methicillin-resistant Staphylococcus 
aureus (MRSA) and Clostridium difficile. Special attention has been given to 
hand hygiene through three national campaigns (in 2005, 2006 and 2009). 
In addition, a committee for antibiotherapy was set up in the hospitals in 
order to promote a better use of antibiotics and to reduce resistance (Royal 
Decree of 12 February 2008). 
In 2007, the first contract for the coordination of quality and patient safety 
in Belgian hospitals was approved. An annual budget of €6.8 million was 
allocated for this project and a total of 164 hospitals (80% of all hospitals) 
agreed to participate (including acute psychiatric and long-term care hospitals) 
(Borgermans et al. 2009). The hospitals had to provide information on the six 
different parts of the contract including: (1) hospital mission and objectives with 
regard to quality and patient safety; (2) overview of existing structures regarding 
quality and safety of care; (3) organizing a survey on patient safety culture; (4) 
reporting and analysing incidents and near incidents; (5) introducing “quality” 
projects concerning three out of four topics (i.e. economic performance, capacity 
and innovation, clinical performance and patient safety); and (6) selecting 
indicators from the “multidimensional feedback” (only for acute hospitals) 
and answering specific questions with regard to the selected indicators. These 
multidimensional indicators are based on administrative data and were used as 
benchmarking measures among acute care hospitals. 
The first contract allowed hospitals to formulate recommendations 
concerning (among others) information and ICT needs, financial support and 
harmonization of policies at the federal and federated level. Between 2008 
Health systems in transition  Belgium56
and 2012, hospitals must follow a pluri-annual plan focused on three pillars 
including: (1) structure: development of safety management systems; (2) process: 
analysis of processes; and (3) results: the development of multidimensional set 
of indicators. For psychiatric hospitals, specific settings on quality and safety 
were established. Indeed, the pillar-process mentions that internal transfers as 
well as vigilance regarding aggression are important issues for these institutions 
(FPS Health, Food Chain Safety and Environment 2008c). The participation of 
hospitals has increased constantly and reached 90% for the 2009–2010 contract, 
which is a clear indicator for the success of the pluri-annual programme. 
Integration of care and multidisciplinary collaboration
Since 2000, the reform and modernization of hospital services have been tackled 
again. The new objectives of policy-makers were to integrate care between 
organizations by improving multidisciplinary collaboration between health 
professionals and facilities in order to rationalize supply and improve quality 
of care. Incentives were created for hospitals within the hospital financing 
system to rationalize supply, to create complementarities between different 
hospital sites or to reduce their number of beds. Hospitals were encouraged 
to adhere to “care areas”, which could lead to more complementarities within 
a region. At the same time, powerful incentives were created to modernize 
hospital infrastructure by covering, within the hospital financing system, a 
greater part of the construction cost, by increasing the tariffs of construction 
ceilings and by facilitating renovations. Additional measures to foster quality 
of care were through the increased interest in clinical pathways (see Section 5.2 
Patient pathways). In particular, for certain disease groups, such as diabetes and 
renal failure, quality of care could be improved through better coordination of 
multidisciplinary teams and a tool for establishing more integrated care, also 
linking the hospital with the primary care level. 
Feedback and reference amounts
Also hospitals receive feedback on the activities of their practising physicians, 
compared with other hospitals. Systems of peer review were set up to compare 
practices and outcomes between physicians in Belgium and against 
internationally accepted standards. Feedback on pre-operative examinations 
(2005) and on prenatal care (2007) was also provided (see also the following 
section).
In order to address significant differences in medical practice between 
hospitals which can not be explained medically, a system of reference amounts 
for standard interventions was introduced. This recuperation system has 
been applied to admissions since 1 October 2002. For standard interventions, 
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a significantly divergent consumption profile is compared to a national 
reference amount (the average of national expenditures increased by 10%). This 
recuperation system is only applied for 34 APR-DRGs (see Table 2.2), two 
severity levels of the disorder (levels 1 and 2), and three services groups (see 
below). Severity should be taken into account because average consumption per 
patient increases systematically with the degree of severity. Recuperation will 
only be applied for severity classes 1 and 2. The number of cases that fall under 
severity classes 3 and 4 is limited for most pathology groups. It may for example 
involve a (rare) serious complication or a patient with significant co-morbidity. 
In the selection of APR-DRGs, the starting point was that medically 
homogeneous and simple pathologies that occur frequently had to be included. 
Table 2.2 shows the APR-DRGs that were ultimately included in the system of 
reference amounts, and that qualify for recuperation.
Moreover, only the following groups of services are taken into account:
• clinical biology, with the exception of lump sum payments;
• medical imaging, with the exception of lump sum payments and nuclear 
MRI; and
• internal medicine, physiotherapy and various technical medical services.
The first stage of the system consists of identifying hospitals which should 
be taken into account for reimbursement. For this, the difference between the 
real expenditure of the hospital and the expenditure of the reference (= number 
of stays concerned in the hospital × reference amount) are calculated for 
each selected APR-DRG (after the elimination of outliers), severity levels 
and services groups (i.e. 204 differences: 34 × 2 × 3). These differences are 
then added and only hospitals with a positive result are selected. In 2009 (based 
on 2006 data), 34 of the 125 hospitals were selected (NIHDI 2009i).
The second stage consists of the determination of the amount that should 
be reimbursed. For this, the difference between the real expenditure of the 
hospital and the median national expenditure is calculated for each selected 
APR-DRG (after the elimination of outliers), severity levels and services groups. 
Then, all positive differences are added. If this total amount is greater than 
€1000, this amount must be reimbursed by the hospital. In 2009 (based on 2006 
data), a total of €5 982 577 had to be reimbursed (NIHDI 2009i) (see Table 2.3).
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Table 2.2
APR-DRGs in the system of reference amounts
APR-DRG Description
024 Extracranial vascular procedures
045 CVA with infarct
046 Non-specific CVA and precerebral occlusion without infarct
047 Transient ischaemia
072 Extraocular procedures except orbit
073 Lens procedures with or without vitrectomy
097 Tonsillectomy and adenoidectomy procedures
134 Pulmonary embolism
136 Respiratory malignancy
139 Simple pneumonia
171 Permanent cardiac pacemaker implant without AMI, heart failure or shock
176 Cardiac pacemaker and defibrillator device replacement
179 Vein ligation and stripping
190 Circulatory disorders with AMI
202 Angina pectoris
204 Syncope and collapse
225 Appendectomy
228 Inguinal and femoral hernia procedures
244 Diverticulitis and diverticulosis
263 Laparoscopic cholecystectomy
302a Major joint and limb reattachment procedure of lower extreme except for trauma if nomenclature 
code 289085 – arthroplasty of the hip with total prosthesis (acetabulum and femur head) 
were charged
302b Major joint and limb reattachment procedure of lower extreme except for trauma if nomenclature 
code 290286 – femorotibial arthroplasty with sectional prosthesis was charged
313 Knee and lower leg procedures except foot if nomenclature code 300344 – therapeutic arthroscopy 
(partial or total menisectomy) was charged
318 Removal of internal fixation device
445 Minor bladder procedures
464 Urinary stones with ESW lithotripsy
465 Urinary stones without ESW lithotripsy
482 Transurethral prostatectomy
513a Uterine and adnexa procedures for ca in situ and nonmalignancy if nomenclature code 431281 – 
total hysterectomy by abdominal route was charged
513b Uterine and adnexa procedures for ca in situ and nonmalignancy if nomenclature code 431325 – 
total hysterectomy by vaginal route including posterior colpoperineorrhaphy was charged
516 Laparoscopy and tubal interruption
517 Dilation, curettage and conization
540 Caesarean delivery
560 Vaginal delivery
Notes: CVA: Cerebrovascular accident; AMI: Acute myocardial infarction.
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Table 2.3
Amounts to be reimbursed in 2009 (based on 2006 data)
Total expenditures € Amounts to be reimbursed € %
Medical imaging 15 336 099 1 908 862 12.4
Clinical biology 6 289 410 780 569 12.4
Technical medical 
services
23 197 377 3 293 146 14.2
Total 44 822 886 5 982 577 13.3
Source: NIHDI 2009i.
The first reference amounts were for 2003, but the system was abrogated for 
the years 2003–2005 by the Health Law (Act of 31 December 2008). The first 
reference amounts were then determined for 2006 with a new methodology 
based on recommendations from a KCE report (Van de Sande et al. 2005). Then, 
a new methodology was applied for hospital stays ending after 31 December 
2008. This 2009 methodology provides reference amounts in advance in order to 
allow hospitals to adapt their behaviour accordingly and to use mechanisms in 
order to avoid a downward spiral of the average national amounts. More details 
on these methodologies can be found on the NIHDI website (NIHDI 2009i). 
Quality policy and plan in Flanders
Initiatives have also been taken by the Flemish community. In 1997, the Flemish 
community created a framework to improve quality of care in health care 
institutions. The decree concerning quality of health and welfare stipulated 
that the aim of the health care system is to supply health care to each patient 
without distinction with regard to age or gender, ideological, philosophical 
or religious conviction, race or nature and financial situation of the person 
concerned. When developing an integrated quality policy, attention must be 
given to justified care which meets the requirements of effectiveness, efficiency, 
continuity, social acceptability and user orientation.
Each health care institution in Flanders (general hospital, psychiatric 
hospital, home for the elderly, nursing home and centre for mental health care) 
must implement a quality policy by means of a quality manual and quality 
plan. The quality manual describes the vision and the objective of the internal 
quality policy. This manual is translated into a quality plan that includes a 
description of the existing situation and the operational objectives concerning 
specific fields imposed by the government. Every care institution is expected 
to set up improvement schemes and to evaluate them periodically. The imposed 
topics by the government are:
Health systems in transition  Belgium60
• clinical performance concerning hospital mortality, unplanned 
readmissions, obstetric care, average length of stay, day care and 
transfusion reactions;
• operational performance defined as a permanent monitoring and 
improving the general organization;
• satisfaction of patients;
• satisfaction of employees.
The quality plan also provides details concerning timing and evaluation. 
Also, a quality coordinator is selected to carry out the policy. Care institutions 
can only obtain, preserve and extend their accreditation if they fulfil the 
requirements of the quality decree.
Along with the implementation of quality legislation, Flemish health care 
institutions began to address the issue of quality in a more structured way. A 
dialogue began between the health care institutions themselves and between 
the government and the health care institutions. From this dialogue, the focus 
on quality took the direction of specific, systematic and integrated bottom-up 
quality control (Valepyn 2005).
Health professionals
Several measures to increase the quality of the health system were undertaken 
for health professionals, including establishing an accreditation system, 
strengthening primary care and making health care providers more accountable. 
The measures undertaken after 2007 are described in Chapter 6.
Accreditation of physicians 
To further increase quality of care, a system of physician accreditation has been 
developed. Two national laws define the conditions of accreditation in Belgium. 
The law of 14 July 1994 (Moniteur Belge 1994) describes the accreditation 
scheme for GPs that refers to the certification of doctors who fulfil specific 
criteria. There are four domains: medical practice criteria (especially the 
minimal threshold of patient contacts), continuing medical education (learning 
activities with accumulation of a minimum number of points), an evaluation of 
medical practice (participation in meetings with a local quality evaluation group 
(LOK-GLEM)) and rational prescribing. Accreditation is not mandatory, but it 
is encouraged through financial incentives for accredited physicians: increased 
consultation fees and an annual contractual indemnity (Van der Brempt 2007).
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All physicians have to keep medical records of their patients, collect at least 
20 credits of continuing medical education per year, have at least 1250 patient 
encounters per year, and not have an outlier prescription profile. GPs should 
attend LOK-GLEM meetings at least twice a year. Each LOK-GLEM strives 
for consensus about subjects chosen by the group concerning medical strategies, 
evaluates prescribing profiles and develops an annual evaluation report.
Increasing accountability
In 2001, the Belgian government felt that insufficient progress had been made 
towards the efficient use of health care resources. Significant differences were 
noted in the practice of physicians, without medical explanations for these 
differences. For the same problem or the same group of patients, considerable 
differences were observed in the choice of pharmaceuticals, treatments, and 
techniques of medical imaging and clinical biology.
The government therefore asked physicians, sickness funds and managers 
of hospitals to: (1) formulate proposals for reducing individual differences in 
practice to an acceptable level of variation with respect to scientifically based 
objective standards; and (2) develop techniques as a result of which prescribers 
and providers would be held individually accountable for the resources they use 
and the costs they generate. 
Drawing from the consultation conclusions, the government devised a policy 
to make providers more accountable, from 2003 onwards, upon the following 
principles:
• promoting quality by encouraging good medical practice on the basis of 
recommendations and feedback that gives physicians the opportunity to 
compare their medical practice with respect to other physicians; and
• preventing and (if necessary) sanctioning divergences from good medical 
practice and the correct application of the stipulations provided for in the 
compulsory health insurance system.
The National Council for Quality Promotion, set up in 2002, is responsible 
for quality promotion. It is composed of representatives of the physicians, the 
universities, the scientific medical associations, the sickness funds and the 
Minister of Social Affairs and Public Health. Data on prescribing behaviour, 
together with recommendations on good medical practice, are first checked 
for their relevance in a limited number of local quality evaluation groups 
(LOK-GLEM). After this evaluation and any modification, all physicians (GPs 
and specialists) receive feedback. Then, in Local Medical Evaluation Groups, 
physicians test their own individual behaviour against that of their colleagues 
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with the aim of improving quality of care. Reviews are not compulsory. The 
recommendations on good medical practice are provided to offer physicians 
a frame of reference. Health providers or health care institutions have 
received feedback on the following areas: antibiotics (2001, 2003, 2007, 2010), 
hypertensive prescriptions (2002, 2003), pre-operative examinations (2005), 
extreme outliers (amoxiclav, quinolones, sartan, 2005), the prescription of a 
minimum percentage of cheap medicines (2006, 2007, 2008, 2009), prenatal 
care (2007) and breast cancer screening (2002, 2004, 2005, 2006, 2007, 2009) 
(see also Chapter 6).
The Department for Medical Control of the NIHDI was reformed in 2003 
to tackle the issue of divergences with respect to good medical practice. Since 
1989, this office already had the task of controlling the misuse of diagnostic and 
therapeutic freedom, related in particular to over-consumption. However, the 
existing legislation for combating over-consumption was considered inadequate 
due to unrealistic penalties, legal uncertainty and the unwieldy structure. As a 
result of the reforms introduced to make health care providers more individually 
accountable, the Department for Medical Control became the Department for 
Medical Evaluation and Inspection (DGEC-SECM) and received two new 
assignments:
• evaluating the reimbursement of medical care consumption in light of the 
measures taken to prevent and detect misuse; and
• providing information to health care providers, such as recommendations 
on good medical practice and indicators of over-consumption.
As a logical result of the recommendations of good medical practice, the 
National Council for Quality Promotion was given the task of establishing 
indicators of divergence with respect to normal medical practice. The 
Commission for the Reimbursement of Pharmaceuticals (CRP-CTG-CRM) 
formulates recommendations in connection with the prescribing behaviour 
of certain proprietary pharmaceuticals. The DGEC-SECM can also submit 
a proposal of indicators to the National Council for Quality Promotion or the 
Committee for the Evaluation of Medical Practices for Drugs on the basis of a 
scientifically underpinned dossier.
As soon as an indicator of divergence is definitely established, the 
DGEC-SECM provides information, on an individual anonymous basis, about 
the relevant services. Any divergences are reported to the Committee of the 
DGEC-SECM. Subsequently, all health care providers that score more than the 
set indicator value are requested to account for their behaviour and to justify 
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the divergence in medical practice. If it appears after investigation that the 
explanation received is a satisfactory clarification for their divergence from the 
norm, this is communicated to the care provider in question. If the explanation 
is unsatisfactory or the request for additional information was not complied 
with, the care provider is placed under monitoring for six months. 
During the monitoring period, the provider’s entire practice and/or 
prescribing behaviour is evaluated for a minimum of six months on the basis of 
all useful indicators with variation from the normal medical practice or, in their 
absence, on the basis of a comparison with the practice of a normally prudent 
and diligent care provider in similar circumstances. After the monitoring period, 
the practice is re-evaluated. If it appears that the care providers in question have 
not modified their behaviour to normal medical practice, they are requested to 
provide a written explanation. This explanation is either accepted or considered 
unsatisfactory. If unsatisfactory, the case will be heard by two members of the 
Committee of the DGEC-SECM. A decision will then be taken and a sanction 
may be imposed.
Through the reform, it is possible to sanction all establishments or people 
that organize health care provision, such as hospitals and their managers, for 
carrying out or having carried out unnecessarily costly or unnecessary services, 
at the expense of the statutory medical insurance, with the sole aim of increasing 
their incomes.
Prior to the reform of 2003, the sanctions against over-consumption consisted 
of suspension of both the third-party payer arrangement and the reimbursement 
of unnecessary or unnecessarily expensive services. The problem with the 
suspension of the third-party payer arrangement was that it affected not only 
the physician but also the patient, since the latter had to change physician or pay 
the full fee. Furthermore, such a sanction was discriminatory. The third-party 
payer arrangement is mainly applicable in the case of specialists and only for a 
limited proportion of GP activities. 
Consequently, sanctions now consist of administrative fines and withdrawal 
of accreditation of the care provider in question. However, the first aim of 
this reform remains to prevent divergent behaviour by providing information 
and by monitoring medical practice. If these measures are not successful in 
bringing the provider’s medical practice in line with the guidelines, then fines 
are imposed. After a first evaluation of this reform at the end of 2006, some 
changes were introduced to clarify and improve the procedure and the rights of 
the prescribers. Divergent prescription profiles are not examined case by case, 
and they are to be evaluated in the light of the doctor’s overall practice. 
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Strengthening primary care 
Although GPs do not have a gatekeeping role in Belgium, a number of decisions 
were taken in past years to reassess and strengthen primary care, as well as to 
reappraise and promote the profession. The most important of these are listed 
below.
In 1999, the Global Medical File (GMD) was established to increase the 
availability of medical, social and administrative patient information and access 
to such information. This measure was introduced with the aim of optimizing 
the quality of primary care provided and avoiding unnecessary or duplicated 
care and contradictory prescriptions. The GP holds the GMD with the patient’s 
consent and shares relevant information with other providers responsible for the 
patient. The GMD was initially only implemented for those 60 years old and 
over, from 1999 to 2000. Its use was eventually extended for those over 50 on 
1 May 2001 and, finally, since 1 May 2002, the entire population was eligible. 
Only one GP can hold the patient’s file. GPs charge a fixed amount per year, 
fully reimbursed by compulsory health insurance, to keep the patient’s GMD. 
Consequently, for each consultation in that year with the GP holding the GMD, 
co-insurance by the patient is reduced by 30%. Similar patient contribution 
reductions for home visits apply to vulnerable groups, such as the chronically 
ill or patients over 75 years old. 
An additional incentive for patients to use their GP as a preferential entry 
point is the increased reimbursement (up to the preferential reimbursement rate) 
for the first visit to a specialist if referred by a GP. 
To discourage ambulatory patients with problems that can be solved by the 
front-line system from directly accessing the accident and emergency (A&E) 
services in hospitals, different measures have been tested. First, as of 1 March 
2003, hospitals were allowed to charge patients a fixed amount of €12.50 for 
using a hospital A&E unit (no co-payment for some exceptions). On 1 July 2005, 
this user charge had become compulsory for all hospitals and had been reduced 
to €9.50 (€4.75 for patients who are beneficiaries of preferential treatment). The 
list of co-payment exceptions has also been enlarged. Since 1 July 2007, fixed 
co-payments have been replaced by modulated ones. The amount of co-payment 
depends on the status of the patients, and is reduced if patients are brought to 
the A&E unit via emergency medical aid or if they are referred by a physician. 
From 2003, GP circles were established. Within a GP circle, local GPs work 
in collaboration to reach an agreement with local authorities to organize out-of-
hours shifts, improve emergency care, arrange locums for GPs who are ill or 
on holiday, take measures for GP safety, conclude agreements with domiciliary 
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care providers, inform the population and set up local care programmes in the 
context of preventive medicine. Funding for GP circles is mainly based on the 
number of inhabitants in the GP area where the circle operates. Additional 
funds support GP circles with the organization and operation of a central 
telephone line for out-of-hours calls.
Another more recent initiative taken to promote the use of front-line medical 
assistance is the creation of primary care outposts, which are permanently 
organized on-call services for GPs, with the necessary infrastructure to treat 
minor urgencies. These new primary care outposts are established under the 
form of pilot projects. 
Because of the varied geographical distribution of GPs, an impulse fund was 
created in 2006 to grant interest-free loans and subsidies to doctors starting a 
GP practice in an area with a shortage of GPs (see also Chapter 6).
With the increase of chronic conditions, the primary care level will be 
required to play an increasingly important role in guiding patients through 
the health system and coordinating and managing home care. Along with the 
GP, who is a vital link in this context, Integrated Services for Home Care 
(ISHC-GDT-SISD) have been created and funded since 2003 by compulsory 
health insurance to support a multidisciplinary approach within primary care 
(see also Section 5.8 Long-term care for the elderly). These ISHC-GDT-SISDs 
are to support in a care zone the practical organization and coordination of 
home care provided by professionals of various disciplines. In particular, the 
role of the ISHC-GDT-SISD is to evaluate the autonomy of the patient, draw 
up and follow up on a care plan, divide the tasks between the different care 
providers and organize a multidisciplinary consultation, which, since 1 January 
2006, is reimbursed for patients at home or institutionalized patients who will 
be returning home. 
2.7 Patient empowerment
2.7.1 Patient information
Patients in Belgium have the right to receive all information necessary to gain 
insight into their state of health from their care provider. This information 
should be supplied in clear language and, in principle, verbally. Patients have 
the right to refuse to be informed. Despite the right not to know, health care 
professionals can still decide to inform the patient if there is a risk of serious 
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detriment to the health of a patient or third parties. The health care professional 
can also decide not to inform the patient if the communication may cause 
obvious damage to the patient’s health and if another health care professional 
has been consulted. If the health care professional decides not to inform the 
patient, he or she must note the professional reasons for this choice in the 
patient’s record and notify the potential confidant of the patient.
The right to give informed consent establishes that the prior consent of 
patients is required for every intervention by health care professionals. The 
patient should at least be given information on the aim of the intervention (e.g. 
diagnostic or therapeutic), nature of the intervention (e.g. painful or not), degree 
of urgency, duration, frequency, contra-indications relevant for the patient, 
side-effects and risks, after-care, possible alternatives, financial consequences 
and possible consequences in the case of refusal or withdrawal of consent. 
Patients also have the right to a patient file that is carefully maintained and 
secure. Patients are entitled to inspect their patient file and must be offered 
the possibility to do so. Information exclusions apply to information on a third 
party; and to the personal notes of the health care professional (unless the 
patient is assisted by another health care professional appointed by the patient 
as a confidant). Maximum amounts are in place that patients can be charged 
for a copy of his/her medical file: €0.10 per text page, €5 per figure and €10 
per CD-ROM, with a maximum total of €25 (FPS Health, Food Chain Safety 
and Environment 2009b).
A study performed by the Vlaams Patiëntenplatform (VPP) showed that most 
physicians informed their patients about the aim and nature of the intervention, 
and the degree of urgency. However, less attention was paid to providing 
information on potential alternatives and consequences in case of refusal or 
withdrawal of consent. Moreover, information on the related cost for the patient 
was not mentioned by a quarter of the interviewed doctors. This study also 
highlighted information difficulties for specific patient groups, that is, foreign 
patients, patients with mental disorders, patients with a low qualification levels 
and patients unable to give informed consent. Patients have the right to obtain 
information in easily understood language and the VPP highlighted that more 
attention for this aspect is needed (Schoonacker and Louckx 2006). 
An assessment by the Socialist Sickness Fund on patients’ rights also showed 
that 65% of the hospitalized patients received insufficient information on the 
expected cost of the stay and one in four patients was not sufficiently informed 
beforehand about their treatment by the physician. Moreover, the study showed 
that lower-income people were less informed beforehand about their treatment 
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than higher-income people and that the elderly patients (≥ 71 years old) were less 
informed than younger patients (≤ 50 years old) (Socialistische Mutualiteiten 
2008).
Nurses are also involved in providing information to patients. As defined in 
the Nursing Minimum datasets (see Section 2.5.2 Information systems), patient 
education is considered as a nursing activity.
Patients can also obtain relevant information from official organizations. 
Most sickness funds run a health promotion and patient education service to 
produce information folders and to organize information meetings, with a focus 
on primary prevention, health promotion and general health topics. They also 
provide information to health care providers, mostly by means of periodicals. 
However, a study performed by the Socialist Sickness Fund highlighted that 
few patients (63%) were aware of the possibility of receiving information from 
their sickness funds and that more than three out of four respondents (79%) 
had not requested information from their sickness fund prior to hospitalization 
(Socialistische Mutualiteiten 2008).
Information on tariffs, reimbursed acts and consultations as well as 
reimbursement of pharmaceuticals can also be found on the NIHDI web site. 
Some federal organizations such as the KCE, the IPH and the Belgian Centre for 
Evidence-based Medicine (CEBAM) are other potential sources of information 
but are more focused on health professionals. 
Patient associations are also important sources of information. The French 
federation, Ligue des Usagers des Services de Santé (LUSS), and the Flemish 
federation VPP have 200 and 82 patient associations, respectively. There is also 
the federation Patiënten Rat & Treff for the German community and Radiorg 
for rare diseases. The consumer organization Test-Achats is also a potential 
source of information and provides advice and evaluations of practices related 
to health care in a specific magazine called Test-Santé.
Concerning initiatives to increase access to information for disabled people, 
the labelling of pharmaceutical products in Braille has become mandatory 
since May 2006. The instructions must also be made available by companies 
in a format suitable for blind and visually impaired people upon the request of 
patient organizations.
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2.7.2 Patient choice
Belgium promotes freedom of patient choice and competition between providers. 
Patients have free choice of health care professionals and health care institutions 
(e.g. hospitals). Patients also have free choice of sickness funds and the sickness 
funds cannot refuse a patient. Conversely, according to the medical code of 
ethics and except in case of emergency or of failing in his duty of humanity, 
a physician has the possibility to refuse to treat a patient for professional or 
personal reasons. In this case, the physician must inform the patient or his/her 
relatives, continuity of care must be maintained and any useful information 
must be passed to the successor physician (Ordre des médecins 2009).
The right to free choice of health care professional gives patients the choice 
to contact several different health care professionals before choosing one. 
Patients can always choose to consult with another health care professional and 
may change their choice of health care professional (right to a second opinion) 
(FPS Health, Food Chain Safety and Environment 2009b). 
According to the Itinerat Institute, too little information about the quality of 
care is available to the patients to help them in their choice (Daue and Crainich 
2008). Moreover, in hospitals, the choice is limited by supply and, in some 
specialties and/or hospitals, the choice can be limited (Schoonacker and Louckx 
2006).
2.7.3 Patients’ rights 
The rights and obligations of the population have been stated since 1997 in “the 
Charter of the socially insured”. The main purpose of the charter is to “protect 
the population through a whole set of rules to be respected by all social security 
institutions” (FPS Social Security, 2009c). The basic principles of the Charter 
can be summarized as follows: (1) information and answers to questions on 
population rights must be provided by the social security institution; (2) the 
institution must grant any particular benefit if the person seems to be entitled to 
it; (3) benefits must be granted in a rapidly and without exceeding a four-month 
delay; (4) if exceeding such a delay the institution must pay interest to the 
entitled; (5) reasons as well as other resources (appeal procedures, reference 
number, etc.) relating to any decision must be provided to the socially insured; 
and (6) the socially insured can appeal any decision of the social security 
institution within three months. 
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In August 2002, Belgium introduced legislation on patients’ rights. The 
purpose of the Patients’ Rights Act is to strengthen the legal status of the patient. 
Prior to this Act, patients’ rights could be inferred from general legal principles, 
international treaties and constitutional and criminal stipulations. The 
Patients’ Rights Act regulates the rights of patients with regard to health care 
professionals, including physicians, dentists, pharmacists, nurses, midwives, 
physiotherapists and paramedics. Every health care professional must comply 
with the patients’ rights legislation. Hospitals are also obligated to comply with 
the stipulations of the law on patients’ rights with regard to the medical, nursing 
and other health care professional aspects of the legal relationship with patients. 
Two national campaigns were organized to raise awareness and make patients’ 
rights better known to the public.
The following rights are established by law:
• right to quality of service provision
• right to free choice of health care professional
• right to patient health state information
• right to give informed consent
• right to inspect and to have a copy of the patient file
• right to protection of privacy
• right to submit a complaint to the competent ombudsperson
• right to palliative care and pain relief.
Each patient has the right to health care that best corresponds to their needs 
according to the medical knowledge and technology available, and health care 
must be provided with respect for human dignity and the patient’s autonomy, 
without any discrimination.
Moreover, patients are entitled to respect of their privacy for every 
intervention provided by the health care professional. Other people may be 
present only if it is required for professional reasons (FPS Health, Food Chain 
Safety and Environment 2009b). Patients’ rights concerning patient information 
and patient choice are described above, and those regarding complaints are 
described in the next sections. 
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The Socialist Sickness Fund interviewed 7000 members to assess respect 
of patients’ rights. They found that less than a half were aware of their rights 
as patients. Also, around half were not aware of the possibility to submit a 
complaint to an ombudsperson and to have access to their medical file 
(Socialistische Mutualiteiten 2008).
2.7.4 Patients and cross-border care
In Belgium, cross-border care and care for foreigners are mainly funded on the 
basis of the European Council Regulation on the coordination of social security 
schemes (883/2004 and 987/2009)11 and of the rulings of the Court of Justice of 
the European Communities (ECJ). However, regulations 1408/71 and 574/72 
will for the time being remain in force for relations between the EU27 and 
Iceland, Liechtenstein, Norway and Switzerland if Regulation 858/2003 (third-
country nationals) is not replaced by a new regulation.
If a Belgian travels in a country of the EEA or in Switzerland and if he or she 
must receive unforeseen medical treatment which becomes medically necessary 
during his or her stay, taking into account the nature of the benefits in kind 
and the expected length of stay, his or her medical expenses will be covered 
according to the legislation in the host country upon presentation of his or her 
European Health Insurance Card (EHIC). Depending on the country, medical 
care will be totally or partially reimbursed on the spot or soon after returning 
home. The EHIC is not valid for private hospitals or treatments, is individual 
(each family member must have his or her own EHIC), is limited to temporary 
stays and is reserved for unplanned care (Belgium Federal Portal 2009). 
For planned treatment in another country of the EEA or in Switzerland, 
medical costs can be covered by the Belgian sickness funds using the E112 
form or under the rulings of the ECJ. To be covered, this medical care must be 
among the benefits reimbursed in Belgium.
For hospital care, a prior authorization from the sickness fund is required 
but not for non-hospital care, unless the treatment requires the use of highly 
specialized and cost-intensive medical infrastructure or medical equipment, 
which is normally only to be found in a hospital environment and which does 
not require an overnight stay. However, the distinction between non-hospital 
and hospital treatment is not clearly defined and it is highly recommended that 
patients seek advice from the sickness funds. In Switzerland, reimbursement 
according to the rulings of the ECJ is possible (applicable since 1 July 2008) 
(Coheur 2009; Mutualité professionnelle et libre de la région wallonne 2009). 
11 Since May 2010 in the EU27.
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In the case of planned non-hospital care (beyond the exceptions already 
mentioned), the reimbursement of the costs of cross-border health care is not 
subject to a prior authorization (E112) under the so-called “Kohll and Decker 
procedure”. The insured person is entitled to reimbursement of the costs incurred 
within the limits of and under the conditions of the Belgian reimbursement rates.
The standard procedure for obtaining the E112 form is to apply for a prior 
authorization to the medical examiner of the sickness fund. The insured must 
submit a medical report prepared by a Belgian physician containing a description 
of the treatment and/or intervention; a clarification of why the treatment cannot 
be provided within a reasonable period, taking into account the state of health 
and the probable cause of the illness of the insured person and, if necessary, an 
explanation of why the treatment can take place in better medical conditions 
abroad;12 and contact details of the place where the treatment can be carried 
out. If the treatment is not among the benefits provided for by the Belgian 
legislation, no authorization will be given. If the treatment can be provided in 
Belgium at the same quality level and within a reasonable period, again, no 
authorization will be given. With the E112 form, the treatment cost will be 
covered at the treating country’s coverage rate. If the Belgian reimbursement 
amount is higher than in the treating country, the patient, upon request, will 
be entitled to an additional reimbursement by his sickness fund; however, the 
reimbursed sum may not exceed the costs actually incurred by the patient and 
the sickness fund does not have to reimburse more than the sum it would have 
to pay if the same treatment had been provided in Belgium (Coheur 2009; 
Mutualité professionnelle et libre de la région wallonne 2009).
Most, if not all, private hospitals refuse the E112 form. In this case, instead 
of the E112 form, it is possible to apply Article 294 (§1, 2°) of the Royal Decree 
of 3 July 1996. This concerns medical treatment for which the patient has 
received a prior authorization from the medical examiner of his sickness fund 
in case treatment can be provided under better medical conditions in a hospital 
abroad. According to this Article, the patient will pay the treatment cost and 
can then ask for reimbursement from his sickness fund within the limits of and 
under the conditions of the Belgian reimbursement rates. When an international 
convention cannot be applied or does not exist, Belgian insured persons must 
refer to this section of the Royal Decree which concerns hospitalizations only 
(Coheur 2009; Mutualité professionnelle et libre de la région wallonne 2009). 
12 The issuing of an E112 is based on the criteria mentioned in the regulation. The condition of “better medical 
conditions” is not part of the regulation but rather a condition mentioned in the Belgian national legislation.
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A proposal for a new directive on patient mobility from the European 
Commission is in progress. This directive should clarify procedures for 
citizens seeking health care abroad. The major principles of this directive are to 
improve legal security for the patient seeking cross-border health care, common 
principles in European health care systems, and more collaboration between 
Member States. 
Moreover in 2007, a bill regarding patient mobility was passed in 
Belgium. This law will come into force on a date determined by ministerial 
decree, which is expected to be in July 2010. The law aims to deal with the 
bottlenecks in hospital financing caused by patient mobility, and guarantees 
for Belgian patients are provided. The law also creates an Observatory for 
Patient Mobility at the NIHDI and the FPS Health, Food Chain Safety and 
Environment (BS–MB 2007).
Beyond this, more and more cross-border cooperation has been developed. 
In Belgium, residents of specific border regions have access to medical care 
in specific areas on the other side of the border through a more f lexible 
procedure of issuing the specific E112 form. This system applies to people 
living within 15 km of the border and wanting to be treated in a facility up 
to 25 km on the other side of the border; people living in Eupen, Malmedy, 
Sint-Vith, Arlon, Messancy, Bouillon, Chimay, Couvin and Gedinne; people 
living in the administrative districts of Virton and Bastogne; or people living 
in Mellier, Léglise, Ebly, Juseret, Vitry and Anlier. The E112 “border” form 
is issued without providing any medical motivation or justification. However, 
only specific care is concerned (mainly hospitals and dialysis care) (Mutualité 
professionnelle et libre de la région wallonne 2009).
Moreover, residents of the Euregio Meuse-Rhine can use the form EMR 
E112+ to simplify the authorization process further. The geographical area 
of the Euregio Meuse-Rhine includes the provinces of Liège and Limburg 
in Belgium; the province of North Brabant and Limburg in the Netherlands; 
Aix-la-Chapelle and the districts of Bitburg, Prüm and Daun in Germany. The 
form EMR E112+ provides access to outpatient specialist medical care (and 
subsequent hospital treatment as well as the prescription of pharmaceuticals 
and medical devices) and is issued without medical report or agreement of the 
medical examiner of the sickness fund. However the use of prior authorization 
can be maintained for specific services (Mutualité professionnelle et libre de 
la région wallonne 2009).
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Several cooperation agreements between French and Belgian hospitals have 
also been set up to improve access and quality of care, and allow patients 
to overcome the requirement of a prior authorization for medical care across 
the border. Each convention has its own specificities regarding the hospitals’ 
partners, the medical fields covered and the people involved (Belgian patient in 
France or vice versa). Four Organized Cross-border Areas for Access to Care 
(ZOAST) have also been created between France and Belgium. These ZOAST 
ensure continuity of care through the free movement of patients between 
France and Belgium. In these areas, Belgian patients can receive hospital and/
or ambulatory care in specific French hospitals on the basis of a specific E112 
form (e.g. E112 MRTW or E112 ARLWY), which is issued by their sickness 
fund without providing any medical motivation or justification. Cooperation 
agreements on cross-border urgent medical transport have also been developed 
in border area between France and Belgium.
Moreover, in 2005, a framework agreement has been set up to offer a global 
legislative framework to all the inter-hospital conventions and agreements 
between France and Belgium. This agreement has already been ratified by the 
parliament of France and was in the process of being ratified by the Belgian and 
competent regional parliaments at the time of writing (De Cock 2009).
Other initiatives with Germany, Luxembourg and the Netherlands are 
under way. A Benelux decision on cross-border urgent medical transport was 
approved in 2008 (Secrétariat Général Benelux, Van Haver and Boon 2008).
To reduce waiting lists, Dutch and English health care purchasers have 
concluded direct contracts with Belgian hospitals. For example, people living in 
the Dutch region Zeeuws-Vlaanderen and in Noord Brabant have the possibility 
of receiving specialized treatment in specific Belgian hospitals. The OZ and CZ 
Dutch sickness funds estimated that the number of affiliates treated in Belgian 
contracted hospitals was 2203 in 2000 and 7267 in 2004.
In 2003, the English National Health Service (NHS) also concluded contracts 
with seven Belgian hospitals, and five of them were extended until 31 March 
2007. All these five contracts concerned knee and hip replacements. Between 
May 2003 and November 2004, a total of 432 NHS patients with hip and knee 
problems have been treated in one of these five hospitals. However, since 
September 2004, the flow of English patients to Belgium has been reduced 
because of an increase of capacity in England and the end of the “London 
Patient Choices” project and its budget for overseas treatment (Glinos, Baeten 
and Boffin 2006). 
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The aim of cross-border cooperation is to improve access and quality of care. 
Nevertheless, if the increase of cross-border care is not embedded in properly 
balanced regulations, it may carry the risk of eroding Belgian public health care 
funding and thus diminishing current overall health standards for a given public 
budget. The financial and non-financial (waiting lists, distributional equity 
across hospitals, quality of care) consequences linked to these flows need to 
be studied. The KCE will study these issues in a future report (programmed 
in 2010–2011). This report will also try to give a general overview of foreign 
patients undergoing elective surgery in Belgium (ambulatory and inpatient). 
Even if data on E112 procedures are available, private interventions or data 
regarding contracts between different parties such as hospitals or health insurers 
are lacking. The number of E112 forms for the treatment of foreign patients in 
Belgium (including both ambulatory and inpatient care) was estimated to be 
10 773 in 1998 and 19 378 in 2008. Patients coming from the Netherlands 
represent around 66% of non-Belgian patients (Glinos, Baeten and Boffin 2006). 
2.7.5 Complaints procedures (mediation, claims)
The law on patients’ rights also grants the right to a complaints procedure. 
Patients can submit their complaint to an ombudsperson. The ombudsperson 
should in the first instance, support communication between the patient and 
the health care professional. If the patient and health care professional do 
not reach a solution, the ombudsperson has to proceed to mediation. If the 
ombudsperson’s mediation does not lead to a solution, the ombudsperson has 
to inform patients about other alternatives for taking the complaint forward. On 
the basis of the information obtained as a mediator, the ombudsperson makes 
recommendations to prevent similar complaints in future. Under the hospital 
legislation, and following the set standards, every hospital must appoint an 
ombudsperson. 
In ambulatory care, any conflict between a patient and a health care 
professional is managed by a federal ombuds service. The federal ombuds 
service has been established in the FPS Public Health, Food Chain Safety and 
Environment. Complaints are treated by the federal ombuds service if there 
is no competent local ombudsperson. These may be about, for example, GPs, 
dentists, pharmacists, independent nurses and physiotherapists. The federal 
ombuds service also has to deal with complaints concerning the way in which 
conciliation by the local ombudsperson has been carried out. However, the 
federal ombuds service is not a substantive profession agency for complaints, 
which should be treated in the first instance by the local ombudsperson where 
available.
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In the mental care sector, mediation is exercised either by an external 
ombuds service (external mediation) or by the hospital ombudsman (Cobbaut 
et al. 2009).
In 2008, the federal ombuds service received 482 complaints and 290 
requests for information (Gryson, Verhaegen and Debreyne 2008). Moreover, an 
assessment by the Socialist Sickness Fund of patients’ rights showed that 49% 
of the 7000 interviewed patients were unaware of the existence of a mediation 
service in the hospital where they were treated (Socialistische Mutualiteiten 
2008).
2.7.6 Patient safety and compensation
The professional liability of a physician, except for disciplinary liability, is 
not governed by special laws. This means that both the civil liability and the 
criminal liability of the physician for damage or injury caused by improper 
performance of the duties entailed in the discharge of his or her professional 
functions are governed by the general rules of civil and criminal law (Nys 1997).
Obtaining professional liability insurance for health care professionals was 
advised but was not mandatory. A bill to oblige every individual or institutional 
health care provider to have liability insurance is still in progress (Act of 
15 May 2007).
A patient is entitled to recover damages in respect of negligent medical 
treatment only if he or she has actually suffered damage. In principle, all the 
damage, moral damage included, has to be compensated. 
Fault is the main basis of a claim for malpractice. Deviation from the 
professional standard is to be considered as a fault in the practice of medicine. 
Patients who have been the victim of a medical fault are faced with many 
obstacles in recovering damages. Long legal procedures are often necessary 
while results are uncertain. Patients who experience damage after a medical 
intervention or treatment can only receive compensation if they themselves 
can prove that damage has been caused by a fault. The plaintiff must prove not 
only that the defendant physician was negligent, but also that the defendant’s 
negligence was the cause of the damage sustained. Damage that is not caused 
by a fault is therefore not compensated.
Therefore, a bill based on the French system has been developed in Belgium 
to compensate, under certain conditions, damage resulting from health care 
that does not involve the responsibility of the caregiver. Under this new system, 
damage resulting from an act of care, prevention or diagnosis that does not 
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involve the responsibility of the caregiver, that shows a certain degree of 
seriousness and that is abnormal in relation to the patient’s health and to the 
state of science will be compensated for without the patient having to prove 
the medical fault. In these cases, the condition for indemnity will therefore no 
longer be the existence of fault and the causal link between damage and fault. 
The payment for these damages will be entrusted to a fund to be established 
with this aim.
For several years now a patient safety policy within the hospitals has been 
developed through pilot projects on issues including incident reporting in the 
case of medication mistakes and the development of patient safety indicators 
based upon the MCD. In 2007, committees for quality and patient safety were 
created in the hospitals involving a coordinator who sets up and follows the 
incident reporting in order to create a “no shame, no blame” culture within the 
institution.
2.7.7 Patient participation/involvement and patient satisfaction
In Belgium, the question of patient participation in the health care system is 
linked to the role of sickness funds. Sickness funds in Belgium are more than 
simple insurers; their role is also to represent the patients and to make their 
voices heard in the health care policy-making process. However, because of 
their multiple tasks, their positioning is complex and they are more focused on 
the representation of the whole insured population’s interests rather than the 
representation of specific interests of individuals (Tegenbos et al. 2008; Leys 
et al. 2007). 
Patients’ associations also represent patients’ interests. With the increase 
of patients’ associations, French, Flemish and German federations have been 
created: the LUSS, the VPP, the Patiënten Rat & Treff and Radiorg. These 
federations receive public subsidies from federal and federated authorities and 
have representatives in the Federal Commission of Patients’ Rights. The aim of 
the Federal Commission of Patients’ Rights is to collect and treat information, to 
formulate notices to the Minister of Social Affairs and Public Health, to assess 
the application of patients’ rights, to assess mediations processes and to treat 
claims related to mediations processes (Tegenbos et al. 2008; Leys et al. 2007). 
In order to increase patients’ participation in the health care system, different 
initiatives have been undertaken and some organizations have included 
representatives of patients’ associations in their management processes. For 
example, the Walloon Institute for Mental Health (IWSM) has included 
representatives of patients’ associations in their administrative board and 
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the Flemish Association for Mental Health (VVGG) involves representatives 
of patients’ associations in their management. Representatives of patients’ 
associations for disabled people and their relatives are also involved in the 
management of the AWIPH and the VAPH. Subsidized homes for the elderly 
must also have a resident council included in their management (Tegenbos et al. 
2008, Leys et al. 2007).
According to the Eurobarometer report of 2002 on the public’s satisfaction 
with the health care system, a clear majority (65.1%) of the Belgian population 
is satisfied with the present organization of health care. The system runs well 
according to 23.8% of Belgians (compared to 13.2% in the EU15). However, 
41.3% of Belgians said that minor changes are needed (30.7% in the EU15), 
22.7% felt that fundamental changes are needed (38.2% in the EU15) and 5.2% 
want to rebuild the health care system completely (13.5% in the EU15) (OECD 
2009a). According to the Eurobarometer report of 2007 on health and long-term 
care in the EU, the quality of care and the availability and accessibility of health 
care were positively perceived by the Belgian population compared to European 
perceptions (see Table 2.4) (Eurobarometer, 2007).
2.7.8 Physical access 
According to the United Nations Convention on the Rights of Persons with 
Disabilities of 13 December 2006, disabled people have the right to live 
independently and participate fully in all aspects of life. States must take 
appropriate measures to ensure, on an equal basis with others, access to the 
physical environment, to transports, to information and communication, and to 
other facilities and services open or provided to the public, both in urban and 
rural areas. These measures, which include the identification and elimination of 
obstacles and barriers to accessibility, apply to buildings, roads, transportation 
and other indoor and outdoor facilities, including schools, housing, medical 
facilities and workplaces; and to information services, communications services 
and other services, including electronic services and emergency services 
(Conseil d’État 2009). This Convention was transposed into Belgian legislation 
by the Act of 13 May 2009.
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Table 2.4
Perception of the health care system
Type of health care Belgium EU27
Hospitals
Fairly good to very good quality 93% 71%
Fairly easy to very easy access and availability 87% 76%
Dental care
Fairly good to very good quality 95% 74%
Fairly easy to very easy access and availability 87% 74%
Medical or surgical specialist services
Fairly good to very good quality 93% 74%
Fairly easy to very easy access and availability 75% 62%
Family doctor services
Fairly good to very good quality 95% 84%
Fairly easy to very easy access and availability 97% 88%
Care services for dependent people
Fairly good to very good quality 77% 42%
Fairly easy to very easy access and availability 74% 41%
Nursing home services
Fairly good to very good quality 75% 41%
Fairly easy to very easy access and availability 61% 39%
Source: Eurobarometer 2007.
Moreover, according to the Act of 23 October 1964 on the setting of 
standards for hospitals, specific services, such as geriatric and rehabilitation 
services, must allow easy access adapted to the disabilities of patients. Any 
barriers to access, such as steps, stairs and other obstacles, should be avoided 
and any risk of slipping must be prevented. The environment for patients must 
be facilitated by the installation of railings and handrails. Sanitary facilities 
must also be adapted, and wheelchairs in sufficient numbers must be provided 
in the corridors. Numerous regional regulations to improve the access and 
integrity of disabled people have also been developed. 
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3.1 Health expenditure
In 2007 (latest available year), total health expenditure as a percentage of GDP in Belgium was 10.2% (see Table 3.1 and Fig. 3.1). At this percentage of GDP, Belgium ranked third among the EU Member States, including 
those acceding to the EU in May 2004 and January 2007 (EU27) (see Fig. 3.2). 
Between 1982 and 1994, the evolution of health expenditure as a percentage of 
GDP in Belgium was in line with the evolution of the EU15 average (Member 
States belonging to the EU before May 2004) (Corens 2007). Since 1994, 
Belgium’s total health expenditure as a proportion of GDP has been slightly 
above the EU27 average (see Fig. 3.1).
The growth in health expenditure in Belgium is similar to that in other 
western European countries and can be explained by several factors, such as 
the increasing number of elderly people, higher expectations, growth in real 
GDP and increasing implementation of new technology in the health care sector.
Belgium has the sixth highest health expenditure per capita measured in 
PPP US$ among EU27 countries (see Fig. 3.3).
Table 3.1
Trends in health expenditure in Belgium, 1990–2007 (selected years)
1990 2000 2005 2007
Total health expenditure per capita 1 1 479 2 121 2 681 2 761
Total health expenditure as % of GDP 7.2 8.6 10.3 10.2
1980–1990 1990–2000 – 2000–2007
Mean annual real growth rate in total health expenditure 1 3.5 4.0 – 4.4
Mean annual real growth rate in GDP 1 2.0 2.1 – 2.0
Source: OECD 2009a.
Note: 1 in € at 2000 GDP price level. Data before 2003 are based on national accounts estimates and 2003–2007 data are based on the 
joint OECD-Eurostat-WHO System of Health Accounts (SHA) collection.
1 This chapter was written by Sophie Gerkens, Carine Van de Voorde, Anja Desomer and Christian Léonard.
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Fig. 3.1
Trends in health expenditure as a share (%) of GDP, Belgium and neighbouring 
countries, 1990–2007
Source: WHO Regional Office for Europe 2010.
Note: Because of the introduction of SHA, a series rupture between 2002 and 2003 can be observed. Growth rate estimates should 
therefore be treated with caution. 
As Table 3.2 indicates, curative care services represent almost half (46.5%) 
of total health expenditure, while prevention and public health services represent 
around 4% of total health expenditure (in 2007).
Table 3.2
Health expenditure by service programme (% of total health expenditure), 2007
Total as % of total current 
expenditure on health
Public as % of total public 
expenditure on health
Services of curative care 46.5 45.0
Services of rehabilitative care 4.1 3.4
Services of long-term nursing care 16.9 20.3
Ancillary services to health care 2.4 2.4
Medical goods dispensed to outpatients 17.6 13.4
Prevention and public health services 4.1 5.4
Health administration and health insurance 8.5 10.0
Source: OECD 2009b.
Note: The SHA methodology was used to estimate these data.
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Fig. 3.2
Health expenditure as a share (%) of GDP in the WHO European Region, 2007 or latest 
available year
Source: WHO Regional Office for Europe 2010.
Note: Not all of these countries apply the SHA methodology. Comparisons should thus be done with caution.
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Fig. 3.3
Health expenditure in US$ PPP per capita in the WHO European Region, 2007 or latest 
available year
Source: WHO Regional Office for Europe 2010.
Note: Not all of these countries apply the SHA methodology. Comparisons should thus be done with caution.
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3.2 Sources of revenue and financial flows
Belgium has a compulsory system of health insurance with a very broad 
benefits package that covers almost the entire population. Health insurance 
is one of the six sectors of the social security system, which also include old 
age and survivors pensions, unemployment, insurance for accidents at work, 
work-related health and occupational diseases, family allowances, health and 
disability insurance.
Social security contributions and subsidies from the federal government are 
the main funding sources for the compulsory health insurance system. In 2009, 
social contributions accounted for 66%, state subsidies for 10%, alternative 
financing (mainly from indirect tax revenues) for 14%, and allocated and 
diverse receipts (special contributions of social security, solidarity contributions 
and contributions by employers for early retirement) for 10% of the compulsory 
health insurance. Social security contributions are related to income (rates set 
by law) and are independent of risk.
The compulsory health insurance is managed by the NIHDI which gives 
a prospective budget to the sickness funds to finance the health care costs of 
their members. In the past, sickness funds’ expenditures were systematically 
reimbursed; but since 1995, they have been held financially accountable for 
a proportion of any discrepancy between their actual spending and their 
normative risk-adjusted health expenditures.
Payment mechanisms are mainly characterized by fee-for-service payment. 
There are two systems of payments: (1) a direct payment, where the patient pays 
for the full cost of the service and then obtains a refund from the sickness fund 
for part of the expense; and (2) a third-party payer system, where the sickness 
fund pays the provider directly and the patient is only responsible for paying 
any co-payments, supplements or non-reimbursed services. Reimbursement 
depends on the type of service provided as well as the patient’s status.
Financial flows are presented in Fig. 2.1 (see p.17) and Fig. 3.4. Generally, 
the direct payment system applies to ambulatory care and the third-party payer 
system applies to inpatient care and pharmaceuticals. However, the third-
party payer system can apply to ambulatory care in some special cases and an 
extension of this method is currently under discussion.
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Fig. 3.4
Schema of health expenditures by sources of revenue
Table 3.3 and Fig. 3.5 present an overview of the most important components 
of health expenditure by source of revenue. The main share of total health 
expenditure (71.3% in 2006) is publicly funded (by taxes and social security 
contributions), mostly through reimbursement taking place within the 
compulsory health insurance (67.3%). Federated and local governments 
represent a modest share in health spending with 1.5% and 2.0%, respectively. 
Out-of-pocket payments and VHI represent 23.3% and 5.1%, respectively (in 
2006). Among out-of-pocket payments, official co-payments were estimated to 
be around €1771 billion in 2006, that is, around 5.7% of total health expenditure.
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Table 3.3
Total and public health expenditures (in million €), 2000–2006 (selected years)
2000 % 2002 % 2004 % 2006 %
Total public expenditures  
(1) = (2) + (3) + (4)
16 113 72 17 626 71 20 669 72 21 997 71
Federal government (2) 15 394 69 16 837 68 19 678 69 20 915 68
NIHDI 14 128 63 15 477 63 19 518 68 20 766 67
Health insurance 12 845 57 14 189 58 16 594 58 17 446 57
Social maximum billing (MAB) 179 0.6 232 0.8 – – – –
Fiscal maximum billing (MAB) 51 0.2 57 0.2 – – – –
Hospital budget (22.7% of day price) 1 183 4.1 1 354 4.4 – – – –
Administration costs RIZIV-INAMI 318 1.4 218 0.9 252 0.9 319 1
Administration costs sickness funds 586 2.6 641 2.6 701 2.5 765 2.5
Other 379 1.7 430 1.7 559 2 593 1.9
FPS Health, Food Chain Safety 
and Environment*
1 102 4.9 1 194 4.8 0 – – –
Other 165 0.7 166 0.7 160 0.6 149 0.5
Federated governments (3) 259 1.2 283 1.1 426 1.5 451 1.5
Local governments (4) 461 2 507 2.1 564 2 631 2
Total self-financing (5) 6 259 28 6 964 28 7 786 27 8 752 28
Out-of-pocket payments 5 295 24 5 891 24 6 533 23 7 178 23
VHI 964 4.3 1 074 4.3 1 253 4.4 1 575 5.1
Sickness funds 588 2.6 625 2.5 708 2.5 894 2.9
Commercial insurance companies 375 1.7 449 1.8 545 1.9 681 2.2
Total work injuries (6) 97 0.4 101 0.4 103 0.4 110 0.4
Total health expenditures  
(7) = (1) + (5) + (6)
22 469 100 24 692 100 28 558 100 30 859 100
Reinsurance (8) 1 025 4.6 1 233 5 1 601 5.6 1 892 6.1
Sickness funds and commercial 
insurance companies
982 4.4 1 152 4.7 1 371 4.8 1 603 5.2
Maximum billing (MAB) 43 0.2 81 0.3 230 0.8 289 0.9
Total net health expenditures  
(9) = (7)–(8)
21 444 95 23 458 95 26 957 94 28 967 94
Net cost for the patients (10) = (5)–(8) 5 234 23 5 731 23 6 185 22 6 861 22
Total health expenditure as a percentage 
of the GDP (9)/GDP
– 8.9 – 9.2 – 9.9 – 9.7
Total net health expenditure as a 
percentage of the GDP (9)/GDP
– 8.5 – 8.8 – 9.3 – 9.1
Net cost for the patients as a percentage 
of the GDP (10)/GDP
– 2.1 – 2.1 – 2.1 – 2.2
Public spending as a percentage of 
the GDP (1)/GDP
– 6.4 – 6.6 – 7.1 – 6.9
Source: National Bank of Belgium, National Institute of Statistics, NIHDI-RIZIV-INAMI, Mutual Health Fund Control Office, Insurance 
Control Office, National Accounts, household budget surveys, ANMC data and own calculations based on a methodology developed 
by Avalosse 2009.
Note: *Until 2003, the FPS Health, Food Chain Safety and Environment partially funded the per diem charges for hospitalizations. 
From 2004, the operating hospitals’ budgets are fully funded by the NIHDI.
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Because of a different method compared to the System of Health Accounts 
(SHA), total health expenditures as a percentage of the GDP presented in 
Table 3.3 differ from those in Table 3.1.
Fig. 3.5
Percentage of total expenditure on health according to source of revenue, 2006
3.3 Population coverage and basis for entitlement
3.3.1 Coverage
Breadth: who is covered?
Almost 99% of the population is covered by the compulsory health insurance. 
There are two main schemes: (1) the general scheme for the whole population 
except for the self-employed, and (2) the scheme for the self-employed. The 
general scheme covers a large but limited number of categories of people such 
as employees, employees in incapacity, the unemployed, retired people, widows, 
orphans, students, residents and so on. Residents are defined as people who are 
registered in the Belgian National Registry.
Since 1 January 2008, both major and minor risks are covered by both 
schemes.2 Major risks include hospital care, delivery of babies, major surgery, 
dialysis functional rehabilitation care, implantable medical devices and 
2 In the past, both major and minor risks were covered for people in the general scheme and only major risks were 
covered for the self-employed.
5.1%  Voluntary health insurance
23.3%  Out-of-pocket
0.4%  Other governments
2.0%  Local governments
1.5%  Regional governments
67.8%  Federal government
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specialist care, among others. Minor risks include physicians’ visits, dental 
care, minor surgery, home care and pharmaceuticals for outpatient care, among 
others.
The basic principle for health insurance coverage is that people benefit 
in accordance with their actual or past professional activity. Both active and 
non-active people, as well as their dependants are covered. The main insured 
members are entitled to health insurance on the basis of their current or previous 
profession. Dependants are covered based on their relationship with the main 
entitled person, that is, a member of the family of the entitled person living in 
the same main place of residence. In 2008, over 9.4 million people (88.5%) were 
insured under the general scheme and over 1 million (9.7%) under the scheme 
for the self-employed (NIHDI 2008a).
To be covered, each individual must join or register with a sickness fund. 
The choice is free except for railway workers.3 Before 1998, health insurance 
status was evaluated each quarter. There used to be a waiting period for 
enrolment in the health insurance system of six months between being affiliated 
and qualifying for health insurance benefits. In 1998, insurability rules were 
changed and the principle of an annual entitlement was introduced. The waiting 
period was abolished.
Scope: what is covered?
The services that are covered by compulsory health insurance are described 
in the nationally established fee schedule (called the nomenclature), which is 
extremely detailed and lists more than 8000 services. For each service, an 
identification number, contractual fee and reimbursement rate are specified. 
Services not included in the fee schedule are not reimbursable. Sickness funds 
are legally bound to reimburse any claim from their insured members for 
care delivered by any recognized health care provider (see Chapter 4) at the 
agreed fee levels. The fee schedule is negotiated yearly or biennially between 
representatives of the sickness funds and of the health care professionals. 
Recommendations can be made by the KCE, but the KCE is not involved in the 
policy decisions themselves nor in their implementation (see Section 2.5.1 HTA).
Within the NIHDI there are conventions and agreements for most groups 
of care providers and institutions: physicians, dentists, physiotherapists, 
nurses, prosthetists, orthopaedists, hospitals, homes for the elderly and 
nursing homes, and initiatives for sheltered living for psychiatric patients (see 
3 This is due to the fact that in the past, the national railway company insured its active and retired personnel. This 
scheme is now integrated in the general scheme (Royal Decree of 20 February 1991) and the railway company 
operates as a sickness fund for its employees.
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Section 3.6 Payment mechanisms). These conventions and agreements regulate 
the financial and administrative relationships between the insured, represented 
by their sickness funds, and health care providers. In addition to fees and 
reimbursement tariffs, the conventions and agreements also contain a huge 
array of conditions related to content, quality and quantity of care. Examples 
of decisions that have been agreed for physicians are: accreditation, quality 
control and the GMD-DMG (to optimize the quality of primary care provided, 
and avoid unnecessary or duplicated care and contradictory prescriptions) (see 
Subsection Strengthening primary care in Section 6.1.2. Assuring health care 
quality). An arrangement or agreement is only possible if it falls within the 
budget provided for the sector involved and has been subject to advice from the 
Commission for Budgetary Control.
At regular intervals, new treatments are introduced into the benefits package 
and treatments that have become obsolete are removed. The fee schedule has 
been criticized as adapting too slowly to change. Another disadvantage of the 
fee schedule is that it consists mainly of administrative prices with no or little 
relation to real production costs.
Plastic surgery, spectacles and orthodontics are only reimbursable under 
certain conditions. Moreover, certain types of health care are not covered by 
the compulsory health insurance. For example, alternative therapies such as 
acupuncture, homeopathy and osteopathy are excluded but may be partially 
covered by complementary insurance. Some preventive health care costs are 
co-financed by the federal government and the communities, and are provided 
free to patients (e.g. vaccinations for children and breast cancer screening).
Depth: how much of benefit cost is covered?
User charges in Belgium apply for outpatient care, inpatient care and 
pharmaceuticals. They can be official and provided by law or supplements 
charged on top of official user charges. Co-payments are the same for everyone 
except for people with preferential reimbursement status (see Section 3.4 
Out-of-pocket payments). As shown in Table 3.2 (see p.80), patients’ total 
charges, including out-of-pocket payments (official co-payments, supplements 
and non-reimbursed acts, drugs or medical devices) and premiums for 
sickness funds and commercial insurance companies, represent 28.4% of total 
health expenditure. By taking into account reinsurance (MAB and voluntary 
insurance), net charges for patients represent 22.2% of total health expenditure.
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3.3.2 Collection
The public financing of social security is composed of social contributions, 
subsidies from the state, alternative financing (mainly value added taxes), and 
allocated and diverse receipts (special contributions of social security, solidarity 
contributions and contributions of employers for early retirement). The federal 
government subsidizes the difference between social security contributions and 
the a priori determined budget with general taxation revenue (see Section 3.3.3 
Pooling of funds). The alternative financing aims to limit government subsidies 
and to reduce employers’ contributions. Instead of taxing labour, the government 
seeks alternative means to finance the whole of social security (value added tax, 
taxes on tobacco, etc.) (FPS Social Security 2009f).
One part of the public financing of social security is directly related to 
the health system (so-called “own receipt” of the health system), while the 
other part is related to a “global management of the financing system” for all 
social security sectors: health and disability insurance, old age and survivors 
pensions, unemployment, insurance for accidents at work, work-related health 
and occupational diseases, and family allowances.
For the Belgian health system, public funding for the year 2009 (budgetary 
data) is presented in Table 3.4. Public funding of the Belgian health system is 
composed of “own receipts” (€4.8 million; 17.9%) and transfers from the “global 
management of the financing system” for the general scheme (€19.8 million; 
74.4%) and for the self-employed scheme (€1.9 million; 7.7%).
Because of the “global management” of the financing system, the 
composition of the Belgian health system has to be estimated. Only the share 
of alternative financing is known. For other sources of funding, it was assumed 
that the distribution of the resources in the global management of the financing 
system for the general scheme and the self-employed scheme was respected 
(see Table 3.5).
The public funding of the Belgian health system is thus estimated to be 
composed of social contributions (66% of the total), subsidies of the state (10% 
of the total), alternative financing (14% of the total), and allocated and diverse 
receipts (10% of the total).
Both in the general system and in the system for the self-employed, 
social security contributions are related to income and independent of 
risk. Contribution rates are fixed by law as a percentage of income. Social 
contributions collection is organized differently in the two systems.
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Table 3.4
Public financing of the health system (budgetary data), 2009
Composition in million € %
Own receipts 4 754.6 17.9
Social contributions 825.6 3.1
Subsidies 0.0 0.0
Alternative financing 2 499.0 9.4
Allocated receipts 1 098.6 4.1
Diverse receipts 331.5 1.2
Transfer from the “global management” system 21 839.0 82.1
General scheme 19 793.1 74.4
Self-employed scheme 2 045.9 7.7
Total public financing of the health system 26 593.6 100.0
Total public financing of social security 69 714.3 –
Public health care funding in % of GDP 7.7 –
Public health care funding in % of social security funding 38.1 –
Social security funding in % of GDP – 20.2
Source : Budgetary data from the vade mecum of social security in Belgium (FPS Social Security 2009f).
Table 3.5
Estimated composition of the public financing of the Belgian health system, 2009  
(in million €)
Own receipts
Transfers from 
general scheme
Transfers from 
self-employed Total
Social contributions 825.6 15 430.1 1 380.3 17 635.9 (66.3%)
Subsidies 0.0 2 252.3 525.3 2 777.6 (10.4%)
Alternative financing 2 499.0 1 048.8 102.2 3 650.0 (13.7%)
Allocated receipts 1 098.6 447.6 6.8 1 553.0 (5.8%)
Diverse receipts 331.5 614.2 31.4 977.1 (3.7%)
Total 4 754.6 19 793.1 2 045.9 26 593.6 (100%)
Source: Budgetary data from the vade mecum of social security in Belgium (FPS Social Security 2009f) and own calculations.
In the employed workers’ scheme, there is an employee’s contribution 
(13.07% of gross income) and an employer’s contribution (24.77% of gross 
income without the social contributions paid for annual holidays), which are 
paid to the NSSO-RSZ-ONSS. The social contributions are calculated on the 
entire gross income. Since 1982, no ceiling is applied to calculate the amount 
to be paid (FPS Social Security 2009a).
The self-employed pay their own social insurance contributions to the 
social insurance fund to which they are affiliated, which in turn forwards the 
funds to the NSSO for the self-employed. The contribution is calculated on 
the self-employed person’s net professional labour income in a reference year. 
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The reference year is the third calendar year preceding the year during which 
the contributions were paid. Contributions, paid per trimester, are only due on 
the income below a ceiling (i.e. in 2009, €75 246.19 for revenues of 2006) (see 
Table 3.6) (FPS Social Security 2009b).
Table 3.6
Social contribution rates for self-employed, applied in July 2009
Net professional income Contributions
Up to €11 824.39 €650.34 per trimester
Between €11 824.39 and €51 059.94 22.00% of the net professional income (5.5% per trimester)
Between €51 059.94 and €75 246.19 14.16% of the net professional income (3.54% per trimester)
Above €75 246.19 €0
Source: FPS Social Security 2009b.
3.3.3 Pooling of funds
The budget for the health system is determined on an annual basis using a 
six-step procedure: (1) determining needs; (2) carrying out technical estimates; 
(3) identifying potential economy measures; (4) suggesting the global budget 
objective and partial objectives; (5) determining the budget; and (6) negotiating 
conventions and agreements. These steps are described in turn below. 
Furthermore, Fig. 3.6 details the process for determining the global budgetary 
objective and its breakdown into partial budgetary objectives in terms of the 
structures involved and the missions achieved.
Fig. 3.6
The budgetary process
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(1) Determining needs. The conventions and agreements commissions 
make an inventory of the changes which are necessary for financing their 
branch of industry, based upon the expenses level (on the assumption of 
unchanged legislation) as established by the Health Care Department of the 
NIHDI. The inventory of needs is centralized by the Health Care Department 
and submitted to the different management boards (Insurance Committee, 
General Management Committee). This takes place from April to June of the 
year preceding the financial year.
(2) Carrying out technical estimates. The Health Care Department of the 
NIHDI sends its technical estimates to the Insurance Committee, the General 
Management Committee, the Budget Control Committee and the Ministers 
of Social Affairs and Budget no later than 30 June of the year preceding the 
financial year. These technical estimates are the result of the extrapolation of 
the expenses of the last four to five years. Two weeks before the first Monday 
in October, the Health Care Department sends the reviewed technical estimates. 
The expenses of the first five months of the year preceding the financial year 
are taken into account. In other words, the technical estimates carried out on 
30 June are now checked against more recent information.
(3) Identifying potential economy measures. The Budget Control Committee 
presents some saving measures to the Insurance Committee, the General 
Management Committee and the Ministers of Social Affairs and Budget no later 
than 15 September of the year preceding the financial year. These measures 
are based upon the permanent audit reports and must be applied in several 
sectors in order to establish the global budgetary projection in compliance with 
the growth rate and the increase of the health care index. The Budget Control 
Committee also sends these saving measures to the conventions and agreements 
commissions concerned.
(4) Suggesting the global budget objective and partial objectives. The 
Insurance Committee sends to the General Management Committee and the 
Budget Control Committee a global proposition in compliance with the growth 
rate and the increase of the health care index. This must be sent no later than 
the first Monday in October of the year preceding the financial year. In order 
to establish the partial budgetary projections of that global proposition, the 
Insurance Committee mentions for the sectors concerned, in proportion to the 
technical estimates and according to the case, either the amount to be saved 
(and the concrete corresponding saving measures, with the date at which they 
will take effect), or the amounts corresponding to positive measures (and a 
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description of these measures, with the date at which they will take effect). If 
there is no proposition on the first Monday of October, the General Management 
Committee is empowered to establish the partial projections.
(5) Determining the budget. Considering the global proposition of the 
Insurance Committee and the savings measures suggested by the Budget 
Control Commission, the General Management Committee approves the 
annual global budgetary projection of the health insurance as well as the annual 
partial budgetary projections of the conventions and agreements committees. 
This occurs no later than the third Monday in October of the year preceding 
the financial year. To approve the global budgetary projection, the General 
Management Committee must take into consideration the real growth rate (4.5% 
since 2004), the health care index and the influence of the algebraic differences.
The General Management Committee also approves the structural savings 
(content of the measures, annual amount and date when the measures will take 
effect) which are necessary to comply with the growth rate and the increase of 
the health care index. The Committee suggests the global budgetary envelopes 
(called the budgets of financial means) for some services (or groups of services) 
to which that envelope applies (e.g. the envelope for pharmaceuticals).
If the budgetary projection is not approved, the General Management 
Committee informs the Minister of Social Affairs. In that case, the Council 
of Ministers fixes, on the proposal of the Minister, the amount of the annual 
budgetary projection of the health insurance, the partial projections and the 
global budgets of financial means for the provisions (or group of provisions) to 
which that system applies.
(6) Negotiating conventions and agreements. After approving the global 
budgetary objective and its breakdown into partial budgetary objectives, this 
decision is notified to the Insurance Committee and the various conventions 
and agreement commissions. That is when the negotiations start in the various 
conventions and agreement commissions in order to conclude new conventions/
agreements or to adapt existing conventions/agreements. This process has to be 
terminated before the start of the new budgetary year. (See also Section 3.6.2 
Paying health care professionals.)
Controlling expenses
An important instrument in the budgetary process towards controlling 
the expenses is the so-called audit reports. The audit allows for systematic 
reporting of the evolution of expenditure for each sector, irrespective of any 
budget overrun. The audit gives information on: the difference between the 
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fixed budget and the evolution of expenditure; savings measures; the initiatives 
of the government and the conventions and agreements commissions; and the 
evolution of the most important areas of activity within a health care sector.
Another important instrument in controlling expenses is the competence 
of the Minister of Social Affairs as well as the General Board (possibly at 
the suggestion of the Commission for Budget Control) to suggest economy 
measures at any time in order to observe the partial budgetary provisions. The 
conventions and agreements commissions concerned have 30 days, starting 
from the notification of these measures, to make comments and to forward them 
either to the Minister of Social Affairs or to the General Board, depending on 
the case.
Financial accountability of sickness funds
Since 1995, Belgian sickness funds have been made more financially 
accountable for the expenditure of their insured members while being 
compensated for differences in risk structure. They receive a prospective 
budget to finance the health care costs of their members and are held financially 
responsible for a proportion of any discrepancy between their actual spending 
and their so-called normative, that is, risk-adjusted health expenditures. This 
risk-adjustment system is based on the results of a regression analysis with 
demographic and socioeconomic variables, such as insurance status (pensioners, 
disabled, widows), age, sex, household composition, unemployment rate, 
income, mortality rate, degree of urbanization, morbidity criteria and work 
disability status. Furthermore, the model has shifted from a more aggregated 
level to a more individual level. The main proclaimed purpose of this system is 
to increase cost-effectiveness through a more active role of competing sickness 
funds while guaranteeing a level playing field.
This reform has been introduced gradually because none of the important 
players in the system wanted to question the crucial importance of equity and 
equal access for all citizens. The gradual process of giving the sickness funds 
financial responsibility began in 1995 with the implementation of a risk-based 
capitation formula as a partial basis of funding for the sickness funds. In the 
years 1995–1997, 10% of the funds’ total budget was allocated on a prospective 
basis, rising to 20% in 1998–1999 and 30% since 2000. The remaining 
proportion of the budget is retrospectively allocated on the basis of the share 
of expenditure of each sickness fund. The proportion of any discrepancy 
between received budget and actual spending for which funds were to be held 
responsible was limited to 15% in 1995–1997, 20% in 1998–1999 and 25% since 
2000. However, their financial accountability for the deficit can never exceed 
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2% of the total budget. Sickness funds are not to be held responsible for any 
deficits caused by external factors such as wage increases granted to health 
care personnel.
In order to cover for potential deficits, social insured members are obliged 
to pay a nominal premium to the reserve fund, amounting to at least €4.46 per 
policyholder (Act of 14 July 1994). If a sickness fund has incurred a surplus, its 
individual share is automatically paid into this reserve fund.
3.3.4 Purchasing and purchaser–provider relations
In Belgium, purchaser–provider relations are based on “indemnity insurance”. 
In this case, no contractual arrangements exist between insurers and providers 
(Colombo 2004). Although no direct price controls for the remuneration of 
providers exist, fees are established between the sickness funds and the 
representatives of the physicians (for more information see Section 3.6.2 Paying 
health care professionals). Physicians who do not agree with this convention 
(non-conventioned physicians) can set fees freely. In 2009, almost 80% of 
physicians accepted and implemented the fees established in the agreement 
(NIHDI 2010b). For conventioned physicians who do not respect the established 
fees, financial sanctions can be enforced (Moniteur Belge 1994). However, there 
is little information on the extent to which these sanctions are actually put into 
practice.
3.4 Out-of-pocket payments
3.4.1 Cost-sharing (user charges)
For outpatient care, patients are in principle required to pay upfront the full 
fee and then claim reimbursement from their sickness fund. For inpatient care 
and medicines purchased in pharmacies, the third-party payer system applies 
and patients only pay user charges. User charges can be either official and 
provided by law, or supplements charged on top of official user charges, which 
are allowed under certain conditions (see in particular Subsection Patient 
contributions at the end of Section 3.6.1 Paying for health services).
Co-payments vary from service to service but are equal for everyone, with 
the exception of patients with preferential reimbursement who pay reduced 
co-payments. Co-payment rates are about 25% for GP consultations, 35% for 
GP home visits and 40% for specialist consultations, physiotherapy, speech 
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therapy, podology and dietetics. The co-payment for preferential reimbursement 
rate beneficiaries depends on the type of service and amounts to about 10% for 
GP consultations, about 15% for specialist consultations, and about 20% for 
physiotherapy, speech therapy, podology and dietetics.
Before July 2007, in order to qualify for preferential reimbursement, a 
patient had to belong to a socioeconomically vulnerable group and earn less 
than a minimum income threshold. People and their dependants defined as 
socioeconomically vulnerable groups are: pensioners, widowers/widows, 
orphans, disabled people receiving a disability benefit, long-term unemployed 
aged 50 years and older with at least one year of full unemployment, civil 
servants who are made redundant because of illness or infirmity for at least 
one year, disabled children entitled to increased child allowance, and people 
entitled to one of the following allowances: integration or income replacement 
for disabled persons, income guarantee for the elderly, disability benefit, 
subsistence level income (leefloon-revenue d’intégration), support from the 
public municipal welfare centre (OCMW-CPAS) and allowance for assistance 
for the elderly.
On 1 July 2007, the system was extended (now called the OMNIO system) 
and the socioeconomic group criterion was abolished. In 2009, in order to 
qualify for preferential reimbursement the gross annual taxable income of 
the household (or isolated person) must not exceed €14 339.94 + €2654.70 per 
dependant (NIHDI 2009c).
Concerning medicines, about 2500 pharmaceuticals are reimbursable in 
Belgium. In the case of pharmaceuticals obtained from a pharmacy, the patient 
pays co-insurance (i.e. the patient pays a certain fixed proportion of the cost 
of a service and the third-party payer covers the remaining proportion).4 The 
percentage is determined by the pharmaceutical category, which reflects the 
social importance of the pharmaceutical, pharmacotherapeutic criteria and price 
criteria. A distinction is made between category A (pharmaceuticals for serious 
and long-term illnesses), B (socially and medically useful pharmaceuticals), and 
C (socially and medically less useful pharmaceuticals). The different rates are 
given in Table 3.7.
Moreover, a system of reference reimbursement has been developed. With this 
system, the basis of reimbursement of an original pharmacological product for 
which there is a less expensive version (often a generic or a “copy”) is decreased. 
4 It should be noted that in the rest of this report, the term “co-payment” is used to refer to both co-payment and 
co-insurance. Both are cost-sharing arrangements which require the individual covered to pay part of the cost 
of care. A co-payment refers to a fixed fee (flat rate) per item or service and a co-insurance refers to a fixed 
proportion of the total cost.
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From 1 July 2005, the decrease is 30%. This implies that the patient will pay 
a reference supplement when the more expensive medication is prescribed. 
From 1 January 2009, the basis of reimbursement for original pharmaceutical 
products which have been in the system of reference reimbursement for two 
years undergoes a further decrease of 2.5% (NIHDI 2009c).
Table 3.7
Co-payments for outpatient pharmaceuticals on 1 January 2009
Reimbursement category Non-preferential treatment Preferential treatment
A–vital drugs (e.g. insulin for 
diabetics, cancer drugs, 
antiretrovirals)
100% reimbursement, no co-payment 100% reimbursement, no co-payment
B–therapeutically significant drugs 
for non-life-threatening diseases 
(e.g. antibiotics, antiasthmatics, 
antihypertensives)
75% reimbursement, co-payment: 
25% with a maximum of €10.80 
(€16.10 when there are generics/
copies)
85% reimbursement, co-payment: 
15% with a maximum of €7.20 
(€10.80 when there are generics/
copies)
B large package size–therapeutically 
significant drugs for non-life-
threatening diseases (e.g. antibiotics, 
antiasthmatics, antihypertensives)
75% reimbursement, co-payment: 
25% with a maximum of €13.50 
(€24.20 when there are generics/
copies)
85% reimbursement, co-payment: 
15% with a maximum of €8.90 
(€16.10 when there are generics/
copies)
C–therapeutically less significant 
drugs for systematic treatment 
(e.g. antiemetics, spasmolytics)
50% reimbursement, co-payment: 
50% with a maximum of €13.50 
(€24.20 when there are generics/
copies)
50% reimbursement, co-payment: 
50% with a maximum of €8.90 
(€16.10 when there are generics/
copies)
Cs–drugs used in certain chronic 
illnesses (e.g. drugs used in coronary 
heart disease), antihistamines 
and vaccines
40% reimbursement, co-payment: 
60% without maximum
40% reimbursement, co-payment: 
60% without maximum
Cx–contraceptives and 
antispasmodics
20% reimbursement, co-payment: 
80% without maximum
20% reimbursement, co-payment: 
80% without maximum
D–non-reimbursable drugs 0% reimbursement, co-payment: 
100% 
0% reimbursement, co-payment: 
100%
Source: NIHDI 2009c.
For inpatient care, a patient’s out-of-pocket payments consist of:
• a flat rate per day for hospitalization;
• a room supplement when the patient has requested a single or double 
room;
• the physician’s fee supplements for non-conventioned physicians or for 
conventioned physicians (conventioned physicians can only ask for a fee 
supplement when the patient has requested a single room);
• costs of certain non-reimbursable medical products or pharmaceuticals; 
and
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• a flat rate charge per day for pharmaceuticals (€0.62/day), and flat rate 
charges per inpatient stay for biological tests (€7.44/stay), for radiology 
(€6.20/stay) and for technical acts (€16.40/stay).
3.4.2 Maximum billing (MAB-MAF)
In 1993, within the context of the economic recession, it was decided that 
there should be a significant increase of the legal co-payments. Because of 
the increase in the financial burden for patients and the induced (short-term) 
volume decrease, especially for visits to and consultations with GPs, the 
government decided in 1994 to introduce a “social and fiscal exemption”, in 
order to put a ceiling on the total amount of co-payments to be paid. However, 
although access has been improved, there were still certain categories of people 
for whom costs for health care remained a problem. The system did not meet 
the needs of two high-risk groups in society: people with chronic illnesses and 
people who belong to a family with a low or modest income and who do not 
belong to a specific social category with protective measures.
On 5 June 2002, MAB was therefore introduced alongside the existing 
preferential reimbursement levels. The MAB is set according to the family’s 
net income, such that each household has an annual out-of-pocket maximum 
for all “necessary health care expenses” (see Table 3.8). As soon as expenses 
reach the set ceiling, any further health care costs are covered in full by the 
health insurance fund for the remaining part of the year. This measure therefore 
improved the out-of-pocket maximum, already introduced under the social and 
fiscal exemption mechanism for certain vulnerable categories, by extending the 
scheme to all households and to other types of user charges.
MAB covers the following health care costs:
• non-refundable health care expenses, up to the officially agreed fee, 
relating to physician consultations and visits, and those relating to all 
technical treatments by GPs and/or specialists, physiotherapists, nursing 
staff and paramedics;
• non-refundable health care expenses relating to necessary 
pharmaceuticals (i.e. categories A, B and C) and personal contributions 
towards costs for pharmaceuticals in hospitals;
• personal contributions towards the per diem rate paid for inpatient care, 
limited to the first year in a psychiatric hospital; and
• non-refundable medical expenses relating to certain types of expensive 
medical devices (NIHDI 2009c).
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There are currently three types of MAB:
• social MAB: a threshold of €450 is applied at the household level for 
specific vulnerable groups; it is applicable to households with at least 
one individual with preferential reimbursement or who is entitled to an 
allowance for disabled persons; as soon as the limit of €450 is exceeded, 
the co-payments are reimbursed;
• MAB for children: a threshold of €650 is applied at the level of the child; 
all children under 19 years with total co-payments of €650 become 
individually entitled without taking into account family income; and
• income MAB: the principle of MAB is applied in a gradual way according 
to net family income (see Table 3.8).
Table 3.8
Means-tested annual out-of-pocket maximums, 2009
Net family income Out-of-pocket maximum
Up to €16 114.10 €450
€16 114.11 – €24 772.41 €650
€24 772.42 – €33 430.75 €1 000
€33 430.76 – €41 728.30 €1 400
Above €41 728.31 €1 800
Source: NIHDI 2009c.
3.4.3 Fixed payments to patients
In order to protect people who can be expected to have high medical expenditure, 
for example chronically ill patients, fixed payments systems have also been 
introduced by Royal Decree. These have included those for chronically ill 
patients (Royal Decree of 2 June 1998), for incontinence material (Royal 
Decree of 2 June 1998), for palliative treatment at home (Royal Decree of 
2 December 1999) and for patients in a persistent vegetative state (Royal Decree 
of 18 November 2005). Additional measures taken after 2007 are described in 
Chapter 6.
3.4.4 Solidarity fund
From 1990, the Special Solidarity Fund was established at the NIHDI in order 
to grant additional reimbursement for patients with a rare illness or who need 
a very specific treatment. Additional reimbursement is possible for: (a) a rare 
indication or (b) rare disorder, (c) a rare disorder which needs continuous and 
complex care, (d) the application of innovative medical aids or treatments 
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(excluding pharmaceuticals), (e) chronically ill children and (f) some treatments 
abroad (NIHDI 2006). For each case, specific conditions must be fulfilled and 
the total reimbursement is set according to the availability of funds.
3.5 VHI
VHI represents approximately 5% of total health expenditure (see also 
Section 3.2 Sources of revenue and financial flows). The sickness funds provide 
two kinds of additional insurance for their members beyond the compulsory 
health insurance – the so called “complementary” and “voluntary” insurance. 
VHI is also provided by private profit-making insurance companies.
The expenditures covered by complementary insurance are determined by 
each sickness fund. Depending on the sickness fund, a member can automatically 
be insured by the “complementary” insurance (mandatory membership) and 
thus has to pay the extra premium. The services covered include orthodontics, 
homeopathy, osteopathy and supplements for hospitalization in a double room 
among others. The market for complementary health insurance provided by 
sickness funds has grown steadily from €494 million in 1995 to €774 million 
in 2007, with an annual average increase of 3.6% (see Table 3.9) (Avalosse 2009).
Table 3.9
Evolution of expenditure covered by additional insurance of the sickness funds  
(in million €), 1995–2007 (selected years)
1995 2000 2005 2006 2007
Complementary insurance 494 539 705 751 774
Voluntary hospitalization insurance 59 91 155 174 190
Source: Avalosse 2009.
The second type of additional insurance provided by the sickness funds is 
“voluntary” insurance (which could be classified as supplementary insurance). 
Health care costs, such as hospital costs (not covered by the “complementary” 
insurance), are covered. Sickness fund members take out this insurance mostly 
in order to cover the expenses for hospitalization in a single room. Some form of 
risk selection is possible, but it differs between the sickness funds. Expenditure 
covered by this voluntary hospitalization insurance has grown from €59 million 
in 1995 to €190 million in 2007 (see Table 3.9) (Avalosse 2009).
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Since 2007, sickness funds are prohibited from refusing people under 
65 years old and people with pre-existing diseases or disorders (Royal Decree 
of 11 May 2007). In addition since 2008, differential payments according to 
gender were abolished (law of 21 December 2007).
VHI is also provided by private profit-making insurance companies. Group 
hospitalization insurance policies are collectively organized and risk selection 
on this type of insurance is therefore difficult. They are set up annually, often as 
a result of negotiations between the social partners (employers and trade unions). 
Individual VHI is characterized by tariff segmentation and selection of risks.
Since 2007, sickness funds and private insurance companies are prohibited 
from refusing people under 65 years old with pre-existing diseases or disorders. 
Sickness funds are now allowed to reduce the benefits for pre-existing diseases 
or disorders to, for example, €12.50 per hospital day. Private profit-making 
insurance companies may exclude pre-existing diseases and disorders as a 
whole in conditions enumerated by the law (law of 20 July 2007 and law of 
11 May 2007). In addition, since 2008, differential payments according to 
gender were abolished (law of 21 December 2007).
Private companies provide a variety of insurance with three main 
subdivisions related to health, including: guaranteed income, insurance for 
dependants and health insurance, of which 74.2% in 2008 was hospitalization 
insurance. This type of insurance can be clustered in an individual contract 
or in a collective contract (paid by employers) and mostly provides for the 
coverage of costs charged to patients during a hospital stay.
The compound annual growth rate of the number of people with a private 
individual or group VHI was 4.6% between 2001 and 2008. In 2008, there 
were 5.3 million affiliated members providing a turnover of €826.2 million 
(compared to €490.5 million in 2003) (Assuralia 2010). This large increase can 
be attributed to the fact that some employers provide this type of insurance as 
an added benefit for employees.
Expenditures covered by private VHI have grown from €134 million in 
1995 to €609 million in 2008 (see Table 3.10). The insurance companies are 
supervised by the Banking, Finance and Insurance Commission (CBFA).
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Table 3.10
Evolution of expenditure covered by private VHI (in million €), 1995–2008 
(selected years)
1995 2000 2005 2006 2007 2008
Costs covered by individual contracts 36 78 149 157 174 183
Costs covered by collective contracts 98 181 344 361 394 426
Total 134 258 493 518 568 609
Source: Avalosse 2009.
In September 2008, the European Commission told the Belgian government 
to adapt the complementary insurance system of the sickness funds so as to 
comply with European guidelines. This has resulted in a new regulation of the 
sickness funds’ complementary insurance products.
3.6 Payment mechanisms
This section describes payment mechanisms for health services and health 
care personnel. Payment mechanisms for pharmaceuticals are discussed in 
Section 3.4 Out-of-pocket payments and Section 5.6 Pharmaceutical care.
3.6.1 Paying for health services
Paying for hospitals
General structure of the Belgian hospital financing system
The basic feature of the Belgian hospital financing is its dual financing 
system according to the type of services provided.
• Services of accommodation (nursing units), emergency services 
(anaesthesia, sterilization, operating room, plaster room) and nursing 
activities in day hospitalizations are financed via a fixed prospective 
budget system based on so-called “justified activities”.
• Medical and medico-technical services (consultations, laboratories, 
medical imaging and technical procedures) and paramedical activities 
(physiotherapy) are mainly paid via a fee-for-service system to the 
service provider.
Together, these two remuneration systems account for almost 80% of a 
hospital’s revenue (see also Table 3.11).
Health systems in transition  Belgium 103
Hospitals receive additional funding from:
• outpatient and inpatient sale of pharmaceutical products (financed per unit 
or pack);
• a prospective budget for pharmaceuticals for inpatient care;
• specific ambulatory activities, such as day care, dialysis and rehabilitation, 
which are mainly reimbursed per patient via lump sums;
• subsidies for investments from the federated authorities (communities);
• supplements charged to patients;
• non-hospital activities, such as commercial operations and homes for the 
elderly, nursing homes, cafeteria, newspaper shop, etc.; and
• private legacy or corporate grants.
An additional complexity of the system concerns the distinction made 
between so-called “net” and “all-in” fees. Net fees only cover activities performed 
by physicians. They are applicable to the provision of surgical, anaesthesia and 
emergency services. The remaining costs of nonmedical staff, consumables 
and infrastructure are paid in these services via the hospital budget. Therefore, 
among the services charged to the hospital budget, physicians are still paid 
via a fee-for-service system. For services other than surgical, anaesthesia and 
emergency services, the “all-in” or global fees cover all costs relating to the 
medical provision. This means that each additional provision again results in 
the integral financing of all costs.
Table 3.11
General hospitals’ revenue distribution in % (2007, aggregated average)
Revenue 100%
Hospital budget 38.8%
Pharmaceutical products 15.3%
Physicians’ fees 40.0%
Other 5.9%
Source: Dexia 2009.
The next sections will provide a description of the financing mechanism of 
nonmedical activities and of the other sources of hospital financing.
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Financing of nonmedical activities
The current financing of nonmedical hospital activities is based on the reforms 
introduced in 2002. Between the Hospital Act of 23 December 1963, which 
was the first law to determine a per diem rate per hospital and per department, 
and the reform of 2002, hospital financing was characterized by a gradual 
move from a retrospective cost-based system towards prospective financing. 
During this period, the “per diem rate” and “day quota” (i.e. the number of days 
a hospital should provide given certain predefined parameters) were the central 
concepts in the financing system. Since 1994, pathology information has also 
been used to determine the hospital budget. Since 1986 an annual national 
budget is set for hospitals’ operating costs. This closed-end budget is paid to 
the hospitals by the compulsory health insurance system via the sickness funds. 
Detailed information on the history of financing of hospital activities can be 
found in the previous edition of the HiT report on Belgium (Corens 2007) and 
in KCE report 121 (Van de Sande et al. 2010).
Since 1 July 2002, the concepts of per diem rate and day quota have 
disappeared and there has been a gradual switch to the notions of “justified 
activities” and “justified beds”, with a focus on pathology-weighted length of 
stay (LoS). The new system places less emphasis on the structure of a hospital 
but focuses more on its activity as expressed in terms of treated pathologies 
and justified beds.
In order to determine a hospital’s justified patient-days the case mix of each 
individual hospital is multiplied by the national average LoS per pathology 
group, called the “justified LoS”. This LoS is defined by the federal government 
and is based on the hospital discharge dataset called MCD-MKG-RCM, which 
captures patient characteristics, diagnoses, interventions and hospital LoS. 
In order to have a stable LoS, a reference period of three years is used. For 
outliers, stays with a LoS above Q3 + 2 x (Q3–Q1), different financing rules 
are defined. Per department or group of departments, the number of justified 
patient-days is divided by 365 to translate the days into the “justified beds” and 
by the normative capacity utilization of a service (e.g. 70% for paediatrics and 
maternal wards; 90% for geriatric wards and 80% for surgical wards). This is 
the volume part of the hospital’s budget.
Components of the hospital budget
The second part is the cost part of the hospital budget. The budget part is 
composed of three major parts (A, B and C), which are further divided into 
subparts. The share of each (sub-)part in the total budget is given in parentheses.
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• Part A (capital costs) (8%) consists of investment charges (A1), short-term 
credit burdens (A2) and investment charges for some medico-technical 
services (A3), which are exclusively financed via the hospital budget 
(not via fees).
• Part B (operational costs) (more than 90% of the budget) mainly covers:
 •  B1 common operational costs (administration, maintenance, laundry) 
(30%)
 •  B2 clinical costs (personnel and medical equipment) (40–50%)
 •  B3 medico-technical departments (radiotherapy, MRI and PET scans) 
(1%)
 •  B4 some specific (mostly) lump sum costs (as a result of legal 
obligations), e.g. hospital hygiene, quality assessment, palliative care and 
recording of hospital data
 •  B5 pharmacy costs (2%)
 •  B6 costs for carrying out the social agreements for personnel not 
included in the budget of financial means (2%)
 •  B7 extra costs for teaching hospitals or university function of 
the hospital (applied scientific research, the development of new 
technologies and the training of specialists) (3%)
 •  B8 specific costs for patients with a weaker socioeconomic profile or 
social function of the hospital (0.5%)
 •  B9 extra-legal financial benefits.
• Part C (corrective measures).
Calculation of the individual hospital budget
The distribution of the national hospital budget to the individual hospitals is 
based on a very multifaceted calculation. Each budget component has its own 
calculation method with its own determining parameters. Here we focus on 
the calculation of the budget for B2, since this is the main part of the hospital 
budget. The budget (B2) consists of two major parts: a basic part based on 
justified beds and a supplementary part based on activity and care profile. For 
the calculation of both parts a point system is used. The starting point for 
the basic part is the number of justified beds and the minimal nursing staff 
ratios that have been set in the past for various types of nursing departments 
(e.g. 0.58 FTE/justified bed for maternity and 2 FTE for intensive care). This 
basic financing is called the “functional” part of the budget. The annual global 
prospective budget for hospitals is divided by the total number of financial 
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B2 points earned by all hospitals. This results in a financial value per point 
and allows the final budget calculation for each hospital. In 2009, the financial 
value of a B2-point was €22 519.
The supplementary part is developed for specific nursing departments 
(surgery and internal medicine, paediatrics). Each hospital earns supplementary 
points according to its relative position among all hospitals. All hospitals are 
ranked according to their nursing profile and according to their profile based 
on medical interventions. Hospitals are divided in deciles in accordance with 
their ranking and points are allocated. The number of supplementary points 
per justified bed that can be allocated varies from 0 points for the lowest 
decile to 0.34 points for the highest decile for surgery and internal medicine, 
or 0.38 points for paediatrics. This means that for hospitals in the highest 
decile the budget is augmented by an amount ranging from 34% to 38%. The 
supplementary part is called the “activity” part of the budget.
Payment of the individual hospital budget
The payment of the budget of financial means of a hospital contains two parts: 
a fixed part and a variable part. The fixed part is paid by the sickness funds on 
the basis of monthly advances (the so-called provisional twelfths), depending on 
the share of each sickness fund in the total expenses of the hospital (in the most 
recent financial year). This part includes 80% of subparts B1 and B2, and 100% 
of all other parts. The variable part, including 20% of subparts B1 and B2, is 
paid according to the number of admissions (10% of the budget) and the number 
of nursing days (10% of the budget) for the general hospitals, and exclusively 
according to the number of days (20% of the budget) for the other hospitals, by 
an invoice. This invoice is submitted by the hospitals to the sickness funds for 
all patients enrolled in a sickness fund; for patients not enrolled in a sickness 
fund, the invoice (with the full day-price) is sent to the paying authorities (such 
as work accident insurance). The amounts per admission and per nursing day 
are hospital-specific and also depend on the type of hospital stay (e.g. acute 
care, palliative care). They are adapted twice a year.
Other sources of hospital financing
Capital financing
Hospital investments are included in the hospital budget (A1, A3 and C1). 
Subpart A1 contains investments in real property consisting of investments 
that increase the patrimony and replacement investments. Although the 
distinction between the two categories of investments is not always clear, it 
is important, since the first category can in principle be subsidized by the 
federated authorities while this is not the case for the second category.
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Federated authorities are allowed to enact own rules concerning hospital 
financing. In the Flemish region these rules are summarized in the Flemish 
Infrastructure Fund for Personal Affairs (VIPA), the Brussels-Capital region 
has its own rules and in the Walloon region the federal rules apply since no 
new rules were enacted. Regional authorities can subsidize 60% of hospitals’ 
capital investments. The remaining part is covered by federal authorities via 
the hospital budget (subpart A1) if the investment is mentioned on the building 
calendar (which determines the maximum budget at the federal level, the 
division of the budget at the regional level and the investments which will be 
subsidized per year and per hospital) and if the investment is subsidized by the 
regional authority.
Medico-technical services
Laboratory testing
To counter the increasing expenditures during the 1970s and 1980s, 
a fixed national budget for laboratory testing (1988) was introduced, with 
a differentiation between the inpatient sector and the ambulatory sector. A 
mixed financing system was introduced. Financing partly consists of fee-for-
service payments and, for the greater part, of lump sum payments. The lump 
sum payments for hospitalized patients contain a daily rate and a lump sum 
per admission. Both rates are independent of the number of performed tests. 
For ambulatory patients the lump sum is related to the type and the number of 
performed tests and consists of a lump sum per day for prescriptions and a lump 
sum per admission for day care. The lump sum per day for hospitalized patients 
is hospital-specific and depends on the case mix of each hospital. It consists 
of pathology information (APR-DRG) (40%); mean national expenditure per 
type of hospital stay (multiplication of the number of nursing days per type of 
stay and the national average expenses of clinical biology per day per service 
group) (40%); number of intensive care beds in the hospital (10%); organization 
of a permanent duty service (24/7) of laboratory technicians (10%). Lump sums 
per admission consist of a basic lump sum and an additional lump sum related 
to the characteristics of the laboratory of the hospital (e.g. number of staff, 
emergency department).
Medical imaging
The payment for medical imaging is similar to the payment for laboratory 
testing, with a fixed national budget and lump sum payments. Since April 
2009, the lump sum per admission is determined by the case mix of the hospital 
(APR-DRGs and severity level) and by the national average expenses for medical 
imaging per hospital stay. Hospitalized patients pay a lump sum per admission 
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and a lump sum consultancy fee, independent of the number of performed 
medical imaging services. Ambulatory patients and patients in day care pay a 
consultancy fee related to the number of medical imaging services used.
Day centres
Day care
In this section only the financing of day care will be discussed; further 
explanation on day care can be found in Section 5.4.2 Day care. The agreement 
between the hospitals, sickness funds and the NIHDI defines a day hospital as 
“an organized and integrated function of day care under the supervision of a 
medical specialist with fixed procedures concerning selection of patients, safety, 
quality, continuity, reporting and cooperation with several medico-technical 
services”.
Since 1988, day care has been financed by lump sums (mini, maxi, super, 
plaster room, A, B, C and D). The national agreement (1 July 2007) introduced 
some new lump sums, resulting in the following summary (amounts for 2009):
• Mini lump sum: is hospital-specific and can be charged in case of urgent 
admission or intravenous therapy for therapeutic reasons.
• Maxi lump sum: is hospital-specific and can be charged in case of general 
anaesthesia or the administering of chemotherapeutic agents.
• Day hospital lump sum: contains seven groups of lump sums (equivalent 
to a selection of nomenclature codes); payments vary between €140 
and €247.
• Lump sum “chronic pain”: contains three lump sums with corresponding 
nomenclature codes; payments vary between €72 and €196.
• Lump sum “plaster room”: fixed amount of €26.10.
• Lump sum haemodialysis (further explained in the next section, on the 
NIHDI conventions).
Day-surgery centre
The financing of day-surgery centres is included in the hospital budget. The 
general costs are included in part B1 and costs specific to the day-surgery centre 
and its activity in the operating room are included in part B2. Two types of stays 
are defined as justified activities:
• stays in day care for which at least one surgical nomenclature code from a 
specified list (list A) was recorded; and
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• stays in day care for which at least one nomenclature code from a 
specified list (list B) was recorded.
Unjustified inpatient stays meet all of the following criteria:
• one of the 32 selected APR-DRGs
• an inpatient stay
• a scheduled admission
• maximum length of stay of three days
• severity of illness rate of 1 (minor)
• no decease during the stay
• a risk of mortality rate of 1 (low)
• patient’s age under 75 years.
NIHDI conventions
Haemodialysis
Haemodialysis performed in a recognized centre for chronic dialysis (in 
a hospital) is financed by a lump sum with an additional fee of 20% of the 
hospital’s per diem rate (defined on 30 June 2002) and by fee-for-service 
payments. The lump sum is a variable amount depending on the proportion of 
patients treated with alternative dialysis modalities. More detailed information 
about the financing of haemodialysis modalities in Belgium can be found in 
KCE report 124 (Cleemput et al. 2010).
Rehabilitation conventions
The financing of rehabilitation conventions with hospitals or rehabilitation 
centres consists of lump sum payments. An explanation of the content of the 
rehabilitation conventions can be found in Section 5.7 Rehabilitation care.
Patient contributions
Inpatient care is covered by the third-party payer system. While the bulk of the 
cost of treatment is directly paid by the sickness fund to the hospitals, out of 
pocket payments of patients consist of two parts, co-payments and supplements.
A co-payment is defined as the difference between the convention tariff and 
the reimbursement by the NIHDI. Health care providers can charge a higher 
tariff than the official tariff (NIHDI reimbursement + co-payment), resulting 
in supplementary payments by patients. Hence, supplements are defined as 
the difference between the total payments and the convention tariff. In the 
case of services lacking a convention tariff (i.e. services not covered by the 
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compulsory health insurance), the patient pays the full price out of pocket. 
Several supplements exist for hospitalized patients: fee supplements for (para)
medical services, room supplements, material supplements, supplements 
for (para)pharmaceutical products (not included in the nomenclature code) 
and supplements for diverse items (e.g. telephone, television, refrigerator). 
Supplements have been regulated by the government. A detailed description of 
hospital supplements can be found in KCE report 50 (De Graeve et al. 2006).
The fee schedules for physicians are determined in agreements between 
representatives of the sickness funds and of the organizations of physicians. 
Physicians who accede to the agreements have to adhere to the fee schedule as 
determined in the nomenclature. For hospitalized patients staying in a shared 
room or a two-person room, physicians who have joined the agreement cannot 
charge fee supplements. Only in a single room are fee supplements allowed. 
Physicians who reject the agreement can charge supplements, irrespective of 
the choice of room of the patient, but patients have to be told about this and a 
maximum supplement has to be agreed. In addition, they have to respect agreed 
tariffs in two-person or shared rooms for specific vulnerable groups, such as 
beneficiaries of preferential reimbursement and patients who are eligible for the 
lump sum for chronic diseases. For patients staying in a single room, there is 
still a limitation on the fee supplements that can be charged. For physicians who 
have joined the agreement, fee supplements are not allowed when the medical 
condition of the patient, or the technical conditions for investigation, treatment 
or supervision necessitate a stay in a single room; when the necessities of the 
service or the unavailability of two-person or common rooms require a stay 
in a single room; when the patient is, beyond his or her control, admitted to 
an emergency unit or intensive care unit for the duration of the stay in such 
a unit; for children accompanied by a parent. For physicians who rejected the 
agreement, the rules applicable in a two-person or shared room apply in the 
above-mentioned cases.
Room supplements can only be charged if the patient asks to stay in a single 
room. There is no legally determined upper limit. Room supplements for a 
two-person room were abolished on 1 January 2010. Moreover, as specified in 
the previous paragraph, room supplements for single rooms are not allowed for 
physicians who joined the agreement under certain conditions (e.g. when the 
medical condition of the patient, or the technical conditions for investigation, 
treatment or supervision necessitate a stay in a single room, etc.).
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3.6.2 Paying health care professionals
Tariffs and fees for services provided by health professionals within the context 
of compulsory health insurance are fixed collectively within the NIHDI between 
sickness funds and the representative organizations of health professionals. 
These price agreements (for physicians and dentists) and conventions (for other 
health care professionals) are embedded within a budgetary procedure (see 
Section 3.3.3 Pooling of funds).
Physicians
Delivery of health care in Belgium is mainly private. Physicians are 
self-employed, as are most dentists, pharmacists and physiotherapists. Most 
physicians, whether GPs or specialists, are paid on a fee-for-service basis. 
The patient pays the set fee for the consultation directly to the physician, and 
patients are then directly reimbursed by their sickness funds.
Less than 1% of physicians with a clinical practice are salaried. Most of 
these salaried physicians work in medical practices of integrated health care 
which are owned and managed by the physicians themselves, and where 
usually (though not always) the physicians are paid by the NIHDI according to 
a capitation payment. The rest of the salaried physicians provide other medical 
and social services such as preventive care, and may work in hospitals (mostly 
university hospitals).
Specialists working in hospitals are also paid on a fee-for-service basis. The 
fee-level for specialists working in hospitals is the same national negotiated 
fee-level as for office-based specialists. In theory, the fees are paid (by a 
combination of patients and sickness funds) directly to the physicians themselves. 
However, in practice, specialists sign an agreement with the hospital in which 
they work, allowing the hospital to retain a significant proportion of the fees as 
compensation for the space, equipment, staff and overhead services provided 
to the physician.
The extent of fee-sharing between the hospital and the specialist is variable 
and depends on elements such as relative scarcity/abundance of specialists 
in that specialty, extent of hospital facilities, the hospital’s reputation, the 
specialist’s reputation and experience. A system of pooled fees works in most 
hospitals too, that is, all fees received by all physicians working within the 
hospital are pooled and redistributed monthly. Medical fees cover all costs 
directly or indirectly linked to the performance of medical services (Article 154 
of the Hospital Act, Coordinated Law of 10 July 2008). These include the cost of 
medical, nursing, paramedical, caring, technical, administrative, maintenance 
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or other supportive staff, as well as the costs related to the use of rooms, the 
purchasing and maintenance of equipment, and materials not included in the 
budget of financial means (Van de Sande et al. 2010).
Based on a survey among hospitals, data could be retrieved on the 
contribution of physicians to hospitals (Dexia 2010). In 2009, the average 
contribution percentage of hospital physicians was around 40% (sample size = 
70 hospitals). As shown in Fig. 3.7, physicians working in medico-technical 
services (e.g. radiology, laboratory or biology services) ceded on average around 
60% of their fees to the hospital while physicians working in non medico-
technical services (e.g. in surgery or obstetrics services) only ceded on average 
20% of their fees to the hospital. This difference can mostly be explained by the 
higher operating and investment costs of a medico-technical service.
In university hospitals where physicians are salaried, physicians receive a 
monthly salary independent of their activity. Consequently, it is important to 
stimulate medical activity and financial awareness by other means, for example 
by linking a growth of medical staff to a sufficient growth of fees or activity 
(Van de Sande et al. 2010).
Fig. 3.7
Contribution percentage of hospital physicians (aggregated average), 2005–2009 
Source: Dexia 2010.
The fees for GPs, specialists in hospitals and office-based specialists are 
negotiated at the national level in the National Commission of Representatives 
of Physicians and Sickness Funds of the NIHDI (see Section 3.3.3 Pooling 
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of funds). The resulting agreement needs the endorsement of the Minister of 
Social Affairs and is normally concluded for a two-year period. The agreement 
is then referred to all individual physicians for approval. The agreement enters 
into force unless more than 40% of all physicians within a region have notified 
their refusal to adhere to it, or if more than 50% of GPs and 50% of specialists 
have refused to adhere to it. If the agreement is rejected, the government has 
three options: to impose fees unilaterally for some or all services; to submit 
an alternative draft agreement; or to set the reimbursement levels, leaving 
physicians free to set their own fees (see Fig. 3.8). As an incentive for physicians 
to adhere to the conventional tariffs, the NIHDI contributes to a fund for 
granting additional old age or disability pensions to providers who respect the 
conventional tariffs.
Fig. 3.8
The collective contracting mechanism for physicians
Source: Palm and Robert 1995.
When the agreement comes into force, each physician who has accepted 
the agreement becomes a conventioned physician and is obliged to respect 
the set fees. Non-conventioned physicians can set their fees freely. However, 
the agreement will also set certain conditions under which even conventioned 
physicians can charge higher fees (e.g. time and place of consultation). Partial 
conventionment is also possible (e.g. where a physician works at a hospital as 
conventioned, and has a private practice as non-conventioned).
Endorsement by the Minister of Social Affairs
Official publication of the tariffs
Evaluation by individual doctors
If 60% in a region and 50% of both GPs and
specialists do not reject
If 40% in a region and 50% of both GPs and
specialists do not reject
National Commission of representatives of Physicians and Sickness Funds
Publicly impose feesEntering into force of
agreed tariffs
Restart negotiations Fix reimbursement tariffs
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Dentists
Dentists’ fees are determined by a committee composed of representatives of 
sickness funds and dentists, following the same procedure as that for physicians. 
This procedure applies to the fees for general dentists, orthodontists and 
periodontists.
Pharmacists
Since April 2010, a new system of remuneration for pharmacists has come into 
force (see also Chapter 6). The objective of this new system is to reinforce the 
intellectual role of the pharmacist and to partly disconnect the pharmacists’ 
remuneration from the drug price. The remuneration is composed of a basic fee 
of €3.88 per reimbursed product (per box) and an economic margin of 6.04% 
of the ex-factory price (+ 2% for ex-factory prices above €60). A specific lump 
sum of €1.20 is also provided for each prescription under the International 
Nonproprietary Name (INN) of the active ingredient (Conseil des ministres 
2010).
Nurses
Nurses working in hospitals are salaried, while those providing home care are 
either self-employed or salaried.
Different payment systems contribute to the financing of home nursing, 
most importantly lump sum payment and fee-for-service. There is additional 
financing for specific costs for home nursing organizations, and those related to 
information and communication technologies. Reduced social tax contributions 
play an additional role. Specific arrangements cover particular nursing activities 
(e.g. nursing assistance in haemodialysis and peritoneal dialysis at the patient’s 
home).
A per diem lump sum system covers nursing interventions for patients with 
deficiencies in the activities of daily living (ADL). A patient’s dependency 
is assessed using the Belgian Evaluation Scale for Activities of Daily Living 
(BESADL), which is adapted from the Katz scale. At the same time, the fee-for-
service system covers technical nursing interventions. All technical nursing 
interventions, except hygienic care, require a doctor’s prescription. In order to 
limit supply-induced care provision in the fee-for-service financing, a maximum 
day-limit was fixed, which equals the smallest lump sum, i.e. for the lowest 
level of dependency (level A). The payment for nursing home care is covered 
by the insurers, and patients only pay relevant user fees.
In the past, nurses have felt their pay low relative to their workload and have 
organized strikes, which have sometimes proved successful.
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Previously, reimbursement and tariffs were generally not linked to the 
qualification level of the nurse. All nurses were authorized to perform most of 
the nursing interventions of the nomenclature. Since 2003, there is a growing 
trend to only reimburse some nursing interventions if they are performed by a 
nurse with higher professional qualifications. For example, self-management 
education of a diabetic patient is only reimbursed if performed by a nurse 
specialized in diabetes.
The nomenclature of nursing activities is regarded as obsolete, complex 
and lacking in integration, for example, much of technical home nursing 
activities regularly performed are not currently included and the rules avoiding 
cumulative reimbursement lack consistency.
Other health care providers (paid by fee-for-service)
For other health care providers, paid by fee-for-service (e.g. physiotherapists), 
fees are also determined by the conventions and agreements commissions within 
the NIHDI (see Section 3.3.3 Pooling of funds) following a similar procedure, 
except that some formalities about their convention and implementation differ 
from dentists’ and physicians’ agreements. As indicated in Fig. 3.9, the main 
differences are that in this case no regional counting of rejections of the 
convention is applied for all providers. Also, these other providers are required 
to actively report on their adherence to the conventions. Furthermore, the 
reimbursement of providers who do not adhere to the convention can be reduced 
by up to a maximum of 25%.
Other health care providers (salaried)
Salaries and career evolution for salaried employees (e.g. technical and 
administrative staff) in the health sector are negotiated through a series of 
collective agreements. Salaries are indexed with respect to the cost of living 
and are fixed according to length of service as well as level and field of 
expertise (CSC Public Sector 2007). Other aspects, such as age of retirement, 
are also negotiated through these agreements (Royal Decree of 13 March 2006). 
Negotiations can take place at the federal or federated level (e.g. depending on 
the hospital’s ownership – private vs public).
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Fig. 3.9
Scheme of the collective contracting mechanism for other health care professionals
Endorsement by the Minister of Social Affairs
Official publication of the convention
Tariffs take effect in regions where
more than 60% subscribed
Entering into force of the
conventioned tariffs
Reimbursement rate for non-contracted
providers can be reduced by 25% max.
Convention committees
Individual providers have 30 days to subscribe (no reaction means that their
acceptance/rejection of the previous convention applies)
If less than 60% have subscribedIf 60% have subscribed
4. Physical and human resources 1
4.1 Physical resources
4.1.1 Infrastructure
Hospitals
Until the early 1980s, the number of hospital beds in Belgium increased by an average of 1000 per year to a record number of 92 686 or 9.5 per 1000 inhabitants in 1981. Since then, the Belgian hospital sector has 
been restructured in order to respond to evolving needs, such as more geriatric 
provison, shorter stays, expansion of day hospitalization, admission of elderly 
people in need and alternative provisions in the psychiatric sector. 
Among measures for restructuring the hospital sector, in 1982, beds in 
nursing homes were classified in a different category from acute and chronic 
hospital beds. As a consequence, different reimbursement mechanisms were 
established. In addition, a moratorium was established on the number of general 
hospital beds, limiting them to not more than those existing on 1 July 1982. 
This meant that creation of new beds must be compensated for by the closure 
of a bed somewhere else in the hospital system. Alongside the moratorium, a 
compensation scheme was introduced to cover hospitals for closures or non-use 
of beds. However, the total number of hospital beds did not decrease as desired 
by the government, which led to a new process of scaling down the capacity. In 
1989, the minimum bed capacity was fixed at 1502 beds for general hospitals, 
and mergers and closures were supported financially. 
Changes in the number of hospitals have corresponded more to restructuring 
procedures (mergers) than an actual decrease. All these measures led to an 
overall decline in the total number of acute beds per 1000 persons and an 
increase in the average capacity of a Belgian hospital since the mid 1980s. 
Between 1980 and 2008, the number of hospitals decreased from 521 to 207 
1 This chapter was written by Sophie Gerkens, Maria Isabel Farfan and Sabine Stordeur. 
2 With the exception of hospital beds in the German community, where minimum capacity was fixed at 135 beds.
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(see Section 4.1.2 Capital stock and investments), and the average capacity 
of a Belgian hospital rose from 177 to 339 beds. It should also be noted that 
since 2000, the number of beds in hospitals per 1000 persons has been almost 
constant (see Table 4.1).
Table 4.1
Mix of beds in inpatient care facilities, per 1 000 population, 1980–2008  
(selected years)
 1980 1990 2000 2005 2008
Number of beds in hospitals 9.5 7.9 7.1 6.8 6.6
Acute care hospitals 5.5 5.6 5.2 5.0 4.8
Specialized and geriatric 1.5 0.4 0.3 0.3 0.3
Psychiatric 2.5 1.9 1.6 1.5 1.5
Number of beds in homes for the elderly and nursing homes – 1.2 12.0 12.1 12.2
Source: Raw data provided by FPS Health, Food Chain Safety and Environment, own calculation.
Since 1980, there has been a steady decrease in the average length of 
stay in acute hospitals (see Table 4.2). This can be attributed to (among other 
reasons) transfers of patients to other infrastructures (e.g. rehabilitation), higher 
incentives for day hospitalization and the inclusion of length of stay per DRG in 
hospital financing (Perelman and Closon 2007). Indeed, by including length of 
stay in hospital financing, there is some evidence that inpatient stays become 
shorter but more intensive, that is, more resource-consuming (Perelman and 
Closon 2007). 
Table 4.2
Acute care hospitals utilization, 1980–2007 (selected years)
1980 1990 2000 2001 2002 2003 2004 2005 2006 2007
Average length of 
stay (days)
10.0 8.7 8.5 8.4 8.4 8.3 8.1 8.0 7.9 7.8
Occupancy rate (%) 77.7 81.9 67.3 68.3 67.9 65.9 70.5 67.6 66.6 66.6
Source: OECD 2009a.
A slight decrease in admissions per 100 population for classic hospitalization 
and an increase in day hospitalization have taken place in acute care hospitals 
between 2000 and 2007 (see Table 4.3). This might also be due to the fact that 
hospitals have strong incentives to provide shorter hospital stays (Perelman 
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and Closon 2007). Admissions per 100 population have slightly decreased in 
specialized and geriatric hospitals and slightly increased in psychiatric hospitals 
since 2000. 
Table 4.3
Admissions per 100 population, 2000–2007
 2000 2001 2002 2003 2004 2005 2006 2007
Acute care hospitals
   Classic hospitalization 16.63 16.49 16.30 16.18 16.17 16.19 16.11 15.87
   Day hospitalization 7.12 7.76 8.47 9.47 10.06 10.40 10.74 11.52
   Proportion day hospitalization 30% 32% 34% 37% 38% 39% 40% 42%
Specialized and geriatric hospitals 0.20 0.19 0.19 0.19 0.19 0.19 0.18 0.18
Psychiatric hospitals 0.85 0.87 0.86 0.87 0.88 0.90 0.91 –
Source: Raw data provided by FPS Public Health, Food Chain Safety and Environment: Maxi Feedback 2000–2007, own calculation.
Table 4.4 indicates that for acute hospitals the average length of stay and 
the number of acute hospital beds per 1000 population are higher in Belgium 
than the EU15 and EU27 averages. The decrease in the number of beds in 
Belgium since 1990 follows a similar path to that of other European countries 
(see Fig. 4.1). Compared to most other European countries (except for Germany 
and Austria), the number of acute hospital beds per 1000 population is still 
much higher in Belgium. Compared to EU15 and EU27 averages, Belgium has 
lower admissions per 100 000 population, but a higher average length of stay. 
However, the latter must be interpreted with caution as average lengths of stay 
in Belgium include a diverse number of hospitalization types, and activities 
performed in hospitals differ between countries (different national definitions 
and concepts).
Long-term residential care
Belgian long-term residential care comprises service-homes, homes for the 
elderly and nursing homes (Vander Stichele et al. 2007). Service-homes provide 
elderly individuals with the option of living independently and some services 
(such as meals, house-cleaning, etc.) can be provided upon request. Homes 
for the elderly and nursing homes are used by individuals having moderate 
to serious health conditions (Vander Stichele et al. 2007) (see also Section 5.8 
Long-term care for the elderly for precise definitions).
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Table 4.4
Inpatient utilization and performance in acute hospitals in the WHO European Region, 
2006 or latest available year
 
Hospital beds per 
100 000 population
Admissions per 
100 population
Average length of 
stay in days
Occupancy rate 
(%)
Western Europe
Andorra 195.3 9.2 6.7 g 70.0 g
Austria 638.5 26.4 6.0 79.7
Belgium 468.7 16.0 7.9 66.6
Cyprus 350.8 7.8 5.8 78.8
Denmark 310.7 c 17.8 f 3.5 b 84.0 f
Finland 241.7 19.5 4.0 74.0 k
France 361.8 16.3 5.9 77.1 c
Germany 572.9 19.8 7.9 75.1
Greece 394.4 14.5 h 5.7 c 71.6 c
Iceland 368.2 j 16.5 b 3.5 b 70.3 m
Ireland 274.2 14.0 6.4 86.5
Israel 206.7 17.3 4.1 95.0
Italy 336.3 14.0 b 6.7 b 77.3 b
Luxembourg 503.61 c 18.4 l 7.7 h 74.3 l
Malta 284.9 11.3 5.3 89.6
Monaco 1553.6 k – – –
Netherlands 304.1 10.5 6.6 68.1
Norway 297.6 17.6 5.0 88.4
Portugal 298.5 b 11.2 b 7.1 b 73.2 b
Spain 271.0 11.7 6.6 78.2
Sweden 282.3 b 15.2 6.0 77.5 j
Switzerland 364.8 b 16.4 h 8.2 86.9
Turkey 267.1 8.1 d 4.4 a 64.4
United Kingdom 241.6 h 21.4 j 5.0 j 80.8 h
Central and south-eastern Europe
Albania 259.7 – – –
Bosnia and Herzegovina 327.5 h 7.2 h 9.8 h 62.6 g
Bulgaria 755.4 j 14.8 j 10.7 j 64.1 j
Croatia 360.3 15.0 7.6 86.6
Czech Republic 603.9 20.2 8.0 72.9
Estonia 393.5 16.8 5.9 70.9
Hungary 552.8 22.4 6.4 70.3
Latvia 527.4 20.3 – –
Lithuania 510.1 20.7 6.9 76.1
Montenegro 322.0 10.0 7.8 66.1
Poland 410.8 – – –
Romania 505.2 – – –
Serbia – 9.4 a 7.8 a 67.1 a
Slovakia 601.6 18.0 8.0 68.2
Slovenia 383.4 17.1 5.8 71.6
The former Yugoslav Republic of 
Macedonia
326.4 9.2 b 7.2 b 55.5 b
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Hospital beds per 
100 000 population
Admissions per 
100 population
Average length of 
stay in days
Occupancy rate 
(%)
EU average 395.3 17.0 6.5 76.3
EU15 375.2 16.7 6.5 76.4 c
Source: WHO Regional Office for Europe 2010 (January).
Notes: a 2007; b 2005; c 2004; d 2003; e 2002; f 2001; g 1999; h 1998; i 1997; j 1996; k 1995; l 1994; m 1989; Minor discrepancies may occur 
in national versus international data reporting. This is entirely consistent with norms and stems from differences in analytical 
classifications.
Fig. 4.1
Acute hospital beds per 100 000 population in Belgium and selected countries, 
1990–2007
Source: WHO Regional Office for Europe 2009 (June). 
Note: Minor discrepancies may occur in national versus international data reporting. This is entirely consistent with norms and stems 
from differences in analytical classifications.
The first nursing homes were created in 1982 with the explicit intention to 
create an intermediary structure between a home for the elderly and a hospital. 
However, in practice many residential institutions can be considered as both 
homes for the elderly and nursing homes. Homes for the elderly and nursing 
homes are mainly run by community social services, by private non-profit-
making authorities and by private profit-making corporations. 
The Federal Minister of Social Affairs and Public Health determines, in 
agreement with the communities and the regions, the budget and planning of 
beds for elderly persons. The federal government is in charge of setting quality 
standards as well the NIHDI’s financial allocation mechanism for providing 
beds in residential institutions for the elderly. The accreditation criteria for 
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residential institutions (beds) are mostly determined by the communities 
(Flemish, French and German communities). The only exception being 
institutions in the Brussels region, which receive accreditation by one of the 
following authorities: COCOF, GGC-COCOM or VGC. Since 1997, three 
protocol agreements (1997, 2003 and 2005) between the federal government 
and the communities have formulated common objectives of elderly care and 
fixed a moratorium programme on the number of beds. These agreements 
allow each authority to determine their common objectives autonomously 
according to local demographic needs (Declercq and Van Audenhove 2004). 
The global number of accredited beds amounted to 130 920 in March 2010, 
divided into 66 180 beds in homes for the elderly and 62 987 beds in nursing 
homes. Compared to the moratorium (of 132 237 beds), 1317 additional beds 
should be created.
Table 4.5
Moratorium for beds in homes for the elderly and nursing homes, 2010
Regions Moratorium programme a
Number of accredited beds in homes for the 
elderly and nursing homes b
Flemish 68 138 67 433
Walloon 47 546 47 272
Brussels-Capital 15 703 15 474
German community 850 741
Total 132 237 130 920
Sources: a Van Audenhove et al. 2009; b NIHDI 2010j.
4.1.2 Capital stock and investments
Current capital stock
In Belgium, hospitals can be classified into two categories: general and 
psychiatric. In 2008, there were 207 hospitals, of which 139 were general and 
68 were psychiatric (see Table 4.6). The general hospital sector consists of acute 
(112), specialized (19) and geriatric hospitals (8). Geriatric hospitals are dedicated 
solely to elderly patients needing specialized care. Specialized hospitals 
concentrate on one or a few health care specialties such as cardiopulmonary 
diseases, locomotorial diseases, neurological disorders, palliative care, chronic 
diseases and psychogeriatric care. Psychogeriatric and neuropsychiatry care 
units can also be found in some acute hospitals (in particular for short-stay 
treatment). 
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Table 4.6
Inpatient care facilities, 1980–2008 (selected years)
 1980 1990 2000 2005 2008
Number of hospitals 521 374 223 215 207
   Acute care 285 254 123 116 112
   Specialized and geriatric 159 48 31 30 27
   Psychiatric 76 72 69 69 68
Number of beds in hospitals 92 436 79 346 72 304 70 795 70 084
   Acute care 53 960 56 058 53 170 52 127 51 649
   Specialized and geriatric 14 304 4 142 3 128 3 048 2 897
   Psychiatric 24 172 19 146 16 006 15 620 15 538
Number of beds in homes for the elderly and nursing homes a – 12 203 122 996 126 423 129 775
Sources: FPS Health, Food Chain Safety and Environment; a source from 1980 to 2000: WHO Regional Office for Europe 2009 (June); 
source from 2005 to 2008: NIHDI and FPS Public Health, Food Chain Safety and Environment.
Hospitals in Belgium are private non-profit-making (150, equal to 72%) or 
public institutions. Public hospitals are for the most part owned by a municipality, 
a province, a community or an inter-municipal association (which is a legal 
form of association that groups together local authorities, public welfare centres 
and in some cases the provincial government or private shareholders) (Van de 
Sande et al. 2010). Financing mechanisms as well as legislation are common 
to all hospitals, the only exception being that, for public hospitals, internal 
management rules are more tightly defined and their deficits are covered, under 
certain conditions, by local authorities or inter-municipal associations.
Acute hospitals include seven university hospitals, which have special status 
owing to their teaching and research functions. The “university” label does not 
necessarily mean that a university owns the hospital; however, it does mean that 
a certain proportion of beds are registered as university beds. 
Partly as a result of the lack of referral structure between different types of 
hospitals in Belgium (or a precise distinction between primary, secondary and 
tertiary care), the location of hospitals and hospital services is more the result 
of historical evolution than of geographical planning. The overall density of 
beds in general hospitals is the same in the Flemish region and the Walloon 
region (4.9 per 1000 inhabitants in 2008). However, there is a greater provision 
of psychiatric beds in the Flemish region (1.6 beds per 1000 inhabitants) than 
in the Walloon region (1.3 beds per 1000 inhabitants). In the Brussels region, 
the density of general hospital beds is very high (7.2 beds per 1000 inhabitants), 
partly because of the presence of three university hospitals. However, the 
density in Brussels of psychiatric beds is the lowest of all three regions, at 
1.0 bed per 1000 inhabitants.
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Investment funding
The federal government finances 40% of the capital investments for hospital 
building, alterations and first establishment. Regions and communities decide 
– within the commonly fixed calendar on hospital construction – on the 
subsidizing of these investments, and may directly subsidize up to a maximum 
of 60% of the costs. The amortization costs of the other 40% are taken into 
account by the hospital budget, financed by the federal government and the 
national health insurance.
Since the infrastructure of most hospitals is more than 30 years old, their 
renewal has become a priority. A new agreement was concluded to meet the 
needs because the investment capacity of regions and communities was not 
sufficient and the federal capacities were underused. Since 2007, “priority” 
construction works have the possibility to benefit from a ratio of a maximum 
of 10% subsidy and 90% amortization. Priority constructions mainly concern 
investments dedicated to the rationalizing supply, improving patients’ comfort 
or complying with new standards.
Community social services are in charge of investment for residential elderly 
care infrastructure. However, they receive funds from federated authorities 
based on each community’s projects and needs. The improvement of existing 
residential care institutions and the establishment of new ones must be in 
accordance with the protocol agreements. Three distinct authorities are in 
charge of allocating funds to community social services: VIPA for the Flemish 
region, GGC-COCOM for Brussels-Capital and the Walloon Government for 
the Walloon region. Estimates for the total cost of infrastructure investment 
corresponding to the planning of beds in homes for the elderly and in nursing 
homes (according to protocol 3) account for approximately €180 million (up to 
€250 million) in Flanders, €90 million in Brussels (up to €100 million) and €175 
million in the Walloon region (Research Direction Dexia Bank 2007).
4.1.3 Medical equipment
In Belgium, the installation of heavy medical equipment requires approval 
from the minister of public health of the appropriate community. There are 
special accreditation norms and criteria for the installation and running of 
heavy medical equipment in hospitals. If a hospital fails to meet these criteria, 
the NIHDI can refuse to reimburse treatment provided with the equipment in 
question and the hospital can be penalized by a budget cut of up to 20%. The 
hospital can also be forced to restart the whole process of accreditation for the 
equipment. The areas covered by this legislation are: units for medical imaging 
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with CT scanners; MRI units and PET units. Table 4.7 shows that the number 
of MRI, CT, radiotherapy and PET scanner units per million inhabitants has 
increased significantly since 1990.
Table 4.7
Medical technology per million inhabitants, 1990–2007 (selected years)
 1990 1995 2000 2005 2006 2007
MRI 2 3.3 6 7 7.1 7.5
CT 16.1 16.7 c 21.8 38.7 e 39.8 41.6
Radiotherapy 6.1 a 6.1 12.5 12.8 12.8 14.1
Lithotriptors 1.6 b – 4.8 4.7 4.6 4.6
PET (approved) – – 0.3 d 1.2 1.2 1.2
Source: OECD 2009a (June). 
Notes: a 1991; b 1992; c 1994; d 2001; e break in series. 
The number of official reimbursed PET scan examinations per 1000 
population was 1.9 in 2008 (see Table 4.8). However, this number does not 
represent the real number of PET scan examinations performed in Belgium. In 
fact, since 2002, additional PET scan examinations can be reimbursed through 
the nomenclature code “scintigraphy double tomography”. In its 2009 report, 
the KCE estimated that the number of additional PET scan examinations was 
around 20 000 (that is, +1.9 per 1000 population) (Cleemput et al. 2005; Vlayen 
et al. 2009). This study also showed that, in addition to the 13 approved PET 
scanners, a number of non-approved scanners seem to be operational (Cleemput 
et al. 2005; Vlayen et al. 2009).
Table 4.8
Medical technology activity, number of examinations per 1 000 population,  
1995–2008 (selected years)
 1995 2000 2005 2006 2007 2008
CT 102.2 116.7 148.3 158.7 169.7 180.8
Ambulatory care 66.0 75.9 101.2 110.2 119.9 130.7
Inpatient care 36.3 40.8 47.1 48.5 49.7 50.1
MRI – 23.7 44.6 46.4 48.5 54.1
Ambulatory care – 19.9 38.1 39.8 42.0 47.4
Inpatient care – 3.8 6.6 6.6 6.5 6.7
Ratio CT/IRM – 4.9 3.3 3.4 3.5 3.3
PET 0.06 0.68 1.46 1.59 1.73 1.87
Ambulatory care 0.03 0.54 1.18 1.32 1.44 1.58
Inpatient care 0.04 0.14 0.28 0.27 0.29 0.29
Source: NIHDI (own calculation).
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Compared to other European countries, the Belgian supply of CT scanners 
per million inhabitants and the ratio of CT to MRI units are high (see Table 4.9). 
The number of examinations per 1000 population and the ratio of CT to MRI 
examinations are also high in Belgium (see Table 4.10). A recent KCE study 
showed that the supply of radiologists is high and that both for CT and MRI 
examinations, average waiting times in Belgium tend to be very short compared 
to some neighbouring countries (less than two weeks versus two months or 
more) (Demaerel et al. 2006).
Table 4.9
Medical technology in selected European countries per million inhabitants, 2007
CT MRI Ratio of CT/MRI PET 
Austria 29.8 17.7 1.7 N/A
Belgium 41.6 7.5 5.5 1.2 a
Czech Republic 12.9 4.4 2.9 0.5
Denmark 13.9 b 10.5 b 1.3 b 3.7
Finland 16.4 15.3 1.1 N/A
France 10.3 5.7 1.8 1.0
Germany 16.3 8.2 2.0 1.0
Hungary 7.3 2.8 2.6 0.6
Ireland 14.3 8.5 1.7 1.4
Italy 30.3 18.6 1.6 0.6
Luxembourg 27.3 10.5 2.6 2.1
Poland 9.7 2.7 3.6 N/A
Portugal 26.0 8.9 2.9 N/A
Slovakia 13.7 5.7 2.4 0.6
Spain 14.6 9.3 1.6 0.7
Sweden 17.8 b 11.1 b 1.6 b N/A
Sources: OECD 2009a (June); Demaerel et al. 2006; a NIHDI data; b year 2006.
Compared to other European countries, Belgium has a high medical 
radiation exposure. Despite the publication of national guidelines about the 
referral for diagnostic imaging in 2004, the medical radiation exposure in 
Belgium rose from 2.15 to 2.42 mSv per capita between 2005 and 2008, mainly 
due to CT examinations that accounted for 52.6% of the medical radiation in 
2005 and rising to 58.4% in 2008. The contribution of X-rays and scintigraphies 
is decreasing (Vlayen et al. 2010).
Health systems in transition  Belgium 127
Table 4.10
Medical technology activity, number of examinations per 1 000 population in selected 
European countries, 2007
 CT MRI CT/MRI
Belgium 167.7 48 3.5
Czech Republic 75.1 24.5 3.1
Denmark 33.9 a 17.4 a 1.9 a
France 45.1 21.8 2.1
Germany 42.0 14.5 2.9
Hungary 58.8 27.9 2.1
Luxembourg 176.9 63.3 2.8
Netherlands 41.3 a 25.0 a 1.7 a
Spain 57.0 a 21.4 a 2.7 a
Sweden 88.9 a 38.9 a 2.3 a
United Kingdom 59.1 28.8 2.1
Source: OECD 2009a (June).
Note: a year 2006, Demaerel et al. 2006.
4.1.4 Information technology
In 2009, 67% of Belgian households had access to the Internet in their place of 
residence compared to 65% in the European population (EU27). Among people 
aged between 16 and 24 years, 77% used the Internet daily or almost every day 
(EU27: 73%). For people aged between 16 and 74 years, this percentage fell to 
56% (EU27: 48%) (Eurostat 2009).
In 2007, Internet or other electronic data exchange networks were used by 
73.5% of GPs to obtain results from laboratories (EU27: 39.8%), and by 13% 
of GPs to exchange medical data (EU27: 10.3%) or administrative data (EU27: 
9.7%) (see Table 4.11). E-prescribing was only used by 2% of GP practices in 
2007 (EU27: 6.3%) (Dobrev et al. 2008). The implementation of e-prescribing in 
Belgium is currently in progress, i.e. the Royal Decree of 7 June 2009 regulates 
the use of e-prescribing by physicians and dental practitioners in hospitals and 
a project on the use of e-prescribing for ambulatory care is in development.
In Belgium, every GP who uses approved software to manage the electronic 
medical files of his/her patients may ask to obtain an allowance paid by the 
NIHDI the following year. The physician has to complete a form and make a 
sworn statement about the fact that the software belongs to the list of approved 
software (Vlayen et al. 2010). In 2008, this allowance was €755.04. Among 
all GPs with at least 500 patient-contacts per year, those having received the 
allowance increased from 6012 (55%) in 2004 to 6985 (65%) in 2008. The 
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rate of GPs with more than 2500 contacts who received the allowance in 2008 
amounted to 74%. The rate was higher in the Flemish region. Importantly, not 
all GPs using software applied for the allowance (Vlayen et al. 2010).
Table 4.11
Percentage of GP practices using electronic patients’ data exchange networks,  
by purpose, 2007
 
Results from 
laboratories
Medical data to 
care providers/
professionals
Administrative 
data to other 
care providers
Administrative 
data to 
reimbursers
Prescription to 
pharmacies 
Medical data 
cross-border
EU27 39.8 10.3 9.7 15.1 6.3 0.7
Belgium 73.5 12.9 12.9 2.5 1.6 0.9
Source: Dobrev et al. 2008.
Several initiatives have been undertaken in Belgium in order to facilitate the 
administrative procedures and to increase the interoperability between health 
care actors. 
The Crossroads Bank of Social Security (CBSS-BCSS-KSZ) was created 
by the Act of 15 January 1990 to organize and manage an electronic network 
which facilitates information exchange among agencies of Social Security and 
the National Register (CBSS 2009). 
Since 1998, all beneficiaries of the social security system have a digital 
social identity card, the SIS card, permitting them to check insurability rights 
and allowing third-party payments (CBSS 2009). 
In 1999, the Belgian Health Telematics Commission was set up to work on 
standards concerning the exchange of health information and to give advice 
on e-health to the government. They have working groups specific to data, 
hospitals, telemedicine and homologation of (para)medical software (FPS 
Health, Food Chain Safety and Environment 2009d). 
In 2004, the “CareNet” project was implemented to facilitate administrative 
procedures between sickness funds and hospitals. A second project, the 
“MyCareNet” project, aims to expand the CareNet project to other health care 
professionals (e.g. pharmacists, physicians, nurses, etc.) and to more applications. 
This project currently focuses on home nursing (CareNet 2010).
After an experimental phase of three years, the FPS Public Health now 
supports decentralized operational health networks on a regional basis in the 
three regions of Belgium – Wallonia, Brussels and Flanders. These health 
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networks were created to give quick access to patient health data and to avoid 
the duplication of data for repeated examinations and procedures. To enable a 
structured clinical information exchange, the summarized Electronic Health 
Record (Sumehr) was developed. This summarizes the minimal set of data a 
physician needs to quickly understand the medical status of his patient and to 
ensure continuity of care (FPS Health, Food Chain Safety and Environment 
2009d). 
With the Act of 21 August 2008, a Belgian eHealth digital platform has 
been set up to permit an electronic exchange of secured data between all health 
actors. This platform is a public institution of social security and provides digital 
access to all health information and applications through one portal site. The 
mission of the platform is to promote and support a well-organized exchange 
of electronic information among all actors in health, with the necessary 
guarantees regarding the patient’s security, the protection of the patient’s and 
caregiver’s privacy and respect for medical confidentiality. The objectives are: 
to optimize quality and continuity of care; to optimize patient safety; to simplify 
administrative procedures; and to provide strong support to health care policy. 
The responsibilities of the Belgian Health Telematics Commission, such as the 
determination of standards and the homologation of (para)medial software, are 
now under the responsibility of the eHealth platform (eHealth 2008). Vesta, a 
system of electronic data exchange between the Flemish Agency for Care and 
Health and recognized home care services, also uses the eHealth platform.
In addition to this, Vaccinet is an online system for vaccinations in the 
Flemish and Brussels-Capital region. With this application, vaccinators can 
order vaccines at any time and adjust the delivery times, where appropriate. 
4.2 Human resources
4.2.1 Trends in health care personnel
Physicians
The overall number of practising physicians, defined as a physician having 
provided more than one medical act during the year, increased from 28 999 
(2.83 per 1000 population) in 2000 to 31 281 (2.93 per 1000 population) in 20083 
(see Table 4.12). In 2008, the total number of practising GPs and specialists 
was 12 273 (8360 FTE) and 18 566 (12 429 FTE), respectively (NIHDI 2010d). 
3 Before 2000, data on health care personnel included both practising and non-practising physicians. Since 2000, 
a new calculation methodology has been used such that only practising personnel are counted.
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In addition to this, 311 FTE GPs work exclusively in collective infrastructures 
other than hospitals, for example, nursing homes. It should also be noted that 
for GPs, a minimum activity threshold of 500 contacts per year is usually 
considered to determine the number of practising GPs. In 2008, 10 877 GPs 
have reached this threshold (i.e. 1.02 per 1000 population).
Table 4.12
Practising physicians and dentists per 1 000 population, 2000–2008 (selected years)
2000 2005 2006 2007 2008 
2008 
(in FTE) 
Total practising physicians 2.83 2.88 2.90 2.92 2.93 1.97
GPs 1.20 1.19 1.18 1.17 1.15 0.78
Specialists 1.53 1.64 1.67 1.71 1.74 1.17
Non-specialized physicians a 0.10 0.05 0.05 0.04 0.04 0.03
Dentists b 0.75 0.74 0.74 0.73 0.72 0.53
Source: NIHDI 2010d. 
Notes: Definition: physicians having provided more than one medical act during the year; a e.g. non-recognized physicians; b includes 
specialists in stomatology with a recognition for dental stomatology.
These figures are now the common basis upon which to compute practising 
physician-to-population ratios, notably by international institutions such as 
the OECD. On the basis of these figures, in 2006, Belgium was ranked 13th 
in terms of practising physicians per 1000 population (with 2.9 practising 
physicians per 10 000 inhabitants). The EU15 average was 3.4 physicians per 
1000 population (see Fig. 4.2). However, it is crucial to note that the definition 
of practising physicians among countries may vary. The number of registered 
physicians, including non-active physicians, is described in Table 4.13.
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Fig. 4.2
Practising physicians per 1 000 population in EU15, 2006
Source: OECD 2009a (June) (except for Belgium). For Belgium, data used corresponds to that provided by the NIHDI (physicians having 
provided more than one medical act during the year). Comparisons should thus be made with caution because definitions of practising 
physicians vary between countries. OECD health data were not used for Belgium because they represented the number of registered 
physicians and not the number of practising physicians.
Table 4.13
Registered health care personnel per 1 000 population, 1990–2008 (selected years)
1990 1995 2000 2005 2006 2007 2008
Total registered physicians 3.3 3.6 3.9 4.1 4.1 4.0 4.1
GPs 1.9 2.0 2.1 2.1 2.1 2.0 2.0
Specialists 1.4 1.6 1.8 2.0 2.0 2.0 2.1
Dentists 0.7 0.8 0.8 0.8 0.8 0.8 0.8
Pharmacists 1.2 0.9 1.0 1.1 1.2 1.2 1.2
Physiotherapists 1.8 2.3 2.6 2.4 2.4 2.4 2.4
Source: NIHDI 2008d.
Nurses
Currently, there is no federal register for nurses in Belgium. The nurses register 
is in preparation and not yet up to date. Thus, no recent data are available on 
the number of practising nurses working in hospitals or nursing homes. The 
NIHDI only acquires data on registered nurses and midwives with an NIHDI 
number, including non-active nurses and midwives. NIHDI also publishes a 
profile, that is, the number of nurses and midwives with an NIHDI number 
and having performed at least one act in the year or in the two preceding years 
(see Table 4.14). 
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Table 4.14
Number of registered nurses and midwives in ambulatory care (with profiles),  
2003–2008
Year Number of nurses Number of midwives
Number of profiles 
(nurses and midwives)
2003 60 088 4 920 20 610
2004 62 211 (+3.5%) 5 084 (+3.3%) 21 241 (+3.1%)
2005 64 191 (+3.2%) 5 300 (+4.2%) 22 071 (+3.9%)
2006 65 952 (+2.7%) 5 467 (+3.2%) 22 802 (+3.3%)
2007 62 700 (-4.9%) 5 505 (+0.7%) 23 622 (+3.6%)
2008 64 756 (+3.3%) 5 592 (+1.6%) – 
Source: NIHDI 2008d.
Other health care personnel
Since 2000, the number of practising dentists has been stable at around 7600 (see 
Table 4.12, p.130). The number of physiotherapists has declined by almost 3% as 
a result of the introduction of a quota mechanism (see Section 4.2.2 Registration/
licensing and planning of health care personnel). For physiotherapists, no 
official register is established at the NIHDI. 
4.2.2 Registration/licensing and planning of health care 
personnel
Registration/licensing
The authenticity of diplomas in Belgium is verified by provincial medical 
committees of the FPS Public Health, Food Chain Safety and Environment. FPS 
Public Health registers all physicians, dentists, pharmacists, physiotherapists, 
nurses, midwives and other allied professionals with an authentic diploma. 
Anyone who is not properly registered is not allowed to practise. The licence 
is given for an unlimited time, that is, once health care professionals have 
been given the right to practise they do not have to reapply to keep that right. 
However, in cases of malpractice, licences can be withdrawn.
In order to practise medicine in Belgium, every physician must be recorded 
on the register of the Order of Physicians (see Section 2.3.4 Nongovernmental 
bodies). This mandatory registration applies to all physicians, even those coming 
from other EU Member States or foreign physicians who wish to establish 
themselves in Belgium. This registration has to be made in the province where 
the physician will have his/her main medical practice. The Order investigates 
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illegal and unethical practices under its strict Code of Ethics and has the right 
to impose penalties and strike doctors off the register if necessary (Belgian 
Order of Physicians 2010).
Similar obligations apply to pharmacists, who must be recorded on the 
register of the Order of Pharmacists.
Since 2006, new rules clarifying the status and roles for nurse-aids have been 
established by law (Royal Decree of 12 January 2006 fixing register of nurse-
aids; Royal Decree of 12 January 2006 fixing conditions needed for nurse-
aids to perform nursing acts). These new regulations are aimed at improving 
working conditions for nurse-aids, as well as creating a clear legal framework 
to identify under what conditions they can perform nursing acts. Approximately 
130 000 nurse-aids are expected to be registered at the NIHDI.
For pharmacy assistants, dieticians and occupational therapists, recognition 
procedures will be applied from 1 October 2010 (for pharmacy assistants and 
dieticians) and from 2011 for occupational therapists. 
Planning
As is the case in other countries, the major goal of medical personnel supply 
planning in Belgium is to guarantee the availability of a sufficient health 
workforce to meet population health needs. Oversupply and undersupply of 
physicians may end in unmet needs, lower quality, unnecessary services or 
increased costs (Roberfroid et al. 2008).
In the late 1990s, Belgium was characterized by a physician/population 
ratio that was one of the highest in the industrialized countries (3.6 registered 
physicians per 1000 inhabitants in 1995). The assumption of a positive 
relationship between physician densities and health care utilization was a 
major argument in favour of medical supply restrictions. Moreover, important 
interregional variations (i.e. a higher ratio in the French-speaking southern 
community) were considered neither politically acceptable nor financially 
sustainable given the federal financing of health care (Léonard, Stordeur and 
Roberfroid 2009; Roberfroid et al. 2008). 
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Consequently, the federal government decided in 1997 4 on a numerus clausus 
to limit the number of medical practitioners in the health care sector. The 
numerus clausus became effective in 2004, that is, after all students who had 
enrolled before the government decision could complete their training. The 
objective was to limit the total number of physicians working in the curative 
sector and gradually to reduce the existing discrepancy in medical density 
between the communities. A supply-based model served to estimate the number 
of physicians who should be attributed a practice (Roberfroid, Léonard and 
Stordeur 2009). This model took into account: the current number of physicians 
under 74 years old; the annual inflow from Belgian universities; the annual 
inflow due to international migration; and the outflow due to mortality. Factors 
impacting on productivity were also considered: the feminization process; the 
ageing of the medical population; and the working time reduction that has been 
introduced over a long period of time. Such a model is useful for visualizing 
likely trends in medical workforce supply, and to produce scenarios, particularly 
regarding the impact of various levels of inflow on the future workforce 
(Roberfroid, Léonard and Stordeur 2009).
Practically, the restriction mechanism was applied immediately after the 
basic training (seven years) and limited the number of trainees allowed to 
specialize as GPs or specialists. The maximum number of medical graduates 
who will be accepted for further training leading to practising was set at 757 for 
the years 2008–2011, 890 for 2012, 975 for 2013, 1025 for 2014 and 1230 for the 
years 2015–2018 (in comparison to approximately 1200 recognitions in 1999). 
Furthermore, these numbers are to be shared between the Dutch-speaking (60%) 
and the French-speaking (40%) regions,5 and between GPs (minimum 300 GPs 
for the years 2008–2014 and 360 for the years 2015–2018) and specialists (with a 
minimum of 20 specialists in child psychiatry, 10 specialists in acute medicine, 
and 5 specialists in emergency medicine; no minimum was defined for other 
specialties). 
4 The federal government introduced the planning of the numbers of physicians and dentists in 1996, when the 
Committee for Medical Supply Planning was established to give advice on the numbers of physicians and dentists 
qualified to practise in Belgium. Later, the remit of this Committee was extended to cover physiotherapists, nurses, 
midwives and logopaedists. The Committee is responsible for formulating proposals to the Federal Minister of 
Social Affairs and Public Health on the annual number of candidates per community that are eligible for being 
granted the professional titles of physician, dentist or physiotherapist, after obtaining the relevant diploma. 
Furthermore, the Committee has to evaluate on an ongoing basis the impact of its proposals on training for these 
professionals. An annual report is drawn up on the relationship between needs, and the number of those currently 
studying and moving on to practical training with a view to obtain the special professional titles of physician, 
dentist or physiotherapist.
5 In the area of education, the German community is included as part of the Walloon region.
Health systems in transition  Belgium 135
The number of new licences for dentists was limited to 140 per year for the 
years 2002–2010, 150 for the years 2011–2013 and 160 for the years 2014–2015. 
In order to achieve these objectives, the communities, which are in charge 
of education policy, have had to take measures to limit the number of medical 
and dental students. In 1997, the Flemish community introduced entrance 
examinations. The exam is organized on an inter-university basis by the 
Flemish Minister of Education and is common for both medicine and dentistry. 
It is an exam and not a competition: everyone who passes the exam is eligible 
to register for university training, without any number restriction. Each student 
can try to pass this exam more than once. 
The French community adopted a system to limit the number of medical 
students after their third year of medical education on the basis of the first 
three years’ results. The selection in the French community was introduced 
for the first time in the academic year 1997–1998 and was suppressed in 2003. 
Since 2006, the selection was re-initiated but, this time, after the first year 
(Community Decree of 26 June 2005). Whatever the selection system adopted, 
the global number of trainees exceeds the quotas in both communities. 
In the Flemish community, the number of successful candidates after the 
entrance exam increased from 447 in 1998 to 1295 in 2009. In the French 
community, students who successfully ended their first year in medical 
faculties and were not authorized to pursue their training appealed, and the 
Belgian Court of Justice eventually acknowledged the illegality of that selection 
process. Consequently, in 2008, the Minister of Higher Education and Scientific 
Research in the French Community unilaterally decided to (temporarily) stop 
restricting student access to the full medical degree course. However, the 
restriction is still valid at the federal level and it is unclear how the additional 
students will legally practise.
Similarly, from 1998 the number of physiotherapists who are granted access 
to the professional title of physiotherapist and who obtain the right to practise 
within the compulsory health insurance system has been restricted to 450 for 
the years 2005–2015. Again, these numbers convert into 60% for the Dutch-
speaking region and 40% for the French-speaking region. Since 2003, each 
year a national exam is organized by the federal government to select the 
physiotherapists who will receive a recognition (ICHD) number if the number 
of candidates in each community is higher than the quota. 
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4.2.3 Professional mobility of health workers
The “physicians directive”, passed in 1993 (93/16/EEC), confers the right to 
professionals to establish themselves or to provide services anywhere in the EU. 
Since 2004, the number of foreign physicians licensed to practise in Belgium has 
sharply increased year after year. New visas granted to foreign medical doctors 
on an annual basis rose from 78 before 2004 to 430 in 2008. Before 2004, the 
inflow originated largely from neighbouring countries (France, the Netherlands 
and Germany) and to a lesser extent from Spain and Italy. Since 2004, the 
larger group of immigrant doctors are from the Eastern part of the EU (Poland 
and Romania). The same rule applies for students, and those originating from 
countries with a numerus clausus are keen to search for training opportunities 
in other countries. Foreigners specializing in Belgium as a GP or specialist have 
increased from 38 training plans submitted in 2004 to 78 in 2006, that is, 4.4% 
and 10.4% of all training plans submitted, respectively. Meanwhile, in 2007, 
around 400 doctors with a Belgian visa left the country just after obtaining 
their diploma (Roberfroid, Léonard and Stordeur 2009).
The enlargement of the EU since 2004, as well as the implementation of 
the internal market for services and the mutual recognition of professional 
qualifications between the Member States, contributed to the increase of 
foreign physicians. Another contributing factor has been the limitation of 
medical trainees in Belgium, resulting in a decrease of medical assistants and 
lower available staffing in hospitals (Roberfroid, Léonard and Stordeur 2009). 
The same trend is observed for registered and specialized nurses. Hospitals 
in Brussels facing a current shortage in nurses and experiencing a higher 
competition for recruitment try with the support of international recruitment 
agencies to recruit nurses from Romania, Lebanon and, more recently, from 
Tunisia.
It should also be noted that the phenomenon is poorly documented so 
far. Only crude data are available, while important parameters such as the 
proportion of immigrants obtaining a practice licence for training reasons 
(specialization) who will stay in Belgium, turnover rates or activity profiles 
are poorly documented (Roberfroid, Léonard and Stordeur 2009).
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4.2.4 Training of health care personnel
From 2011, medical training in Belgium will be a six-year university course.6 
Belgium has seven medical schools with a complete training scheme for 
physicians. Medical studies are divided into two cycles: the first covers basic 
scientific education (Bachelor’s degree); the second cycle includes clinical 
studies and practical training in a hospital or a medical practice (Master’s 
training). After these six years, students will receive their physician’s diploma. 
For the last 15 years, the number of students receiving their physician’s diploma 
has been around 1100 per year. Pharmacists and dentists follow a five-year 
university course.
However, to be able to practise, a physician needs a licence granted by 
the Federal Minister of Social Affairs and Public Health. Further training is 
needed to obtain this recognition. Students wishing to become specialists follow 
training from three to six years depending on the specialty. Their choice can 
be constrained by the small number of training posts available at teaching 
hospitals. Specialization is restricted to a limited number of candidates. To be 
eligible for specialization, students have to submit a training plan indicating the 
name of the supervisor with whom they want to specialize and the in-service 
department where they want to work. They also have to submit the agreement 
of the supervisor and the in-service department. The training plan has to be 
approved by the licensing commission for the specialty concerned. In 2008, 
there were 30 recognized specialties (including general medicine) (NIHDI 
2008b). Those wishing to practise general medicine undergo three years of 
training.7
All nurses need to have one of the nursing qualifications that are recognized 
by Directive 2005/36/EC. In Belgium, two levels of nurses (bachelor-level [A1] 
and diploma-level [A2]) comply with the EC directive. Nursing assistant is a 
lower educational level of the nursing profession (obtained after two years of 
professional nursing education); this qualification level is fading out. Different 
nursing specialties are recognized in Belgium. All bachelor-level nurses can 
undertake specialized and complementary training in fields such as oncology, 
geriatrics, etc. For nurses working in home care, two specializations are 
recognized by the NIHDI for nurses of both qualification levels after completion 
of a postgraduate course: specialist nurse in diabetes and specialist nurse in 
wound care. Nurses with a bachelor-level can study at university to obtain a 
Master’s level, then they can study to obtain a PhD level (Sermeus et al. 2010).
6 Seven years before 2011.
7 With the seven-year university course (before 2011), GPs only underwent two years of specialization training.
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4.2.5 Doctors’ career paths
According to Lorant et al. (2008), an increasing percentage of GPs’ inactivity 
in the curative sector was reported, up from 4% in 1995 to 12% in 2005. This 
phenomenon was observed among licensed GPs of all age groups, genders and 
communities. It also applies to small practices (Lorant et al. 2008). However, 
the level of inactivity seems to be most prevalent for those aged 30–49. This 
suggests a recruitment problem in general practice (adding postgraduates with 
an MD degree to the pool of practising GPs). A longitudinal follow-up confirms 
that inactivity among newly qualified GPs increased in the more recent cohorts 
compared with the older ones. Unfortunately, this lack of activity of newly 
registered GPs in the curative sector is not counterbalanced by GPs who come 
back to the curative sector after a period of inactivity.
The inactivity of specialists in the curative sector was less important four to 
six years after their specialist registration but slightly rose with time (from 1.4% 
in 1994 to 2% in 2005). In particular, the young female and male specialists 
aged 30 to 39 years were both more likely to be inactive in the curative sector 
in 2005 than their GP counterparts (Lorant et al. 2008).
4.2.6 Other health staff career paths
To increase the attractiveness of the health care professions, social agreements 
have been concluded including: end-of-career and other measures to improve 
the workload, status, organization and quality of the work, the balance between 
professional and private life, and remuneration. This section specifically focuses 
on measures taken for nurses. 
Since 2000, concrete measures to improve the perception of the nursing 
profession were put into place. Two hundred public servants were offered the 
possibility to complete nursing studies (of three years) while receiving their 
total salaries (“Plan 600”, in accordance with the Social Agreement of the 
22 June 2000). This plan will be renewed in 2010–2011. In addition, nurses 
aged 45 years or older who were active in the health care sector (in hospitals, 
residential care for the elderly or for disabled individuals) could reduce the 
number of hours worked per week without any salary penalty (or work full-time 
and obtain a salary bonus). In 2008, an attraction plan was proposed, based on 
four specific actions (reducing work load; improving qualifications; improving 
salaries; and better social recognition) (AFIU 2008) (see Chapter 6).
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For nurse-aids the biggest change with respect to their profession occurred 
with the recognition based on registration and the creation of a legal context 
allowing them to perform certain nursing acts. 
In the Belgian sample of the nurses’ early exit (NEXT) European study, 
performed between 2002 and 2005, researchers observed that nurses easily leave 
one health care institution for another without leaving the nursing profession 
(Hasselhorn, Müller and Tackenberg 2005). The demand for qualified nurses 
enables them to change frequently and easily. However, this turnover is a 
burden for health care institutions: it obliges human resources management 
departments to spend substantial amount of time and energy in recruitment 
procedures; it forces executives and head nurses to inform, train and socialize 
newcomers; it increases pressure on nurses who remain in their institutions; it 
also results in hidden costs and decreased standards of patient care. 
The NEXT European study observed that nursing turnover was not uniform 
across Belgian health care organizations: from 0.6% to 13.1% in the hospital 
sector; from 0.8% to 22.6% in homes for the elderly; and from 3.6% to 21% 
in the home care sector. These remarkable differences in turnover rates 
between institutions led researchers to compare low-turnover institutions, 
defined as attractive, and high-turnover institutions, defined as conventional, 
in the Belgian sub-sample. If structural characteristics (size, ownership, past 
reorganizations, financial balance, etc.) did not help in differentiating attractive 
and conventional institutions, nurses’ perceptions of management features and 
work environment made the difference. Globally positive features reported 
by nurses were: flat organizational structure, decentralized decision-making, 
flexibility in scheduling, positive nurse–physician relationships, opportunities 
for professional development, a good balance between effort and reward, a 
manageable workload, a good balance between work demands (foreseeable and 
flexible work schedules, limitation of last-minute changes in the timetable due 
to unforeseen recall) and personal life, and nursing leadership that supports 
investment in education for nurses and values their expertise. In addition to 
organizational factors that contribute to the working environment, nursing 
practice plays an important role in attractive institutions: high level of autonomy, 
opportunity to exercise control over one’s professional practice, and sustainable 
demands both quantitatively and emotionally (Stordeur, D’Hoore and Next 
Study Group 2007). 
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These results, congruent with research findings in the “American Magnet 
hospitals”,8 emphasize the positive impact of a high level of job autonomy, 
nursing leadership, organizational support, and sustainable quantitative and 
emotional demands on nurses’ retention. Nurses face difficulties in their work 
situations, but some hospitals are perceived as healthy organizations. The 
concept of attractive institutions could serve as a catalyst for improvement 
in nurses’ work environments in Europe (Stordeur, D’Hoore and Next Study 
Group 2007).
8 A Magnet hospital is a hospital that meets quantitative and qualitative standards developed by the American 
Nurses Credentialing Center (ANCC) and corresponds to a high quality of nursing practice and patient care.
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5. Provision of services 1
5.1 Public health
Public health is “a social and political concept aimed at improving health, prolonging life and improving the quality of life among whole populations through health promotion, disease prevention and other forms of health 
intervention” (WHO 1998). These interventions can include promoting healthy 
behaviour, screening people appropriately for relevant disease, and reducing 
the number of individuals susceptible to infectious and chronic diseases. In all 
cases, public health policies and programmes are focused on the population 
as a whole in contrast to health care policies and programmes that tend to be 
focused on the individual.
5.1.1 Health promotion and preventive health care
In Belgium, the communities are responsible for health promotion and 
prevention of disease. However, a number of decisions directly related to 
public health are taken by the federal government. For instance, the level of 
taxes on cigarettes and alcohol, which are intended to reduce consumption, 
are determined by the federal authorities. On regular occasions, the federal 
government and the communities collaborate to coordinate and finance health 
policies (e.g. breast cancer screening, vaccinations against poliomyelitis and 
hepatitis B). 
The Flemish community
The policy framework for the organization of preventive health care in the 
Flemish community was first described in the decree of 21 November 2003 
(Vlaams Agentschap Zorg en Gezondheid 2004). This decree called for 
the establishment of initiatives concerning exogenous factors, endogenous 
factors and diseases in the initial phase. Initiatives concerning endogenous 
factors include: the detection of genetic factors and the prevention of specific 
1 This chapter was written by Anja Desomer, Maria Isabel Farfan, Maïté le Polain, Sabine Stordeur, 
Stefaan Van de Sande and Sophie Gerkens.
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diseases, such as cardiovascular diseases, cancer, mental illness, congenital 
diseases, developmental disorders and so on. Initiatives concerning diseases 
and exogenous factors are further described in the section on disease outbreaks 
and vaccinations (Section 5.1.5 Mechanisms for notification and surveillance 
of disease outbreaks).
Specific measurable health objectives were formulated in a health conference 
and approved by the Flemish Parliament, including:
• prevention of depression and suicide
• breast cancer screening
• promotion of healthy food and physical activity
• discouragement of smoking, drinking and using illegal drugs
• prevention of deadly accidents (private and traffic accidents)
• prevention of infectious diseases (in particular, by further increasing the 
vaccination rates for polio, pertussis, tetanus, diphtheria, measles, mumps 
and rubella).
Health conferences aim to define specific health objectives and consist of 
representatives of the Flemish government, experts, target groups and local 
health networks (LOGOs). For specific aspects, other representatives can be 
involved in a health conference, such as representatives of partner organizations, 
organizations in the field and so on.
Additionally, strategies for collaboration with other organizations are 
formulated so that they can work together to meet the health objectives. These 
organizations include: supportive working groups, the so-called partner 
organizations defined as centres of expertise in preventive health care, field 
organizations, individual health care workers, other governments and LOGOs.
LOGOs are intended to lead health promotion work at the district level, 
covering a territory with 97 000–475 000 inhabitants. They are composed of 
local initiatives and structures already in existence, and are meant to include 
all health and welfare workers. Each LOGO is supported and coordinated 
by a multidisciplinary central team and has to facilitate the implementation 
of evidence-based actions, which aim to reach certain health targets, set by 
the government. In 2010, the number of LOGOs was reduced from 26 to 15, 
with each LOGO now concentrated around a regional city (zorgregiodecreet) 
(Vlaams Agentschap Zorg en Gezondheid 2010d). In a resolution of the Flemish 
government (29 May 2009), the objectives of the LOGOs were extended to the 
prevention of health problems due to environmental factors. 
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For support with health promotional activities, the Flemish government 
appeals to the Flemish Institute of Health Promotion and Sickness Prevention 
(VIGeZ). VIGeZ is a centre of expertise that delivers a strategic vision, quality 
recommendations and training for professionals in health promotion. VIGeZ 
focuses on topics such as tobacco, healthy eating, promotion of physical activity 
and accident prevention. VIGeZ aims at intermediate target groups such as 
schools, working environments, local communities and the underprivileged. 
The Flemish government formed an agreement with VIGeZ in which subsidies 
and objectives were fixed. The objectives are: disseminating information to 
the whole population and making recommendations to the government and 
scientists; developing a methodology for different organizations which are 
responsible for working within the preventive health policy (such as the 
LOGOs); helping to introduce this methodology into the functioning of these 
organizations; evaluating the interventions; and organizing the training of 
professionals. The tasks are defined in an annual plan, which must be approved 
by the Flemish Care and Health Agency (VIGeZ 2010)
The French community
The government of the French community defines its objectives for health 
promotion in a five-year programme. In the latest five-year programme (2004–
2008), the priorities in the areas of health promotion and prevention were 
(Ministère de la Communauté française, Direction Générale de la Santé 2008):
• prevention of addiction
• prevention of cancer
• prevention of infectious diseases (by promoting vaccination programmes, 
prevention of AIDS and sexually transmitted diseases (STDs) and the 
fight against tuberculosis)
• prevention of injuries and promotion of security
• promotion of physical activity
• promotion of oral/dental health
• promotion of cardiovascular health
• promotion of well-being and mental health
• health promotion for early childhood
• promotion of a healthy environment.
The 2008–2009 programme emphasizes the following priorities, based 
on the objectives of the five-year programme (Ministère de la Communauté 
française – Direction Générale de la Santé 2009): 
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• prevention of AIDS and STDs 
• fight against tuberculosis
• screening of neonatal deafness
• screening of congenital anomalies.
In the French community, health promotion is organized by the Local 
Centres for Health Promotion (CLPS), which have to coordinate, on the local 
level, the implementation of the five-year programme and the community 
plans for health promotion. These local centres operate at the request of all 
the actors within the competence of their territory. The responsibilities of the 
CLPSs are: to work out an action plan respecting the objectives of the five-year 
programme; to coordinate the execution of the action plan on the level of the 
organizations or people who mediate with the population or the public targeted 
by the objective; to bring methodological help to the organizations and people 
who develop actions in the field of the health promotion and preventive health 
care; and to encourage the development of partnerships in the territory, in 
particular by the realization of local conferences in health promotion. There are 
nine CLPSs in Wallonia and one in Brussels (Communauté française, Centre 
de documentation administrative 1997; Communauté française, Centre de 
documentation administrative 2009).
Health promotion and preventive health care policies in the French 
community are assisted by the Community Services for Health Promotion 
(SCPS). These community services give logistic and methodological assistance 
(i.e. formation, documentation, communication, research and evaluation) 
to the government, the CLPSs, the Superior Council of Health Promotion 
and the organizations or people who develop actions in the field of health 
promotion. There are four accredited community services, each with their own 
specificity: “Question Santé”, a non-profit-making organization responsible 
for communication in health promotion; RESOdoc-UCL (Unité d’Education 
pour la Santé) of the Catholic University of Louvain (UCL) responsible for 
documentation, research and formation; SIPES-ULB (Service d’Information 
Promotion Education Santé) of the Free University Brussels responsible for 
methodological help for the collection and diffusion of data; and APES-ULG 
(Appui en Promotion et Education pour la Santé) of the University of Liège 
for intervention and evaluation methodology (Ministère de la Communauté 
française, Direction Générale de la Santé 2010).
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The German community
In the German community, the Council for Health Promotion (Beirat für 
Gesundheitsförderung) defines the global concept of health promotion, 
consisting of a structural level (improving infrastructure, health promotion 
networks, and coordination between health care organizations) and an individual 
level (age-specific information and self-responsibility). In the global concept, 
specific health objectives are determined every two years (German Community 
2006). For 2008–2009, the three main objectives for health promotion are:
• promotion of healthy nutrition
• promotion of physical activity 
• promotion of well-being and mental health. 
These objectives are elaborated in information and sensitization campaigns, 
focused on the prevention of health hazards and determined for age-specific 
groups (e.g. the elderly, youngsters, young parents). The Council for Health 
Promotion, composed of representatives of the German-speaking government, 
sickness funds, social health services and Service for Child and Family 
(Dienst für Kind und Familie), supports health promotion on the local level by 
co-financing non-profit-making organizations and specific projects (German 
Community 2004). 
5.1.2 National screening programmes
In Belgium, two national screening programmes for early detection of diseases 
exist: breast cancer screening and neonatal screening for congenital metabolic 
diseases. 
Breast cancer screening
In 2000, the communities and the federal government signed a protocol to 
organize and finance, on a national scale, a campaign for breast cancer 
screening for women between 50 and 69 years old, based on the directives 
developed by the Europe Against Cancer programme (Christiaens et al. 2007). 
The federal government pays for the radiological costs (via the NIHDI), while 
the organization’s costs are paid for by the communities. 
The responsibility for the coordination of the campaign is attributed to 
recognized screening centres. Seven screening centres were identified: one 
in the Walloon region, five in Flanders (in four Flemish universities and one 
in Bruges) and one screening centre for Brussels. The screening centres are 
responsible for the identification of the target group, sending the invitations, the 
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second assessment of the mammography,2 data recording and reporting to the 
referring physician. In Flanders, the campaign started in June 2001, while in 
the Walloon and Brussels-Capital regions, the campaign started in June 2002. 
Breast cancer screening in the German community is part of the programme 
of the French community. The coverage of breast cancer screening in Belgium 
is detailed in Section 7.5 Quality of care. 
Neonatal screening
The goal of neonatal screening is the early detection of 11 congenital metabolic 
diseases in neonates. To guarantee the quality of test performance, centres 
for detection of metabolic diseases (specialized laboratories) are certified by 
the communities (three in the French community and three in the Flemish 
community) (Communauté française 2009). These laboratories collaborate with 
partners who take the blood samples (from maternity wards, GPs, independent 
midwives) and partners who take care of the follow-up for babies with a positive 
test result (paediatricians, centres for metabolic diseases). 
A Flemish study group developed a strategy for the standardization and 
optimization of neonatal screening. This strategy is a working instrument for 
all health care workers and is updated on a regular basis (Vlaams Agentschap 
Zorg en Gezondheid 2010e). 
5.1.3 Non-national screening initiatives
Other screenings initiatives are not yet organized at federal level but exist at 
the level of communities. 
Since March 2009, the detection of colorectal cancer for those aged 50–74 
is organized in the French and the German communities. The test consists of 
an examination of blood in the stools, followed by a colonoscopy in persons 
at risk and is performed every five years after normal results, or every 1–3 
years depending on the number of adenomas found during colonoscopy. In the 
Flemish community the screening is organized in local pilot projects and with a 
different diagnostic technique (examination of the blood with immunochemical 
tests) (Jonckheer 2009). 
The detection of cervical cancer in women aged 25–64 is organized in pilot 
projects or as opportunistic tests in Belgium. The target group is invited to 
have a Pap smear taken once every three years (Stichting Tegen Kanker 2010). 
The coverage of cervical cancer screening in Belgium is detailed in Section 7.5 
Quality of care. 
2 The radiologist performs a first assessment of the mammography and the screening centre provides 
a second assessment.
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The prevention campaign for cervical cancer is extended with the availability 
of a vaccination against the human papilloma virus (HPV) for girls aged 12–18. 
This vaccination is reimbursed by the NIHDI. (Hoge Gezondheidsraad 2007; 
BS–MB 2008)
5.1.4 Family and child health care
Three different institutions (K&G for the Flemish community, ONE for the 
French community and Kind und Familie for the German community) are in 
charge of the organization of preventive medical, psychosocial and parenting/
pedagogical services for parents-to-be and families with young children. In 
addition to this, they provide consultations for children up to six years old as 
well as childhood immunizations. 
Vaccination coverage is described in Table 5.1. Levels of child immunization 
against diphtheria, tetanus, pertussis and poliomyelitis have been stable and 
reached 99% in 2007. Immunizations against Haemophilus influenzae type b 
and hepatitis B have increased significantly since 2000, up to 97.5% and 94.4% 
respectively in 2007 (see Table 5.1). Since 2004, the financing of all vaccines 
(listed in the vaccination calendar) is regulated with the same distribution code 
for all communities: two-thirds is financed by the federal government and 
one-third is financed by the communities (NIHDI 2007b).
These institutions also organize hearing screening for neonates. This 
comprises screening, the possibility of controlled referral to a highly qualified 
centre, diagnosis, treatment and home-based guidance, as well as registration 
in a central database. The screening test is free. 
A pioneering community-based eye screening for amblyogenic factors 
has been organized by K&G, in collaboration with five Flemish university 
ophthalmologic departments. The programme aims to reduce the number 
of children with lazy eye from 6% to 2%, using a powerful and convenient 
infrared video-refractometer. The programme covers screening, referral to an 
ophthalmologist, follow-up, registration and feedback. Nurses perform the test 
in children at the age of 1 and 2 years old.
In both the Flemish and French communities, school health care services 
are provided for nearly every nursery, primary and secondary school (up to the 
age of 18 years old). On a regular basis (once in primary school and twice in 
secondary school), pupils go to a school medical centre for a preventive medical 
examination, which includes screening for physical and mental disorders, 
sight and hearing tests, vaccinations (such as hepatitis B) and verification of 
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vaccination dates. In addition, teams composed of a physician and a graduate 
nurse visit schools for prevention of communicable health problems (e.g. 
tuberculosis, head lice) and health education.
Table 5.1
Levels of child immunization in Belgium (%), 1990–2007 (selected years)
1990 1995 2000 2005 2006 2007
Diphtheria 93 94 95 97 99 99
Tetanus 93 94 95 97 99 99
Pertussis 93 94 95 97 99 99
Measles 85 85 82 88 92 92
Poliomyelitis 95 92 96 97 99 99
Haemophilus influenzae type b – – 86 95 98 98
Hepatitis B – – 60 78 94 94
Source: WHO Regional Office for Europe 2010.
5.1.5 Mechanisms for notification and surveillance of disease 
outbreaks
Notification of an infectious disease
The specific proceedings to encounter an infectious disease outbreak are 
regulated by the communities. 
In the Flemish community, the proceedings for infectious diseases contain 
five domains: primary prevention (vaccination of the population); curative 
approach (diagnostic and treatment); surveillance of infectious diseases; case 
management (individual contagion); and outbreak management (collective 
contagion) (Burgmeyer, Hoppenbrouwers and Bolscher 2007).
The Flemish community determines the list of infectious diseases, 
the proceedings for notification and the assignment of the local state 
epidemiologists (one per province) (Vlaams Agentschap Zorg en Gezondheid 
2004; Flemish Government 2009b). These health inspectors are responsible 
for taking measures to confront the disease outbreak (such as communicating 
with the health authorities, organizing the medical examination of patients and 
the provision of specific medical treatment) and supervising the performance 
of these measures. The measures for dealing with an outbreak of disease also 
depend on the target group (patient, unknown patient, susceptible contacts and 
individuals) and the different components of contagion. 
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Every physician, head of a laboratory of clinical biology and supervising 
physicians working in a school, work environment and in residencies for 
children, youth and elderly are compelled to report a case of an infectious 
disease to a health inspector within 24 hours. The mentioned diseases are listed 
in a pre-determined and regularly updated list (which is the responsibility of the 
communities) (Flemish Government 2009a). More detailed information about 
infectious diseases can be found on the web site of the Flemish community 
(Vlaams Agentschap Zorg en Gezondheid 2010c). The reporting of a case 
contains information about the disease (syndrome, diagnostic technique, course 
and beginning of the disease) and demographic components. 
In the French community, the notification of infectious disease outbreaks 
occurs in a similar way as in the Flemish community. The list of diseases 
includes: food poisoning, active tuberculosis, STDs, diseases which can be 
prevented by vaccination, bacterial infections, legionnaires’ disease, widespread 
diseases, zoonosis and rare diseases. More detailed information about the list 
of diseases can be found on the web site of the French community (French 
Community 2010b).
The German community applies the same proceedings as the French 
community. 
On the federal level, the FPS Health, Food Chain Safety and Environment 
is supported by the Superior Health Council (scientific advisory department). 
In the case of a major disease outbreak (e.g. the risk of national contagion or 
a disease outbreak in neighbouring countries), the communities will collaborate 
with the federal government to coordinate a national action plan. 
Surveillance of an infectious disease
The goal of surveillance is the organization of the systematic collection, analysis, 
interpretation and dissemination of data in order to optimize the preventive 
programmes of each community. The surveillance of infectious diseases occurs 
in three ways: compulsory notification of infectious diseases by physicians and 
laboratories; registration by an extensive network of sentinel laboratories; and 
the organization of projects and programmes (for example the programme for 
STDs). 
The IPH gathers the necessary epidemiological information (by using 
and/or reinforcing the existing surveillance system or by creating new ones), 
coordinates the risk assessment and gives epidemiological support (e.g. 
intervention, survey) to the health authorities.
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5.1.6 Measures on lifestyle behaviours
Alcohol consumption
A national campaign against drink-driving (BOB-campaign) was set up in 1995 
by the Belgian Institute for Traffic Safety (BIVV-IBSR). Because of its huge 
success, the BOB-campaign has been renewed at the end of each year and has 
been copied by other countries. Local projects on the prevention and treatment 
of addictions can be financed by the Fund for the Fight Against Addictions. 
In 2008, a National Action Plan for Alcohol was also defined (see Chapter 6). 
The main restrictions in place to protect minors from the negative effects 
of alcohol abuse include age limits (strong drinks, e.g. hard liquor, can only be 
sold to adults over 18 years old, other alcoholic beverages, e.g. beer and wine, 
only to persons over 16 years old). Advertisements for alcoholic products are 
also restricted. They may not be aimed at minors or involve minors (Act of 
17 November 2006) (FPS Health, Food Chain Safety and Environment 2010a).
Smoking
Prohibition of tobacco use includes the ban on smoking in public places, schools 
and work environments. Also, since January 2010, it is prohibited to smoke in 
the catering industry. The only exception is allowed for drinking houses where 
only drinks are served (Royal Decree of 22 December 2009 and Royal Decree 
of 13 December 2005). In addition, there are numerous prevention campaigns 
organized by schools and local health networks. 
Schools are supported in providing a “smoke-free” school environment and 
a “smoke stop” course is organized to help adolescents give up smoking. 
In line with European legislation, the sale of tobacco products is restricted 
to adolescents over 16 years old (Act of 1 December 2004). In places that sell 
tobacco products, leaflets and posters must warn the buyer of the health risks of 
smoking. Advertising tobacco products (and sponsorship by these companies) 
is prohibited. Furthermore, a warning about health risks on the cigarette packs 
is compulsory (Ministerial Decree of 27 October 2005). 
Overweight
Several initiatives are in place to promote healthy eating and exercise in schools. 
These include promoting the consumption of healthy food and drinks (eating 
fruit, healthy drinks and healthy snacks) and the integration of a nutrition 
and physical activity policy (see also Subsection Prevention measures in 
Section 6.1.1 Increasing accessibility). The promotion of healthy nutritional 
eating habits is coordinated by the local health networks.
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5.2 Patient pathways 
5.2.1 In hospital
Efforts to develop patient pathways are, so far, mainly related to pathways in 
hospitals. Generally, these pathways are called clinical pathways. In the context 
of hospitals, clinical pathways are often defined as schedules of medical and 
nursing procedures, including diagnostic tests, medications and consultations 
designed to provide an efficient and coordinated programme of treatment. 
Several initiatives have been undertaken to stimulate the use of clinical 
pathways in Belgian hospitals. 
In 2000, the Centre for Health Services and Nursing Research of the 
Catholic University Leuven (KUL) launched the Belgian Dutch Clinical 
Pathway Network to support hospitals in developing, implementing and 
evaluating clinical pathways. The first activity of the Network is to provide 
education on clinical pathways and related concepts such as patient safety, 
quality control, multidisciplinary teamwork, operations management and 
evidence-based medicine. The second activity is to support multidisciplinary 
teamwork, in-hospital projects on pathways and multi-centre research projects 
and benchmarking. The third activity is research and international collaboration 
(FPS Health, Food Chain Safety and Environment 2006a). 
Some research projects are funded by the federal government. Since 2003, 
a joint venture, called Network of Clinical Pathways (Het Netwerk Klinische 
Paden), between the Centre for Health Services and Nursing Research of 
the KUL, the Dutch Institute for Health Care Improvement (CBO) and the 
UCL has been established. The team incorporates competences in patient 
care management, change management, cost-accounting, operations research, 
evidence-based medicine and information and communication technology. In 
2008, 106 organizations were members of the Network, including acute hospital 
trusts, rehabilitation centres and home care organizations. 
Within the Network, a clinical pathway is defined as: a collection of methods 
and tools to guide the members of a multidisciplinary and interdisciplinary 
team towards patient-focused collaboration for a specific patient population. 
It is a (systematic) way of identifying and defining the different tasks of the 
different team members. The goal is to assure qualitative and efficient care. It 
is a tool to systematically plan and follow up a patient-focused care programme. 
More than 450 pathways are under development or have been implemented 
(KUL 2006; Sermeus and Vanhaecht 2002).
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A KCE survey showed that clinical pathways have a higher penetration 
in predominantly Dutch-speaking acute hospitals and larger acute hospitals. 
The impact of clinical pathways at present is below 10% in most of the 
hospitals, but there is a large potential for growth covering up to 40–60% of 
patients. A multitude of pathways already exists for a large number of frequent 
interventions in surgery, obstetrics-gynaecology and, to a lesser extent, internal 
medicine and neurology. Currently, less than two-thirds of the pathways fulfil 
the three characteristics of clinical pathways: a timeline, multidisciplinary work 
and a detailed overview of key elements (Devriese, Lambert and Eyssen 2005).
Apart from specific clinical pathways by pathology, a general pathway can 
be formulated, for example, for a woman who is in need of a hip replacement 
as shown in Box 5.1.
5.2.2 In ambulatory care 
In 2009, care pathways (zorgtraject/trajet de soins) for the treatment and 
follow-up of certain chronic diseases were developed and implemented to 
enhance the collaboration in care between the patient, the GP, the specialist 
and other caregivers (Royal Decree of 21 January 2009). The collaboration 
between caregivers is described in a “care pathway” contract that lasts four 
years. Financial incentives are given to the physicians (yearly lump sum of €80 
per patient) and to the patient (complete reimbursement for consultations, more 
access to specific devices and, for example, reimbursed consultation with a 
dietician, a personal care plan and the guarantee that the care plan is individually 
adapted to his or her specific needs, etc.). Currently, two pathways already exist: 
one for patients with chronic kidney insufficiency (since 1 June 2009) and one 
for patients with diabetes type 2 who no longer respond to oral treatment (since 
1 September 2009) (NIHDI 2009a; NIHDI-Care Pathways 2009).
To enhance the collaboration between all caregivers and optimize the 
quality of care, local multidisciplinary networks were set up as a supportive 
service for the caregivers. The local GP circles are the initiators for setting up 
an operational plan in collaboration with the local ISHC-GDT-SISD. The aim 
of this operational plan (under the supervision of a care pathway promoter) is 
the gathering of information about the caregivers and the local organizations, 
the facilitation of communication between caregivers and the evaluation of the 
local network. The local networks receive a yearly sum (in agreement with the 
Assurance committee) adjusted to the number of inhabitants in the local region 
(NIHDI-Care pathways 2009). 
Health systems in transition  Belgium 153
5.3 Primary/ambulatory care
In this section, primary health care is defined as the first point of contact 
between an individual and the health system. Since there is no referral system in 
Belgium, for several specialties (in particular for gynaecology, ophthalmology, 
dermatology, paediatrics and otorhinolaryngology) the specialist often forms 
the first point of contact with the patient in the health care system. They will 
therefore be considered in this section along with GPs.
Delivery of ambulatory care in Belgium is mainly private and based on 
the principles of independent medical practice, that is, independent medical 
practitioners and paramedics are remunerated via fee-for-service payment and 
there is free choice of physician by the patient. The vast majority of physicians 
 Box 5.1
 Patient pathway example: woman in need of a hip replacement
A woman in need of a hip replacement due to arthritis would take the following steps:
•  She can contact a GP with whom she can be registered (i.e. the GP who keeps her 
GMD-DMG). She can also contact an orthopaedic specialist directly.
•  The GP or the orthopaedic specialist can prescribe any necessary pharmaceuticals.
•  The GP refers her to a hospital orthopaedic department for examination and, subsequently, 
an operation. 
•  She has free access to any accredited hospital, public or private. Thus, the GP makes 
the referral in consultation with the patient. 
•  After consultation with the orthopaedic specialist, the decision is made for admission 
and surgery. Waiting lists are limited.
•  During hospitalization, any necessary medication and physiotherapy are prescribed by 
the responsible orthopaedic specialist.
•  Following surgery and primary rehabilitation at the hospital, the responsible orthopaedic 
specialist, together with staff from social services in the hospital, the patient and her 
family,  develops a plan for further care.
•  After discharge from hospital, she can go home (where she might need home care) or, 
if she is 60 years or older, she can go to a residential home, a home for the elderly or 
a nursing home.
•  The GP receives a discharge summary from the hospital which will be added to 
the GMD-DMG. The GP is responsible for any further follow-up, such as referral to 
a physiotherapist.
•  A follow-up visit to the hospital outpatient department or with the private specialist is 
likely to take place to check the treatment’s outcome.
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work as independent, self-employed health professionals. Medical specialists 
can work in health institutions (mostly hospitals) and/or on an ambulatory basis 
in private practice. GPs mostly work in private practice; they rarely work in 
hospitals except to perform deliveries in maternity units and in emergency care 
units. Because there is no referral system between GPs and other specialists, 
every citizen has free access to medical specialists and hospital care, even as 
the first point of contact with the health care system. 
Domiciliary visits to patients by GPs are a regular practice in Belgium. 
Indeed, in 2008 there were 46 345 577 visits to GPs of which 15 017 280 (32%) 
were domiciliary. Visits to specialists can either take place at a hospital or in 
an outpatient department (most often situated in a hospital). The total number 
of visits to specialists was 26 023 318 in 2008. Patients do not usually have to 
wait long for access to either GPs or specialists. 
The number of outpatient contacts per person per year decreased from 6.9 in 
2000 to 6.5 in 2007, but increased again to 6.8 in 2008. In particular, the number 
of physicians’ visits to patients at home has decreased from 2.3 in 1995 to 1.4 
in 2008. The number of visits by patients to GPs and specialists has increased 
to 2.9 and 2.4 per person per year, respectively (2008). In the past decade, the 
number of outpatient contacts seems to have stabilized at around 7.0 contacts 
per person per year (see Table 5.2) (NIHDI 2008d). 
Table 5.2
Outpatient contacts per person per year, 1995–2008 (selected years)
 1995 2000 2005 2006 2007 2008
Consultation at GP’s office 2.5 2.7 2.7 2.7 2.8 2.9
Consultation with a specialist 2.0 2.1 2.3 2.3 2.3 2.4
Physician visits (mostly GPs) to patients at home, nursing 
home, hospital, etc.
2.3 2.0 1.6 1.5 1.4 1.4
Other* 0.1 0.1 0.0 0.0 0.0 0.0
Total 6.8 6.9 6.6 6.5 6.5 6.8
Source: Raw data provided by NIHDI.
Note: *GP assistance during emergency transport, advice and multidisciplinary dialogues (from 2006). Calculation based on the date of 
the service.
Physicians (GPs and specialists) operate in solo or group3 practices, frequently 
without any staff except perhaps a medical secretary. Most group practices 
correspond to integrated health care practices, such as medical houses (maison 
médicale/wijkgezondheidscentra), which operate a multidisciplinary team, 
including (at least) several GPs, administrative and reception staff, nurses, a 
3 First estimates showed that around a quarter of recognized GPs operate in group practices. More accurate data on 
group practice will be available from the end of 2010.
Health systems in transition  Belgium 155
physiotherapist and a psychotherapist. The number of such practices is growing, 
although there is still only a small minority of people affiliated to them. Group 
practices can operate a fee-for-service payment system like other physicians, 
but also a capitation system (NIHDI 2010i). The total number of medical houses 
using a capitation system increased from 53 in 2003 to 99 in 2009.
The provision of many other health care services (e.g. pharmacies and dental 
services) is also private. 
Primary care services are also to a large extent provided by other health care 
professionals, such as nurses and physiotherapists. Nurses play a key role in 
providing services to people with chronic diseases or disability. Primary care 
services provided by nurses include, for example, wound and diabetes care. 
There are also centres for family planning (which have a minimum staff 
of one physician, one psychiatrist or psychologist, one lawyer and one social 
assistant), which are subsidized by the communities for their equipment, 
personnel and running costs. 
Physiotherapists are also largely involved in primary care services. Indeed 
in 2008, the Professional Association of Physiotherapists estimated that primary 
care treatments corresponded to 80.9% of all acts performed by physiotherapist 
(Axxon 2009). As is the case for nursing care, demand for physiotherapy 
services has increased due to the ageing population and also because of 
increasing lifestyle related health problems (such as lack of physical activity). 
5.3.1 The GP gatekeeping role
GPs do not serve a gatekeeping role in Belgium. Patients have free choice 
concerning the first physician to contact, can change physicians at any time, get 
a second opinion, or even consult several physicians at a time. Moreover, they 
can directly access specialists or enter hospitals. The free choice of physician 
is an important right granted to patients. Nevertheless, the average number 
of physician contacts per person in Belgium is in line with the EU27 average 
(6.9 outpatient contacts4 per person in 2008, compared to the average of 6.86 
in the EU27) (see also Fig. 5.1).
4 The WHO Regional Office for Europe (2010) defines outpatient contacts per person per year as: “The total number 
of primary health care or ambulatory care contacts divided by the population. An outpatient contact is one episode 
of examination/consultation performed by a physician or by a nurse in the presence of a physician, in relation to 
one outpatient at one time and location, normally at the physician’s office or the patient’s home. The number of 
outpatient contacts includes: patient’s visit to physician’s office; physician’s visit to patient’s home or other place; 
call for ambulance; day-patient cases.” For Belgium this number includes advice, patient’s visit to physician’s 
office (GPs and specialists), physician’s visit to patient’s home and medical assistance during urgent transfer to a 
hospital (in an ambulance); day-patient cases are not included.
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Fig. 5.1 
Outpatient contacts per person per year in the WHO European Region, 2008 or latest 
available year
Source: WHO Regional Office for Europe 2010.
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Concerning the contact between patients and GPs, the national HIS of 2004 
showed that a large majority of the population (95%) had a regular GP, and that 
the mean number of contacts per year was 4.5 (self-reported by the patient). 
The survey indicated that people with a low education level (primary education 
diploma) contacted GPs more often than people with the highest education 
level (higher education diploma), with 7.8 and 3.3 contacts, respectively. This 
difference in the number of contacts between patients and GPs might be due 
to the fact that less educated people have poorer health. Only 10% of GP 
contacts resulted in a patient referral to a specialist for treatment or additional 
investigation. This low figure could reflect the high proportion of patients that 
directly seek a specialist consultation (Van der Heyden et al. 2003).
Despite the importance attached to the principle of free choice of provider, 
measures have been taken to strengthen the position of the GP as the preferred 
entrance point for health care (see Section 2.6.2 Regulation of providers and 
Subsection Strengthening primary care in Section 6.1.2 Assuring health care 
quality).
5.3.2 Out-of-hours primary care
In order to contain the number of patients relying exclusively on hospital 
emergency services for more or less urgent questions and problems, and 
because out-of-hours care is a heavy burden for GPs, both out-of-hours duties 
and remuneration have been expanded. In 2002, a lump sum of €125 per 
24-hour period was assigned to GPs on duty during the weekend or public 
holidays. The fee applies to GPs for each 24-hour weekend shift that they are 
on call, irrespective of the number of consultations given.
In a given area, GP circles are responsible for local health policy; collaboration 
with other health care providers and hospitals; and the organization of out-of-
hours primary care. Although GP circles are financed for mainly administrative 
aspects, they can receive extra funding if the out-of-hours service is further 
extended with a unique phone number, or if the population density is less than 
125 inhabitants per km.
In 2007, the National Commission of Representatives of Physicians and 
Sickness Funds proposed additional “experimental” measures which aimed to 
ensure a structured organization for out-of-hours visits (for their own patients, 
visits after 18:00) and organized duty services (for every patient in a specific 
area). Organized duty services are accessible for everybody during the weekend, 
holidays and week nights.
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These are temporary measures, which will be evaluated at the end of 2010. 
Two measures concern organized duty services. First, duty services may start 
at 19:00 instead of 20:00. As of January 2010, the NIHDI will pay a supplement 
of €5.66 per hour for these extended hours. Second, a further fee supplement 
of €2.11 is offered for patients visiting their doctor between 19:00 and 21:00. 
Patients are fully reimbursed for the duty supplement. 
An “availability” supplement is also afforded to physicians who remain 
available to their patients between 18:00 and 21:00. The “availability” supplement 
of €2.11 can be charged to patients. Patients receive full reimbursement for the 
“availability” supplement if they have a GMD-DMG (NIHDI 2010l).
In 2008, there were 20 organized duty centres: ten in the Flemish community, 
six in the French community and four in Brussels-Capital. 
5.3.3 Geographical distribution of primary health care 
physicians
A recent KCE study reported on the geographical distribution of GPs and 
specialists in Belgium. In 2005, the lowest densities were observed in Antwerp, 
Limburg, West Flanders and East Flanders, with 9.8, 9.9, 9.9 and 10.2 GPs 
per 10 000 inhabitants, respectively. The highest densities were observed 
in Luxembourg and Namur with 14.2 and 14.4 GPs per 10 000 inhabitants, 
respectively. Intermediate densities were observed for Flemish Brabant, 
Hainaut, Liège, Brussels and Walloon Brabant (11.1, 11.4, 13.1, 13.2, 13.6 per 
10 000 inhabitants, respectively). 
The density of practising specialists is lowest in Limburg and West Flanders 
(8.4 and 9.4 specialists per 10 000 inhabitants), whereas the highest densities 
were observed in Brussels and Walloon Brabant (21.7 and 24.0 specialists per 
10 000 inhabitants). The relatively high density of specialists in Liège, Brussels 
and in the Flemish Brabant can be related to the higher number of hospital beds 
in those provinces.
In Belgium, all doctors are free to choose their practice location. In order 
to relocate doctors to medically deprived areas, in 2006 the government 
launched a dedicated fund for this purpose called the Impulseo I fund (see 
Subsection Mechanisms to provide an adequate supply in Section 6.1.1 
Increasing accessibility) (Roberfroid et al. 2008).
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5.4 Secondary care (specialized ambulatory care/
inpatient care)
Secondary care in Belgium refers to inpatient care in hospitals as well as in 
day care.
5.4.1 Hospitals
According to the Belgian Hospital Act, several primary conditions have to be 
met for a health care establishment to be labelled as a hospital:
• continuity of care (“at any time”)
• basic coverage in diagnostic and therapeutic medicine (“appropriate 
examinations and/or treatment within the field of medicine, surgery and 
in certain cases obstetrics”)
• multidisciplinary setting
• appropriate organization and infrastructure (“necessary and appropriate 
medical, medico-technical, nursery, paramedical and logistical 
framework”)
• possibility of overnight stay(s) 
• function as quickly as possible in relation to requirements of care 
(according to a patient’s condition, required care must be provided in 
order to treat or alleviate disease, restore or improve their state of health, 
or stabilize lesions as quickly as possible). 
In Belgium, hospitals are private or public non-profit-making organizations 
that are classified into acute, psychiatric, geriatric and specialized hospitals (see 
also Section 4.1.2 Capital stock and investments). 
People are free to choose which hospital they visit and public hospitals have 
to accept all patients. Thus, there is no formal referral system between primary 
and secondary/tertiary care, but, in practice, it is usually the GP or the private 
specialist who decides to send the patient to a hospital. 
Waiting lists that occur in some European health systems are quite rare 
in Belgian hospitals. For specific interventions, waiting lists may occur 
due to external reasons, such as the shortage of donors in the case of organ 
transplantation. To alleviate the shortage of organs (especially kidneys and 
livers), a campaign was set up among the population and care providers 
under the name “BELDONOR”. Since then, the number of candidate donors 
has increased steadily from 33 850 in 2005 to 100 581 in 2009. In 2009, the 
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campaign continued and took a particular focus on specific target groups, such 
as students in secondary education. In addition, the GIFT project was set up 
in intensive care units of 60 hospitals. Under this project, “transplantation 
correspondents” can undertake early screening of potential organ and/or tissue 
donors and can later discuss with family members and providers about the 
importance of donation (FPS Health, Food Chain Safety and Environment 
2008a).
As mentioned before, hospital accreditation is regulated by the federal 
government and implemented by the communities (see Section 2.6.2 Regulation 
of providers). The system of accreditation is primarily concerned with aspects 
relating to safety, hygiene, quality and continuity of care. In recent years, 
hospital planning and accreditation is moving away from considering the 
hospital as an overall infrastructure towards defining it in terms of its various 
medical and supportive services.
The concepts “care programme” and “care function” were introduced. A 
programme is a coherent set of care services for a well-defined target patient 
group. The programme is first defined by the case treated and the type of care 
given. Then, norms describing infrastructure, number of personnel, minimum 
activity level and so on are allocated to this programme. A distinction is made 
between basic programmes for regular conditions and specialized programmes 
for rarer conditions, which will not be available in every hospital. A function 
describes a set of hospital services which are not aimed at a specific patient 
group. They are not provided in a defined unit, that is, they are not directly 
linked to hospital beds and all the programmes and services of the hospital can 
use them. The idea is that hospitals would be comprised completely of a series 
of basic programmes and basic functions (which would have to be present in 
every hospital) as well as some specialized functions and programmes. Among 
basic functions, general hospitals must ensure the availability of non-surgical 
procedures for adults (such as cardiology, gastroenterology and endocrinology), 
a maternity unit, an emergency unit as well as a unit for children and elderly 
(Belgian Federal Government 2010). 
At present, there are care programmes for reproductive medicine, cardiac 
pathology, oncology, paediatric and geriatric patients (Royal Decree of 15 
February 1999).
For oncology, the professional title of medical oncologist was introduced, 
making oncology an exclusive discipline. In addition, a care programme for 
breast cancer was developed, as a specialized programme with the intention of 
improving the preventive as well as curative approaches to breast cancer.
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The care programme for children was created with two objectives: reducing 
the number of paediatric services with a low occupancy rate to the benefit of 
paediatric services with a higher occupancy rate, and establishing paediatric 
services that offer the whole range of treatment forms – from consultation to 
day hospitalization to classical hospitalization.
The care programme for geriatric patients was developed from the same logic. 
This programme integrates different treatment modes in the form of different 
modules: polyclinic treatment, day hospitalization, classic hospitalization, 
and internal and external liaisons. The liaison function should guarantee a 
transmural approach in the form of care pathways. Also, geriatric treatment is 
guaranteed for patients who are treated in hospital units other than the geriatric 
service.
According to the Hospital Act, a medical council has to be established in 
every hospital. Through this council, the hospital physicians participate in the 
decision-making process of the hospital. The medical council gives advice to 
the hospital manager on five matters: general regulations, medical activities, 
relations with other hospital staff, financial means and techniques necessary for 
medical activity. For well-defined matters, this advice obliges the manager to 
consult an intermediary in case of disagreement on this opinion and the advice 
of the medical council. The Hospital Act imposes an obligation upon every 
hospital to determine a so-called general regulation on the legal relationship 
between the hospital and its physicians, as well as the organizational, working 
and financial conditions. Under this general regulation, the rights and 
obligations of every hospital physician and the hospital manager, including their 
working conditions, have to be laid down in writing, either in an agreement 
between both parties or in a unilateral act of appointment.
The geographical distribution of hospital care facilities and the total number 
of beds per type of hospital in each province is in line with the distribution of 
the population in Belgium (see Table 5.3). In the province of Luxembourg, with 
the lowest density of habitants, the lowest number of hospitals is found (4) and 
the highest number of hospitals is found in Brussels (28). 
In the provinces near Brussels, such as in the Flemish Brabant and the 
Walloon Brabant, the number of hospitals is lower compared to the other 
provinces, due to the high number of hospitals in Brussels. 
Also, the total number of beds is higher in the Flemish region (40 233) than 
in the Walloon and the Brussels Capital Regions (21 575 and 8594, respectively). 
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Table 5.3
Geographical distribution of hospital care facilities and total number of beds per type 
of hospital per province, 2008
 Acute hospitals
(number of beds)
Specialized hospitals
(number of beds)
Geriatric hospitals
(number of beds)
Psychiatric hospitals
(number of beds)
West Flanders 14 (6 582) 4 (374) 1 (54) 7 (1 856)
East Flanders 14 (6 933) 2 (111) 0 12 (2 489)
Antwerp 18 (8 395) 3 (193) 1 (152) 6 (2 933)
Limburg 8 (3 242) 1 (120) 0 5 (1 254)
Flemish Brabant 6 (3 603) 2 (312) 0 8 (1 630)
Brussels 12 (6 834) 1 (117) 5 (613) 10 (1 030)
Walloon Brabant 2 (878) 2 (314) 0 4 (391)
Hainaut 18 (7 304) 1 (6) 0 7 (1 540)
Liège 11 (4 936) 2 (126) 1 (395) 5 (1 440)
Namur 6 (1 944) 1 (10) 0 3 (776)
Luxembourg 3 (998) 0 0 1 (199)
Source: Raw data from the FPS Health, Food Chain Safety and Environment.
5.4.2 Day care
Day care is defined as a programmed hospitalization of a patient for a surgical 
intervention (surgical day care) or a number of diagnostic or therapeutic tests 
(medical day care), which occur within the traditional hospitalization, but can 
be carried out efficiently and safely in one day (according to the OECD). Day 
care is organized in a specific hospital unit, which is a part of an acute hospital 
with an adapted specialized medico-technical environment.
The agreement between the hospitals, the sickness funds and the NIHDI 
defines a day hospital as “an organized and integrated function of day care 
under the supervision of a medical specialist with fixed procedures concerning 
selection of patients, safety, quality, continuity, reporting and cooperation with 
several medico-technical services” (Roberfroid et al. 2008).
Day care has been introduced for oncology, paediatric and geriatric activities, 
and has increased significantly in the last decade. The proportion of day-care 
admissions increased from 30% in 2000 to 42% in 2007 in acute hospitals.
Day care in long-term care facilities is described in Section 5.8 Long-term 
care for the elderly.
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5.5 Emergency care
Emergency care has been regulated in Belgium since 1964. The Emergency 
Medical Assistance Act aimed to improve medical assistance at public places 
by introducing a uniform telephone number and regulating first aid on the spot 
and transport to hospital.
Emergency care is defined by the Emergency Medical Assistance Act as the 
immediate supply of adapted aid to all persons whose medical condition – as a 
result of an accident, a sudden disorder or a sudden complication of a sickness – 
requires emergency mediation after calling the uniform telephone number as a 
result of which the assistance, the transport and the relief in an adapted hospital 
service can be assured.
Emergency medical assistance is seen as a chain which has several links. 
The first is the bystander who, in a correct manner, must call the emergency 
centre on the uniform telephone number (“100”) and if possible, must be able 
to offer the appropriate first help on the spot. The following links include the 
person in charge at the emergency call centre “100”, the ambulance service, the 
MUG-SMUR and the emergency department in the hospital. 
The organization of the aid centres “100”, including the installation and 
the functioning of the uniform call scheme, falls under the responsibility of 
the Minister of Social Affairs and Public Health. In 2009, there were 17 aid 
centres. The costs are paid by the federal government. The Council Decision 
of 29 July 1991 introduced the single European emergency call number 112 
(91/396/EEC). Since 2002, all fixed and mobile phones are free of charge to 
this number. The latest Eurobarometer report on the use of the 112 number 
mentioned that Belgian (along with Slovakia) had the largest increase in 
respondents who identified the 112 as the emergency number from anywhere 
in the EU (European Commission 2010).
The main tasks of those responsible in the aid centre are: to inform the 
nearest ambulance service or a GP, to decide about the possible mediation of 
a MUG-SMUR and to make sure that the patient is transported to the most 
suitable hospital. Each patient must be transported to the nearest emergency 
care department of an acute care hospital except if the hospital can not provide 
the appropriate care. 
The MUG-SMUR is a part of specialized emergency care and is specialized 
in the treatment of vital emergencies in very specific situations which require 
a high level of competence. For this specific care, a fast intervention vehicle 
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carries the necessary equipment to provide care to the patient on the spot. The 
MUG-SMURs are not in charge of the transport of patients. If the situation is 
serious, the physician goes with the ambulance and looks after the patient until 
they arrive at the hospital. The physician can also recommend the appropriate 
hospital according to the pathology of the patient. To avoid traffic jams and to 
cover more rural areas, the MUG-SMUR disposes of two helicopters, which 
can also be used to transport the patient (Royal Decree of 10 August 1998).
Each mobile urgency and resuscitation service is managed by a hospital or 
an association of hospitals and is linked with the emergency care department 
of an acute care hospital. The MUG-SMUR ensures a 24-hour service. The 
number of MUG-SMURs is based on the number of inhabitants and population 
density. In 2009, there were 79 recognized MUG-SMURs, of which 15 were 
managed by two or more hospitals. The MUG-SMURs are financed by the 
federal government.
Specialized emergency care services are organized in acute hospitals (Royal 
Decree of 27 April 1998). Not every hospital has to have a specialized emergency 
care service, but all hospitals must provide first emergency capabilities where 
the treatment of patients with an acute pathology can be provided (under 
authorization of the Minister of Social Affairs and Public Health, Royal Decree 
of 27 April 1998). Specialized emergency care services are led by a recognized 
specialist in emergency care medicine and a nurse specialized in intensive and 
emergency care (or with at least five years of experience). A 24-hour service 
must be provided by at least one recognized physician in emergency care 
medicine or acute medicine and two nurses. The number of medical staff has 
to be adapted to the intensity of activities of the specialized emergency care. 
To ensure first aid to the patient, the physician must have access to at least 
three beds in intensive care, a polyvalent surgical headquarters, a laboratory for 
clinical biological tests, a medical imaging service (with a mobile radiological 
device and a transversal axial tomography device), a stock of red blood cells or 
supply from a hospital blood bank and access to the archives of medical files 
(with 24-hour accessibility). The emergency physician can also be assisted by 
several specialists (organized within an out-of-hours service). Besides medical 
care, the medical staff are also responsible for registration of the activities and 
continuous training in resuscitation techniques of all personnel in the hospital.
In order to organize the collaboration between all services and to formalize 
protocols for emergency care (also in collective emergency situations), a 
commission with representatives of all emergency caregivers was founded 
in 1998. 
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Since 2006, the federal government has also financed an experimental project 
called Paramedical Intervention Teams (PITs). A PIT is composed of a nurse 
specialized in emergency care and an ambulance driver, and covers emergency 
care needs when the presence of an emergency physician is not required. 
Moreover, they are supported by a physician via a secure radio connection. PITs 
are also attached to a hospital. In 2006, the law also established the conditions 
necessary to set up automated external defibrillators (AED) in public places. 
This measure aimed at improving survival chances for individuals having a 
heart attack (FPS Health, Food Chain Safety and Environment 2006b).
In case of large-scale emergency situations a Medical Intervention Plan 
(MIP) will coordinate the emergency care by setting up a medical post for 
triage of the injured and a Psychosocial Intervention Plan (PSIP) to support the 
victims (FPS Health, Food Chain Safety and Environment 2010b).
Box 5.2 shows an example of a patient pathway in an emergency case.
 Box 5.2
 Example of a patient pathway in an emergency care episode
A man with an emergency care need on a Sunday morning would take the following steps:
• the man (or someone else) calls the GP out-of-hours service; 
• the GP visits the man at home or the man comes to the practice;
•  the GP makes the diagnosis and decides if he can treat the patient or if the patient has  
to go to an emergency care department in a hospital.
Another possibility is that the man goes directly to the emergency department, without 
consulting the GP. If the man is seriously injured, he or a bystander calls the “100” centre 
(or the European number 112), which will send an ambulance to give first aid on location 
and transport the patient to the nearest hospital (with an emergency department).
5.6 Pharmaceutical care
The pharmaceutical industry is one of the leading sectors in the Belgian 
economy. According to the professional organization Pharma.be, approximately 
29 400 people worked in the sector in 2008, of which about 20% are high-skilled 
researchers. More than 150 companies have operations in Belgium, of which 33 
have a production sites in the country. Pharmaceuticals amount to 11% of the 
country’s exports (Pharma.be 2009).
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Pharmaceuticals are exclusively distributed through community pharmacies 
and hospital pharmacies. In 2009, Belgium had 5 229 community pharmacies. 
The establishment of new pharmacies has been strictly regulated since 1973, 
controlling the opening of pharmacies in new areas. In 1994, a five-year 
moratorium imposed a limit on the number of pharmacies. This was prolonged 
in 1999 for ten years and in 2009 for an additional five years. As a result, the 
number of pharmacies has slightly decreased, thus increasing the population-to-
pharmacy ratio from 1900 in 1999 to 2040 in 2009 (Minister of Social Affairs 
and Public Health 2009). The restriction on the number of pharmacies means 
that although in theory graduate pharmacists can go straight into practice after 
their five-year university course, in fact they are usually employed in existing 
practices or have to pay exorbitant prices to buy their own pharmacy.
Only physicians and (to the extent that their profession requires) dentists 
and midwives can prescribe pharmaceuticals. About 2500 pharmaceutical 
products are on a positive list and therefore are partly or fully reimbursable. 
The percentage of the cost borne by the sickness funds varies depending on the 
therapeutic importance of the pharmaceutical (see Section 3.4.1 Cost-sharing). 
The patient only pays the non-reimbursable percentage as a co-insurance to 
the pharmacy. The sickness funds reimburse the reimbursable percentage 
directly to the pharmacies through the third-party payer system. Beneficiaries 
of the system are inhabitants of the country covered by compulsory health 
insurance. Since 2008, the self-employed also receive reimbursement for their 
pharmaceutical consumption (because of the coverage of their minor risks, see 
Section 3.3.1 Coverage). 
Public expenses for pharmaceuticals reimbursement account for a large 
proportion of the compulsory health insurance budget, approximately €3.75 
billion, representing 18.12% of public health care expenditure in 2008 (NIHDI 
2008a; NIHDI 2008d).
More than 72% of expenditure for reimbursed ambulatory pharmaceuticals 
in Belgium is prescribed by GPs (Table 5.4).
To curb pharmaceutical expenditure, several measures have been employed 
of which the most important are mentioned below. Since 2000, the following 
measures were introduced to modernize pharmaceutical policy:
• simplifying the procedures and structures for the approval of new 
pharmaceuticals and using scientific research to review products already 
on the market;
• guaranteeing the supply of pharmaco-therapeutic innovations;
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Table 5.4
Expenditure for each anatomical group (compulsory health insurance reimbursement 
and out-of-pocket payments) prescribed by GPs, specialists, dentists or student 
physicians for ambulatory reimbursed pharmaceuticals, 2008
GPs 
(thousand €)
Others 
(thousand €)
Total 
(thousand €)
GPs 
(%)
Others 
(%)
Total 
(%)
A Alimentary tract and metabolism 219 275.4 59 083.4 278 358.9 78.8 21.2 100.0
B Blood and blood-forming organs 110 640.0 43 144.9 153 784.9 71.9 28.1 100.0
C Cardiovascular system 567 431.6 56 555.2 623 986.8 90.9 9.1 100.0
D Dermatologicals 15 449.7 12 449.7 27 899.4 55.4 44.6 100.0
G Genito-urinary system and sex hormones 22 943.3 13 754.5 36 697.8 62.5 37.5 100.0
H  Systemic hormonal preparations excluding 
sex hormones and insulins 
37 990.1 35 852.6 73 842.8 51.4 48.6 100.0
J Anti-infectives for systemic use 170 797.7 95 032.9 265 830.6 64.3 35.7 100.0
L  Antineoplastic and immunomodulating 
agents 
88 464.5 226 771.2 315 235.6 28.1 71.9 100.0
M Musculo-skeletal system 89 954.9 17 019.7 106 974.6 84.1 15.9 100.0
N Nervous system 325 611.8 115 373.4 440 985.1 73.8 26.2 100.0
P  Antiparasitic products, insecticides and 
repellents 
418.5 402.5 821.0 51.0 49.0 100.0
R Respiratory system 179 011.9 38 635.2 217 647.1 82.2 17.8 100.0
S Sensory organs 6 967.4 23 836.2 30 803.6 22.6 77.4 100.0
V Various 20 948.6 5 726.4 26 675.0 78.5 21.5 100.0
Total 1 855 905.5 743 637.8 2 599 543.3 71.4 28.6 100.0
Source: NIHDI 2010g.
• encouraging pharmaceutical use based on evidence and medical 
guidelines, with attention to the price-quality ratio of the various 
alternatives and the place of pharmaceutical products in the overall 
medical care given;
• setting realistic budgetary targets based on objective policy options and 
with the introduction of recuperation mechanisms when the budget is 
exceeded; and
• ensuring affordability for the patient.
More details on recent measures in the pharmaceutical field are given in 
Section 5.6.3 Pharmaceutical policy.
5.6.1 Regulation of pharmaceuticals
The federal Minister of Social Affairs and Public Health is responsible for the 
market authorization of pharmaceuticals. In order to protect public health, a 
pharmaceutical must satisfy a number of requirements regarding quality, safety 
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and efficacy. To register a product, the pharmaceutical company must submit an 
application at European level or nationally. This official registration is a basic 
condition of introducing a pharmaceutical on the market in Belgium by means 
of a pharmacy or by a physician (for sample pharmaceuticals) (NIHDI 2009b).
Since January 2007, the national registration procedure is the responsibility 
of the Federal Agency for Medicines and Health Products (FAMHP). The 
application for registration must be accompanied by a complete file that 
contains the results of clinical tests from which the quality, safety and efficacy 
of the product is established for specific indications. In his/her decision the 
Minister considers the recommendations of the FAMHP (FAMHP 2010b). For 
certain applications (vaccines, sera, etc.), the Minister seeks advice from the 
Superior Health Council (NIHDI 2009b). According to the European Directive 
2004/27/EC, the recording procedure cannot take more than 210 days (European 
Directive of 6 November 2001).
The determination of the maximum price for a pharmaceutical product is 
the responsibility of the federal Minister of Economic Affairs. For reimbursed 
pharmaceuticals, the Minister considers the recommendations of the Pricing 
Committee for Pharmaceuticals when setting prices or considering price increase 
requests. In the case of non-reimbursable pharmaceuticals, recommendations 
are given by the Price Regulation Commission (FPS Economy 2010; NIHDI 
2009b).
The federal Minister of Social Affairs is responsible for reimbursement 
decisions. Since January 2002, he/she is advised on these matters by the 
CRP-CTG-CRM. The CRP was set up at the NIHDI and is composed of 30 
representatives of the sickness funds, pharmacists, physicians, academics, 
pharmaceutical companies (producers of originators and generics), the 
government and the NIHDI. The latter three stakeholders do not have voting 
rights (NIHDI 2009b). The three most important tasks of the Commission are:
• to formulate proposals to register pharmaceuticals on the list of 
reimbursable pharmaceuticals; these proposals are based on expert reports 
applying methods of HTA;
• to give recommendations on the request of the Minister about policy 
matters concerning the reimbursement of pharmaceuticals;
• to formulate proposals for the Committee for Health Care Insurance 
of the NIHDI or interpret rules concerning the reimbursement of 
pharmaceuticals; and
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• to formulate reimbursement modalities for pharmaceuticals 
described in Article 34 first paragraph °5 d of the law of 14 July 1994 
(i.e. radio-isotope).
5.6.2 Pharmacovigilance
Since 1976, there has been a notification system for adverse events in Belgium. 
These can be reported freely or by health care providers (physicians, pharmacists 
and dentists). FAMHP deals with and analyses adverse events and transmits 
them to the European database, EudraVigilance, of the European Medicines 
Agency (EMEA). The Belgian Centre for Pharmacovigilance (BCGH-CBPH) 
for human drugs, part of the FAMHP is the central point for collecting data on 
adverse drug reactions in Belgium (Test-Achats 2009; FAMHP 2009). 
In 2008, the FAMHP received 4125 notifications, of which 616 were from 
health care providers. All other notifications were provided by the responsible 
firms, the authorities that conduct clinical studies or the consumer organization 
Test-Achats (see Section 2.7.1 Patient information) (FAMHP 2008). For these 
organizations, notification is a legal obligation. 
In 2007, the FAMHP and Test-Achats undertook a collaboration agreement 
for reporting adverse effects by patients. Test-Achats forwards reports of 
adverse reactions related to medicines to the FAMHP with the authorization of 
the person issuing the notification (Test-Achats 2009). In 2008, 175 notifications 
were received through this method (FAMHP 2008).
Also in 2008, the FAMHP launched the “active pharmacovigilance 
programme”, which aimed to increase the number of notifications to FAMHP 
from health care providers and to improve the quality of reporting. One year 
after its launch, the number of reports of adverse reactions received from health 
care providers had almost doubled (Test-Achats 2009; FAMHP 2009).
5.6.3 Pharmaceutical policy
The high public expenditure on pharmaceutical consumption and its rapid 
growth has been a constant concern for health policy-makers. However, this 
financial challenge needs to be balanced with the fundamental task of ensuring 
timely access to the best available pharmaco-therapeutic treatments. A series of 
measures has been taken over the last few years to achieve this. These measures 
have included: a new system for pricing and reimbursement, a claw-back system, 
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a reference pricing system, prescribing and dispensing “low-cost” alternatives, 
tender process, price reductions, regulation of pharmacists’ margins and 
measures directed at hospital pharmacies.
New pricing and reimbursement system
At the beginning of 2002, a new system of pricing and reimbursement 
was introduced with faster and more streamlined procedures. Pricing and 
reimbursement decision time was on average 595 days in 2000, well above the 
180 days stipulated in the European Price Transparency Directive 89/105/ECC. 
Therefore, the government’s first aim was to bring Belgium in line with the 
provisions and obligations of the Transparency Directive.
Henceforth, pricing and reimbursement procedures run in parallel (see 
Table 5.5). The pharmaceutical company submits the pricing file to the FPS of 
Economic Affairs and the reimbursement request file to the CRP. These files 
contain detailed information on the new drug in comparison to pharmaceuticals 
already on the market in terms of: the degree of innovation; cost savings; the 
scientific, social and health economic added value; and arguments in support of 
the requested price. The Minister of Economic Affairs sets the maximum price, 
advised by the Pricing Committee for Pharmaceuticals. The decision is taken 
within 90 days and then transmitted to the CRP (NIHDI 2010c).
At the same time, the reimbursement request file is examined by the CRP, 
which formulates proposals to the Minister of Social Affairs. The reimbursement 
procedure consists of two successive steps. 
First, the CRP examines the new product’s therapeutic added value 
compared with existing pharmaceutical products. This is a binary decision: 
proven therapeutic added value (Class 1) or analogous value (Class 2). Apart 
from these, class 3 regroups “copies” and generics, and specific procedures exist 
for “orphan” drugs and parallel imported drugs. This evaluation (of therapeutic 
value) is executed within 90 days and assesses the following five criteria: 
efficacy, effectiveness, safety (side-effects), convenience of use and applicability.
Second, taking into account the price, the budget impact, the cost-efficiency 
and the therapeutic added value, the CRP has 90 days to issue a proposal on 
whether the new pharmaceutical should be reimbursed, the percentage of the 
cost borne by the public health care payer and possible restrictions/conditions 
to reimbursement. 
Last, the Minister, on the basis of the proposal, takes a definitive decision 
within 30 days (Royal Decree of 21 December 2001). Thus, the total procedure 
for pharmaceutical approval to public reimbursement takes no more than 
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180 days. If the pharmaceutical company does not receive a decision within 
180 days, its application for reimbursement is accepted. However, the positive 
reimbursement decision is applied after its publication in the Belgian Official 
Journal (BS–MB).
Table 5.5
Belgian’s fourth hurdle procedure
Step Actions Timeline
Pre Market authorization is mandatory. Positive advice from the EMEA’s Committee for Medicinal 
Products for Human Use (CMPH) is sufficient to start reimbursement procedures in some cases.
1 Submission of reimbursement request file by the applicant, the pharmaceutical company, to the 
Secretary of the CRP simultaneously with the pricing request file sent to the Ministry of 
Economic Affairs.
Day-0
2 Brief provisional evaluation of product characteristics transferred to the applicant and the 
Ministry of Economic Affairs.
Day-30
3 In-depth evaluation report on therapeutic value is presented, discussed and approved in a plenary 
session of the CRP. Report sent to the applicant who is allowed to reply within 20 days.
Day-60
4 The Minister of Economic Affairs communicates the maximum price allowed. Day-90
5 Draft proposal of the CRP on reimbursement modalities: presentation, discussion and approval  
in a plenary session of the Committee. Proposal sent to the applicant who is allowed to reply  
within 10 days. 
Day-120
6 Final proposal of the CRP on reimbursement modalities: presentation, discussion and approval  
in a plenary session of the Committee. Proposal sent to the Minister and to the applicant.
Day-150
7 Advice from the Budget Minister and from the State Council
8 The Minister takes a decision as to the therapeutic value, the reimbursement modalities, the time 
limits and the elements that should be evaluated for the individual revision. 
Day-180
9 If the reimbursement decision is positive, the pharmaceutical product is added to the list of 
reimbursable pharmaceutical products. The positive decision is publicized in the BS–MB.
10 Application of the decision on the first day of the month following a 10-day period after  
the positive decision is publicized.
Source: Adapted from Van Wilder and Dupont 2009.
Claw-back system
In order to curtail the steep increase of pharmaceutical expenditure 
(see Section 3.1 Health expenditure) and constant budget overruns, the 
pharmaceutical companies were forced to contribute to the financing of 
public pharmaceutical expenditure. In 2001, a closed annual budget for 
pharmaceuticals was established within the compulsory health insurance system. 
If this budget is exceeded, pharmaceutical companies have to reimburse 65% 
(later increased to 72%) of the budgetary deficit with regard to pharmaceutical 
expenditure. Although initially planned for one year, this claw-back system 
has been continued. In 2006, a special provision fund was created, funded by 
the pharmaceutical industry, to pay back 100% in case of overspending but 
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limited to a maximum of €100 million. Since 2008, this special fund has been 
replaced by a new system in which the companies’ contributions are based on 
the reimbursed pharmaceuticals turnover for the year of budget overruns.
Reference pricing system
In order to create headroom for innovation, the use of generic pharmaceuticals 
was advanced by the introduction of a series of measures. Historically, the 
generic pharmaceutical market has been relatively small in Belgium. From the 
perspective of the public health care payer, generic pharmaceuticals in 2002 
represented only 1.14% of the volume and 0.72% of the value of reimbursed 
pharmaceuticals consumed in Belgium. In 2008, these shares amounted to 
24.03% and 10.77% respectively (NIHDI 2008a; NIHDI 2008d). 
First of all, a reference pricing scheme was introduced in June 2001 for 
reimbursed pharmaceuticals with generic equivalents (Article 35 of the 
Coordinated Law of 14 July 1994; see also Section 2.6.2 Regulation of 
providers). A reference pricing scheme is mainly characterized by its scope 
(how are drugs grouped into clusters?) and by the maximum reimbursement 
level, that is, its reference price level (how is it fixed?). The initial cluster 
definition was all drugs with the same active ingredient, same dosage and 
same administration route. Since 2005, drugs are included independently of 
the dosage and administration routes. From April 2010 onwards, the system 
will be enlarged by including a number of variants of the currently included 
active ingredient (e.g. isomers). The Belgian reference price level is calculated 
as a percentage reduction on the original brand drug price. This percentage 
reduction has gradually increased from 16% at the introduction of the system 
in 2001 to 20% in July 2002, 26% in January 2003 and 30% in May 2005. In 
2009 and 2010, additional percentages were added for drugs in the reference 
pricing scheme for over two and four years. 
Prescribing and dispensing of “low-cost alternatives”
From April 2006, physicians are obliged to prescribe a certain percentage of 
“low-cost medicines” depending on the physician’s specialty (Royal Decree of 
17 September 2005). For example, GPs have to prescribe at least 27% of “low-cost 
medicines”, compared to dentists 30%, cardiologists 29%, neurosurgeons 
15%, paediatricians 14% and gynaecologists 9%. Physicians who do not reach 
these minimal targets can lose their supplementary fees within the quality 
accreditation system. Legally, three types of pharmaceuticals are considered to 
belong to the category of “low-cost medicines”. These include:
• original branded pharmaceuticals without patent that have reduced their 
price to the reference price (i.e. price of generic pharmaceuticals);
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• generic pharmaceuticals and copies of original pharmaceuticals;
• pharmaceuticals which are prescribed on the basis of International 
Nonproprietary Name (INN), even if they are not “cheaper”. From 
October 2005, prescription and reimbursement on the basis of the INN 
of the active ingredient was made possible.
Since their establishment, these prescribing quotas have largely been 
attained by physicians. 
Tender process
In June 2006, a pharmaceutical tender process was introduced (the Belgian 
“Kiwi” procedure). In this system the government invites the pharmaceutical 
companies to tender for certain pharmaceuticals. This can lead to differentiated 
repayment according to the propositions received (e.g. the cheapest proposed 
pharmaceutical will receive the most favourable reimbursement). The aim is to 
encourage pharmaceutical companies that put similar pharmaceuticals on the 
market to offer the lowest price for their product. 
In contrast to similar systems abroad, the Belgian model considered only 
off-patent drugs and so far has only been applied to cholesterol-lowering 
pharmaceuticals. Furthermore, it is not the intention to refund only one 
selected pharmaceutical. Based on this procedure, similar pharmaceuticals 
from different companies can be classified either: (a) in a different category of 
reimbursement; or (b) to receive the lowest reimbursement established for that 
category. In this way, pharmaceutical companies proposing a higher price will 
receive a lower reimbursement. 
Price reductions
Additionally, price reductions have been regularly imposed on “old” 
pharmaceuticals (i.e. products reimbursed for over 12 or 15 years). As of 2010, 
pharmaceuticals reimbursed for over 12 years will see their reimbursement 
basis decreased by 15% and drugs reimbursed for over 15 years will see their 
reimbursement basis decreased by an additional 2.35%. These compulsory 
reductions will be applied twice a year (Act of 23 December 2009).
Regulation of pharmacists’ margins
For their role in dispensing and providing advice to patients, pharmacists 
receive a percentage of the public price of pharmaceuticals (i.e. a maximum of 
31% with a limit on the absolute amount of €7.44). As generic pharmaceuticals 
are considerably cheaper than original products, pharmacists received less in 
absolute terms when dispensing a generic pharmaceutical. In 2001, pharmacists’ 
profits on generic pharmaceuticals were set equal to their profits on original 
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pharmaceuticals in absolute terms to neutralize the dispensing of generic 
pharmaceuticals from a financial perspective. Despite this measure, triggered 
price competition led original brand drugs to decrease their prices and, as 
a consequence to further decrease the pharmacists’ margin. To avoid this 
negative impact on pharmacists’ income a new system to establish pharmacists’ 
margins came into force in April 2010 (see Subsection Protection measures in 
Section 6.1.1 Increasing accessibility).
Hospital pharmacy measures
Several measures were taken for pharmaceuticals dispensed in hospitals as 
well. Until 1983, hospital drugs were completely reimbursed on a fee-for-
service basis. For all pharmaceutical specialties, the purchasing price plus 
10% profit margin was charged. There were no financial incentives for the 
optimization and rational use of drugs. Because of increasing expenditures for 
pharmaceuticals, the federal government attempted to control the budget by 
introducing a co-payment per person per day in 1983 (€0.62). This co-payment 
is charged irrespective of actual consumption. The hospital also received a 
reimbursement percentage from the NIHDI. Since that year all pharmaceutical 
specialties have been assigned to a reimbursement category. The reimbursement 
percentage of the compulsory health insurance depends on those categories 
(category A, B, C, Cs, Cx, D). The pharmaceutical specialties of category 
A, B and C are considered as “necessary” drugs. Category D consists of non- 
reimbursable drugs.
Considering the percentages of reimbursement, the lump sum of €0.62 per 
day had to cover €0.37 for each package for medicines in category B, 50% of 
the medicines in category C, 60% of the medicines in category Cs and 80% of 
the medicines in category Cx. Analysis of these data indicate that the lump sum 
did not cover hospital costs for pharmaceuticals.
In an effort to control escalating expenditure on pharmaceuticals for 
hospitalized patients, the first step towards prospective pharmaceutical 
budgeting was made in 1997, when a fixed sum reimbursement was introduced 
for the prophylactic use of antibiotics for surgical interventions, since 
unnecessary long administration or inadequate choice of drugs (too broad 
spectrum) may lead to high costs and microbial resistance.
From 1 July 2006 (two Royal Decrees of 16 May 2006), a prospective budget 
for all pharmaceuticals administered to patients hospitalized in an acute hospital 
was introduced. The purpose of a prospective budget is to optimize the use 
of pharmaceuticals through a permanent and constructive dialogue between 
hospital pharmacists, physicians, nurses, medical directors and administrators. 
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Most pharmaceuticals are integrated in the prospective budget for 75% of 
their value. The remaining 25% of their value is still reimbursed per product, 
thus allowing the tracking of consumption of these products. Each hospital’s 
prospective budget is calculated based on its case mix and the national average 
cost per APR-DRG, taking into account the severity of illness. These average 
costs are established annually, based on the linked MCD and HBD for all 
NIHDI-reimbursed hospital stays of the last available year (generally three 
years earlier).
The prospective pharmaceutical budget is limited to inpatients (patients who 
stay at least one night in hospital). However, it is not applicable to psychiatric 
hospitals or chronic hospitals with isolated rehabilitative or geriatric services, 
nor for ambulatory care. Furthermore, it does not include all pharmaceuticals. 
In general, an active pharmacological compound is not included if it is very 
relevant to medical practice, in terms of its therapeutic and social value as well 
as its innovative character, and if the cost can strongly delay its administration 
to a hospitalized patient through its inclusion in the prospective budget. Other 
specific products are excluded by law from the prospective budget (e.g. orphan 
drugs, cytostatics, immunoglobulins and albumins, retroviral drugs, radio-
isotopes, etc.). The list of excluded pharmaceuticals is updated monthly and 
these products remain reimbursed entirely per product. At a later date, this 
system can be extended to day care in acute hospitals and to hospitalized 
patients in psychiatric, geriatric and specialized hospitals.
Next to the measures described above, more rational use and prescribing 
were encouraged via campaigns and periodical feedback to prescribers (see 
also Section 2.6.2 Regulation of providers).
As a result of all these measures the compound annual growth rate on 
pharmaceutical expenses was 4.7% between 2004 and 2009 (NIHDI 2008d).
5.7 Rehabilitation care
Rehabilitation concerns supplying medical care after the acute phase of a 
disorder or an accident with the aim of repairing, improving or maintaining 
the functional situation of the patient as much as possible. The NIHDI has the 
following definition: rehabilitation encompasses coordinated multidisciplinary 
activities aimed at enhancing the activities and participation of persons with 
function restrictions, taking into account relevant external and personal factors.
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Rehabilitation is supplied in hospitals (department of physical medicine and 
rehabilitation for less complex rehabilitation, with no or reduced remaining 
residual injury) and in specific institutions for rehabilitation (type 2 centres for 
more complex impairments with a impact on activities and participation and 
type 3 centres for more complex impairments in need of specialized knowledge 
[Categorial centres]), and is organized on the basis of an agreement between 
the concerned institution and the NIHDI. These agreements are concluded 
individually with each institution and are related to a well-defined, therapeutic 
project. 
Such agreements define the target group (i.e. a description of the indications 
that the claimant must suffer to be allowed into rehabilitation), the required 
framework (i.e. the composition of the team of care providers) and the contents 
of the packages of care. In general, it concerns “type” agreements, where the 
target group, framework, package of care and insurance allowance are identical 
for all institutions which sign the agreement. Generally, the insurance allowance 
is paid per day, per month or per year. 
Rehabilitation is characterized by its multidisciplinary character. The patient 
is looked after by care providers of several disciplines, who hold meetings at 
regulated times concerning the impact of the therapy and the results of the 
treatment (NIHDI 2010q).
In 2009, the NIHDI had agreements with 856 institutions, concerning 
endocrine and metabolic diseases, blood and immunity disorders, disorders 
of the urogenital system, respiratory and heart disorders, (neuro)locomotorial 
disorders and disabilities, mental and neurological impairments, chronic 
pain and chronic fatigue, sensorial impairments and others (e.g. undesirable 
pregnancy) (NIHDI 2010o).
Reference centres are specialized in the treatment of specific diseases, that 
is, AIDS, cystic fibrosis, rare monogenetic hereditary metabolic illnesses, 
neuromuscular disorders, refractor epilepsy, chronic breathing disorders, 
chronic fatigue syndrome, chronic pain, autism, brain paralysis or cerebral 
palsy and spina bifida.
Not all of the hospital departments of physical medicine and rehabilitation 
have an agreement with the NIHDI. In some hospitals (without such agreements), 
the department of physical medicine and rehabilitation is financed by the 
“nomenclature of medical acts”. In other hospitals, the department of physical 
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medicine and rehabilitation is financed in part by the “nomenclature of medical 
acts” and in part by the insurance allowance fixed by an agreement with the 
NIHDI.
5.8 Long-term care for the elderly
The Belgian elderly care infrastructure comprises home care and community 
services, short-term and long-term residential care and hospital care. Long-term 
residential care includes service-flats, homes for the elderly5 and nursing 
homes.6 A recent study showed that in Belgium, elderly individuals preferred 
to be cared for at home with the help of family and friends, as well as with the 
help of health care professionals. As stated by Willemé, “to achieve the goal of 
delaying or avoiding the move of care-dependent elderly people to [permanent] 
residential care [in homes for the elderly or nursing homes] a major policy goal 
is to diversify the provision of services”. This has led to the development of a 
wide range of home assistance and personal care services as well as short-term 
or temporary care facilities (Willemé 2010). 
Often, entry into a residential institution is related to a serious health episode 
or to the inability of informal caregivers to continue to provide care. Indeed, 
in these cases, the combination of formal and informal help at home is not 
enough to cover the elderly person’s needs. As a consequence, residential 
care facilities are reserved for more severely dependent individuals (Willemé 
2010). Currently, in terms of public policy, the last agreement between the 
different authorities in long-term elderly care (Protocol 3 – for more details 
see Subsection Long-term residential care in Section 4.1.1 Infrastructure) has 
clearly stated that integration and coordination between the different types of 
care (home care, hospital care, residential care, etc.) needs to be considered. 
As a consequence, concrete measures, such as the reclassification of beds 
according to patients’ health status, have been put into place.
An overview of the number of users of long-term care in Belgium is given 
in Table 5.6, and the number of beds recognized by the NIHDI is provided in 
Table 5.7.
5 Woonzorgcentra, previously called Rusthuis in Dutch, Maison de repos pour personnes âgées (MRPA) in French, 
and Altenwohnheime in German.
6 Rust-en verzorgingstehuis (RVT) in Dutch, Maison de repos et de soins (MRS) in French, and Pflegewohnheime 
in German.
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5.8.1 Home care
Coordination of home care services
Service tasks include, for example, cleaning and laundry services, help with 
shopping, post office and bank services, and preparation of meals. Personal 
care can include assistance with meals, getting dressed, personal hygiene and 
mobility. For those in need, subsidized security alarms are available. These 
are linked to family members, GPs, or to the nearest special housing or call 
centre, where a nurse responds and attends to alarms (Peetermans, Hedebouw 
and Misplon 2004).
Until 2002, coordination of home care services was done at the level of 
federated authorities. However, in 2002, the federal government introduced the 
ISHC-GDT-SISD at the local level. The ISHCs have to coordinate all disciplines 
involved in home care in a defined geographical area (maximum 1 per 70 000 
inhabitants per community). Financing of the ISHCs is provided by the NIHDI 
and accounts for €0.19 per inhabitant in 2010. Each ISHC is composed of 
representatives of several health professions, with at least one representative of 
GPs and nurses involved in home care. The main task of each ISHC is to oversee 
the practical organization and to support care providers and their activities 
within the framework of home care. In particular, this includes the evaluation 
of the patient’s ability to perform ADL/IADL (Instrumental Activities of Daily 
Living), the development and monitoring of a health and welfare plan, the 
assignment of tasks between care providers and multidisciplinary consultation 
to achieve objectives (NIHDI 2009g). 
To stimulate multidisciplinary cooperation instead of competition, 
each geographical area can only have one ISHC, with the exception of the 
Brussels region, where both the Flemish and the French communities can 
accredit ISHCs. In addition to this, ISHCs must work in accordance with the 
coordination structures already existing before 2002 at a regional level (De 
Lepeleire et al. 2004). Coordination between the federal ISCH and regional 
coordination structures in the three regions has followed different pathways 
given the specificities of the regional coordination services. The description of 
coordination services at a regional level is provided hereafter. 
In Flanders, the coordination of home services is currently in transition. 
Between 1995 and 2009, home care was coordinated in Flanders by the 
Cooperation Initiatives in Home Care (SIT-HISC). To simplify the organization 
of the SIT-HISC, the Cooperation Initiatives in front-line health care (SELs) 
were founded. These SELs coincide with the GDTs (i.e. ISHCs). The cooperation 
initiatives between the different representatives of health care in a specific 
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region are aimed to optimize front-line health care by organizing activities. A 
SEL covers the area of a regional city (Van Audenhove et al. 2009). SELs are 
active at the micro level (the organization of care around a dependent person) 
and the meso level (cooperation between different health care providers, 
ensuring continuity of care, for example transmural reach agreements, etc.)
In Wallonia, home care is coordinated by 49 centres (Centres de Coordination 
de Soins et de Services à Domicile, (CSSDs)) distributed in 13 ISHC zones 
(Wallonia Public Services 2009). Their main task is to guarantee the quality of 
care and cooperation between workers involved in home care, including GPs, 
home nurses, accredited services for family aid, aid for the elderly and social 
work, and so on. The support and coordination of care are (in the first instance) 
aimed at people who are in serious need of care in order to enable them to 
remain at home as long as possible. 
Home coordination in the care in Brussels region is very complex since 
federal and community rules are applicable. Dutch-speaking coordination 
centres are assembled in BOTs (Brussels Thuis Overleg). For the French-
speaking, since 2007, five CSSDs have been part of a single federation 
(Fédération bruxelloise des centres de coordination de soins et de services à 
domicile). These five centres are financed by the COCOF and share the same 
objectives. Their aims are to evaluate patients’ and their families’ needs and 
resources and put into place the services needed, as well as to follow up on the 
individuals’ situation. The centres also aim to prevent burn-out of informal 
caregivers. 
Financing and services provided for home care 
Access to home care services is usually initiated through a contact between 
the patient (or their family) and a health care provider (GP or nurse) or a 
social worker (Willemé 2010). Although there is not an official assessment 
of the patient’s reported needs, the NIHDI can choose to evaluate the level of 
dependency and the services provided can be reassessed. The NIHDI finances 
medical acts, such as nursing care and physiotherapy according to several 
criteria, including the patient’s dependency level as well as its resources. The 
communities and the regions finance other services, such as family aid and 
delivery of meals, and so on. As for medical acts, the reimbursement level 
depends on the person’s dependency level as well as on their resources.
Nurses providing care at home in Belgium are organized in two ways: 
via employee-nurses and via self-employed nurses (see Subsection Nurses in 
Section 3.6.2 Paying health care professionals). Employee-nurses in home care 
are employed by private non-profit-making organizations with a specific focus 
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on home nursing. A small proportion of employee-nurses are employed by the 
local public centres for social welfare and by self-employed nurses. In the last 
10–15 years, the option of being self-employed has become more attractive, both 
financially and organizationally. As a result, the proportion of the expenditures 
for home nursing spent on employee-nurses has decreased from approximately 
60% in the 1990s to approximately 40% of all NIHDI expenditures on home 
nursing in 2005 (Sermeus et al. 2010).
Remuneration of nursing acts for individuals living in the community 
include the following (adapted from Sermeus et al. 2010). 
1. A fee-for-service payment system covering technical nursing 
interventions: a doctor’s prescription is required for reimbursement of all 
nursing interventions (except for hygienic nursing care).
2. A lump sum payment covering nursing interventions for patients suffering 
from dependency/deficiencies in ADL: a patient’s dependency is assessed 
by scores on the BESADL derived from the Katz scale. A doctor’s 
prescription is not required for nursing care delivery under the lump sum 
system (except for technical acts that require a doctor’s prescription under 
the fee-for-service payment system). 
3. A subsidy for the costs related to the computerization of home nurses.
4. Since 2002, specific costs for home nursing organizations have been 
financed (Royal Decree of 16 April 2002, modified by the Royal Decree 
of 7 June 2004). Specific costs were defined as costs for organization, 
coordination, programming, continuity, quality and evaluation. The 
objective of this subsidy was to promote collaboration of home nurses.
5. Reduced social tax contributions to create additional employment of 
employee-nurses.
6. Special agreements: for example, a specific arrangement covers nursing 
assistance in haemodialysis and peritoneal dialysis at the patient’s home.
7. Social agreements: for example, the agreement to harmonize the salary 
scale between home and hospital nurses.
If the patient’s treatment is related to an acute health care condition or 
long-term illness, a physiotherapist’s visits are reimbursed by the NIHDI. 
A logopaedist’s visits can also be reimbursed by the NIHDI. However, in 
both cases the medical examiner of the NIHDI must have provided prior 
authorization for reimbursement. Other care and services provided by nurse 
Health systems in transition  Belgium 183
aids and family aids are partially financed by the communities and the regions. 
The patient’s payment is established according to income scales set by the 
authority in charge. 
In December 2009, a new protocol agreement between the federal 
government, the communities and regions has more clearly defined the role 
played by family aids, nurse aids and other health care professionals (in 
particular nurses) in the care of dependent individuals at home. Several other 
services (e.g. meal delivery, transport services, etc.) can also be provided by 
the CSSD and individual’s payment is usually set according to income scales. 
Day-care centres, community-care centres and night centres
Day-care centres (Centra voor dagverzorging – Centres de soins de jours) 
provide day nursing care to elderly people without overnight facilities. This 
is a valuable option for elderly individuals who do not need intensive medical 
interventions and do not wish to move to a residential setting permanently, 
but who need care or supervision and aid in ADL. Transportation to and from 
the day-care centre is arranged (Arnaert, van den Heuvel and Windey 2005). 
A day-care centre is allied with a residential home. The number of day-care 
stays (places) is programmed at the federal level. Currently, the number of 
a minimum stays is equal to 3 per 1000 elderly aged 75 years and older and 
restricted to a maximum of 3.9 per 1000 elderly aged 75 years and older. 
To be admitted in a day-care centre a resident must be strongly physically or 
mentally dependent on the aid of others in their daily operations. Dependency is 
scored on the basis of the Katz scale. A fixed daily compensation is reimbursed 
by the compulsory health insurance.
Community care centres (Dagverzorgingscentra – Centre d’accueil de 
jour) can provide more accessible professional health care to dependent 
elderly individuals (Arnaert, van den Heuvel and Windey 2005). Individuals 
admitted in these facilities are less dependent than those in day-care centres. 
The communities establish the number of places in community care centres as 
follows: (a) two stays per 1000 individuals aged 60 years or older in the French 
community; (b) one stay per 3000 elderly aged 65–69, five stays per 3000 elderly 
aged 70–89, and 25 stays per 3000 elderly aged more than 90 years in the 
Flemish community; (c) 1.5 stays per 1000 individuals aged 60 years or older 
in the German community. Community centres are also evolving into day-care 
centres in order to provide the care needed for individuals with increasing 
demand for care.
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Night centres offer overnight accommodation only, but without nursing care. 
Night care can be provided in centres of convalescence (after surgery for serious 
diseases) and in short-stay units for a shorter period. These units are dedicated 
to elderly patients who suffer a sudden health crisis or who need care while 
family caregivers are away. These centres take care of the elderly during a 
restricted period of day and night or only during the night (for a maximum of 
60 consecutive days). 
5.8.2 Residential care
Long-term residential care
Long-term residential care comprises “service-flats”, homes for the elderly and 
nursing homes (Charlot et al. 2010). In these types of residential care, the usual 
family and household care is given partly or completely (Article 2, paragraph 
6 of the Decree of the Flemish Government of 18 December 1991; Article 2 of 
the Decree of the French Region of 5 June 1997; Article 1 of the Decree of the 
German community of 4 June 2007). Residential care is available to elderly 
people, who are defined by the legislator as individuals aged 60 years and older. 
The following sections differentiate between the three types of residential care. 
The preference of the elderly to live in housing where they can continue to 
live independently is supported by service-flats and service-housing complexes, 
that is, two sorts of housing care facilities for the elderly. In “service-flats”, 
elderly individuals without major health conditions live in independent units 
but are offered a broad range of services (meals, house-cleaning, primary care 
at home, etc.). Use of services is not required but is available on demand. The 
service-flat programme aims to have two apartment units per 100 people 
aged 60 years and older. Currently, service-flats are increasing in the Belgian 
landscape. Moreover in Flanders, with increasing dependency of individuals, 
service-flats become “care-flats”, combining the housing qualities of a service-
flat with the care qualities of residential care. The individual house units are 
adapted to the needs of the elderly and a house assistant is present to stimulate 
the social network and aid in emergency situations (Arnaert, van den Heuvel 
and Windey 2005; Vlaams Agentschap Zorg en Gezondheid 2009a).
Homes for the elderly and nursing homes are defined as one or more buildings 
that functionally generate a collective residence in which elderly people live 
on a long-term basis. Services such as meals are also collectively provided. 
Both alternatives offer a home replacement environment when possibilities for 
long-term care at home or short-term residential care are no longer sufficient for 
individuals having different levels of disabilities (Vander Stichele et al. 2007). 
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Indeed, nursing homes (or nursing beds) are designed for people with long-term 
care needs, who have serious disabilities in ADL. Eligibility for admission to a 
bed in nursing home or in a home for the elderly rests on the following criteria 
(Declercq and Van Audenhove 2004):
1. The elderly person has undergone all active and reactivating treatment 
but has not regained full competency in ADL. However, daily medical 
supervision or specialized medical treatment is not necessary.
2. All possibilities for at-home care have been explored so that admission 
to residential care is needed.
3. The general health status of the elderly person demands, apart from 
medical care provided by a GP and nursing care, paramedical and/or 
physiotherapeutic care and help with ADL.
4. The elderly person is dependent for bathing, dressing, mobility, toilet and 
continence or eating (Article 158, Royal Decree of 3 July 1996, on the law 
of the compulsory health insurance). 
Usually the institution’s characteristics determine the extent to which 
additional requirements for admission are established. For instance, a couple 
might be admitted to a residential institution, even if only one of the partners 
is dependent (Charlot et al. 2010). Younger individuals might be admitted into 
residential homes only when approved by the responsible authority (Declercq 
and Van Audenhove 2004). These specific cases correspond most often to 
younger individuals who have another long-term illness or disability (not 
age-related).
Each home for the elderly and nursing home must have a coordinating and 
advisory physician who is always a GP. This advisory physician is responsible 
for the coordination of pharmaceutical care, wound care and physiotherapy. 
Each home for the elderly and nursing home must always have a functional 
link with a hospital. They must cooperate with the geriatric service of the 
hospital and a specialized service for palliative care. The degree of a resident’s 
dependency is assessed by the formal caregiver using a standardized instrument 
(Katz scale). The subjects are classified in five iso-resource groups (O, A, B, C, 
Cd). The flat-rate allowance for each group is paid directly to the institutional 
managers. The amounts received are used to pay the formal skilled caregivers 
(number fixed by legal standards) (NIHDI 2010p).
Many residential institutions can be considered as both homes for the elderly 
and nursing homes. Indeed, in March 2010, out of the 1599 residential institutions 
in Belgium (excluding service-flats), 1130 institutions received financing for 
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beds for elderly individuals with different levels of dependency. This system 
merger responds to the changing needs of elderly individuals and has led to 
reclassifying “beds in homes for the elderly” to “beds in nursing homes”.7 This 
reclassification aims at improving the financing of beds in residential care in 
order to guarantee the quality and continuity of care, which means that elderly 
people can receive different levels of care without leaving an institution. In 
order to receive both types of financing, residential institutions must receive 
accreditation and comply with quality standards (Charlot et al. 2010). Thus, it 
is easier to focus the discussion on “beds” rather than “institutions”. 
The distribution of responsibilities between the different authorities is 
complex. However, since 1997 three protocol agreements (1997, 2003 and 2005) 
between the federal government and the communities have formulated common 
objectives for elderly care. These agreements allow each authority to flesh out 
the common objectives autonomously according to local demographic needs 
(Vander Stichele et al. 2007).
These three agreements aimed to progressively shift the number of beds 
in homes for the elderly towards nursing home beds. For Belgium, the actual 
number of available beds amounted to 129 167 units on March 2010, shared 
between 66 180 beds in homes for the elderly and 62 987 beds in nursing homes 
(NIHDI 2010j).
Short-term residential care
Short-stay centres (centrum voor kortverblijf – centres de court séjour) 
provide an alternative to long-term residential care for elderly individuals with 
increasing disability. Short-stay centres must be associated with long-term 
residential care centres. Usually, short-term centres provide care up to 60 days 
consecutively and for a maximum of 90 days per year. 
5.8.3 Hospital care
In acute hospitals, the geriatric ward was distinguished as a separate entity in 
1984, and in 1986 geriatric medicine was recognized as a new medical specialty. 
These steps recognized the need for comprehensive geriatric assessment, 
evaluation and management of frail older patients to reduce morbidity and 
mortality, prevent hospital admission, and delay or postpone institutionalization 
(Arnaert, van den Heuvel and Windey 2005).
7 Protocol no. 3 of 13 June 2005 between the federal government and the federated authorities, Articles 128, 130, 165 
and 138 of the constitution on health care policies for elderly individuals.
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In acute hospitals, a specific care programme for geriatric patients was 
developed (Royal Decree of 29 January 2007). The aims were to optimize 
functional performance and to increase the independence and quality of life of 
elderly patients by providing a specialized, multidisciplinary and intensive care.
The multidisciplinary approach, involving both physical and psychosocial 
aspects, is aimed at shortening hospital stays. In 2008, the Flemish community 
had 4093 geriatric beds, while the French community had 2753 beds in 46 
facilities (63.42% in the Walloon provinces and 36.58% in Brussels in 23 
facilities). 
Elderly patients with cognitive impairments can be treated in psycho-
geriatric departments (dienst SP-psychogeriatrie). In 2008, there were 192 
psycho-geriatric beds in the Flemish community and 196 in the French 
community (Van Audenhove et al. 2009).
As a component of the geriatric care programme, geriatric day hospitals 
were founded. In this setting, an efficient and multidisciplinary screening 
and evaluation of elderly individuals can be performed on an ambulatory 
basis. Besides the diagnostic evaluation, therapy and rehabilitation are also 
provided. In 2008, there were 76 geriatric day hospitals in Belgium. In this 
year, the Ministry of Public Health financed 84 projects concerning geriatric 
day hospitals, of which 52 were in the Flemish community, 24 in the French 
community and 8 in Brussels. 
Finally, specialized centres for dementia were founded to provide information 
and care services to patients (and their families) and caregivers involved with 
dementia. In 2008 in the Flemish community, there were 10 regional centres 
with specific expertise in dementia, supervised by one coordinating centre 
(Expertisecentrum Dementie Vlaanderen). These centres cooperate with 
the Flemish Alzheimer’s League (Vlaamse Alzheimer Liga). In the French 
community, a similar project does not yet exist (Van Audenhove et al. 2009).
5.9 Services for informal carers
There is no national strategy for the protection of informal caregivers in 
Belgium. However, an increasing number of services, including respite care, 
are available at a local level. More recently, planning of new alternatives for 
home care at a national level aim to take into account caregivers’ needs in terms 
of respite care, psychological support and training (BS–MB 2009b).
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According to Belgium’s Civil Code, individuals are legally obliged to 
guarantee minimum living standards to close family members. Parents and 
their children are obliged to mutually support one another and this obligation 
extends down to grandchildren. This legal obligation also extends to the family-
in-law (parents-in-law and sons and daughters-in-law), except in the case of a 
divorce or after the death of the partner when there are no children (Code civil 
du 21 mars 1804). However, there is no exact definition of the extent of these 
obligations. For instance, children are legally obliged to cover part of the cost 
for stays in a nursing home when their elderly parents do not have enough 
financial resources. 
In order to appraise individuals’ involvement in the provision of informal care, 
specific questions on care activities were included in the 2001 Socioeconomic 
Survey of Belgium. The survey covered all residents living in the country for 
that year. Questions were focused on the caregiver. Information on the person 
receiving care is limited to whether the person is a family member (sharing or 
not sharing the same household), friend or neighbour (FPS Economy 2003).
In 2001, 9.3% of residents in Belgium aged 15 years or older provided 
informal care. Among the 719 686 individuals looking after an ill person, 
almost 60% were women. Among caregivers, 51% did not provide care on 
a daily basis and 49% looked after a sick family member or friend every day 
(30% spent less than 2 hours and 19% spent more than 2 hours per day) (Farfan-
Portet et al. 2007).
Training and information for caregivers is mostly provided by non-profit-
making organizations (addressed to specific populations) and no specific 
policies are coordinated at a central level. In the same way, there is no 
centralized policy to provide respite services for caregivers. Nevertheless, 
several short-term respite care services are available. Due to the Belgian 
federalized structure, services are available at different levels in each of the 
country’s regions. Moreover, services at a local level (communes) are also 
provided. Most services tackle specific groups, such as caregivers of dementia 
patients or parents of disabled children. Short-term respite care includes care 
at home, day-care centres and short-term residential care facilities. Financial 
participation of families varies from one institution to another, and in some 
cases, sickness funds reimburse a part of the total expenses. Information on 
services is increasingly available through the Internet.8
8 See: www.aidant-proche.be and http://www.onszorgnetwerk.be
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Income replacement directly related to the provision of informal care is 
not currently available in Belgium. However, individuals participating in the 
labour market are entitled to two types of paid leave to care for an ill person. 
Leave to care for a person in end of life is available to all individuals working 
full-time or part-time. Labour force participants are entitled to a full month of 
leave, renewable once (BS–MB 1995).
The second type of leave can be used to care for a household or family 
member with a serious illness (Congé pour maladie grave d’un membre du 
ménage ou de la famille). The leave can be taken for up to 12 months. However, 
it is restricted to a minimum of one month and a maximum of three consecutive 
months at any one time. For both types of leave, the worker can choose a 
part-time leave (for instance, one day per week for five months) and could 
receive up to €726.85 in 2009 (for a month of full-time leave) (BS–MB 1998).
Two more allowances can be used indirectly to pay for the services of 
informal caregivers. The Flemish community introduced the dependence 
allowance (Vlaamse Zorgverzekering) in 2001. A monthly sum (€130 per month 
in 2009) is granted to dependent individuals living in the community who 
receive informal or formal care. This sum can be used to cover the caregivers’ 
expenses such as travel costs (BS–MB 2001b).
People with disability, living in the community, can also receive the “Personal 
Assistance Budget (PAB)” (Persoonlijke-assistentiebudget, budget d’assistance 
personnel). The PAB was introduced first in Flanders and more recently in 
Wallonia; it consists of a fixed amount that is granted to a disabled person to 
employ a “home-helper”. The PAB cannot be used to pay for services from an 
informal caregiver except if a legal work contract is established between the 
disabled person and the carer. The annual amount of the PAB depends on the 
person’s disabilities and the help used. For 2009, the PAB in Wallonia varied 
from €5000 to €35 000 and in Flanders from €8845.4 and €41 278.30 (BS–MB 
2001a; BS–MB 2009a).
Other allowances relating to disability are also available, but they are 
set up as payments for the disability. The income replacement allocation is 
attributed to a person aged 21–65 who is not able to fully participate in the 
labour market. In 2009, this allocation varied between €5809.20 to €11 618.40 
per year. In addition to this, individuals who incur additional costs relating to 
their disability can receive the integration allocation. This allocation varies 
from €1061.30 to €9550.30 per year according to the level of disability and 
income. For individuals aged 65 years or more, the allocation for the elderly 
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is attributed to individuals who suffer from disability or age-related illness 
leading to loss of autonomy. The amount of the allocation varies from €907 to 
€6087 per year (FPS Social Security 2009g).
5.10 Palliative care
The 2002 WHO definition states that “palliative care is an approach that 
improves the quality of life of patients and their families facing the problems 
associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual” 
(WHO 2007). In Belgium, the gradual development of palliative care started 
in 1985. 
A 2009 report from the KCE proposed that patients should be defined as 
“palliative patients” when they are in “an advanced or terminal stage of severe, 
progressive and life-threatening disease whatever their life expectancy” (Keirse 
et al. 2009). The report estimated that the palliative patient population would 
range between 10 000 and 20 000 patients, that is, between 8000 and 13 000 
palliative patients in the first front line of care, 5500 patients in residential 
facilities and 3000 patients in hospitals (Keirse et al. 2009). 
5.10.1 Structures for palliative care
Three palliative associations have been created in Belgium: Federatie 
Palliatieve Zorg Vlaanderen in the Flemish region, Fédération bruxelloise 
pluraliste des soins palliatifs et continus in the Brussels-Capital region and 
Fédération wallonne des soins palliatifs in the Walloon region. A palliative 
association is a structure that fosters the cooperation between representatives of 
front-line social and medical workers, organizations, institutions, associations 
and services for palliative care. Their mission is to promote communication 
between members, to organize education sessions, to stimulate the development 
of knowledge and research and to be representatives for the authorities. 
Networks of palliative care (samenwerkingsverbanden in palliatieve zorg – 
associations en matière de soins palliatifs) are also present in Belgium: 15 in the 
Flemish provinces, 8 in Walloon provinces, 1 in Brussels and 1 in the German-
speaking community. These networks are responsible for the promotion 
of palliative care through raising awareness in the population, coordinating 
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local care, educating caregivers and volunteers, and evaluating the needs for 
palliative care. Each network is supported by a multidisciplinary counselling 
team. This team counsels the home caregivers.
5.10.2 Services for the patients
Palliative care exists in several settings (FPS Health, Food Chain Safety and 
Environment 2008b; Vlaams Agentschap Zorg en Gezondheid 2009b):
• palliative care at home
• palliative day-care centres
• palliative function in homes for the elderly and nursing homes and 
in hospitals
• palliative care units in hospitals.
Palliative care at home
Home care of the patient is performed by a team of health professionals (GPs, 
nurses, physiotherapists, psychologists), informal carers and volunteers. An 
external multidisciplinary counselling team, specialized in palliative care 
and linked to the palliative networks, can provide counselling by organizing 
consultations with caregivers, coordinating palliative care, and supporting 
caregivers psychologically and morally. Besides the support of the primary 
caregivers, this team will also be responsible for registration of the patients’ 
data and for day-and-night accessibility (by phone) for the caregivers. 
A patient who stays at home and has a life expectancy of less than three 
months can benefit from a “palliative statute”. This statute involves, for example, 
a lump sum and the abolition of the patients’ co-payments for nursing, GP 
visits and visits of the physiotherapist. In 2007, 13 097 patients benefited from 
a palliative lump sum.
The Belgian law also fosters home care with possible career break (part-time 
or full-time, with a maximum of two months) for informal caregivers to give 
support to their next of kin.
Palliative day-care centres
In 2002, a project for day centres for palliative care started. These day centres 
are complementary to home care, offering an adapted and specialized care 
programme, and organizing social activities to increase the social network of 
the palliative patient. After evaluation of the day centres, the financial grants 
were reorganized. 
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Palliative care in homes for the elderly and nursing homes
Homes for the elderly and nursing homes have a “palliative function” whose 
aim is to heighten the caregivers’ awareness and provide them with education 
on palliative care. 
Palliative care in hospitals
In the same way, each hospital has to provide a “palliative function” to ensure 
the quality of care. This function is similar to the one existing in homes for the 
elderly and nursing homes. The multidisciplinary team of the palliative function 
can be assisted by a palliative support team (the mobile team) as a second line 
of support. The palliative function is bound to a palliative care unit in a hospital 
and is a member of a palliative network. 
In some hospitals, palliative care units have 6 to 12 beds and multidisciplinary 
teams take care of the symptoms, psychological and mourning support. In 
Belgium, 379 beds are certified, spread over 5 hospitals in Brussels, 29 hospitals 
in Flanders and 17 hospitals in the Walloon region (NIHDI 2009e).
A recent study of the Vrije Universiteit Brussel described the consumption 
of specialized palliative care. Almost half of the palliative patients (41%) make 
use of the specialized care. The most common reason for palliative care is 
cancer (60% versus 27% other disorders). The results indicate the lack of 
implementation of palliative care for elderly and non-cancer patients (Van den 
Block, van Casteren and Deliens 2008). This conclusion is in accordance with 
the recent findings of the KCE report that advocates for the better identification 
of palliative patients with chronic non-cancer disease (e.g. dementia, chronic 
pulmonary or cardiac disease) (Keirse et al. 2009).
5.11 Mental health care 
The mental health care sector consists of specialized care where psychiatrists 
and psychologists work together with other care providers, such as nurses and 
social workers, to assist people with mental health problems.
5.11.1 Provisions
Mental health care is provided in different structures, which can be broadly 
classified as:
• centres for mental health care
• psychiatric departments in general hospitals
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• psychiatric nursing homes
• initiatives for sheltered accommodation
• psychiatric hospitals.
In addition to these structures, the mental health care sector also comprises 
rehabilitation centres, psychiatric home care, psychiatric annexes in prisons, 
and the private practices of (neuro)psychiatrists and of psychotherapists. 
Rehabilitation centres can be divided into centres that focus on addiction 
problems (medical-social reception centres, day centres, crisis intervention 
centres and therapeutic communities) and centres for psychosocial rehabilitation 
of children and adults.
Patients with a mental health problem can be referred to a mental health 
care centre by their GP or by a centre for student counselling (CLB). Centres 
for mental health care should preferably see patients with a serious problem 
or at risk of developing a serious problem. These centres provide ambulatory 
second-line provision of care; patients can go for a consultation or receive a 
home visit by someone from the centre. Patients carry on living and working 
in their own environment. 
Care is offered by a multidisciplinary team able to address the medical, 
psychiatric, psychological and social aspects of the health problem. The remit 
of mental health care centres is two-fold. On the one hand, their assignment is a 
curative task and, on the other, they also have a preventive task for detecting or 
preventing problems at an early stage to ensure prompt and appropriate support. 
Many centres also provide specific programmes for children and adolescents. 
The main problems dealt with in the centres are anxiety, mood disturbances 
and addictions. 
Mental health care centres are the responsibility of the communities and are 
financed by taxes. The personnel of the centres are almost entirely remunerated 
by the regions; additional activities are reimbursed under the federal health 
insurance system (NIHDI). There are 20 recognized centres for mental health 
care in the Flemish community and 61 centres in the French community (in 
2009) (Vlaams Agentschap Zorg en Gezondheid 2010b; IWSM 2009). 
Psychiatric departments in acute hospitals (PAAZ) provide short-term 
treatment for patients with mental health problems. Psychiatric services of 
general hospitals reserve 10% of their places for part-time hospitalization (day 
hospitalization and night hospitalization).
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Psychiatric nursing homes provide care for patients with a stable condition 
needing permanent care for a long-term mental health problem who do not 
require hospital treatment under surveillance of a specialist in (neuro)psychiatry.
Because of the low number of beds in psychiatric hospitals (0.6 beds per 
1000 inhabitants), patients can stay in psychiatric nursing homes instead. 
These nursing homes are outside the hospital campus and preferably located 
in the local community. There are 42 psychiatric nursing homes: 5 facilities 
(252 beds) in Brussels, 24 facilities (2230 beds) in the Flemish community and 
13 facilities (801 beds) in the French community (NIHDI 2010n). In 2008, there 
were 68 psychiatric hospitals (38 in the Flemish region, 10 in the Brussels-
Capital region and 20 in the Walloon region) exclusively treating people with 
psychiatric problems. They offer intensive and specialized treatment that may 
be short- or long-term. The hospital can have open and closed departments.
With the continued expansion of mental health care centres and psychiatric 
departments within general hospitals, as well as the advent of sheltered 
accommodation initiatives and psychiatric nursing homes, psychiatric 
hospitals acquired another function. Previously, psychiatric hospitals had an 
important residential function, but the focus has shifted to active treatment and 
rehabilitation. In psychiatric hospitals, 15% of places are reserved for part-time 
hospitalization (day hospitalization and night hospitalization).
Sheltered accommodation (Beschut wonen – habitation protégée) aims to 
offer accommodation and support to people with mental health problems who 
need daily help in order to (learn to) live independently. People who do not 
require full-time hospital treatment and whose problems have stabilized can 
find an alternative in sheltered accommodation. Appropriate day activities 
are organized and support is provided to help residents acquire relevant social 
skills that are useful in their living environments. Residents are supervised and 
live with a limited number of other patients in ordinary houses (three to eight 
persons). Since 2000, people can also live in individual houses; however, their 
number can not exceed 20% of the total.
In the Flemish community 45 facilities (2605 beds) for sheltered 
accommodation are certified, along with 27 facilities (764 beds) in the French 
community and 16 facilities (471 beds) in Brussels (2009) (see Table 5.8). 
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Table 5.8 
Sheltered accommodation, 2000–2009
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Brussels a – – – – – 435 451 456 456 471
Flanders b 2 312 2 375 2 421 2 448 2 491 2 486 2 460 2 480 2 554 2 605
Wallonia a – – – – – 708 756 751 755 764
Sources: a Raw data of the FPS Public Health, Food Chain Safety and Environment; b Raw data of the Flemish Agency for Care and Health 
for data between 2000 and 2004.
A traditional form of accommodation in Belgium for people with mental 
health problems is care within a host family. Patients participate in family life 
and sleep in the family house, but are still considered the responsibility of the 
hospital; they spend part of the day or all day in hospital doing various activities 
and can go back to the hospital for observation or in case of crisis. In 2003, 
there were 770 family accommodation places available in the Flemish region 
and 192 in the Walloon region (NIHDI 2010k; Vlaams Agentschap Zorg en 
Gezondheid 2010a).
5.11.2 Structure of mental health care
The current structure of the mental health care sector is the direct result of two 
important reforms that took place in 1990 and 1999. 
The policy reform of 1990 was aimed at cutting back on psychiatric 
hospital beds and substitution through new provisions aiming to stimulate the 
social integration of patients. The new initiatives arose as a reaction to the 
increasing tendency to offer chronic patients, in particular, appropriate shelter 
outside the walls of the psychiatric hospital. Alternative reception facilities for 
mental health care were provided such as psychiatric nursing homes, sheltered 
accommodation and home care. These facilities are also financed by the health 
insurance system, but with a higher financial contribution from the patient. The 
reform also aimed at improving the quality of residential care by resisting large-
scale operations and developing a better regional distribution of the supply of 
mental health care facilities. Dialogue platforms (overlegplatforms), in which 
all types of services in mental health care take part, aim to support dialogue 
about regional coordination of the different existing and new forms of medical 
and psychosocial supply for persons with a mental health disorder. There are 
12 dialogue platforms in Belgium (5 in the Flemish provinces, 5 in the Walloon 
provinces, 1 in Brussels and 1 in the German-speaking province) (Consultation 
Platforms in Mental Health Care 2010).
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The policy reform of 1999 included the following objectives: improving 
intensive and specialized care in psychiatric hospitals, setting up cooperation 
between the intramural and extramural sector, and further shifting hospital 
and elderly care beds to psychiatric nursing homes and places of sheltered 
accommodation.
Since 2003, an agreement makes it possible to further decrease the number 
of beds in psychiatric hospitals and to expand the number of beds in psychiatric 
nursing homes and the number of places in sheltered accommodation.
Since 2006, special attention has been given to young patients. A bridge 
function was developed between the justice department and psychiatric 
provisions, additional forensic psychiatry beds for delinquent youngsters were 
set up and the overall capacity for young patients was increased.
Innovation of care in the mental health care sector has been on the agenda 
for several years. Several pilot projects have been launched: in home care, for 
behaviourally disturbed aggressive patients, dismissal management, family 
care for children and youngsters, special accommodation for delinquent 
youngsters and adolescents, and so on. Besides these forms of care innovation, 
there is also a more comprehensive reform of the mental health care sector, 
whereby care circuits (of care programmes and services) and networks of 
services (collaboration between caregivers, institutions and services) are 
created to enable a more integrated approach to patients through the different 
care arrangements. A care circuit is the whole provision of care programmes 
and care services for a specific target group of (chronically ill) psychiatric 
patients. A network of services is the collaboration between care givers, care 
organizations and services; it coordinates one or more pathways for a specific 
target group. 
In 2004, the realization of this reform began with the setting up of therapeutic 
projects (pathways) and a coordinating network. The aim of this reform is 
the realization of guidelines and a structural frame for optimal care based on 
pathways and networks. The realization of the reform of mental health care is 
in the experimental phase and the KCE is in charge of the evaluation of the 
therapeutic projects (Transversaal Overleg 2009). 
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5.12 Dental care
Dental care is provided by dentists who are mostly self-employed and publicly 
financed through compulsory health insurance on a fee-for-service basis. 
Dentists’ fees are decided by the National Commission of Representatives of 
Dentists and Sickness Funds at the NIHDI. This commission follows the same 
procedure as for physicians. Every two years an agreement is made in which 
the financial and administrative relations between dentists and sickness funds 
are stipulated (the most recent version is the agreement for 2009–2010). 
In the last ten years, more attention has been given to preventive health care, 
to the affordability of dental care and to better follow-up for young people. With 
the exception of orthodontics, dental care for children and adolescents under 
18 years is free for all services mentioned in the fee schedule (i.e. consultations, 
preventive treatments, periodontics, conserving care such as fillings, extractions, 
removable dental prostheses). For radiography a reimbursement of 75% of the 
fee is provided. 
Also, for insured people with preferential reimbursement, all dental services 
are covered by the compulsory health insurance. Moreover, for people with 
mental or physical disabilities, prophylactic cleaning is reimbursed every 
trimester instead of once a year. There is a reimbursement of removable dental 
prostheses for people aged 50 years and over. Between the ages of 18 and 50, 
the reimbursement has to be approved by the Technical Dental Council or the 
advising physician (NIHDI 2010r).
The National Commission also plays a preventive role by organizing public 
awareness campaigns about dental care in children. Dental mobile teams visit 
schools and public places and are equipped for screening children. The aims 
of the mobile dental teams are to encourage dental care in children, to increase 
the responsibility of parents and to register epidemiological data.
The dental societies of the Flemish community (Verbond der Vlaamse 
Tandartsen) and the French community (Societé de médecine dentaire) organize 
prevention campaigns. Examples include: a book for preschoolers, a dental 
suitcase with videos and leaflets, workshops on dental care for preschoolers 
(supported by the LOGOs), and leaflets and websites of advice concerning 
dental-friendly nutrition, oral hygiene, use of fluorides and cessation of smoking 
(Verbond der Vlaamse Tandarsten 2010; Société de Médecine Dentaire 2009).
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5.13 Complementary and alternative medicine
In Belgium, only qualified physicians, dentists and midwives are entitled to 
make diagnoses and to prescribe treatment, and their freedom is absolute. 
Moreover, only these professionals are entitled to use non-conventional practice.
According to the Non-Conventional Practices Act (1999), a non-conventional 
practice is defined as performing actions which aim at improving or monitoring 
the medical condition of a human being, taking into account certain legal 
regulations and conditions. Homeopathy, chiropractic, osteopathy and 
acupuncture are legally considered as non-conventional practices. The number 
of non-conventional practices can be extended by the government. Only those 
individuals registered for a specific non-conventional practice or operation are 
allowed to provide it (BS–MB 1999).
The French community has certified the training for osteopathy, resulting 
in a complementary Master’s degree in osteopathy at the Free University of 
Brussels (ULB). The education is not certified in the Flemish community 
(Institut des Sciences de la Motricité 2010).
Homeopathic medicines have to be produced by certified companies or 
pharmacies and can only be sold (as complementary nutrition supplements) in 
pharmacies. The free sale of homeopathic medicines in pharmacies challenges 
the pharmacist to undertake the dual role of diagnostician and practitioner. 
For these products, the (simplified) proceedings of registration, production 
and notification is regulated by Royal Decrees (3 March 1992, 29 August 1997 
and 12 February 2009), and is controlled by the FAMHP and BCGH-CBPH. 
The labels of the products may not contain any reference to the therapeutic or 
prophylactic effects of the ingredients (European regulation 2007) (FAMHP 
2010a).
Non-conventional practices are not reimbursed by compulsory health 
insurance, but several sickness funds incorporate them in their voluntary health 
insurance with partial reimbursements (€10 per session and a maximum of 
five sessions per year, with a maximum of €75 for homeopathic medicines). 
They anticipate increasing demand by their clients for reimbursement for 
non-conventional practices. 
The last HIS showed that, in 2004, 12% of the population had had contact 
with a non-conventional therapist. These contacts concerned: homeopathy (5.8% 
of the population), osteopathy (3.8%), chiropractic (1.7%) and acupuncture 
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(1.6%). The percentage of the population who had contact with alternative 
medicine increased slightly between 1997 (8%), 2001 (11%) and 2004 (12%) 
(Bayingana et al. 2006).
The Non-Conventional Practices law is enabling legislation, but it has 
never been voted on and an executive commission has not yet been established 
(in March 2010). Furthermore, despite the increase of patients who consult 
practitioners of complementary medicines, their professional titles and 
certification are not yet regulated. 
5.14 Health care for specific populations
5.14.1 Asylum seekers
Medical care in refugee centres focuses on care (treatment and provision of 
medication) and prevention (six-monthly medical imaging of the lungs to trace 
tuberculosis). The health care for children is organized in collaboration with 
K&G in the Flemish community and ONE in the French community (Fedasil 
2009).
5.14.2 Illegal immigrants
The government has developed special proceedings for urgent medical aid for 
illegal immigrants (Royal Decree of 12 December 1996). This concerns urgent 
care in the case of a serious disease or accident, but also contains preventive 
and curative care on an ambulatory or residential basis. Three conditions are 
required: the patient needs care, the patient is staying in Belgium illegally and 
the physician has filled an attestation for the welfare centres. If welfare centres 
cover those medical costs, they are fully reimbursed by the federal government. 
Some welfare centres distribute medical cards to illegal immigrants in need as 
a payment guarantee for physicians (Vreemdelingenrecht 2009).
5.14.3 Other
As specified in Section 3.4.1 Cost-sharing, the NIHDI also provides specific 
reimbursement to some people (e.g. preferential reimbursement, lump sum for 
the chronically ill, solidarity funds, and so on).
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6.1 Analysis of recent reforms
In Belgium, several measures have been taken with the aim of improving the performance of the health system. Table 6.1 provides a chronological overview of the most important reforms since 2007. The major reforms prior 
to 2007 have been discussed earlier in this report (see Section 2.2 Historical 
background).
The following sections focus on recent reforms that are considered to be 
good examples of attempts to achieve the current goals of the health system, 
such as: increasing accessibility; assuring health care quality; and maintaining 
financial sustainability (FPS Social Security 2009e). It should be noted that 
each reform described is categorized under a specific objective, but some of 
them actually cover multiple objectives (e.g. reducing pharmaceutical prices 
aims to both improve access to drugs and maintain the financial sustainability 
of the system).
6.1.1 Increasing accessibility
Ensuring equal access to high-quality health care is one of the main objectives 
of the Belgian health system. In 2004, 10.1% of the households had to postpone 
medical care because of financial reasons (IPH, 2010a). Protection measures 
were therefore taken to avoid an increase in patient charges or to reduce them for 
some socioeconomic categories or diseases (i.e. chronic diseases). Mechanisms 
were also put in place to provide an adequate and sufficient supply of health 
services. Other prevention measures aim to reduce health inequalities.
1 This chapter was written by Sophie Gerkens.
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Table 6.1
Major health care reforms and policy measures, 2007–2010
Year* Reform Description
Accessibility
2007–2009 Protection measures: extension  
of MAB-MAF-MAF
The MAB system was extended in 2007, 2008 and 2009 and 
more categories of out-of-pocket payment are progressively 
being integrated in the MAB-calculation.
April 2007 Social security Law of 31 January 2007 amending the Law of 23 December 
2005 on the solidarity pact between generations
July 2007 Protection measures: OMNIO-system Extension of the preferential reimbursement to all persons 
under a fixed income limit
July 2007 Protection measures: lump sum 
payments
Introduction of lump sum for patients suffering from 
Sjögren’s syndrome (2007)
July 2007 Protection measures: chronically 
ill patients
Introduction of reimbursements for analgesic drugs and 
bandages
July 2007 Protection measures: out-of-pocket 
expenses for cancer patients
Reimbursement of travel expenses for non-hospitalized 
cancer patients
January 2008 Protection measures: coverage  
of self-employed
The compulsory coverage of self-employed was extended 
to minor risks.
March 2008 Public health Launch of cancer plan (2008–2010)
June 2008 Public health Launch of National Action Plan for Alcohol (2008–2010)
June 2008 Adequate supply: medical graduates Increasing of quota for medical graduates
July 2008 Protection measures: dental care Total reimbursement of dental care for children up to 
15 years old
August 2008 Adequate supply: nurses Launch of a plan to increase the attractiveness of the 
nursing profession
September 2008 Protection measure: chronically ill Launch of the Plan for the Chronically Ill 2009–2010
January 2009 Protection measure: chronically ill MAB chronically ill + observatory set up in the NIHDI
March 2009 Public health The Decree of the Flemish government of 31 January 2009 
on the recognition of LOGOs, their scope, composition, 
missions and funding comes into force (Articles 38–43 came 
into force on 31 December 2009 and Articles 3, 23, 24 came 
into force on 1 January 2010).
May 2009 Protection measures: dental care Total reimbursement of dental care for children up to 
18 years old
May 2009 Protection measures: supplements Abolition (or limitations in numbers) of supplements in 
two-person rooms or day hospitalizations for some 
categories of patients 
November 2009 Adequate supply: elderly care The Decree of 30 April 2009 on the accommodation and 
care for the elderly comes into force (Decree of the Walloon 
government of 15 October 2009).
January 2010 Protection measures: supplements Abolition of supplements in two-person rooms for 
all patients 
January 2010 Public health The Decree of the Flemish government of 29 May 2009 
extending the missions of LOGOs to include environmental 
medicine networks
January 2010 Adequate supply: elderly care The Decree of 13 March 2009 on accommodation and care 
comes into force (Decree of the Flemish government of 
24 July 2009) regulating the notification, recognition and 
funding of care structures and infrastructures for the elderly.
January 2010 Adequate supply: elderly care Launch of innovative projects for elderly care
March 2010 Patient safety and compensation A law to compensate, under certain conditions, damages 
resulting from health care that does not involve the 
responsibility of the caregiver was passed on 31 March 2010 
(not yet entered into force) (see Section 2.7.6 Patient safety 
and compensation).
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Year* Reform Description
Quality
January 2007 Impulseo II This fund provides a proportion of the salary costs of  
an administrative employee helping a group of GPs in the 
management of their practice (Royal Decree of 12 August 
2008).
April 2007 Mental health care Launch of the therapeutic projects
May 2007 Responsibility of health care providers Laws of 13, 21 and 27 December 2006 affecting the 
structure, mission and enforcement rules of the Department 
of DGEC-SECM came into force.
June 2008 Performance Signing of the Tallinn Charter
August 2008 eHealth Set up of the eHealth platform
December 2008 Reference amounts in hospitals (1) Abrogation of the system for the years 2003–2005 by 
the Health Law 2008 (Act of 19 December 2008); (2) new 
methodology (2006 methodology) for 2006–2008 
in-hospital stays 
January 2009 Reference amounts in hospitals New methodology for in-hospital stays ending after 
31 December 2008 (2009 methodology)
September 2009 Pathways Introduction of the pathway for type 2 diabetes
June 2009 Pathways Introduction of the pathway for chronic renal failure
Sustainability
2007 Fund for the future of health care From 2007, budgetary reserves have been created (with 
eventually the addition of surpluses) and pooled in a fund 
in order to invest for costs of ageing. This fund can only 
be used at the earliest from 2012.
April 2007 Pharmaceutical policy reform: 
reference reimbursement system
Exemption procedure based on the recognition of a 
significant therapeutic added value in the original drug 
(Royal Decree of 15 February 2007, Art. 41)
March 2008 Implants and medical devices Introduction of commission for reimbursement of implants 
and invasive medical devices
December 2008 Provisional funds for pharmaceuticals New contribution method based on a system of advances 
and deductions (Programme Law of 22 December 2008).
December 2008 Prescribing behaviour National agreement between representatives of physicians 
and sickness funds on starting new drug treatments for 
certain therapeutic classes with cheapest molecules, 
on limiting high prescription volumes and on a better 
prescribing quality
May 2009 Implants and medical devices A notification is now mandatory for each implant with 
a CE label 
May 2009 Pharmaceutical policy reform: 
reference reimbursement system
Reference reimbursement system: (1) additional percentages 
were added for drugs in the reference price system for over 
two years (2.5%, i.e. total reduction of 31.5%); (2) increase 
of the frequency of application to four times per year; (3) the 
similar and cheaper reimbursed alternative must exist and be 
available on the Belgian drug market (Law of 22 December 
2008, Arts 100, 156–157 and Royal Decree of 14 April 2009).
April 2010 Pharmaceutical policy reform: 
reference reimbursement system
(1) Inclusion of some patented or off-patented drugs in the 
system by full right; (2) additional reduction in the 
reimbursement basis of the original drug of 4% (total 
reduction of 32.8%) for drugs in the reference price system 
for over two years, and of 3.5% (total reduction of 35.2%) 
after four years; (3) new exemptions for drugs with a proven 
substantial added value regarding safety and/or efficacy; 
(4) introduction of a legal upper limit on the reference 
supplement (Law of 23 December 2009, Art. 34 and 
Royal Decree of 19 January 2010, Art. 12, 3°, 11°–12°).
April 2010 Pharmaceutical policy reform Introduction of new system of remuneration for pharmacists
*Date on which application/policy came into force.
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Protection measures
As explained in Section 3.3 Population coverage and basis for entitlement, 
almost 99% of the population is covered by the compulsory health insurance. 
Since January 2008, there is no longer any difference between coverage in the 
general scheme and the scheme for the self-employed, as the latter now includes 
coverage for minor risks. 
To protect patients in lower socioeconomic groups, additional protection 
measures have been taken. The system of preferential reimbursement, 
introduced in 1963, has gradually been enlarged over time. Since 1 July 2007, 
eligibility for preferential reimbursement has been extended to all persons under 
a fixed income limit. This extended system of preferential reimbursement is 
called the OMNIO system and is described in Section 3.4.1 Cost-sharing.
Additionally, the system of MAB, described in Section 3.4.1 Cost-sharing, 
was extended in 2007, 2008 and 2009, and more categories of out-of-pocket 
payments are progressively integrated in the MAB-calculation.
• Since January 2007, a rate of 20% is reimbursed for some classes of 
D-medication (painkillers) for chronically ill patients and the remaining 
80% is integrated in the MAB-calculation. A similar mechanism for 
“active bandages” was also introduced (see below on measures for the 
chronically ill). 
• Since July 2008, the safety margins for medical devices and implants have 
been introduced into the MAB-calculation (Schokkaert et al. 2008). 
• Since January 2009, the fixed co-payment for pharmaceutical products 
for patients in psychiatric nursing homes is also taken into account in the 
MAB-calculation (Act of 22 December 2008).
• Since January 2009, the required thresholds are reduced by €100 for 
families where one member incurred medical expenses of at least €450 in 
the two previous years (Royal Decree of 22 March 2008).
• Since 1 July 2009, some non-reimbursed painkillers are registered in 
Pharmanet (see Section 2.5.2 Information systems) and in 2010, around 
€3.7 million are foreseen to include the cost of some painkillers within the 
MAB-calculation.
Complementary to the MAB, and in order to protect people who can 
be expected to have high medical and nonmedical expenditures, such as 
chronically ill patients, certain fixed payments systems have been extended or 
added. Fixed payments introduced before 2007 were for chronically ill patients 
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(Royal Decree of 2 June 1998), for incontinence material (Royal Decree of 2 
June 1998), for palliative treatment at home (Royal Decree of 2 December 1999) 
and for patients in a persistent vegetative state (Royal Decree of 18 November 
2005). In July 2007, a monthly fixed payment for patients suffering from 
Sjögren’s syndrome was also introduced (Royal Decree of 3 June 2007). More 
information about these fixed payments can be found in the reports of De 
Graeve et al. (2006) and Sermeus et al. (2010). 
In January 2010, the annual fixed payment for chronically ill patients 
amounted to €551.65 for patients entitled to home nursing for strong and severe 
dependency; €413.75 for patients receiving disability benefits and receiving 
financial interventions for the help of a third person, for those entitled to 
integration replacement for disabled people, and those entitled to an income 
guarantee for the elderly. For other dependent patients, the fixed payment 
is €275.83. In January 2010, other fixed payments increased to €594.79 for 
palliative treatment at home, to €453.24 for incontinence material, to €7576.04 
for patients in a persistent vegetative state and to €21.05 for patients suffering 
from Sjögren’s syndrome (NIHDI 2010e).
Since 2007, additional measures have been taken for the chronically ill. 
Since July 2007, chronically ill patients receive a 20% reduction in the price of 
paracetamol-based analgesics (and for combination paracetamol and codeine 
products); a lump sum of €20 per month; plus an additional amount of €0.25 
per pack of active bandages for chronic wounds delivered by a pharmacy (Royal 
Decrees of 3 June 2007). Moreover, as described above, the remaining patient 
charges for these products (paracetamol-based analgesics and active bandages) 
will be taken into account in the MAB-calculation. 
On 23 September 2008, the 2009–2010 Plan for the Chronically Ill was 
presented by the Minister of Social Affairs and Public Health to improve 
the access and health care quality of the chronically ill. In January 2009, 
an observatory for the chronically ill within the NIHDI was created. It is 
composed of representatives of sickness funds and patient organizations, so 
that the needs of chronically ill patients, which are insufficiently covered by 
existing mechanisms of accessibility to health care, will be detected and precise 
measures will be proposed.
It should also be noted that supplementary payments are not covered by 
the MAB system. To protect some categories of patients, supplements in 
two-person rooms or in day hospitalizations have been forbidden since May 
2009 for patients entitled to preferential reimbursement, children entitled to 
increased child allowances, patients in palliative units, patients entitled to lump 
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sum payments for incontinence material or palliative treatment at home, or 
patients recognized as chronically ill and entitled to the lump sum payment. 
For other patients, a limitation on the number of supplements has also been 
introduced (Royal Decree of 20 November 2008). Since January 2010, this 
measure has been extended and room supplements for a two-person room were 
abolished.
Other measures to reduce patient co-payments for specific groups of 
patients were also introduced. For non-hospitalized patients with cancer, the 
reimbursement of travel expenses has been improved since July 2007. With 
the pathways for type 2 diabetic patients launched in September 2009, patients’ 
official co-payments were abolished for GP consultations or consultations by 
a diabetic specialist. The “diabetes passport” allows these patients to receive 
assistance for some podological and dietary treatments. A similar mechanism 
also exists for patients with renal failure since June 2009 (see Section 5.2 
Patient pathways). Moreover, since May 2009, dental care that is included in 
the nomenclature is fully reimbursed for children up to 18 years old (except for 
orthodontic treatments).2 They can also use the third payment system. In the 
past, dental care was only free for children up to 12 years old (from September 
2005) and for children up to 15 years old (from July 2008). 
In home nursing, co-payments have also been reduced from 15% to 10% for 
the lump sum C since February 2009 and for the lump sum B since February 
2010. In physiotherapy, co-payments have also been systematically reduced. 
Co-payments for GP home visits for children up to 10 years old were reduced 
in 2009.
Mechanisms to provide an adequate supply
As highlighted in a recent KCE report, in the future Belgium will likely 
experience a potential shortage of GPs (Roberfroid et al. 2008). To respond 
to future needs, the Royal Decree of 12 June 2008 increased the quota for 
medical graduates accepted for further training leading to practise from 757 
for the years 2008–2011 to 1230 for the years 2015–2018. Moreover, measures 
to reinforce the attractiveness of the GP profession were taken.
The Impulseo I fund was created to grant interest-free loans (up to €15 000) 
and subsidies (of €20 000) to doctors starting a GP practice after July 2006 in 
“urban positive active zones” or areas with a shortage of GPs, defined as area 
with fewer than 90 GPs per 100 000 population, or areas with a population 
density of less than 125 per km2 and with less than 120 GPs per 100 000 
population. An additional loan of €30 000 was provided to self-employed GPs 
2 For non-conventioned dentists, the payment of supplements is possible.
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and free administrative assistance during the first 18 months following the start 
of the practice was also provided (Royal Decree of 15 September 2006). About 
5% of active GPs have already used this procedure. 
Fees to encourage increased GP availability were also created. Availability 
fees are allocated to attending GPs for any care provided in a given area and 
population. From July 2008, these fees cover availability for the weekend (48 
hours per weekend), official holidays (24 hours per holiday), and weekdays 
from 7 p.m. until 8 a.m., which have been communicated to the competent 
medical commission (NIHDI 2010h).
A plan to increase the attractiveness of the nursing profession in hospitals, 
nursing homes and home care was also defined in 2008. This plan has four 
areas of action: reduction of workload and stress; promotion of qualifications; 
increase of remuneration and social recognition; and involvement in decision-
making (Chambre des représentants de Belgique 2009). 
In September 2007, a pilot project (VINCA) began, which aims to provide 
nurses with administrative support across mobile computing in order to enter 
patient information at the patient bedside and to facilitate administrative 
procedures (premium of €650 per home nurse) (FPS Health, Food Chain 
Safety and Environment 2010d). In June 2007, pilot projects were developed to 
integrate family/nurse aids in home care, mainly to meet the challenges of an 
ageing population, but also to relieve nurses of some basic tasks.
In 2008, the premium for the use of licensed software for nursing homes rose 
from €350 to €800 per provider (budget of €4.5 million). In July 2008, a budget 
of €16.3 million was allocated for the computerization of the nursing component 
of patient records in order to improve communication between health care 
providers, to improve the quality of care and to allow an automatic extraction of 
the nursing part of the HBD-SHA-AZV (see Section 2.5.2 Information systems). 
In 2009, a hospital budget of €4.7 million was granted to increase the standing 
of nurse services provided in antisocial hours (e.g. night services), and a budget 
of €1 million was granted to promote continuing education. Additionally, two 
nurses were added to the board of directors of the KCE, and two nurses were 
added to the multipartite consultation structure. Since February 2009, home 
nurses can charge for a consultation once a year per patient (Royal Decree of 
15 December 2008). This nursing consultation, which is entirely supported by 
the NIHDI (i.e. no patient co-payment), aims to assess the patient’s condition, 
identify nursing needs and define care objectives. Furthermore, in March 2009, 
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the Federal Council for the Quality of the Nursing Activity was established 
(Royal Decree of 27 April 2007) to externally assess the quality of nursing 
activity in hospitals.
In 2010, the hospital budget for nurse services provided in antisocial hours 
was increased by €40 million (total budget of €44.7 million). Budgets of around 
€16 million and around €800 000 were also foreseen for nurse services in 
antisocial hours in nursing homes and psychiatric nursing homes, respectively. 
With this budget, a specific remuneration was offered for services provided 
between 7 p.m. and 8 p.m. as well as night remuneration for services provided 
between 8 p.m. and 6 a.m.3 Measures to improve the remuneration of multiple 
services of home nurses were also taken (e.g. financing recognition for the 
preparation of oral medication or for the third and fourth visits in home care 
for patients under lump sum). An annual premium of €175 was given for the 
continuous training of nurses in home care (total budget of around €1.75 million). 
Also in 2010, around €27 million was allocated to promote the specialization 
of nurses. With this budget, a gross annual premium was given for nurses 
with a professional title in intensive care and emergency medicine, geriatrics or 
oncology (of €3341.50) and for nurses with a specific qualification in geriatrics 
(of €1113.80). Professional titles and specific qualifications are obtained after a 
complementary training of 900 hours and 150 hours, respectively. To preserve 
these titles or qualifications, nurses also have to undergo continuous training 
and work in the corresponding sector. Finally, the VINCA II project for home 
nurses also started in April 2010 (€800 000). Subsidies are granted to develop 
evidence-based nursing by producing guidelines and recommendations on good 
practice.
A protocol agreement has been concluded in the interministerial conference 
of 14 December 2009 to improve the structural organization and collaboration 
between family aid for the elderly and home care given by health professionals 
(e.g. nurses).
Concerning elderly care, the Royal Decree of 2 July 2009 launched a call for 
innovative projects. The objectives of these projects are to allow older people 
to remain in their homes as long as possible by receiving appropriate care; to 
guarantee the continuity of care and promote collaboration between caregivers; 
to support informal caregivers; and to provide accessible care. These projects 
began in January 2010 and a second call will be held in May 2010 for projects 
that will start in October 2010. 
3 Services beginning before 6 a.m. but ending after 6 a.m., or services beginning before 8 p.m. but ending after 
midnight are also considered night services.
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Moreover, a budget of more than €88 million was used between 2006 and 
2009 to convert around 12 800 beds in homes for the elderly into nursing home 
beds. In 2010, an additional budget of around €26 million is foreseen. Moreover, 
the KCE will examine the question of maintaining a moratorium in homes for 
the elderly (Chambre des représentants de Belgique 2009).
Prevention measures
Many ideas, initiatives and projects prevail in Belgium in the field of health 
promotion and prevention (see Section 5.1 Public health). This section details 
some holistic plans defined in interministerial conferences since 2007 in the 
field of public health (FPS Health, Food Chain Safety and Environment 2010c).
First, the National Health and Nutrition Plan, signed in June 2005, will 
continue until 2010. This Plan aimed to adopt a global approach to promoting 
healthy nutrition and physical activity. The protocol agreement on the breast 
cancer screening programme4 for women aged 50–69, which was first 
implemented in October 2000, was prolonged for a further five-year period in 
January 2004 and again in January 2009. 
Furthermore, the 2009–2010 plan to eliminate measles and rubella was 
adopted at the interministerial conference of 2 March 2009. Moreover, on 
28 September 2009, a protocol agreement on prevention was adopted. This 
protocol provides a general framework that should allow the communities 
to realize their prevention programmes with the support of the federal 
government and funding by the health insurance, in respect of the communities’ 
individual competences. The organization of prevention programmes remains 
the responsibility of the communities.
In addition, to integrate all aspects of cancer prevention, a continuous cancer 
plan was launched on 10 March 2008, the so-called Cancer Plan 2008–2010. 
Roundtables gathered different stakeholders involved in cancer care: care 
providers, governments, sickness funds, patient associations, psychosocial 
workers, the Belgian Cancer Registry Foundation, the centres for the screening 
of breast cancer, NIHDI, FPS Public Health, IPH, researchers, pharmaceutical 
industry, universities, health care institutions and so on. In this plan, 32 concrete 
actions were defined. These actions are organized into three main principles: 
actions on prevention and screening; actions on care, treatment and support 
given to the patients; and actions on research, technological innovation and 
assessment (see Table 6.2). 
4 Women aged 50–69 can benefit from free mammography every two years. This “mammotest” has to take place 
under conditions determined by the legislation (see also Chapter 7).
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Table 6.2
Cancer Plan, 2008–2010
Actions “prevention and screening”
1. To reimburse consultations for help in smoking cessation 
2. To screen and support persons at risk of being predisposed to genetic cancer
3. To extend the age of girls’ vaccination against HPV from 12 to 18 years
4. To improve the screening and early diagnosis of breast cancer 
5. To establish a systematic programme of screening for cervical cancer
6. To promote preventive consultations on health risks
Actions “care, treatment and support to patients”
7. To provide specific support when the diagnosis of cancer is provided to the patient
8. To re-evaluate the multidisciplinary oncology consultation (COM)
9. To establish pathways for patients with cancer
10. To provide nursing and psychosocial support to patients through health care programmes on oncology (PSO)
11. To finance a data manager in the health care programmes on oncology (PSO)
12. To define and fund a health care programme on paediatric oncology
13. To manage rare tumours
14. To recognize oncology nurses
15. To improve coverage of cancer treatment by compulsory health insurance 
16. To support radiotherapy and medical imaging in oncology
17. To provide structural support for banks and cell therapy units concerning colony-forming unit-spleen and cord blood
18. To improve reimbursement of certain secondary costs related to cancer treatment 
19. To develop the functional rehabilitation of patients with cancer in remission state
20. To set the conditions for the recognition of a disability “post-treatment of cancer”
21. To support parents who have a child with cancer
22. To provide access to psychological support or to discussion or support activity groups 
23. To provide structural funding for a paediatric pathway on continuing care for children
24. To support pilot projects on oncogeriatry
25. To improve the provision of palliative care for patients with cancer
26. To take actions in consultation with relevant ministers at the federal level
Actions “research, innovative technologies and assessment” 
27. To establish a tumour bank
28. To provide structural funding for the coordination of translational research in hospitals
29. To support translational research
30. To use hadrontherapy in Belgium 
31. To strengthen the Belgian Cancer Registry Foundation
32. To establish a reference centre for cancer
A National Action Plan for Alcohol 2008–2012 was approved during the 
interministerial conference of 17 June 2008. The main objectives of this Plan 
are to prevent and reduce alcohol-related damage; to fight against excessive, 
problematic and risky alcohol consumption (and not only against alcohol 
dependency); and to have a policy oriented towards targeted risk group 
(especially young people and pregnant women) and risk situations. 
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Finally, on 28 September 2009, a protocol agreement on prevention was 
adopted. This protocol provides a general framework that should allow the 
communities to implement their prevention programmes with the support 
of the federal government and funding by the health insurance, in respect of 
individual competences. The organization of prevention programmes remains 
the responsibility of each community.
6.1.2 Assuring health care quality
To assure the quality of the health system, several measures have been taken, 
such as assessing the performance of the health system, making health care 
providers accountable, strengthening primary care and promoting continuity 
of care and the integration of the supply. eHealth measures to facilitate 
administrative procedures and to improve the quality of care have been 
described (Section 4.1.4 Information technology). As described in this section, 
a Belgian eHealth digital platform was set up in 2008 (Act of 21 August 2008). 
Assessing the performance of the health system
On 27 June 2008, the Tallinn Charter on health systems was signed by 
Ministers of Health from the 53 Member States of WHO European Region. 
By signing this charter, the Member States committed themselves to “promote 
transparency and be accountable for health system performance to achieve 
measurable results” (WHO 2008b). To realize this commitment, an evaluation 
of health system performance and balanced cooperation with stakeholders at 
all levels of governance were thus needed.
As already described (see Section 2.5.1 HTA), the KCE provides scientific 
support to health care decision-makers and publishes, among others, 
international comparisons of specific topics in health care (e.g. financing 
of hospital drugs). The KCE also compiled an inventory of the utility and 
shortcomings of existing health care databases. Also, the IPH has performed 
a number of studies related to patient satisfaction and accessibility of health 
care and health outcome research (e.g. health interview surveys, health care 
associated infections, AB-use, GP-sentinels, diabetes, mucoviscidosis, nursing 
homes, etc.) However, neither the KCE nor the IPH have provided a systematic 
performance assessment.
Therefore, during an interministerial conference on the subject, the NIHDI, 
the FPS Public Health, the FPS Social Security, the IPH and the KCE proposed 
to develop regular reporting on health system performance in Belgium. Towards 
this end, a working group has been established which brings together federal 
and federated entities. The aim of the first report was to agree on a set of 
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performance indicators, to study the feasibility of these indicators, to facilitate 
the collection and aggregation of information, and to perform a first evaluation 
of health system performance. This first report was published by the KCE in 
collaboration with other federal and federated entities, such as the IPH, in June 
2010 and results are summarized in Chapter 7 (Vlayen et al. 2010).
Making health care providers accountable
Measures taken before 2007 are described in Section 2.6.2 Regulation of 
providers. As described previously, feedback was provided on antibiotics (2001–
2003), hypertensive prescriptions (2002–2003), pre-operative examinations 
(2005), extreme outliers (amoxiclav, quinolones, sartan, 2005), the prescription 
of a minimum percentage of cheap medicines (2006), as well as on the screening 
of breast cancer (2002, 2004, 2005, 2006). Since 2007, additional feedback 
has been gathered. At the initiative of the National Council for the Promotion 
of Quality, the NIHDI sent new feedback on prenatal care to 13 700 GPs, 
gynaecologists and midwives in January 2007. New feedback on the screening 
of breast cancer has also been sent out in 2007 and 2009. Additional feedback 
on the prescription of a minimum percentage of cheap medicines has been sent 
in 2007, 2008 and 2009. Moreover, new feedback on antibiotic prescriptions 
was gathered and distributed in 2007 and 2010 (NIHDI 2010f).
Concerning the system of reference amounts in hospitals, created in 2002 in 
order to address significant differences in medical practice between hospitals, 
new measures have been introduced. The system was abrogated for the years 
2003–2005 by the Health Law (Act of 19 December 2008). The first reference 
amounts were then determined for 2006, with a new methodology based on 
recommendations from a KCE report (Van de Sande et al. 2005). Then, a new 
methodology (2009 methodology) was applied for hospital stays ending after 
31 December 2008 (see also Section 2.6.3 Mechanisms to ensure the quality 
of care).
Moreover, after agreement between different actors, further incentives (and 
penalties) were established by law in order to further improve the prescribing 
behaviour of medical personnel. The prescription of all pharmaceutical 
products can be screened in order to verify that prescription patterns follow 
recommendations established by law.5 Inappropriate prescription is evaluated 
based on recommendations made by the Reimbursement Commission through 
a series of indicators defined by the Committee for the Evaluation of Medical 
Practices for Drugs. The institution in charge of evaluating the prescribing 
5 Modification of the article 35bis § 10 and 73 §2 – §3 of the law of 14 July 1994 on mandatory health insurance and 
benefits. Modifications were set in the law of 8 June 2008 and the law of 19 December 2008. 
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behaviour of medical personnel is the DGEC-SECM. Among measures to 
improve the quality of care, legal reforms affecting the structure, mission and 
enforcement rules of the DGEC-SECM were also set. The changes that apply 
to this institution included the establishment of new definitions on what is 
considered as “breach of responsibilities” from health care providers, as well 
as penalties and measures undertaken for such cases. Direct appearance in 
court during the process was also granted to health care providers. In addition 
to this, new procedures guaranteed independence between the members of the 
DGEC-SECM evaluating the case files and the officers leading the investigation.
Strengthening primary care
Measures taken before 2007 to strengthen primary care are described in 
Section 2.6.2 Regulation of providers. More recently, new initiatives on the 
GMD-DMG have been achieved. Since January 2009, the fees for GMD-DGM 
paid to the GP have been increased to €27.50. These annual fees paid by the 
patients are fully reimbursed by the NIHDI. The preventive role of the GP is 
also expanding (see Section 6.2 Future development) (NIHDI 2010a).
Moreover, in 2009, recognized GPs registered for duty services organized 
by circles of GPs and having at least 1250 in-office consultations or home visits 
per year received an annual fee of €1043 (NIHDI 2010a).
To promote the grouping of GPs, the Impulseo II fund was created (Royal 
Decree of 12 August 2008). This fund provides a proportion of the salary costs 
for an administrative employee helping a group of GPs in the management of 
their practice. The financial contribution is equal to half of the actual salary 
costs, with a maximum of €8250 per year for a group of two GPs managing 
at least 500 GMD-DMGs6 and employing at least a 0.5 FTE person, and with 
a maximum of €16 500 per year for a group of three or more GPs managing 
at least 1000 GMD-DMGs7 and employing at least one FTE person. Moreover, 
they must use homologated computerized medical files (Royal Decree of 
12 August 2008).
Promoting the integration of health services and multidisciplinarity
In Belgium, a set of methods and ways to organize care between institutions 
(systems of reference) and to promote cooperation between primary care and 
other levels of the health system have been developed. For example, agreements 
are in place specifying the tasks to be performed for patients suffering from 
diabetes, kidney failure, heart failure, asthma or obstructive bronchitis. 
6 Number reduced by 20% in 2007–2008 and by 50% for groups of recently recognized physicians.
7 Number reduced by 20% in 2007–2008 and by 50% for groups of recently recognized physicians.
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The Royal Decree of 21 January 2009 on patient pathways entered into force 
in April 2009 and a large campaign has been launched. Pathways for chronic 
renal failure and type 2 diabetes began in June and September 2009, respectively. 
In the Flemish region, these pathways are part of a broader coordination of 
primary care called “samenwerkingsinitiatieven eerstelijnsgezondheidszorg”. 
When necessary, coordination among providers of care is complemented by 
coordinated social assistance through the creation of networks/platforms. More 
details about these topics are detailed elsewhere (Section 5.2 Patient pathways 
and Section 5.8 Long-term care for the elderly). 
The promotion of multidisciplinarity in mental health care is described in 
Section 5.11 Mental health care. Therapeutic projects in mental health care 
started in April 2007 and aimed to implement an “integrated health services 
model”, guaranteeing continuity of care, providing needs-based care to the 
patient and promoting rehabilitation in society.
The National Cancer Plan (described in Subsection Prevention measures 
in Section 6.1.1 Increasing accessibility) also aims to strengthen collaboration 
between all levels of government and to increase multidisciplinarity and greater 
coordination between health care providers.
6.1.3 Maintaining financial sustainability
To maintain the financial sustainability of the health system, lump sum financing 
has been introduced (see Section 3.6 Payment mechanisms). Initiatives to 
ensure access to innovative pharmaceuticals are also described in Section 5.6 
Pharmaceutical care.
To be able to respond to the increasing needs of the population, especially 
due to ageing, a fund for the future has been created (Act of 27 December 2006). 
At the end of 2009, more that €985 million has been saved and in 2010 a further 
€299.7 million will be added. 
Also in 2006, a provisional fund for pharmaceutical products was created in 
order to compensate for budgetary excess (€100 million over a two-year period). 
Since December 2008, a new contribution mechanism has been established 
based on a system of advance payments and deductions (Programme Law of 
22 December 2008).
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Measures to reduce pharmaceutical prices and to promote the prescription 
of low-cost drugs were also taken before 2007 (described in Section 5.6 
Pharmaceutical care and Section 3.4.1 Cost-sharing).8 Prescription quotas for 
low-cost drugs have not been updated since they were established in 2006. 
The 2009–2010 agreements between the representatives of physicians and 
sickness funds included a commitment to initiate therapy with the “least costly” 
drug(s) within a group of (initially) six pharmaceutical groups. The “least costly” 
medication (or the group of “least costly” medications) is identified by the 
NIHDI and updated on a monthly basis. 
For the reference reimbursement system, different measures have been 
taken since 2007. Since April 2010, the basis of reimbursement for original 
pharmaceutical products undergoes an additional decrease of 4% (total 
reduction of 32.8%) after two years in the reference reimbursement system 
and a further decrease of 3.5% (total reduction of 35.2%) after four years in 
the system (Law of 23 December 2009). Moreover, since April 2010, a legal 
upper limit on the reference supplement has been introduced to exclude from 
the reimbursement list all drugs with a reference supplement of more than 25% 
of the reimbursement basis (with a maximum of €10.80) (Law of 23 December 
2009). 
A new system of remuneration for pharmacists also came into force in 
April 2010. The objective of this new system is to reinforce the intellectual 
role of the pharmacist and to partly disconnect the pharmacists’ remuneration 
from the price of drugs. The remuneration is composed of a basic fee of €3.88 
per reimbursed product (per pack), which is expected to make up 75% of the 
pharmacists’ total remuneration. Second, they will receive an economic margin 
of 6.04% of the ex-factory price (+ 2% for ex-factory prices above €60). This 
new reduced percentage was calculated so that the share of the economic 
margin amounts to approximately 15% of the total remuneration. A specific 
lump sum of €1.20 is also provided for each prescription under the INN of the 
active ingredient. Moreover, an annual lump sum of €500 per pharmacy will 
be provided in 2010 to encourage the pharmacist to give detailed information 
to patients under chronic treatment when giving them their first prescription 
(Conseil des ministres 2010).
8 The prescription quota for low-cost drugs was introduced by Royal Decree of 17 September 2005, instituting 
Article 73, §2 in the Coordinated Law of 14 July 1994 and the reference reimbursement system was introduced  
on 1 June 2001; Articles 35ter and 35quater of the Coordinated Law of 14 July 1994.
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It should also be noted that on 1 March 2008, the Commission for the 
Reimbursement of Implants and Invasive Medical Devices was established 
(Royal Decree of 10 February 2008). The roles of this Commission are to 
determine a list of reimbursed medical devices and invasive implants, to make 
objective proposals on demands for reimbursement and to give advice on 
request of the Minister of Social Affairs and Public Health. This Commission 
is composed of representatives from Belgian universities, sickness funds and 
professional associations of pharmacists in hospitals, of physicians, hospital 
managers and manufacturers, and importers and distributors of implants and 
invasive medical devices. 
Moreover, since 1 May 2009, new rules have been applied for the 
reimbursement of medical implants and invasive devices. A notification is 
now mandatory for each implant with a CE (European Conformity) label and 
only notified implants can be taken into account for reimbursement by the 
compulsory health insurance system. Implants which are not notified, even if 
they meet the conditions of notification, cannot be charged to the patient and 
will be charged entirely to the hospital. The notification does not constitute 
an assessment of the quality of products, but allows the compulsory health 
insurance to have an overview of all existing implants already available on 
the market (NIHDI 2010m). This reform will be completed in 2011 by a new 
reimbursement procedure for implants and invasive medical devices, which will 
guarantee quicker access to innovative devices with added therapeutic value.
6.2 Future development
In the future, measures to improve the accessibility, quality and sustainability 
of the health system will continue. Some of the projects in these fields are 
described below (not exhaustive).
Among other measures to improve the population’s access to the health 
system, there is a discussion about including long-term unemployed people 
(from one year), without any age limitation, and members of single-parent 
families in the group of people entitled to preferential reimbursement. A 
simplification of the administrative procedures related to the regulation of 
preferential reimbursement and of OMNIO status is also foreseen. Additional 
measures for the chronically ill will also continue (Chambre des représentants 
de Belgique 2009). 
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To increase the attractiveness of the GP profession, an Impulseo III fund 
for solo practice is under way (Chambre des représentants de Belgique 2009). 
Additional measures to increase the attractiveness of the nursing profession 
will also be taken. For example, an extension of the professional title for nurses 
in paediatrics, neonatology or psychiatry, and of the specific qualification for 
nurses in diabetics and psychiatry, is foreseen.
Also under way in Belgium are measures to improve the organization of 
medical emergency services accessible to the entire population. In the case 
of a medical emergency, two phone numbers are currently available for use 
in Belgium: the “100” (traditional call number) and the “112” (European call 
number). The European emergency call number “112” has been operational in 
Belgium since 1993, but is currently redirected to the traditional emergency 
call number “100”. In future, medical dispatching will be restructured and 
streamlined with standardized and computerized tools and with a single 
emergency call number, the “112”. An intermediate service between the single 
ambulance and the ambulance under medical supervision (MUG-SMUR) is 
also in progress, the so-called Paramedical Intervention Team (see Section 5.5 
Emergency care). Moreover, using a psychosocial team to intervene in case of 
public emergencies is currently being evaluated (Chambre des représentants 
de Belgique 2009).
Measures to increase the quality of care by making health care providers 
more accountable will also continue. Following the work of an ad hoc task force 
created in 2009, accountability mechanisms on medical imaging and clinical 
biology are currently being investigated. The goal is to reduce both medical 
radiation exposure and the volume of examinations by 25% in 2010 (Chambre 
des représentants de Belgique 2009). 
Furthermore, the determination of recognition standards for paramedical 
professions is a future objective of policy-makers. Moreover, pilot projects 
on telemonitoring to improve the management and follow-up of chronically 
ill patients and to increase their autonomy are in progress (Chambre des 
représentants de Belgique 2009).
Also under way are reforms to increase the preventive role of the GP. In the 
future, a free preventive consultation with a GP every three years is foreseen 
for patients who have a GMD-DMG. An additional fee of €10 per year will be 
given to the GP for each patient who has a GMD-DGM and follows a preventive 
programme. Also planned are the complete reimbursement of the preventive 
consultation for patients with preferential reimbursement, and a reduction of 
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up to €3 of the co-payment for other patients. The National Council for the 
Promotion of Quality will define recommendations on measurable preventive 
objectives for each target group (NIHDI 2010a).
Pilot projects to improve communication between front-line health 
professionals (i.e. GPs, home nurses, physiotherapists) using the prescription 
as a communication tool are also in progress.
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7. Assessment of the health system 1
7.1 Stated objectives of the health system
According to the Belgium report on social protection and social inclusion, the objectives of the health system are grouped on three axes: increasing accessibility, ensuring the quality of care and maintaining 
the sustainability of the system (Council of the European Union 2009). 
In Belgium, a whole set of measures have been taken since 2007 to 
strengthen the accessibility of the health system, to assure health care quality 
and to maintain the financial sustainability of the system (see Chapter 6 on 
recent reforms and Section 2.6.2 Regulation of providers).
As described in Section 6.1.2 Assuring health care quality, assessing the 
performance of the Belgian health system is one of the recent objectives of the 
government. The first pilot study was performed in 2009–2010 by the KCE and 
the IPH, in collaboration with other federal and federated entities (Vlayen et al. 
2010). This chapter is therefore based on the results of this report.
In the report, four dimensions were analysed: quality (in terms of efficacy, 
appropriateness, safety, patient-centredness and continuity), accessibility, 
efficiency and sustainability of the health system in the areas of health 
promotion, preventive care, curative care, long-term care and end-of-life care. 
A total of 55 indicators were selected for the analysis. However, for some 
indicators, no recent national data were available. Unavailable data concerned 
some health indicators, such as mortality and indicators on social protection, 
resources in long-term care, lifestyle and environment. 
This first pilot study suggested that, in general, the health care system is 
good in terms of accessibility (see Section 7.2 Equity), average to good with 
regard to safety (see Section 7.5 Quality of care) and average regarding the 
effectiveness of preventive care (see Section 7.5), the appropriateness of care (see 
Section 7.5), efficiency (see Section 7.4 Technical efficiency) and sustainability 
1 This chapter was written by Sophie Gerkens.
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(see Section 7.3 Efficiency of resource allocation). The effectiveness of curative 
care and continuity were poorly rated by the indicators used in the pilot study 
(see Section 7.5). Furthermore, various inequalities were also identified, but 
these should be examined more closely in terms of equity (see Section 7.2). 
Nevertheless, these findings must be interpreted with caution because of the 
fragmented assessment of certain dimensions, particularly with regard to the 
effectiveness of curative care (lack of data on clinical outcomes) and continuity 
(small number of indicators). Moreover, indicators on patient-centredness and 
equity are not easy to capture and generate lively debate. For these reasons, 
the evaluation of these dimensions requires the creation of ad hoc working 
groups. Some areas, such as end-of-life care, mental health care or care for the 
elderly were also not, or only poorly, investigated by the KCE report (Vlayen 
et al. 2010).
7.2 Equity
As in the KCE report on performance, this section does not study all aspects of 
equity in detail, but should rather be considered as a starting point for a more 
profound study on equity in the health system in Belgium. 
7.2.1 Equity in financing
In Belgium, there is broad concern about the equitable funding of health care, 
based primarily on people’s ability to pay and not on need for health care 
(Corens 2007). As described in Section 3.2 Sources of revenue and financial 
flows, public funding (around 71% of total health expenditure) is based on 
proportional social security contributions related to income, progressive direct 
taxation, and an alternative financing related to the consumption of goods and 
services (value added tax). 
The degree of vertical and horizontal equity of the overall system of funding 
was not analysed in the KCE report on performance and is therefore not covered 
in this section. Rather, this section is focused on the evaluation of the ease with 
which health services are reached in terms of the financial access to health care.
According to the NIHDI, the proportion of uninsured persons in Belgium 
ranges between 0.6% and 0.8%2 which is better than in some EU Member States, 
such as the Netherlands (1.5% in 2006; see Westert et al. 2008), but worse than 
2 Corresponding, for example, to people who have not paid their social security contributions and who are thus 
temporarily excluded.
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in others, such as the United Kingdom, where the insurance coverage is 100%. 
Fig. 7.1 shows the population coverage in Belgium and neighbouring countries. 
The population coverage was higher in France and Germany, but lower in the 
Netherlands and Luxembourg (OECD 2009a).
Fig. 7.1 
Health insurance coverage in Belgium and neighbouring countries (% of population), 
1995–2007
Source: OECD 2009a.
Compared to neighbouring countries, the share of out-of-pocket expenditure 
in Belgium is high. OECD health data shows that in 2007, out-of-pocket 
expenditure constituted 19% of the total health care expenditure in Belgium, 
5.5% in the Netherlands, 6.5% in Luxembourg (2006 data), 6.8% in France 
and 13.1% in Germany (OECD 2009a). Nevertheless, as explained in the KCE 
report on performance, caution is needed when comparing private expenditure 
in different health systems. It should be noted that the Belgian figures contain 
all paramedical purchases, all non-reimbursed drugs, medical devices, medical 
materials and net premiums (premiums minus reimbursement) paid to sickness 
funds and the interventions of private insurance in the cost of care (Vlayen 
et al. 2010).
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As described in Section 3.4 Out-of-pocket payments and Chapter 6 on recent 
reforms, several measures have been implemented to improve accessibility 
and financial equity (i.e. MAB system, OMNIO, lump sum payment systems, 
solidarity funds and suppression of the supplement in double rooms). An 
evaluation of these measures is expected in the near future.
As shown in the KCE report on performance, MAB reimbursement 
represented 0.71% of total health expenditure in 2003 and rose to 0.87% in 2007. 
With the MAB, official co-payments amounted to 7.56% of all reimbursed 
services in 2006 compared to 8.8% without the application of this system (FPS 
Social Security 2009e).
7.2.2 Equity in provision of services
To measure the accessibility of health care services, the KCE report on 
performance tried to assess, among other aspects, the ease with which health 
services are reached in terms of availability of personnel. Some of the indicators 
presented in the KCE report on performance also suggest differences in the use 
of care (Vlayen et al. 2010). Indicators related to waiting times and lists were 
not investigated because Belgium is not affected by this problem.
Personnel availability
Health care accessibility in terms of personnel availability in Belgium is 
difficult to evaluate and more data are needed.
Currently available data show that the number of practising physicians was 
2.96 per 1000 population in 2006 (NIHDI 2009h), which is below the EU15 
average of 3.4 (NIHDI 2009h; OECD 2009a) (see Section 4.2.1 Trends in health 
care personnel). However, because the definition of a practising physician may 
vary between countries, international comparisons must be interpreted with 
caution. 
A recent KCE report also showed that in Belgium less than one-third of 
medical students choose to specialize in general practice, that a quarter of the 
quota for GPs was not filled and that many young qualified GPs never practise 
or move out of the profession after a few years (Lorant et al. 2008; Roberfroid 
et al. 2008). Moreover, this report showed that the geographical distribution 
of GPs was in some cases inadequate. Thus, in future Belgium will likely 
encounter a potential GP shortage. Reforms to increase the attractiveness of the 
GP profession are described in Chapter 6 (see also Section 2.6.2 Regulation of 
providers and Section 5.3 Primary/ambulatory care).
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Concerning the number of active nurses, as explained in Section 4.2.1 Trends 
in health care personnel, this number is difficult to determine. A register of 
nurses is currently in preparation but is not yet up to date. Reforms have been 
undertaken to increase the attractiveness of the nursing profession in Belgium 
and are described in Chapter 6.
Differences in the use of care
Differences in the use of care according to age, socioeconomic factors and 
geographical zone were suggested by some indicators of the KCE report.
A decrease in cervical cancer screening with age was found. In 2007, more 
than 70% of women aged between 28 and 39 years had received a Papanicolaou 
test during the three previous years, while this rate decreased to 43.7% for 
women aged 60–64. For women not eligible under the breast cancer screening 
programme,3 a decrease of opportunistic breast cancer screening with age was 
also identified in Belgium. In 2007, more than one-third of women aged 40–49 
had had a mammogram in the previous two years (34.7%), while this percentage 
was 18.4% in the 72–79 age group. Differences in the number of hysterectomies 
were also highlighted with a peak for the age group 45–49 (2007 data) (Vlayen 
et al. 2010).
The KCE report also found inequalities according to socioeconomic factors 
for breast cancer screening, preventive dental care and hysterectomy rates. 
People in a household with an income exceeding the MAB ceilings had higher 
rates of hysterectomies (Vlayen et al. 2010).
Inequalities in the use of care related to socioeconomic factors were also 
shown in the HIS of the IPH. The coverage of cervical cancer screening was 
higher in women with an income level of over €2500 per month (73% in 2004) 
than in women with an income level below €750 per month (35% in 2004). 
A similar relationship with educational attainment was found. This survey 
also showed that people with a low education level had more contacts with 
a GP and more home visits but fewer contacts with a specialist. Concerning 
hospitalization, the survey showed that the proportion of day hospitalization 
compared to classical hospitalization was higher for people with a high 
education level. Furthermore, differences in the percentage of households 
that had to postpone medical care for financial reasons were also highlighted 
(almost 20% of households with an income level of €1000 or less per month 
compared to 2.5% of households with an income level of over €2500 per month) 
(IPH 2010a).
3 A breast cancer screening programme for women aged 50–69 using the mammotest has existed since 2001 in the 
Flemish region and since 2002 in the Brussels-Capital and Walloon regions.
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A study of the Christian sickness fund showed that children (under 18 years 
old) belonging to the lowest income class had a 28% lower chance of using 
preventive dental care in 2006 compared to other children, and a 36% lower 
chance compared to children belonging to the highest income class.4 This study 
also found that people belonging to the lowest income class had a higher risk 
(20%) of being admitted to the hospital than people belonging to the highest 
income class, and a higher risk (× 2) of being admitted to a psychiatric service 
of a general hospital or to a psychiatric hospital. They also had a 14% higher risk 
of using antidepressant drugs. The use of the GMD was also lower for people 
belonging to the lowest income class (Avalosse et al. 2008).
Furthermore, in Belgium, small regional differences were found in access 
to preventive child health care. In 2007, the percentage of children visiting a 
K&G health centre (in the Flemish community, see Section 2.3.2 Federated 
authorities) in their first year of life was 89.3%, while the percentage of children 
visiting a ONE health centre (in the French community, see Section 2.3.2) in 
their first year of life was 75%. The use of preventive dental care, hysterectomy 
and the GMD were also higher in the Flemish region.
Finally, the use of organized population screening with mammotests 
in women aged 50–69 years (breast cancer screening programme) is more 
pronounced in the Flemish region than in the Walloon and the Brussels-Capital 
regions. The total mammogram coverage for women aged 50–69, including both 
mammotests (breast cancer screening programme) and other mammograms 
(opportunistic cancer screening), was also slightly higher in the Flemish region 
than in the Walloon and the Brussels-Capital regions. Conversely, the use of 
mammography in women aged 40–49 and 70–79 (not eligible for the breast 
cancer screening programme) was higher in the Brussels-Capital and Walloon 
regions (Vlayen et al. 2010).
7.2.3 Equity in health outcomes
Some of the indicators presented in the KCE report on performance suggest 
differences in terms of health outcomes. Indeed, the report showed an 
increasing in-hospital mortality rate after hip fracture and community-acquired 
pneumonia, and an increasing hospitalization rate of pneumonia and influenza 
with age. These rates were also higher for males than for females (Vlayen et al. 
2010). 
4 Five classes were determined using the median net taxable income of each statistical sector (districts). The first 
class corresponded to statistical sectors (districts) where the median incomes were the lowest and the fifth class 
corresponded to statistical sectors where the median incomes were the highest.
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A study of the Christian Mutuality also showed socioeconomic differences 
in terms of health outcomes (see Table 7.1).
Table 7.1
Risk differences in terms of results for people in the lowest income class, 2006
Compared to people in the 
highest income class
Compared to the whole population 
(members of the Christian Mutuality)
Mortality 1.45 1.21
In–home mortality 0.76 0.83
Chronic obstructive lung disease 1.15 1.08
To become disabled (after 12 months 
of incapacity)
1.66 1.33
 Source: Avalosse et al. 2008.
Differences in life expectancy in good perceived health by education level 
also exist in Belgium. At 25 years, differences between people with the lowest 
and highest levels of education was 17.8 for males and 24.7 for females (see 
Fig. 7.2).
Regional differences in terms of life expectancy were also shown. Fig. 7.3 
shows that life expectancy at birth for males was lower in the Walloon region, 
and especially in Hainaut province, with a difference of three years compared 
to Belgian life expectancy and a difference of more than four years compared 
to Limburg province.
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Fig. 7.2
Life expectancy in good perceived health by education level in Belgium, 1997
Source: Bossuyt and Van Oyen 2001.
Fig. 7.3
Life expectancy at birth by provinces, triennial, 2004–2006
Source: Statistics Belgium 2009.
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7.3 Efficiency of resource allocation 
In this section, the health system’s capacity to be innovative and to provide 
and maintain an appropriate infrastructure, including workforce, facilities and 
equipment, were investigated.
Concerning the maintenance of an adequate level of workforce, the number 
of medical and nursing graduates was analysed. Compared to neighbouring 
countries and to the EU15 average, the number of medical graduates per 100 000 
population was higher in Belgium (see Fig. 7.4). The number of nursing students 
increased from 19 314 to 23 069 between 2000 and 2007(Vlayen et al. 2010). 
Pacolet and Merckx (2006) also estimated the total number of nursing and 
midwifery graduates to be around 38 per 100 000 population in 2004, which 
is above the EU15 average of 30.4. However, it should be noted that these data 
include foreign students who return to their country of origin after graduating.
In terms of infrastructure, the number of acute care beds was higher in 
Belgium than the EU15 average (4.7 versus 4.0, respectively per 1000 population 
in 2006) (WHO Regional Office for Europe 2010) and decreased from 5.5 per 
1000 population in 1980 to 4.8 per 1000 population in 2008 (see Section 4.1.1 
Infrastructure).
To maintain the qualification level of physicians, an accreditation system 
was introduced, as explained in Section 2.6.2 Regulation of providers. However, 
the proportion of accredited specialists significantly decreased from 65.4% in 
2004 to 62.3% in 2008. The proportion of accredited GPs has remained stable 
around 68.7% in 2008 (Vlayen et al. 2010). 
In 2008, the proportion of recognized GPs having received an allowance 
for using approved software in their practice was 65% for GPs with more than 
500 contacts per year and 74% for GPs with more than 2500 contacts per year. 
The use of this software is moderate compared to other countries, such as the 
Netherlands, where this rate was estimated to be about 98%. It is nevertheless 
important to highlight the fact that not all GPs using software apply for the 
allowance (Vlayen et al. 2010).
Concerning health expenditure, total health expenditure as a percentage of 
the GDP is higher in Belgium compared to the EU15 average. Compared to 
neighbouring countries, expenditure is nevertheless lower than in France and 
Germany (see Section 3.1 Health expenditure) (OECD 2009a). However, caution 
is needed when comparing total health care expenditure between countries.
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Fig. 7.4 
Number of medical graduates per 100 000 population in Belgium and  
neighbouring countries
Source: OECD 2008 (June, for Belgium); OECD 2009a.
7.4 Technical efficiency
To study the efficiency with which the health system’s output is produced and 
to ensure that the resources are used to yield maximum benefits/results, two 
kinds of indicators were measured by the KCE report on performance: (1) the 
proportion of ambulatory and day care and (2) indicators on the organization 
of acute inpatient care (the use of minimally invasive techniques and of 
standardized processes, the hospital length of stay and the number of acute care 
bed days). These indicators were selected to examine potential savings in the 
Belgian health system through the use of day surgery, less expensive treatment 
alternatives and minimally invasive techniques.
Potential savings on bed occupancy and nursing care can be achieved by 
carrying out elective procedures as day cases. In Belgium, the percentage of 
surgical day cases among total surgical cases increased from 33.5% in 1999 
to 44.3% in 2006 and was above the EU15 average (average for countries with 
available data; see Fig. 7.5) (OECD 2009a).
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Fig. 7.5 
Evolution of surgical day case rate in Belgium and neighbouring countries, 1995–2007 
Source: OECD 2009a.
Note: French data were not available.
Concerning chronic dialysis, haemodialysis in hospital is more expensive 
than alternatives such as haemodialysis in satellite centres or home peritoneal 
dialysis. However, in Belgium the substitution of hospital haemodialysis by 
the less expensive alternatives is lower than in many other countries, although 
the proportion of patients on alternative dialysis modalities increased between 
2002 and 2007 (see Fig. 7.6).
The KCE report on performance also showed that the use of minimally 
invasive techniques for cholecystectomy and cardiac revascularization 
increased in Belgium. Moreover, protocols, guidelines and clinical pathways 
to standardize well-defined care processes are used by many institutions.
As shown in Section 4.1.1 Infrastructure, the average length of stay in 
hospital has been decreasing since 1980, although it is still above the EU15 
average. The number of acute bed days has also decreased but is higher than 
the EU15 average (see Fig. 7.7).
0%
10%
20%
30%
40%
50%
60%
EU15
Netherlands
Luxembourg
Germany
Belgium
2007200620052004200320022001200019991998199719961995
Health systems in transition  Belgium230
Fig. 7.6 
Number of patients under chronic dialysis in Belgium, 2002–2007
Source: Cleemput et al. 2010.
Notes: HD: Haemodialysis; PD: Peritoneal dialysis. 
Fig. 7.7 
Evolution of acute care bed days in Belgium and neighbouring countries, 1995–2007
Source: OECD 2009a.
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7.5 Quality of care
The KCE report on performance assessed the quality of the health system 
by measuring indicators subdivided into five sub-dimensions: effectiveness, 
appropriateness, safety, patient-centredness and continuity.
7.5.1 Effectiveness
Vaccination coverage of children in Belgium increased and was above 90% 
for all vaccines in 2007 (see Table 7.2). Compared to the EU27 average, 
vaccination coverage was slightly below the European average for measles 
and rubella, but was higher than the EU27 average for diphtheria, tetanus, 
pertussis, poliomyelitis and especially for hepatitis B and invasive disease due 
to Haemophilus influenzae type B. Moreover, as shown in Table 7.3, coverage 
for the complete vaccination (up to four doses) remains above 90% and is 
higher in the Flemish than in the French region. Influenza vaccination in the 
population over the age of 65 has remained relatively constant since 2000 and 
covered about 63% of this population group in 2006, which is similar to the 
EU15 average (62.5%).
The coverage of breast and cervical cancer screening has also increased since 
2000, but this increase was moderate compared to other European countries 
(see Table 7.4) (OECD 2009a; Vlayen et al. 2010). The coverage of cervical 
cancer screening is slightly higher than the European average (calculated for 
available countries), but was low compared to some countries, such as the United 
Kingdom and Finland where the coverage was 79.4% and 70.5%, respectively 
(OECD 2009a). No data are currently available on colorectal cancer screening.
Concerning health promotion indicators, a positive tendency can be shown, 
even if certain target groups need to be reached more accurately (see Section 5.1 
Public health; see also the KCE report on performance (Vlayen et al. 2010)). It 
should also be noted that the percentage of children aged under 18 years who 
went to the dentist for an annual check-up increased from 15.6% in 2002 to 
22% in 2007 but was moderate compared to other countries, such as in the 
Netherlands (55.1% for children aged 0–12 years and 64.7% for young people 
aged 12–18 years) (Vlayen et al. 2010; Westert et al. 2008). To increase this 
percentage, since May 2009 dental care is totally reimbursed for children up to 
18 years old (see Subsection Protection measures in Section 6.1.1 Increasing 
accessibility).
Health systems in transition  Belgium232
Table 7.2
Vaccination coverage (% of children), 2007
 
Diphtheria-
tetanus-pertussis
Measles- 
mumps-rubella Meningococcus Poliomyelitis Hepatitis B
Invasive 
disease due to 
Haemophilus 
influenzae 
type b
EU27 94.7 93.0 N/A 95.8 82.7 90.5
EU15 93.6 91.5 N/A 94.9 N/A 90.2
Belgium 98.5 91.9 93.3 98.7 97.5 98.0
Source: WHO Regional Office for Europe 2010; and for Belgium: raw data provided by IPH.
Note: N/A: Not available.
Table 7.3
Vaccination coverage in the French (2009 data) and Flemish (2008 data) communities 
per dose (% of children aged 18–24 months)
 
Diphtheria-
tetanus-pertussis
Measles- 
mumps-rubella Meningococcus Poliomyelitis Hepatitis B
Invasive 
disease due to 
Haemophilus 
influenzae 
type b
French community
Dose 1 100.0 92.4 91.2 99.6 98.8 99.0
Dose 2 100.0 – – 99.6 98.8 99.0
Dose 3 98.6 – – 98.0 96.9 97.5
Dose 4 90.6 – – 90.4 90.4 90.2
Flemish community
Dose 1 99.3 96.6 95.6 99.7 99.0 99.1
Dose 2 98.6 – – 98.8 98.3 98.4
Dose 3 98.3 – – 98.5 98.0 98.1
Dose 4 95.2 – – 95.3 95.1 95.2
Source: Robert and Swennen 2009.
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Table 7.4 
Population coverage of breast and cervical cancer screening, 2000–2006
 2000 2001 2002 2003 2004 2005 2006
Coverage of breast cancer screening*  
(% females aged 50–69)
 Belgium – 43.0 – 54.0 – 57.0 –
 EU15 69.4 66.9 72.3 71.3 72.8 70.9 68.0
Coverage of cervical cancer screening  
(% females aged 20–69)
 Belgium 59.5 63.2 61.0 61.0 63.1 62.2 65.3
 EU15 61.5 63.4 63.7 65.0 59.2 60.1 59.6
Source: OECD 2009a.
Note: *Total mammogram coverage for woman aged 50–69 including both mammotests (National Breast Cancer Screening Programme) 
and other mammograms (opportunistic cancer screening). For regional differences, see Subsection Differences in the use of care in 
Section 7.2.2 Equity in provision of services. 
Concerning the effectiveness of curative care, the KCE report on performance 
tried to measure five-year cancer survival and infant mortality. However, data 
for five-year cancer survival was not available at a national level. The more 
recent Belgian cancer mortality data concerned the year 2004 (one-year 
incidence). In this year, the three most important cancers were lung cancer 
(4828 deaths), colorectal cancer (1453 deaths) and prostate cancer (1377 deaths) 
for males, and breast cancer (2286 deaths), colorectal cancer (1388 deaths) and 
lung cancer (1274 deaths) for females (Belgian Cancer Registry 2008). More 
recent data are available in the Flemish region (2007 data, one-year incidence) 
and showed similar results (Vlaams Agentschap Zorg en Gezondheid 2010f). 
Infant mortality data between 1998 and 2006 were only available for the 
Flemish and Brussels-Capital regions (no national data). Infant mortality in 
these regions has decreased since 1998 and is around the EU15 average in 2006 
(EU15 average: 3.6/1000 live births; Flanders: 4.2/1000 live births; Brussels-
Capital: 3.7/1000 live births) (Brussels-Capital Health and Social Observatory 
2010; OECD 2009a; Vlaams Agentschap Zorg en Gezondheid 2010g).
The KCE report also assessed in-hospital mortality for two clinical 
conditions: hip fracture and community-acquired pneumonia. Even if the risk of 
mortality after these two interventions for these conditions has decreased since 
2004, the rates are higher than those reported in the United States (hip fracture: 
7.5% versus 3.01% in 2007; community-acquired pneumonia: 13.6% versus 
5.49% in 2007) (see Table 7.5) (AHRQ 2007; FPS Health, Food Chain Safety 
and Environment 2008d). More in-depth analysis with adequate risk-adjustment 
Health systems in transition  Belgium234
is needed to explain these differences. To better measure the effectiveness of 
curative care, more recent mortality data are needed5 and in-hospital mortality 
rates for other conditions should also be examined.
Table 7.5 
In-hospital mortality (%) after hip fracture and community-acquired pneumonia, 
2004–2007
 2004 2005 2006 2007
Hip fracture 15.2 13.9 14.5 13.6
Community-acquired pneumonia 7.8 7.7 7.4 7.5
Source: FPS Health, Food Chain Safety and Environment 2008d.
7.5.2 Appropriateness
Previous reports showed differences in practice for rectal cancer, pre-operative 
investigations, the use of antibiotics and antihypertensive agents, and prenatal 
care (NIHDI 2010f; Vlayen et al. 2008). 
The KCE report also showed an increase in medical radiation exposure from 
2.15 mSv per capita in 2005 to 2.42 mSv per capita in 2008, despite national 
guidelines which stressed the need to reduce medical radiation exposure by 
promoting the use of newer technologies requiring less irradiation. As described 
in Section 4.1.3 Medical equipment, Belgium has a high radiation exposure 
compared to other European countries. The published guidelines should thus 
ideally be accompanied by strategies to implement these guidelines (Health 
Protection Agency 2008; NIHDI 2009h; Vlayen et al. 2010).
Concerning the use of minimally invasive techniques, the rate of 
laparoscopic cholecystectomies and the rate of percutaneous transluminal 
coronary angioplasty (PTCA) increased in Belgium and were in line with the 
European average.
The rate of caesarean sections also increased but was below the EU15 
average. Additionally, although the rate of hysterectomies in Belgium decreased 
between 2001 and 2007, this rate was high compared to the European average 
(see Table 7.6) (OECD 2009a; Vlayen et al. 2010).
5 These data will be available again in the near future.
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Table 7.6 
Data on appropriateness of care, 2000–2006
2000 2001 2002 2003 2004 2005 2006
Laparoscopic cholecystectomies (% of total cholecystectomies)
Belgium 81.8 82.8 84.5 85.3 85.6 86.6 86.8
EU15 76.3 78.9 79.7 82.0 86.5 91.7 82.2
PTCA (% of total revascularization procedures : PTCA and coronary artery bypass graft)
Belgium – – 67.6 – 73.5 75.1 76.3
EU15 62.9 63.6 65.7 69.5 74.0 75.6 76.5
Number of caesarean sections per 1000 live births
Belgium 158 174 182 188 188 193 199
EU15 195 208 218 225 236 236 243
Hysterectomies per 100 000 females (inpatient)
Belgium 150 160 166 164 164 158 152
EU15 119 116 117 115 114 125 113
Sources: OECD 2009a; Vlayen et al. 2010.
7.5.3 Safety
The National Surveillance of Infections in Hospitals (NSIH), a section of the 
IPH, is an important source of data for inpatient safety. Inpatient safety can 
be considered as relatively good in Belgium. The incidence of nosocomial 
MRSA infections peaked in 2004 at 3.25 per 1000 admissions and decreased 
to 2 per 1000 admissions in 2008. Recommendations on the control of MRSA 
(since 2003), the national hand hygiene campaigns and the rationalization of 
the use of antibiotics are possible explanations for this decrease. The incidence 
of nosocomial septicaemia also decreased between 2005 and 2008 (7.2 and 
6.1 infections per 1000 admissions, respectively). The evolution of nosocomial 
multi-resistant enterobacter aerogenes was also positive. The incidence rate 
of blood transfusions with adverse effects decreased from 0.0147 per 1000 
discharges in 2004 to 0.0096 per 1000 discharges in 2005 (compared to the 
United States rate of 0.004 per 1000 discharges in 2007) (Vlayen et al. 2010; 
NSIH 2010a; NSIH 2010b; AHRQ 2008).
Nevertheless, according to HELICS data, the incidence of infections 
acquired at intensive care units in Belgium is similar to other European 
countries. However, these data showed that in 2004, except after laminectomy, 
Belgium had a high cumulative incidence of post-operative surgical site 
infections compared to other countries, especially after hip replacement, 
cholecystectomy and colon surgery (see Fig. 7.8) (HELICS 2006).
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Fig. 7.8 
Cumulative incidence of post-operative surgical site infection in Belgium and 
neighbouring countries, 2004
Source: HELICS 2006.
Fig. 7.9 
Antibiotics (ATC J01) prescribed in Belgium and neighbouring countries  
(DDD/1000 inhabitants/day), 2000–2007
Source: OECD 2009a.
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The inpatient incidence of decubitus ulcers also increased from 14.9 per 
1000 discharges in 2004 to 16.3 in 2005 (compared to the United States rate of 
25.1 per 1000 discharges in 2007) (Vlayen et al. 2010; AHRQ 2008).
Concerning antibiotics consumption, Belgian rates (together with France and 
Luxembourg) were high compared to the European average, with a decreasing 
trend between 1998 and 2004, and an increase after 2004 (see Fig. 7.9).
Moreover, as described in Section 7.4 Technical efficiency, a clear shift 
from inpatient care to outpatient and day care can be observed. The average 
length of stay in acute hospitals has decreased in recent years but remains 
about one day longer than the EU27 average in 2008 (7.8 versus 6.7) (WHO 
Regional Office for Europe 2010). The coordination of care may be one of the 
explanatory factors of this decrease (besides others factors such as the financing 
of the system). General data on patient-centredness was not analysed because 
of difficulties with finding appropriate indicators.
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8. Conclusions 1
Belgium currently enjoys qualitatively good health care. Patients have the freedom to choose their sickness fund, health care provider and health care institution. Waiting lists are not considered to be a problem 
in Belgian hospitals as they are in other European countries. The compulsory 
health insurance offers general coverage of health risks and guarantees wide 
access to care. Moreover, for more vulnerable population groups, several 
measures have been put in place to ensure their access to high-quality care. 
Voluntary health insurance has only a limited and mainly additional role. These 
features explain to a significant degree the population’s satisfaction with the 
organization of health care in Belgium. 
The growth in health expenditure in Belgium attained a yearly average real 
growth of 4.4% from 2000 to 2007 and is similar to that in other western 
European countries. To a large extent, the evolution of the budget over recent 
years was due to an explicit choice made by the government. After years of 
adhering to economic limits to meet the budgetary requirements of the EU 
Treaty of Maastricht, the real growth norm of 1.5% was raised to 2.5% in the 
period 2000–2003 and to 4.5% since 2004.
Several factors will continue to put pressure on health expenditure, such 
as the evolution of medical technology and drug innovations, increasing 
population expectations for new and rapidly available treatments, financial 
remuneration of health care providers and an ageing population, consequently 
providing a need for structural changes in the Belgian health system. Indeed, on 
the basis of the expected evolution of demographic as well as non-demographic 
effects, public expenditure on health is expected to rise from 7.3% of GDP in 
2008 to 11.5% in 2060, including an increase for long-term care from 1.2% in 
2008 to 2.8% in 2060 (Conseil supérieur des finances – Comité d’étude sur le 
vieillissement, 2009). 
1 This chapter was written by Sophie Gerkens, Maria Isabel Farfan and Anja Desomer.
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The challenge for the future of the Belgian health system will be to ensure 
the efficiency and performance of the health system at a sustainable cost. Public 
authorities will have to continue to promote the objectives of accessibility, 
quality and sustainability. The reforms that will be carried out in the coming 
years will probably build further on previous achievements and recent reforms. 
Further changes will also aim at simplifying the system in order to make it 
more homogeneous. 
A final consideration will be what role the EU will play in the design 
and strengthening of future health systems. A great challenge will be the 
maintenance of a system mainly based on solidarity in an increasingly global 
world. However, stimulating cross-border collaboration and supporting the 
sharing of resources and experiences could provide an additional asset to health 
systems for improving their overall performance.
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9.2 Useful web sites
Federal government
Belgian Commission for the Coordination of Antibiotic Policy:  
http://www.health.belgium.be/eportal/Myhealth/Care/Properuse/Antibiotics/
index.htm
Belgian Health Care Knowledge Centre:  
http://www.kce.fgov.be
Cabinet of the Minister of Social Affairs and Public Health:  
http://www.laurette-onkelinx.be 
Crossroads Bank for Social Security:  
http://www.ksz-bcss.fgov.be
eHealth Platform:  
https://www.ehealth.fgov.be
Federal Agency for Medicines and Health Products:  
http://www.fagg-afmps.be/
Federal Parliament:  
http://www.dekamer.be and http://www.senate.be
Federal Planning Bureau:  
http://www.plan.be
Federal Portal:  
http://www.belgium.be
Federal Public Service Economy, SMEs, Self-employed and Energy:  
http://economie.fgov.be
Federal Public Service Health, Food Chain Safety and Environment:  
http://www.health.fgov.be
Federal Public Service Justice:  
http://www.just.fgov.be
Federal Public Service Social Security:  
http://www.socialsecurity.fgov.be
Institute of National Accounts:  
http://www.inr-icn.fgov.be
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Intermutualistic Agency:  
http://www.nic-ima.be
National Bank of Belgium:  
http://www.nbb.be
National Institute for Sickness and Disability Insurance:  
http://www.inami.fgov.be
National Social Economic Database Belgostat:  
http://www.belgostat.be
National Social Security Office:  
http://www.onssrszlss.fgov.be
Scientific Institute of Public Health:  
http://www.iph.fgov.be
Statistics Belgium:  
http://www.statbel.fgov.be
Superior Health Council:  
http://www.health.fgov.be/CSH_HGR
Technical Cell for the Management of Clinical and Financial Data:  
https://tct.fgov.be/etct/
Flemish community
Child and Family, Flemish Public Institution for Well-being of Children:  
http://www.kindengezin.be
Flemish Care and Health Agency:  
http://www.zorg-en-gezondheid.be
Flemish Health Council:  
http://www.wvc.vlaanderen.be/vgr
Flemish Institute for Health Promotion:  
http://www.vigez.be
Flemish Patient Platform:  
http://www.vlaamspatientenplatform.be
Legislation Flemish community and region:  
http://www.juriwel.be/
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French community
Appui en Promotion et Education pour la Santé, Université de Liège:  
http://www.apes.be
Association of Health Service Users (French-speaking):  
http://www.luss.be
Birth and Child Office of the French community:  
http://www.one.be
Directorate-General of Health for the French community:  
http://www.sante.cfwb.be
Institut de recherche santé et société (IRSS), Université Catholique 
de Louvain:  
http://www.uclouvain.be/322972.html
Legislation French community and Walloon region:  
http://www.wallex.wallonie.be
Question Santé:  
http://www.questionsante.org
Unité d’Education pour la Santé, Université Catholique de Louvain:  
http://www.md.ucl.ac.be/entites/esp/reso
Unité de Promotion Education Santé, Université Libre de Bruxelles:  
http://www.ulb.ac.be/esp/promes
Walloon Directorate-General of Social Action and Health:  
http://spw.wallonie.be/?q=dgo5
Walloon Institute for Mental Health:  
http://www.iwsm.be
Other
Association of Public Care Institutions:  
http://www.vov-info.be
Belgian Centre for Evidence-Based Medicine:  
http://www.cebam.be
Belgian Centre for Pharmaco-therapeutic Information:  
http://www.bcfi.be
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Belgian Dutch Clinical Pathway Network:  
http://www.nkp.be
Belgian Hospital Association:  
http://www.hospitals.be
Belgian Pharmaceutical Industry Association:  
http://www.pharma.be
Belgian Privacy Commission:  
http://www.privacycommission.be
Brussels-Capital region:  
http://www.bruxelles.irisnet.be/
CareNet:  
http://www.carenet.be
Care Pathways:  
http://www.zorgtraject.be
Centre for Health Services and Nursing Research:  
http://www.czv.kuleuven.be
Centre for Independent Information on Pharmaceuticals:  
http://www.farmaka.be
Centre for Research and Information of Organizations of Consumers 
(CRIOC):  
http://www.oivo-crioc.org
Centre of Expertise on Dementia:  
http://www.dementie.be
Christian Association of Sickness Funds:  
http://www.cm.be
Council of University Hospitals:  
http://www.univ-hospitals.be
Domus Medica (Dutch-speaking GPs):  
http://www.domusmedica.be
Federation of Centres for Ambulatory Rehabilitation:  
http://www.revalidatie.be
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Flemish Association of Care Institutions:  
http://www.zorgnetvlaanderen.be 
Foundation against Cancer:  
http://www.cancer.be
French-speaking Association of Care Institutions:  
http://www.afis.be
French-speaking Association of Nurses in Emergency:  
http://www.afiu.be
German-speaking community:  
http://www.dglive.be
Higher Institute of Labour Studies:  
http://www.hiva.be
Independent Association of Sickness Funds:  
http://www.mloz.be
Liberal Association of Sickness Funds:  
http://www.mut400.be
Neutral Association of Sickness Funds:  
http://www.mutualites-neutres.be
Observatory of Health and Welfare Brussels:  
http://www.observatbru.be
Order of Physicians:  
http://www.ordomedic.be
Professional Union of Insurance Companies:  
http://www.assuralia.be
Psychiatric Minimum Data Set:  
http://www.uhasselt.be/mpg
Scientific Organization of General Practitioners (French-speaking GPs):  
http://www.ssmg.be
Socialist Association of Sickness Funds:  
http://www.fsmb.be
Test-Achats:  
http://www.test-achats.be
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9.3 HiT methodology and production process
The Health Systems in Transition (HiT) profiles are produced by country 
experts in collaboration with the Observatory’s research directors and staff. 
The profiles are based on a template that, revised periodically, provides detailed 
guidelines and specific questions, definitions, suggestions for data sources and 
examples needed to compile HiTs. While the template offers a comprehensive 
set of questions, it is intended to be used in a flexible way to allow authors and 
editors to adapt it to their particular national context. 
Authors draw on multiple data sources for the compilation of HiT profiles, 
ranging from national statistics, national and regional policy documents, 
and published literature. Furthermore, international data sources may be 
incorporated, such as those of the Organisation for Economic Co-operation and 
Development (OECD) and the World Bank. The OECD health data contain over 
1200 indicators for the 31 OECD countries. Data are drawn from information 
collected by national statistical bureaux and health ministries. The World Bank 
provides World Development Indicators, which also rely on official sources.
In addition to the information and data provided by the country experts, 
the Observatory supplies quantitative data in the form of a set of standard 
comparative figures for each country, drawing on the European Health for 
All (HFA) database. The Health for All database contains more than 600 
indicators defined by the WHO Regional Office for Europe for the purpose of 
monitoring Health for All policies in Europe. It is updated for distribution twice 
a year from various sources, relying largely upon official figures provided by 
governments, as well as health statistics collected by the technical units of the 
WHO Regional Office for Europe. The standard Health for All data have been 
officially approved by national governments. With its January 2010 edition, the 
Health for All database started to take account of the enlarged European Union 
(EU) of 27 Member States.
HiT authors are encouraged to discuss the data in the text in detail, including 
the standard figures prepared by the Observatory staff, especially if there are 
concerns about discrepancies between the data available from different sources.
A typical HiT profile consists of 10 chapters.
1 Introduction: outlines the broader context of the health system, including 
geography and sociodemography, economic and political context, and 
population health.
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2 Organizational structure: provides an overview of how the health 
system in the country is organized and outlines the main actors and 
their decision-making powers; discusses the historical background 
for the system; and describes the level of patient empowerment in the 
areas of information, rights, choice, complaints procedures, safety 
and involvement.
3 Financing: provides information on the level of expenditure, who is 
covered, what benefits are covered, the sources of health care finance, 
how resources are pooled and allocated, the main areas of expenditure, 
and how providers are paid.
4 Regulation and planning: addresses the process of policy development, 
establishing goals and priorities; deals with questions about relationships 
between institutional actors, with specific emphasis on their role in 
regulation and what aspects are subject to regulation; and describes the 
process of health technology assessment and research and development.
5 Physical and human resources: deals with the planning and distribution 
of infrastructure and capital stock; the context in which information 
technology systems operate; and human resource input into the health 
system, including information on registration, training, trends and 
career paths.
6 Provision of services: concentrates on patient flows, organization and 
delivery of services, addressing public health, primary and secondary 
health care, emergency and day care, rehabilitation, pharmaceutical care, 
long-term care, services for informal carers, palliative care, mental health 
care, dental care, complementary and alternative medicine, and health 
care for specific populations.
7 Principal health care reforms: reviews reforms, policies and organizational 
changes that have had a substantial impact on health care.
8 Assessment of the health system: provides an assessment based on 
the stated objectives of the health system, the distribution of costs and 
benefits across the population, efficiency of resource allocation, technical 
efficiency in health care production, quality of care, and contribution of 
health care to health improvement.
9 Conclusions: highlights the lessons learned from health system changes; 
summarizes remaining challenges and future prospects.
10 Appendices: includes references, useful web sites and legislation.
Health systems in transition  Belgium 265
The quality of HiTs is of real importance since they inform policy-making 
and meta-analysis. HiTs are the subject of wide consultation throughout the 
writing and editing process, which involves multiple iterations. They are then 
subject to the following:
• A rigorous review process (see the following section).
• There are further efforts to ensure quality while the profile is finalized 
that focus on copy-editing and proofreading.
• HiTs are disseminated (hard copies, electronic publication, translations 
and launches). The editor supports the authors throughout the production 
process and in close consultation with the authors ensures that all stages 
of the process are taken forward as effectively as possible.
One of the authors is also a member of the Observatory staff team and they 
are responsible for supporting the other authors throughout the writing and 
production process. They consult closely to ensure that all stages of the process 
are as effective as possible and that the HiTs meet the series standard and can 
support both national decision-making and comparisons across countries.
9.4 The review process
This consists of three stages. Initially the text of the HiT is checked, reviewed 
and approved by the research directors of the European Observatory. The HiT 
is then sent for review to two independent academic experts and their comments 
and amendments are incorporated into the text, and modifications are made 
accordingly. The text is then submitted to the relevant ministry of health, or 
appropriate authority, and policy-makers within those bodies are restricted to 
checking for factual errors within the HiT.
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